00001;WHAT ARE THE EFFECTS OF CALCIUM ON THE PHYSICAL PROPERTIES OF MUCUS FROM CF PATIENTS?;139;1222
00001;WHAT ARE THE EFFECTS OF CALCIUM ON THE PHYSICAL PROPERTIES OF MUCUS FROM CF PATIENTS?;151;2211
00001;WHAT ARE THE EFFECTS OF CALCIUM ON THE PHYSICAL PROPERTIES OF MUCUS FROM CF PATIENTS?;166;0001
00001;WHAT ARE THE EFFECTS OF CALCIUM ON THE PHYSICAL PROPERTIES OF MUCUS FROM CF PATIENTS?;311;0001
00001;WHAT ARE THE EFFECTS OF CALCIUM ON THE PHYSICAL PROPERTIES OF MUCUS FROM CF PATIENTS?;370;1010
00001;WHAT ARE THE EFFECTS OF CALCIUM ON THE PHYSICAL PROPERTIES OF MUCUS FROM CF PATIENTS?;392;0001
00001;WHAT ARE THE EFFECTS OF CALCIUM ON THE PHYSICAL PROPERTIES OF MUCUS FROM CF PATIENTS?;439;0001
00001;WHAT ARE THE EFFECTS OF CALCIUM ON THE PHYSICAL PROPERTIES OF MUCUS FROM CF PATIENTS?;440;0011
00001;WHAT ARE THE EFFECTS OF CALCIUM ON THE PHYSICAL PROPERTIES OF MUCUS FROM CF PATIENTS?;441;2122
00001;WHAT ARE THE EFFECTS OF CALCIUM ON THE PHYSICAL PROPERTIES OF MUCUS FROM CF PATIENTS?;454;0100
00001;WHAT ARE THE EFFECTS OF CALCIUM ON THE PHYSICAL PROPERTIES OF MUCUS FROM CF PATIENTS?;461;1121
00001;WHAT ARE THE EFFECTS OF CALCIUM ON THE PHYSICAL PROPERTIES OF MUCUS FROM CF PATIENTS?;502;0002
00001;WHAT ARE THE EFFECTS OF CALCIUM ON THE PHYSICAL PROPERTIES OF MUCUS FROM CF PATIENTS?;503;1000
00001;WHAT ARE THE EFFECTS OF CALCIUM ON THE PHYSICAL PROPERTIES OF MUCUS FROM CF PATIENTS?;505;0001
00001;WHAT ARE THE EFFECTS OF CALCIUM ON THE PHYSICAL PROPERTIES OF MUCUS FROM CF PATIENTS?;520;1010
00001;WHAT ARE THE EFFECTS OF CALCIUM ON THE PHYSICAL PROPERTIES OF MUCUS FROM CF PATIENTS?;522;0001
00001;WHAT ARE THE EFFECTS OF CALCIUM ON THE PHYSICAL PROPERTIES OF MUCUS FROM CF PATIENTS?;526;1011
00001;WHAT ARE THE EFFECTS OF CALCIUM ON THE PHYSICAL PROPERTIES OF MUCUS FROM CF PATIENTS?;527;1001
00001;WHAT ARE THE EFFECTS OF CALCIUM ON THE PHYSICAL PROPERTIES OF MUCUS FROM CF PATIENTS?;533;2222
00001;WHAT ARE THE EFFECTS OF CALCIUM ON THE PHYSICAL PROPERTIES OF MUCUS FROM CF PATIENTS?;593;1000
00001;WHAT ARE THE EFFECTS OF CALCIUM ON THE PHYSICAL PROPERTIES OF MUCUS FROM CF PATIENTS?;619;0001
00001;WHAT ARE THE EFFECTS OF CALCIUM ON THE PHYSICAL PROPERTIES OF MUCUS FROM CF PATIENTS?;737;0100
00001;WHAT ARE THE EFFECTS OF CALCIUM ON THE PHYSICAL PROPERTIES OF MUCUS FROM CF PATIENTS?;742;0100
00001;WHAT ARE THE EFFECTS OF CALCIUM ON THE PHYSICAL PROPERTIES OF MUCUS FROM CF PATIENTS?;789;0001
00001;WHAT ARE THE EFFECTS OF CALCIUM ON THE PHYSICAL PROPERTIES OF MUCUS FROM CF PATIENTS?;827;0010
00001;WHAT ARE THE EFFECTS OF CALCIUM ON THE PHYSICAL PROPERTIES OF MUCUS FROM CF PATIENTS?;835;0001
00001;WHAT ARE THE EFFECTS OF CALCIUM ON THE PHYSICAL PROPERTIES OF MUCUS FROM CF PATIENTS?;861;0001
00001;WHAT ARE THE EFFECTS OF CALCIUM ON THE PHYSICAL PROPERTIES OF MUCUS FROM CF PATIENTS?;875;1121
00001;WHAT ARE THE EFFECTS OF CALCIUM ON THE PHYSICAL PROPERTIES OF MUCUS FROM CF PATIENTS?;891;0001
00001;WHAT ARE THE EFFECTS OF CALCIUM ON THE PHYSICAL PROPERTIES OF MUCUS FROM CF PATIENTS?;921;1010
00001;WHAT ARE THE EFFECTS OF CALCIUM ON THE PHYSICAL PROPERTIES OF MUCUS FROM CF PATIENTS?;922;1010
00001;WHAT ARE THE EFFECTS OF CALCIUM ON THE PHYSICAL PROPERTIES OF MUCUS FROM CF PATIENTS?;1175;0100
00001;WHAT ARE THE EFFECTS OF CALCIUM ON THE PHYSICAL PROPERTIES OF MUCUS FROM CF PATIENTS?;1185;0001
00001;WHAT ARE THE EFFECTS OF CALCIUM ON THE PHYSICAL PROPERTIES OF MUCUS FROM CF PATIENTS?;1222;0001
00002;CAN ONE DISTINGUISH BETWEEN THE EFFECTS OF MUCUS HYPERSECRETION AND INFECTION ON THE SUBMUCOSAL GLANDS OF THE RESPIRATORY TRACT IN CF?;169;1000
00002;CAN ONE DISTINGUISH BETWEEN THE EFFECTS OF MUCUS HYPERSECRETION AND INFECTION ON THE SUBMUCOSAL GLANDS OF THE RESPIRATORY TRACT IN CF?;434;1001
00002;CAN ONE DISTINGUISH BETWEEN THE EFFECTS OF MUCUS HYPERSECRETION AND INFECTION ON THE SUBMUCOSAL GLANDS OF THE RESPIRATORY TRACT IN CF?;454;0100
00002;CAN ONE DISTINGUISH BETWEEN THE EFFECTS OF MUCUS HYPERSECRETION AND INFECTION ON THE SUBMUCOSAL GLANDS OF THE RESPIRATORY TRACT IN CF?;498;1000
00002;CAN ONE DISTINGUISH BETWEEN THE EFFECTS OF MUCUS HYPERSECRETION AND INFECTION ON THE SUBMUCOSAL GLANDS OF THE RESPIRATORY TRACT IN CF?;499;1000
00002;CAN ONE DISTINGUISH BETWEEN THE EFFECTS OF MUCUS HYPERSECRETION AND INFECTION ON THE SUBMUCOSAL GLANDS OF THE RESPIRATORY TRACT IN CF?;592;0002
00002;CAN ONE DISTINGUISH BETWEEN THE EFFECTS OF MUCUS HYPERSECRETION AND INFECTION ON THE SUBMUCOSAL GLANDS OF THE RESPIRATORY TRACT IN CF?;875;1011
00003;HOW ARE SALIVARY GLYCOPROTEINS FROM CF PATIENTS DIFFERENT FROM THOSE OF NORMAL SUBJECTS?;23;1000
00003;HOW ARE SALIVARY GLYCOPROTEINS FROM CF PATIENTS DIFFERENT FROM THOSE OF NORMAL SUBJECTS?;40;0010
00003;HOW ARE SALIVARY GLYCOPROTEINS FROM CF PATIENTS DIFFERENT FROM THOSE OF NORMAL SUBJECTS?;139;2122
00003;HOW ARE SALIVARY GLYCOPROTEINS FROM CF PATIENTS DIFFERENT FROM THOSE OF NORMAL SUBJECTS?;190;0001
00003;HOW ARE SALIVARY GLYCOPROTEINS FROM CF PATIENTS DIFFERENT FROM THOSE OF NORMAL SUBJECTS?;221;0001
00003;HOW ARE SALIVARY GLYCOPROTEINS FROM CF PATIENTS DIFFERENT FROM THOSE OF NORMAL SUBJECTS?;246;0001
00003;HOW ARE SALIVARY GLYCOPROTEINS FROM CF PATIENTS DIFFERENT FROM THOSE OF NORMAL SUBJECTS?;309;1000
00003;HOW ARE SALIVARY GLYCOPROTEINS FROM CF PATIENTS DIFFERENT FROM THOSE OF NORMAL SUBJECTS?;311;0011
00003;HOW ARE SALIVARY GLYCOPROTEINS FROM CF PATIENTS DIFFERENT FROM THOSE OF NORMAL SUBJECTS?;325;0001
00003;HOW ARE SALIVARY GLYCOPROTEINS FROM CF PATIENTS DIFFERENT FROM THOSE OF NORMAL SUBJECTS?;345;0010
00003;HOW ARE SALIVARY GLYCOPROTEINS FROM CF PATIENTS DIFFERENT FROM THOSE OF NORMAL SUBJECTS?;347;0010
00003;HOW ARE SALIVARY GLYCOPROTEINS FROM CF PATIENTS DIFFERENT FROM THOSE OF NORMAL SUBJECTS?;356;0010
00003;HOW ARE SALIVARY GLYCOPROTEINS FROM CF PATIENTS DIFFERENT FROM THOSE OF NORMAL SUBJECTS?;370;1001
00003;HOW ARE SALIVARY GLYCOPROTEINS FROM CF PATIENTS DIFFERENT FROM THOSE OF NORMAL SUBJECTS?;374;0001
00003;HOW ARE SALIVARY GLYCOPROTEINS FROM CF PATIENTS DIFFERENT FROM THOSE OF NORMAL SUBJECTS?;375;2221
00003;HOW ARE SALIVARY GLYCOPROTEINS FROM CF PATIENTS DIFFERENT FROM THOSE OF NORMAL SUBJECTS?;439;0001
00003;HOW ARE SALIVARY GLYCOPROTEINS FROM CF PATIENTS DIFFERENT FROM THOSE OF NORMAL SUBJECTS?;440;1120
00003;HOW ARE SALIVARY GLYCOPROTEINS FROM CF PATIENTS DIFFERENT FROM THOSE OF NORMAL SUBJECTS?;454;1220
00003;HOW ARE SALIVARY GLYCOPROTEINS FROM CF PATIENTS DIFFERENT FROM THOSE OF NORMAL SUBJECTS?;515;1000
00003;HOW ARE SALIVARY GLYCOPROTEINS FROM CF PATIENTS DIFFERENT FROM THOSE OF NORMAL SUBJECTS?;520;0010
00003;HOW ARE SALIVARY GLYCOPROTEINS FROM CF PATIENTS DIFFERENT FROM THOSE OF NORMAL SUBJECTS?;524;0010
00003;HOW ARE SALIVARY GLYCOPROTEINS FROM CF PATIENTS DIFFERENT FROM THOSE OF NORMAL SUBJECTS?;526;1010
00003;HOW ARE SALIVARY GLYCOPROTEINS FROM CF PATIENTS DIFFERENT FROM THOSE OF NORMAL SUBJECTS?;527;1220
00003;HOW ARE SALIVARY GLYCOPROTEINS FROM CF PATIENTS DIFFERENT FROM THOSE OF NORMAL SUBJECTS?;533;0001
00003;HOW ARE SALIVARY GLYCOPROTEINS FROM CF PATIENTS DIFFERENT FROM THOSE OF NORMAL SUBJECTS?;535;0010
00003;HOW ARE SALIVARY GLYCOPROTEINS FROM CF PATIENTS DIFFERENT FROM THOSE OF NORMAL SUBJECTS?;560;0010
00003;HOW ARE SALIVARY GLYCOPROTEINS FROM CF PATIENTS DIFFERENT FROM THOSE OF NORMAL SUBJECTS?;561;0001
00003;HOW ARE SALIVARY GLYCOPROTEINS FROM CF PATIENTS DIFFERENT FROM THOSE OF NORMAL SUBJECTS?;571;0010
00003;HOW ARE SALIVARY GLYCOPROTEINS FROM CF PATIENTS DIFFERENT FROM THOSE OF NORMAL SUBJECTS?;584;0010
00003;HOW ARE SALIVARY GLYCOPROTEINS FROM CF PATIENTS DIFFERENT FROM THOSE OF NORMAL SUBJECTS?;604;0002
00003;HOW ARE SALIVARY GLYCOPROTEINS FROM CF PATIENTS DIFFERENT FROM THOSE OF NORMAL SUBJECTS?;623;0010
00003;HOW ARE SALIVARY GLYCOPROTEINS FROM CF PATIENTS DIFFERENT FROM THOSE OF NORMAL SUBJECTS?;633;2222
00003;HOW ARE SALIVARY GLYCOPROTEINS FROM CF PATIENTS DIFFERENT FROM THOSE OF NORMAL SUBJECTS?;733;1000
00003;HOW ARE SALIVARY GLYCOPROTEINS FROM CF PATIENTS DIFFERENT FROM THOSE OF NORMAL SUBJECTS?;742;1010
00003;HOW ARE SALIVARY GLYCOPROTEINS FROM CF PATIENTS DIFFERENT FROM THOSE OF NORMAL SUBJECTS?;854;0100
00003;HOW ARE SALIVARY GLYCOPROTEINS FROM CF PATIENTS DIFFERENT FROM THOSE OF NORMAL SUBJECTS?;856;2112
00003;HOW ARE SALIVARY GLYCOPROTEINS FROM CF PATIENTS DIFFERENT FROM THOSE OF NORMAL SUBJECTS?;950;0010
00003;HOW ARE SALIVARY GLYCOPROTEINS FROM CF PATIENTS DIFFERENT FROM THOSE OF NORMAL SUBJECTS?;967;0001
00003;HOW ARE SALIVARY GLYCOPROTEINS FROM CF PATIENTS DIFFERENT FROM THOSE OF NORMAL SUBJECTS?;1144;1111
00003;HOW ARE SALIVARY GLYCOPROTEINS FROM CF PATIENTS DIFFERENT FROM THOSE OF NORMAL SUBJECTS?;1161;0001
00003;HOW ARE SALIVARY GLYCOPROTEINS FROM CF PATIENTS DIFFERENT FROM THOSE OF NORMAL SUBJECTS?;1172;1000
00003;HOW ARE SALIVARY GLYCOPROTEINS FROM CF PATIENTS DIFFERENT FROM THOSE OF NORMAL SUBJECTS?;1175;0001
00003;HOW ARE SALIVARY GLYCOPROTEINS FROM CF PATIENTS DIFFERENT FROM THOSE OF NORMAL SUBJECTS?;1196;0002
00004;WHAT IS THE LIPID COMPOSITION OF CF RESPIRATORY SECRETIONS?;503;0001
00004;WHAT IS THE LIPID COMPOSITION OF CF RESPIRATORY SECRETIONS?;538;0100
00004;WHAT IS THE LIPID COMPOSITION OF CF RESPIRATORY SECRETIONS?;539;0100
00004;WHAT IS THE LIPID COMPOSITION OF CF RESPIRATORY SECRETIONS?;540;0100
00004;WHAT IS THE LIPID COMPOSITION OF CF RESPIRATORY SECRETIONS?;553;0001
00004;WHAT IS THE LIPID COMPOSITION OF CF RESPIRATORY SECRETIONS?;604;2222
00004;WHAT IS THE LIPID COMPOSITION OF CF RESPIRATORY SECRETIONS?;669;1010
00004;WHAT IS THE LIPID COMPOSITION OF CF RESPIRATORY SECRETIONS?;711;2122
00004;WHAT IS THE LIPID COMPOSITION OF CF RESPIRATORY SECRETIONS?;876;2222
00005;IS CF MUCUS ABNORMAL?;23;2220
00005;IS CF MUCUS ABNORMAL?;47;2221
00005;IS CF MUCUS ABNORMAL?;50;0001
00005;IS CF MUCUS ABNORMAL?;60;0001
00005;IS CF MUCUS ABNORMAL?;114;0011
00005;IS CF MUCUS ABNORMAL?;132;0001
00005;IS CF MUCUS ABNORMAL?;135;0001
00005;IS CF MUCUS ABNORMAL?;139;0010
00005;IS CF MUCUS ABNORMAL?;151;2222
00005;IS CF MUCUS ABNORMAL?;169;0001
00005;IS CF MUCUS ABNORMAL?;189;0001
00005;IS CF MUCUS ABNORMAL?;190;0001
00005;IS CF MUCUS ABNORMAL?;197;0001
00005;IS CF MUCUS ABNORMAL?;200;0001
00005;IS CF MUCUS ABNORMAL?;226;0001
00005;IS CF MUCUS ABNORMAL?;256;2211
00005;IS CF MUCUS ABNORMAL?;265;0010
00005;IS CF MUCUS ABNORMAL?;297;0001
00005;IS CF MUCUS ABNORMAL?;298;0001
00005;IS CF MUCUS ABNORMAL?;299;0001
00005;IS CF MUCUS ABNORMAL?;311;0001
00005;IS CF MUCUS ABNORMAL?;312;0001
00005;IS CF MUCUS ABNORMAL?;325;1011
00005;IS CF MUCUS ABNORMAL?;333;0001
00005;IS CF MUCUS ABNORMAL?;343;0002
00005;IS CF MUCUS ABNORMAL?;347;0012
00005;IS CF MUCUS ABNORMAL?;349;0001
00005;IS CF MUCUS ABNORMAL?;369;0001
00005;IS CF MUCUS ABNORMAL?;370;1211
00005;IS CF MUCUS ABNORMAL?;371;0001
00005;IS CF MUCUS ABNORMAL?;374;2222
00005;IS CF MUCUS ABNORMAL?;386;1001
00005;IS CF MUCUS ABNORMAL?;392;0001
00005;IS CF MUCUS ABNORMAL?;410;0001
00005;IS CF MUCUS ABNORMAL?;420;0001
00005;IS CF MUCUS ABNORMAL?;427;0001
00005;IS CF MUCUS ABNORMAL?;428;0001
00005;IS CF MUCUS ABNORMAL?;430;1001
00005;IS CF MUCUS ABNORMAL?;434;0001
00005;IS CF MUCUS ABNORMAL?;437;0001
00005;IS CF MUCUS ABNORMAL?;439;2222
00005;IS CF MUCUS ABNORMAL?;440;0010
00005;IS CF MUCUS ABNORMAL?;441;0001
00005;IS CF MUCUS ABNORMAL?;450;0001
00005;IS CF MUCUS ABNORMAL?;461;2120
00005;IS CF MUCUS ABNORMAL?;465;1002
00005;IS CF MUCUS ABNORMAL?;478;0001
00005;IS CF MUCUS ABNORMAL?;496;2120
00005;IS CF MUCUS ABNORMAL?;497;2121
00005;IS CF MUCUS ABNORMAL?;498;1122
00005;IS CF MUCUS ABNORMAL?;499;2122
00005;IS CF MUCUS ABNORMAL?;500;1012
00005;IS CF MUCUS ABNORMAL?;501;0100
00005;IS CF MUCUS ABNORMAL?;502;0100
00005;IS CF MUCUS ABNORMAL?;503;2221
00005;IS CF MUCUS ABNORMAL?;505;0001
00005;IS CF MUCUS ABNORMAL?;511;1101
00005;IS CF MUCUS ABNORMAL?;513;0010
00005;IS CF MUCUS ABNORMAL?;516;1010
00005;IS CF MUCUS ABNORMAL?;520;1000
00005;IS CF MUCUS ABNORMAL?;524;1010
00005;IS CF MUCUS ABNORMAL?;531;0001
00005;IS CF MUCUS ABNORMAL?;533;2211
00005;IS CF MUCUS ABNORMAL?;549;0001
00005;IS CF MUCUS ABNORMAL?;553;1001
00005;IS CF MUCUS ABNORMAL?;559;0001
00005;IS CF MUCUS ABNORMAL?;561;0010
00005;IS CF MUCUS ABNORMAL?;568;0001
00005;IS CF MUCUS ABNORMAL?;590;0001
00005;IS CF MUCUS ABNORMAL?;592;1001
00005;IS CF MUCUS ABNORMAL?;593;2222
00005;IS CF MUCUS ABNORMAL?;604;0002
00005;IS CF MUCUS ABNORMAL?;605;0100
00005;IS CF MUCUS ABNORMAL?;633;2122
00005;IS CF MUCUS ABNORMAL?;669;0010
00005;IS CF MUCUS ABNORMAL?;701;0001
00005;IS CF MUCUS ABNORMAL?;702;1000
00005;IS CF MUCUS ABNORMAL?;710;2212
00005;IS CF MUCUS ABNORMAL?;711;0002
00005;IS CF MUCUS ABNORMAL?;722;0001
00005;IS CF MUCUS ABNORMAL?;724;0002
00005;IS CF MUCUS ABNORMAL?;729;0001
00005;IS CF MUCUS ABNORMAL?;731;0002
00005;IS CF MUCUS ABNORMAL?;733;0002
00005;IS CF MUCUS ABNORMAL?;750;0100
00005;IS CF MUCUS ABNORMAL?;761;0001
00005;IS CF MUCUS ABNORMAL?;763;0001
00005;IS CF MUCUS ABNORMAL?;772;0100
00005;IS CF MUCUS ABNORMAL?;779;0001
00005;IS CF MUCUS ABNORMAL?;788;0001
00005;IS CF MUCUS ABNORMAL?;805;2211
00005;IS CF MUCUS ABNORMAL?;843;0002
00005;IS CF MUCUS ABNORMAL?;845;0001
00005;IS CF MUCUS ABNORMAL?;856;2121
00005;IS CF MUCUS ABNORMAL?;857;1000
00005;IS CF MUCUS ABNORMAL?;861;1212
00005;IS CF MUCUS ABNORMAL?;864;0001
00005;IS CF MUCUS ABNORMAL?;867;0101
00005;IS CF MUCUS ABNORMAL?;875;2222
00005;IS CF MUCUS ABNORMAL?;876;0002
00005;IS CF MUCUS ABNORMAL?;888;0002
00005;IS CF MUCUS ABNORMAL?;889;0002
00005;IS CF MUCUS ABNORMAL?;895;2210
00005;IS CF MUCUS ABNORMAL?;925;0001
00005;IS CF MUCUS ABNORMAL?;935;0001
00005;IS CF MUCUS ABNORMAL?;943;0001
00005;IS CF MUCUS ABNORMAL?;944;0001
00005;IS CF MUCUS ABNORMAL?;975;2112
00005;IS CF MUCUS ABNORMAL?;980;2120
00005;IS CF MUCUS ABNORMAL?;982;0002
00005;IS CF MUCUS ABNORMAL?;990;0002
00005;IS CF MUCUS ABNORMAL?;1000;0002
00005;IS CF MUCUS ABNORMAL?;1019;0001
00005;IS CF MUCUS ABNORMAL?;1038;0001
00005;IS CF MUCUS ABNORMAL?;1040;0001
00005;IS CF MUCUS ABNORMAL?;1064;2220
00005;IS CF MUCUS ABNORMAL?;1076;0001
00005;IS CF MUCUS ABNORMAL?;1080;0001
00005;IS CF MUCUS ABNORMAL?;1088;0001
00005;IS CF MUCUS ABNORMAL?;1091;0001
00005;IS CF MUCUS ABNORMAL?;1092;0002
00005;IS CF MUCUS ABNORMAL?;1093;0002
00005;IS CF MUCUS ABNORMAL?;1098;0001
00005;IS CF MUCUS ABNORMAL?;1144;2111
00005;IS CF MUCUS ABNORMAL?;1156;0001
00005;IS CF MUCUS ABNORMAL?;1175;1120
00005;IS CF MUCUS ABNORMAL?;1185;0001
00005;IS CF MUCUS ABNORMAL?;1188;0001
00005;IS CF MUCUS ABNORMAL?;1196;1000
00005;IS CF MUCUS ABNORMAL?;1223;0001
00005;IS CF MUCUS ABNORMAL?;1226;0001
00006;WHAT IS THE EFFECT OF WATER OR OTHER THERAPEUTIC AGENTS ON THE PHYSICAL PROPERTIES (VISCOSITY, ELASTICITY) OF SPUTUM OR BRONCHIAL SECRETIONS FROM CF PATIENTS?;25;0010
00006;WHAT IS THE EFFECT OF WATER OR OTHER THERAPEUTIC AGENTS ON THE PHYSICAL PROPERTIES (VISCOSITY, ELASTICITY) OF SPUTUM OR BRONCHIAL SECRETIONS FROM CF PATIENTS?;31;2222
00006;WHAT IS THE EFFECT OF WATER OR OTHER THERAPEUTIC AGENTS ON THE PHYSICAL PROPERTIES (VISCOSITY, ELASTICITY) OF SPUTUM OR BRONCHIAL SECRETIONS FROM CF PATIENTS?;90;1000
00006;WHAT IS THE EFFECT OF WATER OR OTHER THERAPEUTIC AGENTS ON THE PHYSICAL PROPERTIES (VISCOSITY, ELASTICITY) OF SPUTUM OR BRONCHIAL SECRETIONS FROM CF PATIENTS?;195;0100
00006;WHAT IS THE EFFECT OF WATER OR OTHER THERAPEUTIC AGENTS ON THE PHYSICAL PROPERTIES (VISCOSITY, ELASTICITY) OF SPUTUM OR BRONCHIAL SECRETIONS FROM CF PATIENTS?;326;0001
00006;WHAT IS THE EFFECT OF WATER OR OTHER THERAPEUTIC AGENTS ON THE PHYSICAL PROPERTIES (VISCOSITY, ELASTICITY) OF SPUTUM OR BRONCHIAL SECRETIONS FROM CF PATIENTS?;370;0110
00006;WHAT IS THE EFFECT OF WATER OR OTHER THERAPEUTIC AGENTS ON THE PHYSICAL PROPERTIES (VISCOSITY, ELASTICITY) OF SPUTUM OR BRONCHIAL SECRETIONS FROM CF PATIENTS?;438;0001
00006;WHAT IS THE EFFECT OF WATER OR OTHER THERAPEUTIC AGENTS ON THE PHYSICAL PROPERTIES (VISCOSITY, ELASTICITY) OF SPUTUM OR BRONCHIAL SECRETIONS FROM CF PATIENTS?;440;0010
00006;WHAT IS THE EFFECT OF WATER OR OTHER THERAPEUTIC AGENTS ON THE PHYSICAL PROPERTIES (VISCOSITY, ELASTICITY) OF SPUTUM OR BRONCHIAL SECRETIONS FROM CF PATIENTS?;441;1000
00006;WHAT IS THE EFFECT OF WATER OR OTHER THERAPEUTIC AGENTS ON THE PHYSICAL PROPERTIES (VISCOSITY, ELASTICITY) OF SPUTUM OR BRONCHIAL SECRETIONS FROM CF PATIENTS?;503;1220
00006;WHAT IS THE EFFECT OF WATER OR OTHER THERAPEUTIC AGENTS ON THE PHYSICAL PROPERTIES (VISCOSITY, ELASTICITY) OF SPUTUM OR BRONCHIAL SECRETIONS FROM CF PATIENTS?;511;0010
00006;WHAT IS THE EFFECT OF WATER OR OTHER THERAPEUTIC AGENTS ON THE PHYSICAL PROPERTIES (VISCOSITY, ELASTICITY) OF SPUTUM OR BRONCHIAL SECRETIONS FROM CF PATIENTS?;586;0001
00006;WHAT IS THE EFFECT OF WATER OR OTHER THERAPEUTIC AGENTS ON THE PHYSICAL PROPERTIES (VISCOSITY, ELASTICITY) OF SPUTUM OR BRONCHIAL SECRETIONS FROM CF PATIENTS?;592;1010
00006;WHAT IS THE EFFECT OF WATER OR OTHER THERAPEUTIC AGENTS ON THE PHYSICAL PROPERTIES (VISCOSITY, ELASTICITY) OF SPUTUM OR BRONCHIAL SECRETIONS FROM CF PATIENTS?;593;1000
00006;WHAT IS THE EFFECT OF WATER OR OTHER THERAPEUTIC AGENTS ON THE PHYSICAL PROPERTIES (VISCOSITY, ELASTICITY) OF SPUTUM OR BRONCHIAL SECRETIONS FROM CF PATIENTS?;722;0001
00006;WHAT IS THE EFFECT OF WATER OR OTHER THERAPEUTIC AGENTS ON THE PHYSICAL PROPERTIES (VISCOSITY, ELASTICITY) OF SPUTUM OR BRONCHIAL SECRETIONS FROM CF PATIENTS?;731;0001
00006;WHAT IS THE EFFECT OF WATER OR OTHER THERAPEUTIC AGENTS ON THE PHYSICAL PROPERTIES (VISCOSITY, ELASTICITY) OF SPUTUM OR BRONCHIAL SECRETIONS FROM CF PATIENTS?;734;0002
00006;WHAT IS THE EFFECT OF WATER OR OTHER THERAPEUTIC AGENTS ON THE PHYSICAL PROPERTIES (VISCOSITY, ELASTICITY) OF SPUTUM OR BRONCHIAL SECRETIONS FROM CF PATIENTS?;805;1000
00006;WHAT IS THE EFFECT OF WATER OR OTHER THERAPEUTIC AGENTS ON THE PHYSICAL PROPERTIES (VISCOSITY, ELASTICITY) OF SPUTUM OR BRONCHIAL SECRETIONS FROM CF PATIENTS?;875;1120
00006;WHAT IS THE EFFECT OF WATER OR OTHER THERAPEUTIC AGENTS ON THE PHYSICAL PROPERTIES (VISCOSITY, ELASTICITY) OF SPUTUM OR BRONCHIAL SECRETIONS FROM CF PATIENTS?;922;0010
00006;WHAT IS THE EFFECT OF WATER OR OTHER THERAPEUTIC AGENTS ON THE PHYSICAL PROPERTIES (VISCOSITY, ELASTICITY) OF SPUTUM OR BRONCHIAL SECRETIONS FROM CF PATIENTS?;963;1000
00006;WHAT IS THE EFFECT OF WATER OR OTHER THERAPEUTIC AGENTS ON THE PHYSICAL PROPERTIES (VISCOSITY, ELASTICITY) OF SPUTUM OR BRONCHIAL SECRETIONS FROM CF PATIENTS?;975;1010
00006;WHAT IS THE EFFECT OF WATER OR OTHER THERAPEUTIC AGENTS ON THE PHYSICAL PROPERTIES (VISCOSITY, ELASTICITY) OF SPUTUM OR BRONCHIAL SECRETIONS FROM CF PATIENTS?;1092;0001
00006;WHAT IS THE EFFECT OF WATER OR OTHER THERAPEUTIC AGENTS ON THE PHYSICAL PROPERTIES (VISCOSITY, ELASTICITY) OF SPUTUM OR BRONCHIAL SECRETIONS FROM CF PATIENTS?;1093;0002
00007;ARE MUCUS GLYCOPROTEINS DEGRADED DIFFERENTLY IN CF PATIENTS AS COMPARED TO THOSE FROM NORMAL SUBJECTS?;45;0100
00007;ARE MUCUS GLYCOPROTEINS DEGRADED DIFFERENTLY IN CF PATIENTS AS COMPARED TO THOSE FROM NORMAL SUBJECTS?;53;0001
00007;ARE MUCUS GLYCOPROTEINS DEGRADED DIFFERENTLY IN CF PATIENTS AS COMPARED TO THOSE FROM NORMAL SUBJECTS?;166;0002
00007;ARE MUCUS GLYCOPROTEINS DEGRADED DIFFERENTLY IN CF PATIENTS AS COMPARED TO THOSE FROM NORMAL SUBJECTS?;171;0001
00007;ARE MUCUS GLYCOPROTEINS DEGRADED DIFFERENTLY IN CF PATIENTS AS COMPARED TO THOSE FROM NORMAL SUBJECTS?;256;0101
00007;ARE MUCUS GLYCOPROTEINS DEGRADED DIFFERENTLY IN CF PATIENTS AS COMPARED TO THOSE FROM NORMAL SUBJECTS?;370;0001
00007;ARE MUCUS GLYCOPROTEINS DEGRADED DIFFERENTLY IN CF PATIENTS AS COMPARED TO THOSE FROM NORMAL SUBJECTS?;371;2122
00007;ARE MUCUS GLYCOPROTEINS DEGRADED DIFFERENTLY IN CF PATIENTS AS COMPARED TO THOSE FROM NORMAL SUBJECTS?;386;0001
00007;ARE MUCUS GLYCOPROTEINS DEGRADED DIFFERENTLY IN CF PATIENTS AS COMPARED TO THOSE FROM NORMAL SUBJECTS?;410;0100
00007;ARE MUCUS GLYCOPROTEINS DEGRADED DIFFERENTLY IN CF PATIENTS AS COMPARED TO THOSE FROM NORMAL SUBJECTS?;439;0101
00007;ARE MUCUS GLYCOPROTEINS DEGRADED DIFFERENTLY IN CF PATIENTS AS COMPARED TO THOSE FROM NORMAL SUBJECTS?;535;0001
00007;ARE MUCUS GLYCOPROTEINS DEGRADED DIFFERENTLY IN CF PATIENTS AS COMPARED TO THOSE FROM NORMAL SUBJECTS?;623;2121
00007;ARE MUCUS GLYCOPROTEINS DEGRADED DIFFERENTLY IN CF PATIENTS AS COMPARED TO THOSE FROM NORMAL SUBJECTS?;633;0100
00007;ARE MUCUS GLYCOPROTEINS DEGRADED DIFFERENTLY IN CF PATIENTS AS COMPARED TO THOSE FROM NORMAL SUBJECTS?;634;0100
00007;ARE MUCUS GLYCOPROTEINS DEGRADED DIFFERENTLY IN CF PATIENTS AS COMPARED TO THOSE FROM NORMAL SUBJECTS?;640;0010
00007;ARE MUCUS GLYCOPROTEINS DEGRADED DIFFERENTLY IN CF PATIENTS AS COMPARED TO THOSE FROM NORMAL SUBJECTS?;669;0010
00007;ARE MUCUS GLYCOPROTEINS DEGRADED DIFFERENTLY IN CF PATIENTS AS COMPARED TO THOSE FROM NORMAL SUBJECTS?;831;0100
00007;ARE MUCUS GLYCOPROTEINS DEGRADED DIFFERENTLY IN CF PATIENTS AS COMPARED TO THOSE FROM NORMAL SUBJECTS?;853;0100
00007;ARE MUCUS GLYCOPROTEINS DEGRADED DIFFERENTLY IN CF PATIENTS AS COMPARED TO THOSE FROM NORMAL SUBJECTS?;856;2111
00007;ARE MUCUS GLYCOPROTEINS DEGRADED DIFFERENTLY IN CF PATIENTS AS COMPARED TO THOSE FROM NORMAL SUBJECTS?;857;0100
00007;ARE MUCUS GLYCOPROTEINS DEGRADED DIFFERENTLY IN CF PATIENTS AS COMPARED TO THOSE FROM NORMAL SUBJECTS?;921;0010
00007;ARE MUCUS GLYCOPROTEINS DEGRADED DIFFERENTLY IN CF PATIENTS AS COMPARED TO THOSE FROM NORMAL SUBJECTS?;1027;0100
00007;ARE MUCUS GLYCOPROTEINS DEGRADED DIFFERENTLY IN CF PATIENTS AS COMPARED TO THOSE FROM NORMAL SUBJECTS?;1054;1100
00007;ARE MUCUS GLYCOPROTEINS DEGRADED DIFFERENTLY IN CF PATIENTS AS COMPARED TO THOSE FROM NORMAL SUBJECTS?;1056;0100
00007;ARE MUCUS GLYCOPROTEINS DEGRADED DIFFERENTLY IN CF PATIENTS AS COMPARED TO THOSE FROM NORMAL SUBJECTS?;1057;0100
00007;ARE MUCUS GLYCOPROTEINS DEGRADED DIFFERENTLY IN CF PATIENTS AS COMPARED TO THOSE FROM NORMAL SUBJECTS?;1059;0100
00007;ARE MUCUS GLYCOPROTEINS DEGRADED DIFFERENTLY IN CF PATIENTS AS COMPARED TO THOSE FROM NORMAL SUBJECTS?;1064;1120
00007;ARE MUCUS GLYCOPROTEINS DEGRADED DIFFERENTLY IN CF PATIENTS AS COMPARED TO THOSE FROM NORMAL SUBJECTS?;1161;0001
00008;WHAT HISTOCHEMICAL DIFFERENCES HAVE BEEN DESCRIBED BETWEEN NORMAL AND CF RESPIRATORY EPITHELIA?;23;2112
00008;WHAT HISTOCHEMICAL DIFFERENCES HAVE BEEN DESCRIBED BETWEEN NORMAL AND CF RESPIRATORY EPITHELIA?;169;1000
00008;WHAT HISTOCHEMICAL DIFFERENCES HAVE BEEN DESCRIBED BETWEEN NORMAL AND CF RESPIRATORY EPITHELIA?;322;0100
00008;WHAT HISTOCHEMICAL DIFFERENCES HAVE BEEN DESCRIBED BETWEEN NORMAL AND CF RESPIRATORY EPITHELIA?;370;1000
00008;WHAT HISTOCHEMICAL DIFFERENCES HAVE BEEN DESCRIBED BETWEEN NORMAL AND CF RESPIRATORY EPITHELIA?;386;1000
00008;WHAT HISTOCHEMICAL DIFFERENCES HAVE BEEN DESCRIBED BETWEEN NORMAL AND CF RESPIRATORY EPITHELIA?;435;0001
00008;WHAT HISTOCHEMICAL DIFFERENCES HAVE BEEN DESCRIBED BETWEEN NORMAL AND CF RESPIRATORY EPITHELIA?;439;1100
00008;WHAT HISTOCHEMICAL DIFFERENCES HAVE BEEN DESCRIBED BETWEEN NORMAL AND CF RESPIRATORY EPITHELIA?;463;0001
00008;WHAT HISTOCHEMICAL DIFFERENCES HAVE BEEN DESCRIBED BETWEEN NORMAL AND CF RESPIRATORY EPITHELIA?;496;1000
00008;WHAT HISTOCHEMICAL DIFFERENCES HAVE BEEN DESCRIBED BETWEEN NORMAL AND CF RESPIRATORY EPITHELIA?;497;0001
00008;WHAT HISTOCHEMICAL DIFFERENCES HAVE BEEN DESCRIBED BETWEEN NORMAL AND CF RESPIRATORY EPITHELIA?;498;1000
00008;WHAT HISTOCHEMICAL DIFFERENCES HAVE BEEN DESCRIBED BETWEEN NORMAL AND CF RESPIRATORY EPITHELIA?;499;1122
00008;WHAT HISTOCHEMICAL DIFFERENCES HAVE BEEN DESCRIBED BETWEEN NORMAL AND CF RESPIRATORY EPITHELIA?;503;0001
00008;WHAT HISTOCHEMICAL DIFFERENCES HAVE BEEN DESCRIBED BETWEEN NORMAL AND CF RESPIRATORY EPITHELIA?;605;0001
00008;WHAT HISTOCHEMICAL DIFFERENCES HAVE BEEN DESCRIBED BETWEEN NORMAL AND CF RESPIRATORY EPITHELIA?;683;2220
00008;WHAT HISTOCHEMICAL DIFFERENCES HAVE BEEN DESCRIBED BETWEEN NORMAL AND CF RESPIRATORY EPITHELIA?;710;1000
00008;WHAT HISTOCHEMICAL DIFFERENCES HAVE BEEN DESCRIBED BETWEEN NORMAL AND CF RESPIRATORY EPITHELIA?;750;0010
00008;WHAT HISTOCHEMICAL DIFFERENCES HAVE BEEN DESCRIBED BETWEEN NORMAL AND CF RESPIRATORY EPITHELIA?;771;1000
00008;WHAT HISTOCHEMICAL DIFFERENCES HAVE BEEN DESCRIBED BETWEEN NORMAL AND CF RESPIRATORY EPITHELIA?;867;1000
00008;WHAT HISTOCHEMICAL DIFFERENCES HAVE BEEN DESCRIBED BETWEEN NORMAL AND CF RESPIRATORY EPITHELIA?;875;0001
00008;WHAT HISTOCHEMICAL DIFFERENCES HAVE BEEN DESCRIBED BETWEEN NORMAL AND CF RESPIRATORY EPITHELIA?;944;0001
00008;WHAT HISTOCHEMICAL DIFFERENCES HAVE BEEN DESCRIBED BETWEEN NORMAL AND CF RESPIRATORY EPITHELIA?;1125;2220
00009;WHAT IS THE ASSOCIATION BETWEEN LIVER DISEASE (CIRRHOSIS) AND VITAMIN A METABOLISM IN CF?;165;1122
00009;WHAT IS THE ASSOCIATION BETWEEN LIVER DISEASE (CIRRHOSIS) AND VITAMIN A METABOLISM IN CF?;174;0001
00009;WHAT IS THE ASSOCIATION BETWEEN LIVER DISEASE (CIRRHOSIS) AND VITAMIN A METABOLISM IN CF?;362;0001
00009;WHAT IS THE ASSOCIATION BETWEEN LIVER DISEASE (CIRRHOSIS) AND VITAMIN A METABOLISM IN CF?;370;0001
00009;WHAT IS THE ASSOCIATION BETWEEN LIVER DISEASE (CIRRHOSIS) AND VITAMIN A METABOLISM IN CF?;414;2222
00009;WHAT IS THE ASSOCIATION BETWEEN LIVER DISEASE (CIRRHOSIS) AND VITAMIN A METABOLISM IN CF?;443;0100
00009;WHAT IS THE ASSOCIATION BETWEEN LIVER DISEASE (CIRRHOSIS) AND VITAMIN A METABOLISM IN CF?;794;2110
00009;WHAT IS THE ASSOCIATION BETWEEN LIVER DISEASE (CIRRHOSIS) AND VITAMIN A METABOLISM IN CF?;992;1010
00009;WHAT IS THE ASSOCIATION BETWEEN LIVER DISEASE (CIRRHOSIS) AND VITAMIN A METABOLISM IN CF?;1040;0001
00009;WHAT IS THE ASSOCIATION BETWEEN LIVER DISEASE (CIRRHOSIS) AND VITAMIN A METABOLISM IN CF?;1115;0102
00010;WHAT IS THE ROLE OF VITAMIN E IN THE THERAPY OF PATIENTS WITH CF?;30;2112
00010;WHAT IS THE ROLE OF VITAMIN E IN THE THERAPY OF PATIENTS WITH CF?;126;1001
00010;WHAT IS THE ROLE OF VITAMIN E IN THE THERAPY OF PATIENTS WITH CF?;157;2222
00010;WHAT IS THE ROLE OF VITAMIN E IN THE THERAPY OF PATIENTS WITH CF?;170;1112
00010;WHAT IS THE ROLE OF VITAMIN E IN THE THERAPY OF PATIENTS WITH CF?;296;1212
00010;WHAT IS THE ROLE OF VITAMIN E IN THE THERAPY OF PATIENTS WITH CF?;301;0001
00010;WHAT IS THE ROLE OF VITAMIN E IN THE THERAPY OF PATIENTS WITH CF?;322;0001
00010;WHAT IS THE ROLE OF VITAMIN E IN THE THERAPY OF PATIENTS WITH CF?;370;1100
00010;WHAT IS THE ROLE OF VITAMIN E IN THE THERAPY OF PATIENTS WITH CF?;413;2222
00010;WHAT IS THE ROLE OF VITAMIN E IN THE THERAPY OF PATIENTS WITH CF?;443;1120
00010;WHAT IS THE ROLE OF VITAMIN E IN THE THERAPY OF PATIENTS WITH CF?;581;2222
00010;WHAT IS THE ROLE OF VITAMIN E IN THE THERAPY OF PATIENTS WITH CF?;676;2122
00010;WHAT IS THE ROLE OF VITAMIN E IN THE THERAPY OF PATIENTS WITH CF?;715;0010
00010;WHAT IS THE ROLE OF VITAMIN E IN THE THERAPY OF PATIENTS WITH CF?;722;0001
00010;WHAT IS THE ROLE OF VITAMIN E IN THE THERAPY OF PATIENTS WITH CF?;728;1101
00010;WHAT IS THE ROLE OF VITAMIN E IN THE THERAPY OF PATIENTS WITH CF?;758;1000
00010;WHAT IS THE ROLE OF VITAMIN E IN THE THERAPY OF PATIENTS WITH CF?;782;1010
00010;WHAT IS THE ROLE OF VITAMIN E IN THE THERAPY OF PATIENTS WITH CF?;835;0010
00010;WHAT IS THE ROLE OF VITAMIN E IN THE THERAPY OF PATIENTS WITH CF?;878;2122
00010;WHAT IS THE ROLE OF VITAMIN E IN THE THERAPY OF PATIENTS WITH CF?;941;1000
00010;WHAT IS THE ROLE OF VITAMIN E IN THE THERAPY OF PATIENTS WITH CF?;1115;1222
00010;WHAT IS THE ROLE OF VITAMIN E IN THE THERAPY OF PATIENTS WITH CF?;1215;0010
00010;WHAT IS THE ROLE OF VITAMIN E IN THE THERAPY OF PATIENTS WITH CF?;1218;2122
00010;WHAT IS THE ROLE OF VITAMIN E IN THE THERAPY OF PATIENTS WITH CF?;1234;0001
00010;WHAT IS THE ROLE OF VITAMIN E IN THE THERAPY OF PATIENTS WITH CF?;1239;1101
00011;WHAT IS THE DIFFERENCE BETWEEN MECONIUM ILEUS AND MECONIUM PLUG SYNDROME?;36;0001
00011;WHAT IS THE DIFFERENCE BETWEEN MECONIUM ILEUS AND MECONIUM PLUG SYNDROME?;46;0001
00011;WHAT IS THE DIFFERENCE BETWEEN MECONIUM ILEUS AND MECONIUM PLUG SYNDROME?;96;2210
00011;WHAT IS THE DIFFERENCE BETWEEN MECONIUM ILEUS AND MECONIUM PLUG SYNDROME?;186;1000
00011;WHAT IS THE DIFFERENCE BETWEEN MECONIUM ILEUS AND MECONIUM PLUG SYNDROME?;301;1000
00011;WHAT IS THE DIFFERENCE BETWEEN MECONIUM ILEUS AND MECONIUM PLUG SYNDROME?;428;1002
00011;WHAT IS THE DIFFERENCE BETWEEN MECONIUM ILEUS AND MECONIUM PLUG SYNDROME?;518;2110
00011;WHAT IS THE DIFFERENCE BETWEEN MECONIUM ILEUS AND MECONIUM PLUG SYNDROME?;649;0010
00011;WHAT IS THE DIFFERENCE BETWEEN MECONIUM ILEUS AND MECONIUM PLUG SYNDROME?;652;0001
00011;WHAT IS THE DIFFERENCE BETWEEN MECONIUM ILEUS AND MECONIUM PLUG SYNDROME?;659;0010
00011;WHAT IS THE DIFFERENCE BETWEEN MECONIUM ILEUS AND MECONIUM PLUG SYNDROME?;772;1010
00011;WHAT IS THE DIFFERENCE BETWEEN MECONIUM ILEUS AND MECONIUM PLUG SYNDROME?;796;2222
00011;WHAT IS THE DIFFERENCE BETWEEN MECONIUM ILEUS AND MECONIUM PLUG SYNDROME?;798;2212
00011;WHAT IS THE DIFFERENCE BETWEEN MECONIUM ILEUS AND MECONIUM PLUG SYNDROME?;799;0010
00011;WHAT IS THE DIFFERENCE BETWEEN MECONIUM ILEUS AND MECONIUM PLUG SYNDROME?;835;1000
00011;WHAT IS THE DIFFERENCE BETWEEN MECONIUM ILEUS AND MECONIUM PLUG SYNDROME?;837;0001
00011;WHAT IS THE DIFFERENCE BETWEEN MECONIUM ILEUS AND MECONIUM PLUG SYNDROME?;908;1000
00011;WHAT IS THE DIFFERENCE BETWEEN MECONIUM ILEUS AND MECONIUM PLUG SYNDROME?;909;2222
00011;WHAT IS THE DIFFERENCE BETWEEN MECONIUM ILEUS AND MECONIUM PLUG SYNDROME?;991;2222
00011;WHAT IS THE DIFFERENCE BETWEEN MECONIUM ILEUS AND MECONIUM PLUG SYNDROME?;1119;0100
00011;WHAT IS THE DIFFERENCE BETWEEN MECONIUM ILEUS AND MECONIUM PLUG SYNDROME?;1178;1000
00011;WHAT IS THE DIFFERENCE BETWEEN MECONIUM ILEUS AND MECONIUM PLUG SYNDROME?;1226;0002
00012;WHAT ABNORMALITIES OF AMINO ACID TRANSPORT HAVE BEEN DESCRIBED IN THE SMALL BOWEL OF CF PATIENTS?;70;2212
00012;WHAT ABNORMALITIES OF AMINO ACID TRANSPORT HAVE BEEN DESCRIBED IN THE SMALL BOWEL OF CF PATIENTS?;181;0001
00012;WHAT ABNORMALITIES OF AMINO ACID TRANSPORT HAVE BEEN DESCRIBED IN THE SMALL BOWEL OF CF PATIENTS?;443;2120
00012;WHAT ABNORMALITIES OF AMINO ACID TRANSPORT HAVE BEEN DESCRIBED IN THE SMALL BOWEL OF CF PATIENTS?;466;2220
00012;WHAT ABNORMALITIES OF AMINO ACID TRANSPORT HAVE BEEN DESCRIBED IN THE SMALL BOWEL OF CF PATIENTS?;755;0010
00012;WHAT ABNORMALITIES OF AMINO ACID TRANSPORT HAVE BEEN DESCRIBED IN THE SMALL BOWEL OF CF PATIENTS?;918;1000
00012;WHAT ABNORMALITIES OF AMINO ACID TRANSPORT HAVE BEEN DESCRIBED IN THE SMALL BOWEL OF CF PATIENTS?;1115;0001
00013;WHAT ARE THE CLINICAL OR BIOCHEMICAL FEATURES OF PANCREATITIS IN CF PATIENTS?;156;2112
00013;WHAT ARE THE CLINICAL OR BIOCHEMICAL FEATURES OF PANCREATITIS IN CF PATIENTS?;301;1112
00013;WHAT ARE THE CLINICAL OR BIOCHEMICAL FEATURES OF PANCREATITIS IN CF PATIENTS?;314;2222
00013;WHAT ARE THE CLINICAL OR BIOCHEMICAL FEATURES OF PANCREATITIS IN CF PATIENTS?;322;1220
00013;WHAT ARE THE CLINICAL OR BIOCHEMICAL FEATURES OF PANCREATITIS IN CF PATIENTS?;370;0100
00013;WHAT ARE THE CLINICAL OR BIOCHEMICAL FEATURES OF PANCREATITIS IN CF PATIENTS?;443;1120
00013;WHAT ARE THE CLINICAL OR BIOCHEMICAL FEATURES OF PANCREATITIS IN CF PATIENTS?;462;1010
00013;WHAT ARE THE CLINICAL OR BIOCHEMICAL FEATURES OF PANCREATITIS IN CF PATIENTS?;522;0100
00013;WHAT ARE THE CLINICAL OR BIOCHEMICAL FEATURES OF PANCREATITIS IN CF PATIENTS?;643;1000
00013;WHAT ARE THE CLINICAL OR BIOCHEMICAL FEATURES OF PANCREATITIS IN CF PATIENTS?;695;1220
00013;WHAT ARE THE CLINICAL OR BIOCHEMICAL FEATURES OF PANCREATITIS IN CF PATIENTS?;715;0010
00013;WHAT ARE THE CLINICAL OR BIOCHEMICAL FEATURES OF PANCREATITIS IN CF PATIENTS?;719;0010
00013;WHAT ARE THE CLINICAL OR BIOCHEMICAL FEATURES OF PANCREATITIS IN CF PATIENTS?;722;0001
00013;WHAT ARE THE CLINICAL OR BIOCHEMICAL FEATURES OF PANCREATITIS IN CF PATIENTS?;763;0101
00013;WHAT ARE THE CLINICAL OR BIOCHEMICAL FEATURES OF PANCREATITIS IN CF PATIENTS?;764;0001
00013;WHAT ARE THE CLINICAL OR BIOCHEMICAL FEATURES OF PANCREATITIS IN CF PATIENTS?;791;2211
00013;WHAT ARE THE CLINICAL OR BIOCHEMICAL FEATURES OF PANCREATITIS IN CF PATIENTS?;822;0001
00013;WHAT ARE THE CLINICAL OR BIOCHEMICAL FEATURES OF PANCREATITIS IN CF PATIENTS?;900;0100
00013;WHAT ARE THE CLINICAL OR BIOCHEMICAL FEATURES OF PANCREATITIS IN CF PATIENTS?;902;1101
00013;WHAT ARE THE CLINICAL OR BIOCHEMICAL FEATURES OF PANCREATITIS IN CF PATIENTS?;978;1000
00013;WHAT ARE THE CLINICAL OR BIOCHEMICAL FEATURES OF PANCREATITIS IN CF PATIENTS?;1017;0010
00013;WHAT ARE THE CLINICAL OR BIOCHEMICAL FEATURES OF PANCREATITIS IN CF PATIENTS?;1033;0001
00013;WHAT ARE THE CLINICAL OR BIOCHEMICAL FEATURES OF PANCREATITIS IN CF PATIENTS?;1097;0001
00013;WHAT ARE THE CLINICAL OR BIOCHEMICAL FEATURES OF PANCREATITIS IN CF PATIENTS?;1124;0002
00014;WHAT NON-INVASIVE TESTS CAN BE PERFORMED FOR THE EVALUATION OF EXOCRINE PANCREATIC FUNCTION IN PATIENTS WITH CF?;5;1100
00014;WHAT NON-INVASIVE TESTS CAN BE PERFORMED FOR THE EVALUATION OF EXOCRINE PANCREATIC FUNCTION IN PATIENTS WITH CF?;89;0100
00014;WHAT NON-INVASIVE TESTS CAN BE PERFORMED FOR THE EVALUATION OF EXOCRINE PANCREATIC FUNCTION IN PATIENTS WITH CF?;92;0001
00014;WHAT NON-INVASIVE TESTS CAN BE PERFORMED FOR THE EVALUATION OF EXOCRINE PANCREATIC FUNCTION IN PATIENTS WITH CF?;131;2212
00014;WHAT NON-INVASIVE TESTS CAN BE PERFORMED FOR THE EVALUATION OF EXOCRINE PANCREATIC FUNCTION IN PATIENTS WITH CF?;135;0001
00014;WHAT NON-INVASIVE TESTS CAN BE PERFORMED FOR THE EVALUATION OF EXOCRINE PANCREATIC FUNCTION IN PATIENTS WITH CF?;150;2222
00014;WHAT NON-INVASIVE TESTS CAN BE PERFORMED FOR THE EVALUATION OF EXOCRINE PANCREATIC FUNCTION IN PATIENTS WITH CF?;156;1000
00014;WHAT NON-INVASIVE TESTS CAN BE PERFORMED FOR THE EVALUATION OF EXOCRINE PANCREATIC FUNCTION IN PATIENTS WITH CF?;203;0010
00014;WHAT NON-INVASIVE TESTS CAN BE PERFORMED FOR THE EVALUATION OF EXOCRINE PANCREATIC FUNCTION IN PATIENTS WITH CF?;232;0010
00014;WHAT NON-INVASIVE TESTS CAN BE PERFORMED FOR THE EVALUATION OF EXOCRINE PANCREATIC FUNCTION IN PATIENTS WITH CF?;233;1122
00014;WHAT NON-INVASIVE TESTS CAN BE PERFORMED FOR THE EVALUATION OF EXOCRINE PANCREATIC FUNCTION IN PATIENTS WITH CF?;234;1121
00014;WHAT NON-INVASIVE TESTS CAN BE PERFORMED FOR THE EVALUATION OF EXOCRINE PANCREATIC FUNCTION IN PATIENTS WITH CF?;291;0001
00014;WHAT NON-INVASIVE TESTS CAN BE PERFORMED FOR THE EVALUATION OF EXOCRINE PANCREATIC FUNCTION IN PATIENTS WITH CF?;297;0001
00014;WHAT NON-INVASIVE TESTS CAN BE PERFORMED FOR THE EVALUATION OF EXOCRINE PANCREATIC FUNCTION IN PATIENTS WITH CF?;314;1000
00014;WHAT NON-INVASIVE TESTS CAN BE PERFORMED FOR THE EVALUATION OF EXOCRINE PANCREATIC FUNCTION IN PATIENTS WITH CF?;319;0010
00014;WHAT NON-INVASIVE TESTS CAN BE PERFORMED FOR THE EVALUATION OF EXOCRINE PANCREATIC FUNCTION IN PATIENTS WITH CF?;344;2112
00014;WHAT NON-INVASIVE TESTS CAN BE PERFORMED FOR THE EVALUATION OF EXOCRINE PANCREATIC FUNCTION IN PATIENTS WITH CF?;345;2210
00014;WHAT NON-INVASIVE TESTS CAN BE PERFORMED FOR THE EVALUATION OF EXOCRINE PANCREATIC FUNCTION IN PATIENTS WITH CF?;356;0001
00014;WHAT NON-INVASIVE TESTS CAN BE PERFORMED FOR THE EVALUATION OF EXOCRINE PANCREATIC FUNCTION IN PATIENTS WITH CF?;367;2210
00014;WHAT NON-INVASIVE TESTS CAN BE PERFORMED FOR THE EVALUATION OF EXOCRINE PANCREATIC FUNCTION IN PATIENTS WITH CF?;370;1110
00014;WHAT NON-INVASIVE TESTS CAN BE PERFORMED FOR THE EVALUATION OF EXOCRINE PANCREATIC FUNCTION IN PATIENTS WITH CF?;379;0001
00014;WHAT NON-INVASIVE TESTS CAN BE PERFORMED FOR THE EVALUATION OF EXOCRINE PANCREATIC FUNCTION IN PATIENTS WITH CF?;405;2112
00014;WHAT NON-INVASIVE TESTS CAN BE PERFORMED FOR THE EVALUATION OF EXOCRINE PANCREATIC FUNCTION IN PATIENTS WITH CF?;413;0001
00014;WHAT NON-INVASIVE TESTS CAN BE PERFORMED FOR THE EVALUATION OF EXOCRINE PANCREATIC FUNCTION IN PATIENTS WITH CF?;417;1211
00014;WHAT NON-INVASIVE TESTS CAN BE PERFORMED FOR THE EVALUATION OF EXOCRINE PANCREATIC FUNCTION IN PATIENTS WITH CF?;419;0002
00014;WHAT NON-INVASIVE TESTS CAN BE PERFORMED FOR THE EVALUATION OF EXOCRINE PANCREATIC FUNCTION IN PATIENTS WITH CF?;421;0001
00014;WHAT NON-INVASIVE TESTS CAN BE PERFORMED FOR THE EVALUATION OF EXOCRINE PANCREATIC FUNCTION IN PATIENTS WITH CF?;424;0001
00014;WHAT NON-INVASIVE TESTS CAN BE PERFORMED FOR THE EVALUATION OF EXOCRINE PANCREATIC FUNCTION IN PATIENTS WITH CF?;462;2212
00014;WHAT NON-INVASIVE TESTS CAN BE PERFORMED FOR THE EVALUATION OF EXOCRINE PANCREATIC FUNCTION IN PATIENTS WITH CF?;465;1102
00014;WHAT NON-INVASIVE TESTS CAN BE PERFORMED FOR THE EVALUATION OF EXOCRINE PANCREATIC FUNCTION IN PATIENTS WITH CF?;492;1000
00014;WHAT NON-INVASIVE TESTS CAN BE PERFORMED FOR THE EVALUATION OF EXOCRINE PANCREATIC FUNCTION IN PATIENTS WITH CF?;584;1001
00014;WHAT NON-INVASIVE TESTS CAN BE PERFORMED FOR THE EVALUATION OF EXOCRINE PANCREATIC FUNCTION IN PATIENTS WITH CF?;602;1011
00014;WHAT NON-INVASIVE TESTS CAN BE PERFORMED FOR THE EVALUATION OF EXOCRINE PANCREATIC FUNCTION IN PATIENTS WITH CF?;616;2120
00014;WHAT NON-INVASIVE TESTS CAN BE PERFORMED FOR THE EVALUATION OF EXOCRINE PANCREATIC FUNCTION IN PATIENTS WITH CF?;635;2122
00014;WHAT NON-INVASIVE TESTS CAN BE PERFORMED FOR THE EVALUATION OF EXOCRINE PANCREATIC FUNCTION IN PATIENTS WITH CF?;662;0100
00014;WHAT NON-INVASIVE TESTS CAN BE PERFORMED FOR THE EVALUATION OF EXOCRINE PANCREATIC FUNCTION IN PATIENTS WITH CF?;695;0010
00014;WHAT NON-INVASIVE TESTS CAN BE PERFORMED FOR THE EVALUATION OF EXOCRINE PANCREATIC FUNCTION IN PATIENTS WITH CF?;719;0011
00014;WHAT NON-INVASIVE TESTS CAN BE PERFORMED FOR THE EVALUATION OF EXOCRINE PANCREATIC FUNCTION IN PATIENTS WITH CF?;777;1012
00014;WHAT NON-INVASIVE TESTS CAN BE PERFORMED FOR THE EVALUATION OF EXOCRINE PANCREATIC FUNCTION IN PATIENTS WITH CF?;791;2122
00014;WHAT NON-INVASIVE TESTS CAN BE PERFORMED FOR THE EVALUATION OF EXOCRINE PANCREATIC FUNCTION IN PATIENTS WITH CF?;809;0010
00014;WHAT NON-INVASIVE TESTS CAN BE PERFORMED FOR THE EVALUATION OF EXOCRINE PANCREATIC FUNCTION IN PATIENTS WITH CF?;815;2222
00014;WHAT NON-INVASIVE TESTS CAN BE PERFORMED FOR THE EVALUATION OF EXOCRINE PANCREATIC FUNCTION IN PATIENTS WITH CF?;852;2222
00014;WHAT NON-INVASIVE TESTS CAN BE PERFORMED FOR THE EVALUATION OF EXOCRINE PANCREATIC FUNCTION IN PATIENTS WITH CF?;889;0001
00014;WHAT NON-INVASIVE TESTS CAN BE PERFORMED FOR THE EVALUATION OF EXOCRINE PANCREATIC FUNCTION IN PATIENTS WITH CF?;899;2222
00014;WHAT NON-INVASIVE TESTS CAN BE PERFORMED FOR THE EVALUATION OF EXOCRINE PANCREATIC FUNCTION IN PATIENTS WITH CF?;930;0002
00014;WHAT NON-INVASIVE TESTS CAN BE PERFORMED FOR THE EVALUATION OF EXOCRINE PANCREATIC FUNCTION IN PATIENTS WITH CF?;941;1011
00014;WHAT NON-INVASIVE TESTS CAN BE PERFORMED FOR THE EVALUATION OF EXOCRINE PANCREATIC FUNCTION IN PATIENTS WITH CF?;1000;0001
00014;WHAT NON-INVASIVE TESTS CAN BE PERFORMED FOR THE EVALUATION OF EXOCRINE PANCREATIC FUNCTION IN PATIENTS WITH CF?;1008;2220
00014;WHAT NON-INVASIVE TESTS CAN BE PERFORMED FOR THE EVALUATION OF EXOCRINE PANCREATIC FUNCTION IN PATIENTS WITH CF?;1013;0011
00014;WHAT NON-INVASIVE TESTS CAN BE PERFORMED FOR THE EVALUATION OF EXOCRINE PANCREATIC FUNCTION IN PATIENTS WITH CF?;1100;2222
00014;WHAT NON-INVASIVE TESTS CAN BE PERFORMED FOR THE EVALUATION OF EXOCRINE PANCREATIC FUNCTION IN PATIENTS WITH CF?;1117;2220
00014;WHAT NON-INVASIVE TESTS CAN BE PERFORMED FOR THE EVALUATION OF EXOCRINE PANCREATIC FUNCTION IN PATIENTS WITH CF?;1124;2122
00014;WHAT NON-INVASIVE TESTS CAN BE PERFORMED FOR THE EVALUATION OF EXOCRINE PANCREATIC FUNCTION IN PATIENTS WITH CF?;1135;1002
00014;WHAT NON-INVASIVE TESTS CAN BE PERFORMED FOR THE EVALUATION OF EXOCRINE PANCREATIC FUNCTION IN PATIENTS WITH CF?;1206;1000
00014;WHAT NON-INVASIVE TESTS CAN BE PERFORMED FOR THE EVALUATION OF EXOCRINE PANCREATIC FUNCTION IN PATIENTS WITH CF?;1234;1001
00015;WHAT ARE THE HEPATIC COMPLICATIONS OR MANIFESTATIONS OF CF?;17;0001
00015;WHAT ARE THE HEPATIC COMPLICATIONS OR MANIFESTATIONS OF CF?;59;2122
00015;WHAT ARE THE HEPATIC COMPLICATIONS OR MANIFESTATIONS OF CF?;63;1000
00015;WHAT ARE THE HEPATIC COMPLICATIONS OR MANIFESTATIONS OF CF?;72;0001
00015;WHAT ARE THE HEPATIC COMPLICATIONS OR MANIFESTATIONS OF CF?;91;0001
00015;WHAT ARE THE HEPATIC COMPLICATIONS OR MANIFESTATIONS OF CF?;95;0001
00015;WHAT ARE THE HEPATIC COMPLICATIONS OR MANIFESTATIONS OF CF?;97;0001
00015;WHAT ARE THE HEPATIC COMPLICATIONS OR MANIFESTATIONS OF CF?;98;0001
00015;WHAT ARE THE HEPATIC COMPLICATIONS OR MANIFESTATIONS OF CF?;99;2112
00015;WHAT ARE THE HEPATIC COMPLICATIONS OR MANIFESTATIONS OF CF?;135;0001
00015;WHAT ARE THE HEPATIC COMPLICATIONS OR MANIFESTATIONS OF CF?;149;1011
00015;WHAT ARE THE HEPATIC COMPLICATIONS OR MANIFESTATIONS OF CF?;174;2220
00015;WHAT ARE THE HEPATIC COMPLICATIONS OR MANIFESTATIONS OF CF?;197;1001
00015;WHAT ARE THE HEPATIC COMPLICATIONS OR MANIFESTATIONS OF CF?;204;2222
00015;WHAT ARE THE HEPATIC COMPLICATIONS OR MANIFESTATIONS OF CF?;205;2212
00015;WHAT ARE THE HEPATIC COMPLICATIONS OR MANIFESTATIONS OF CF?;226;0002
00015;WHAT ARE THE HEPATIC COMPLICATIONS OR MANIFESTATIONS OF CF?;232;0100
00015;WHAT ARE THE HEPATIC COMPLICATIONS OR MANIFESTATIONS OF CF?;238;0001
00015;WHAT ARE THE HEPATIC COMPLICATIONS OR MANIFESTATIONS OF CF?;266;2222
00015;WHAT ARE THE HEPATIC COMPLICATIONS OR MANIFESTATIONS OF CF?;297;0001
00015;WHAT ARE THE HEPATIC COMPLICATIONS OR MANIFESTATIONS OF CF?;301;2122
00015;WHAT ARE THE HEPATIC COMPLICATIONS OR MANIFESTATIONS OF CF?;322;2122
00015;WHAT ARE THE HEPATIC COMPLICATIONS OR MANIFESTATIONS OF CF?;339;2212
00015;WHAT ARE THE HEPATIC COMPLICATIONS OR MANIFESTATIONS OF CF?;350;0001
00015;WHAT ARE THE HEPATIC COMPLICATIONS OR MANIFESTATIONS OF CF?;354;0001
00015;WHAT ARE THE HEPATIC COMPLICATIONS OR MANIFESTATIONS OF CF?;355;2112
00015;WHAT ARE THE HEPATIC COMPLICATIONS OR MANIFESTATIONS OF CF?;364;1112
00015;WHAT ARE THE HEPATIC COMPLICATIONS OR MANIFESTATIONS OF CF?;370;2111
00015;WHAT ARE THE HEPATIC COMPLICATIONS OR MANIFESTATIONS OF CF?;385;2222
00015;WHAT ARE THE HEPATIC COMPLICATIONS OR MANIFESTATIONS OF CF?;398;0011
00015;WHAT ARE THE HEPATIC COMPLICATIONS OR MANIFESTATIONS OF CF?;408;0100
00015;WHAT ARE THE HEPATIC COMPLICATIONS OR MANIFESTATIONS OF CF?;410;1102
00015;WHAT ARE THE HEPATIC COMPLICATIONS OR MANIFESTATIONS OF CF?;413;0100
00015;WHAT ARE THE HEPATIC COMPLICATIONS OR MANIFESTATIONS OF CF?;414;0100
00015;WHAT ARE THE HEPATIC COMPLICATIONS OR MANIFESTATIONS OF CF?;420;0001
00015;WHAT ARE THE HEPATIC COMPLICATIONS OR MANIFESTATIONS OF CF?;422;2222
00015;WHAT ARE THE HEPATIC COMPLICATIONS OR MANIFESTATIONS OF CF?;423;2221
00015;WHAT ARE THE HEPATIC COMPLICATIONS OR MANIFESTATIONS OF CF?;424;0010
00015;WHAT ARE THE HEPATIC COMPLICATIONS OR MANIFESTATIONS OF CF?;426;0001
00015;WHAT ARE THE HEPATIC COMPLICATIONS OR MANIFESTATIONS OF CF?;434;0001
00015;WHAT ARE THE HEPATIC COMPLICATIONS OR MANIFESTATIONS OF CF?;443;2222
00015;WHAT ARE THE HEPATIC COMPLICATIONS OR MANIFESTATIONS OF CF?;474;1120
00015;WHAT ARE THE HEPATIC COMPLICATIONS OR MANIFESTATIONS OF CF?;545;1212
00015;WHAT ARE THE HEPATIC COMPLICATIONS OR MANIFESTATIONS OF CF?;549;2112
00015;WHAT ARE THE HEPATIC COMPLICATIONS OR MANIFESTATIONS OF CF?;550;0001
00015;WHAT ARE THE HEPATIC COMPLICATIONS OR MANIFESTATIONS OF CF?;601;2122
00015;WHAT ARE THE HEPATIC COMPLICATIONS OR MANIFESTATIONS OF CF?;603;0011
00015;WHAT ARE THE HEPATIC COMPLICATIONS OR MANIFESTATIONS OF CF?;611;0001
00015;WHAT ARE THE HEPATIC COMPLICATIONS OR MANIFESTATIONS OF CF?;642;1010
00015;WHAT ARE THE HEPATIC COMPLICATIONS OR MANIFESTATIONS OF CF?;643;0001
00015;WHAT ARE THE HEPATIC COMPLICATIONS OR MANIFESTATIONS OF CF?;657;0001
00015;WHAT ARE THE HEPATIC COMPLICATIONS OR MANIFESTATIONS OF CF?;673;0001
00015;WHAT ARE THE HEPATIC COMPLICATIONS OR MANIFESTATIONS OF CF?;690;2121
00015;WHAT ARE THE HEPATIC COMPLICATIONS OR MANIFESTATIONS OF CF?;700;2212
00015;WHAT ARE THE HEPATIC COMPLICATIONS OR MANIFESTATIONS OF CF?;720;2222
00015;WHAT ARE THE HEPATIC COMPLICATIONS OR MANIFESTATIONS OF CF?;722;1122
00015;WHAT ARE THE HEPATIC COMPLICATIONS OR MANIFESTATIONS OF CF?;724;0001
00015;WHAT ARE THE HEPATIC COMPLICATIONS OR MANIFESTATIONS OF CF?;725;1010
00015;WHAT ARE THE HEPATIC COMPLICATIONS OR MANIFESTATIONS OF CF?;729;0001
00015;WHAT ARE THE HEPATIC COMPLICATIONS OR MANIFESTATIONS OF CF?;731;0001
00015;WHAT ARE THE HEPATIC COMPLICATIONS OR MANIFESTATIONS OF CF?;735;0001
00015;WHAT ARE THE HEPATIC COMPLICATIONS OR MANIFESTATIONS OF CF?;747;1010
00015;WHAT ARE THE HEPATIC COMPLICATIONS OR MANIFESTATIONS OF CF?;752;2212
00015;WHAT ARE THE HEPATIC COMPLICATIONS OR MANIFESTATIONS OF CF?;763;1102
00015;WHAT ARE THE HEPATIC COMPLICATIONS OR MANIFESTATIONS OF CF?;764;1001
00015;WHAT ARE THE HEPATIC COMPLICATIONS OR MANIFESTATIONS OF CF?;767;0001
00015;WHAT ARE THE HEPATIC COMPLICATIONS OR MANIFESTATIONS OF CF?;792;0010
00015;WHAT ARE THE HEPATIC COMPLICATIONS OR MANIFESTATIONS OF CF?;794;1000
00015;WHAT ARE THE HEPATIC COMPLICATIONS OR MANIFESTATIONS OF CF?;816;0001
00015;WHAT ARE THE HEPATIC COMPLICATIONS OR MANIFESTATIONS OF CF?;822;0002
00015;WHAT ARE THE HEPATIC COMPLICATIONS OR MANIFESTATIONS OF CF?;833;0001
00015;WHAT ARE THE HEPATIC COMPLICATIONS OR MANIFESTATIONS OF CF?;837;0001
00015;WHAT ARE THE HEPATIC COMPLICATIONS OR MANIFESTATIONS OF CF?;844;0002
00015;WHAT ARE THE HEPATIC COMPLICATIONS OR MANIFESTATIONS OF CF?;853;1000
00015;WHAT ARE THE HEPATIC COMPLICATIONS OR MANIFESTATIONS OF CF?;854;1101
00015;WHAT ARE THE HEPATIC COMPLICATIONS OR MANIFESTATIONS OF CF?;857;1000
00015;WHAT ARE THE HEPATIC COMPLICATIONS OR MANIFESTATIONS OF CF?;863;1001
00015;WHAT ARE THE HEPATIC COMPLICATIONS OR MANIFESTATIONS OF CF?;870;2222
00015;WHAT ARE THE HEPATIC COMPLICATIONS OR MANIFESTATIONS OF CF?;875;0001
00015;WHAT ARE THE HEPATIC COMPLICATIONS OR MANIFESTATIONS OF CF?;888;0001
00015;WHAT ARE THE HEPATIC COMPLICATIONS OR MANIFESTATIONS OF CF?;889;0001
00015;WHAT ARE THE HEPATIC COMPLICATIONS OR MANIFESTATIONS OF CF?;900;1001
00015;WHAT ARE THE HEPATIC COMPLICATIONS OR MANIFESTATIONS OF CF?;944;1002
00015;WHAT ARE THE HEPATIC COMPLICATIONS OR MANIFESTATIONS OF CF?;990;0002
00015;WHAT ARE THE HEPATIC COMPLICATIONS OR MANIFESTATIONS OF CF?;993;1000
00015;WHAT ARE THE HEPATIC COMPLICATIONS OR MANIFESTATIONS OF CF?;994;1221
00015;WHAT ARE THE HEPATIC COMPLICATIONS OR MANIFESTATIONS OF CF?;1000;1002
00015;WHAT ARE THE HEPATIC COMPLICATIONS OR MANIFESTATIONS OF CF?;1013;1001
00015;WHAT ARE THE HEPATIC COMPLICATIONS OR MANIFESTATIONS OF CF?;1016;1001
00015;WHAT ARE THE HEPATIC COMPLICATIONS OR MANIFESTATIONS OF CF?;1027;0010
00015;WHAT ARE THE HEPATIC COMPLICATIONS OR MANIFESTATIONS OF CF?;1033;0001
00015;WHAT ARE THE HEPATIC COMPLICATIONS OR MANIFESTATIONS OF CF?;1040;0002
00015;WHAT ARE THE HEPATIC COMPLICATIONS OR MANIFESTATIONS OF CF?;1093;0001
00015;WHAT ARE THE HEPATIC COMPLICATIONS OR MANIFESTATIONS OF CF?;1098;0002
00015;WHAT ARE THE HEPATIC COMPLICATIONS OR MANIFESTATIONS OF CF?;1115;0002
00015;WHAT ARE THE HEPATIC COMPLICATIONS OR MANIFESTATIONS OF CF?;1162;0012
00015;WHAT ARE THE HEPATIC COMPLICATIONS OR MANIFESTATIONS OF CF?;1184;2222
00015;WHAT ARE THE HEPATIC COMPLICATIONS OR MANIFESTATIONS OF CF?;1187;0001
00015;WHAT ARE THE HEPATIC COMPLICATIONS OR MANIFESTATIONS OF CF?;1192;2222
00015;WHAT ARE THE HEPATIC COMPLICATIONS OR MANIFESTATIONS OF CF?;1195;0001
00015;WHAT ARE THE HEPATIC COMPLICATIONS OR MANIFESTATIONS OF CF?;1226;0002
00015;WHAT ARE THE HEPATIC COMPLICATIONS OR MANIFESTATIONS OF CF?;1232;0001
00015;WHAT ARE THE HEPATIC COMPLICATIONS OR MANIFESTATIONS OF CF?;1234;0001
00015;WHAT ARE THE HEPATIC COMPLICATIONS OR MANIFESTATIONS OF CF?;1235;2220
00016;WHAT ARE THE GASTROINTESTINAL COMPLICATIONS OF CF AFTER THE NEONATAL PERIOD (EXCLUDE LIVER DISEASE AND MECONIUM ILEUS)?;5;0001
00016;WHAT ARE THE GASTROINTESTINAL COMPLICATIONS OF CF AFTER THE NEONATAL PERIOD (EXCLUDE LIVER DISEASE AND MECONIUM ILEUS)?;10;0001
00016;WHAT ARE THE GASTROINTESTINAL COMPLICATIONS OF CF AFTER THE NEONATAL PERIOD (EXCLUDE LIVER DISEASE AND MECONIUM ILEUS)?;17;0001
00016;WHAT ARE THE GASTROINTESTINAL COMPLICATIONS OF CF AFTER THE NEONATAL PERIOD (EXCLUDE LIVER DISEASE AND MECONIUM ILEUS)?;36;0010
00016;WHAT ARE THE GASTROINTESTINAL COMPLICATIONS OF CF AFTER THE NEONATAL PERIOD (EXCLUDE LIVER DISEASE AND MECONIUM ILEUS)?;41;0110
00016;WHAT ARE THE GASTROINTESTINAL COMPLICATIONS OF CF AFTER THE NEONATAL PERIOD (EXCLUDE LIVER DISEASE AND MECONIUM ILEUS)?;46;1111
00016;WHAT ARE THE GASTROINTESTINAL COMPLICATIONS OF CF AFTER THE NEONATAL PERIOD (EXCLUDE LIVER DISEASE AND MECONIUM ILEUS)?;69;0002
00016;WHAT ARE THE GASTROINTESTINAL COMPLICATIONS OF CF AFTER THE NEONATAL PERIOD (EXCLUDE LIVER DISEASE AND MECONIUM ILEUS)?;72;0001
00016;WHAT ARE THE GASTROINTESTINAL COMPLICATIONS OF CF AFTER THE NEONATAL PERIOD (EXCLUDE LIVER DISEASE AND MECONIUM ILEUS)?;89;2222
00016;WHAT ARE THE GASTROINTESTINAL COMPLICATIONS OF CF AFTER THE NEONATAL PERIOD (EXCLUDE LIVER DISEASE AND MECONIUM ILEUS)?;92;0010
00016;WHAT ARE THE GASTROINTESTINAL COMPLICATIONS OF CF AFTER THE NEONATAL PERIOD (EXCLUDE LIVER DISEASE AND MECONIUM ILEUS)?;95;2222
00016;WHAT ARE THE GASTROINTESTINAL COMPLICATIONS OF CF AFTER THE NEONATAL PERIOD (EXCLUDE LIVER DISEASE AND MECONIUM ILEUS)?;97;1000
00016;WHAT ARE THE GASTROINTESTINAL COMPLICATIONS OF CF AFTER THE NEONATAL PERIOD (EXCLUDE LIVER DISEASE AND MECONIUM ILEUS)?;98;1000
00016;WHAT ARE THE GASTROINTESTINAL COMPLICATIONS OF CF AFTER THE NEONATAL PERIOD (EXCLUDE LIVER DISEASE AND MECONIUM ILEUS)?;126;0001
00016;WHAT ARE THE GASTROINTESTINAL COMPLICATIONS OF CF AFTER THE NEONATAL PERIOD (EXCLUDE LIVER DISEASE AND MECONIUM ILEUS)?;129;2120
00016;WHAT ARE THE GASTROINTESTINAL COMPLICATIONS OF CF AFTER THE NEONATAL PERIOD (EXCLUDE LIVER DISEASE AND MECONIUM ILEUS)?;130;0001
00016;WHAT ARE THE GASTROINTESTINAL COMPLICATIONS OF CF AFTER THE NEONATAL PERIOD (EXCLUDE LIVER DISEASE AND MECONIUM ILEUS)?;132;0001
00016;WHAT ARE THE GASTROINTESTINAL COMPLICATIONS OF CF AFTER THE NEONATAL PERIOD (EXCLUDE LIVER DISEASE AND MECONIUM ILEUS)?;134;1000
00016;WHAT ARE THE GASTROINTESTINAL COMPLICATIONS OF CF AFTER THE NEONATAL PERIOD (EXCLUDE LIVER DISEASE AND MECONIUM ILEUS)?;135;0012
00016;WHAT ARE THE GASTROINTESTINAL COMPLICATIONS OF CF AFTER THE NEONATAL PERIOD (EXCLUDE LIVER DISEASE AND MECONIUM ILEUS)?;148;0001
00016;WHAT ARE THE GASTROINTESTINAL COMPLICATIONS OF CF AFTER THE NEONATAL PERIOD (EXCLUDE LIVER DISEASE AND MECONIUM ILEUS)?;150;1000
00016;WHAT ARE THE GASTROINTESTINAL COMPLICATIONS OF CF AFTER THE NEONATAL PERIOD (EXCLUDE LIVER DISEASE AND MECONIUM ILEUS)?;168;0001
00016;WHAT ARE THE GASTROINTESTINAL COMPLICATIONS OF CF AFTER THE NEONATAL PERIOD (EXCLUDE LIVER DISEASE AND MECONIUM ILEUS)?;181;1011
00016;WHAT ARE THE GASTROINTESTINAL COMPLICATIONS OF CF AFTER THE NEONATAL PERIOD (EXCLUDE LIVER DISEASE AND MECONIUM ILEUS)?;182;2222
00016;WHAT ARE THE GASTROINTESTINAL COMPLICATIONS OF CF AFTER THE NEONATAL PERIOD (EXCLUDE LIVER DISEASE AND MECONIUM ILEUS)?;186;2122
00016;WHAT ARE THE GASTROINTESTINAL COMPLICATIONS OF CF AFTER THE NEONATAL PERIOD (EXCLUDE LIVER DISEASE AND MECONIUM ILEUS)?;189;0001
00016;WHAT ARE THE GASTROINTESTINAL COMPLICATIONS OF CF AFTER THE NEONATAL PERIOD (EXCLUDE LIVER DISEASE AND MECONIUM ILEUS)?;197;1000
00016;WHAT ARE THE GASTROINTESTINAL COMPLICATIONS OF CF AFTER THE NEONATAL PERIOD (EXCLUDE LIVER DISEASE AND MECONIUM ILEUS)?;202;1000
00016;WHAT ARE THE GASTROINTESTINAL COMPLICATIONS OF CF AFTER THE NEONATAL PERIOD (EXCLUDE LIVER DISEASE AND MECONIUM ILEUS)?;205;0001
00016;WHAT ARE THE GASTROINTESTINAL COMPLICATIONS OF CF AFTER THE NEONATAL PERIOD (EXCLUDE LIVER DISEASE AND MECONIUM ILEUS)?;212;0001
00016;WHAT ARE THE GASTROINTESTINAL COMPLICATIONS OF CF AFTER THE NEONATAL PERIOD (EXCLUDE LIVER DISEASE AND MECONIUM ILEUS)?;225;0001
00016;WHAT ARE THE GASTROINTESTINAL COMPLICATIONS OF CF AFTER THE NEONATAL PERIOD (EXCLUDE LIVER DISEASE AND MECONIUM ILEUS)?;226;0002
00016;WHAT ARE THE GASTROINTESTINAL COMPLICATIONS OF CF AFTER THE NEONATAL PERIOD (EXCLUDE LIVER DISEASE AND MECONIUM ILEUS)?;238;0011
00016;WHAT ARE THE GASTROINTESTINAL COMPLICATIONS OF CF AFTER THE NEONATAL PERIOD (EXCLUDE LIVER DISEASE AND MECONIUM ILEUS)?;240;2210
00016;WHAT ARE THE GASTROINTESTINAL COMPLICATIONS OF CF AFTER THE NEONATAL PERIOD (EXCLUDE LIVER DISEASE AND MECONIUM ILEUS)?;255;0001
00016;WHAT ARE THE GASTROINTESTINAL COMPLICATIONS OF CF AFTER THE NEONATAL PERIOD (EXCLUDE LIVER DISEASE AND MECONIUM ILEUS)?;288;0001
00016;WHAT ARE THE GASTROINTESTINAL COMPLICATIONS OF CF AFTER THE NEONATAL PERIOD (EXCLUDE LIVER DISEASE AND MECONIUM ILEUS)?;290;0001
00016;WHAT ARE THE GASTROINTESTINAL COMPLICATIONS OF CF AFTER THE NEONATAL PERIOD (EXCLUDE LIVER DISEASE AND MECONIUM ILEUS)?;292;0001
00016;WHAT ARE THE GASTROINTESTINAL COMPLICATIONS OF CF AFTER THE NEONATAL PERIOD (EXCLUDE LIVER DISEASE AND MECONIUM ILEUS)?;297;0001
00016;WHAT ARE THE GASTROINTESTINAL COMPLICATIONS OF CF AFTER THE NEONATAL PERIOD (EXCLUDE LIVER DISEASE AND MECONIUM ILEUS)?;298;1001
00016;WHAT ARE THE GASTROINTESTINAL COMPLICATIONS OF CF AFTER THE NEONATAL PERIOD (EXCLUDE LIVER DISEASE AND MECONIUM ILEUS)?;301;2222
00016;WHAT ARE THE GASTROINTESTINAL COMPLICATIONS OF CF AFTER THE NEONATAL PERIOD (EXCLUDE LIVER DISEASE AND MECONIUM ILEUS)?;314;2120
00016;WHAT ARE THE GASTROINTESTINAL COMPLICATIONS OF CF AFTER THE NEONATAL PERIOD (EXCLUDE LIVER DISEASE AND MECONIUM ILEUS)?;320;0001
00016;WHAT ARE THE GASTROINTESTINAL COMPLICATIONS OF CF AFTER THE NEONATAL PERIOD (EXCLUDE LIVER DISEASE AND MECONIUM ILEUS)?;322;1122
00016;WHAT ARE THE GASTROINTESTINAL COMPLICATIONS OF CF AFTER THE NEONATAL PERIOD (EXCLUDE LIVER DISEASE AND MECONIUM ILEUS)?;330;0001
00016;WHAT ARE THE GASTROINTESTINAL COMPLICATIONS OF CF AFTER THE NEONATAL PERIOD (EXCLUDE LIVER DISEASE AND MECONIUM ILEUS)?;331;0001
00016;WHAT ARE THE GASTROINTESTINAL COMPLICATIONS OF CF AFTER THE NEONATAL PERIOD (EXCLUDE LIVER DISEASE AND MECONIUM ILEUS)?;333;1001
00016;WHAT ARE THE GASTROINTESTINAL COMPLICATIONS OF CF AFTER THE NEONATAL PERIOD (EXCLUDE LIVER DISEASE AND MECONIUM ILEUS)?;350;0011
00016;WHAT ARE THE GASTROINTESTINAL COMPLICATIONS OF CF AFTER THE NEONATAL PERIOD (EXCLUDE LIVER DISEASE AND MECONIUM ILEUS)?;357;0001
00016;WHAT ARE THE GASTROINTESTINAL COMPLICATIONS OF CF AFTER THE NEONATAL PERIOD (EXCLUDE LIVER DISEASE AND MECONIUM ILEUS)?;359;0012
00016;WHAT ARE THE GASTROINTESTINAL COMPLICATIONS OF CF AFTER THE NEONATAL PERIOD (EXCLUDE LIVER DISEASE AND MECONIUM ILEUS)?;364;2112
00016;WHAT ARE THE GASTROINTESTINAL COMPLICATIONS OF CF AFTER THE NEONATAL PERIOD (EXCLUDE LIVER DISEASE AND MECONIUM ILEUS)?;370;2112
00016;WHAT ARE THE GASTROINTESTINAL COMPLICATIONS OF CF AFTER THE NEONATAL PERIOD (EXCLUDE LIVER DISEASE AND MECONIUM ILEUS)?;376;2220
00016;WHAT ARE THE GASTROINTESTINAL COMPLICATIONS OF CF AFTER THE NEONATAL PERIOD (EXCLUDE LIVER DISEASE AND MECONIUM ILEUS)?;386;0001
00016;WHAT ARE THE GASTROINTESTINAL COMPLICATIONS OF CF AFTER THE NEONATAL PERIOD (EXCLUDE LIVER DISEASE AND MECONIUM ILEUS)?;396;2222
00016;WHAT ARE THE GASTROINTESTINAL COMPLICATIONS OF CF AFTER THE NEONATAL PERIOD (EXCLUDE LIVER DISEASE AND MECONIUM ILEUS)?;398;1010
00016;WHAT ARE THE GASTROINTESTINAL COMPLICATIONS OF CF AFTER THE NEONATAL PERIOD (EXCLUDE LIVER DISEASE AND MECONIUM ILEUS)?;413;0001
00016;WHAT ARE THE GASTROINTESTINAL COMPLICATIONS OF CF AFTER THE NEONATAL PERIOD (EXCLUDE LIVER DISEASE AND MECONIUM ILEUS)?;421;1000
00016;WHAT ARE THE GASTROINTESTINAL COMPLICATIONS OF CF AFTER THE NEONATAL PERIOD (EXCLUDE LIVER DISEASE AND MECONIUM ILEUS)?;424;1012
00016;WHAT ARE THE GASTROINTESTINAL COMPLICATIONS OF CF AFTER THE NEONATAL PERIOD (EXCLUDE LIVER DISEASE AND MECONIUM ILEUS)?;428;1002
00016;WHAT ARE THE GASTROINTESTINAL COMPLICATIONS OF CF AFTER THE NEONATAL PERIOD (EXCLUDE LIVER DISEASE AND MECONIUM ILEUS)?;434;0010
00016;WHAT ARE THE GASTROINTESTINAL COMPLICATIONS OF CF AFTER THE NEONATAL PERIOD (EXCLUDE LIVER DISEASE AND MECONIUM ILEUS)?;443;2222
00016;WHAT ARE THE GASTROINTESTINAL COMPLICATIONS OF CF AFTER THE NEONATAL PERIOD (EXCLUDE LIVER DISEASE AND MECONIUM ILEUS)?;462;0010
00016;WHAT ARE THE GASTROINTESTINAL COMPLICATIONS OF CF AFTER THE NEONATAL PERIOD (EXCLUDE LIVER DISEASE AND MECONIUM ILEUS)?;466;1222
00016;WHAT ARE THE GASTROINTESTINAL COMPLICATIONS OF CF AFTER THE NEONATAL PERIOD (EXCLUDE LIVER DISEASE AND MECONIUM ILEUS)?;468;2121
00016;WHAT ARE THE GASTROINTESTINAL COMPLICATIONS OF CF AFTER THE NEONATAL PERIOD (EXCLUDE LIVER DISEASE AND MECONIUM ILEUS)?;472;0010
00016;WHAT ARE THE GASTROINTESTINAL COMPLICATIONS OF CF AFTER THE NEONATAL PERIOD (EXCLUDE LIVER DISEASE AND MECONIUM ILEUS)?;473;0001
00016;WHAT ARE THE GASTROINTESTINAL COMPLICATIONS OF CF AFTER THE NEONATAL PERIOD (EXCLUDE LIVER DISEASE AND MECONIUM ILEUS)?;475;2122
00016;WHAT ARE THE GASTROINTESTINAL COMPLICATIONS OF CF AFTER THE NEONATAL PERIOD (EXCLUDE LIVER DISEASE AND MECONIUM ILEUS)?;478;0011
00016;WHAT ARE THE GASTROINTESTINAL COMPLICATIONS OF CF AFTER THE NEONATAL PERIOD (EXCLUDE LIVER DISEASE AND MECONIUM ILEUS)?;489;0001
00016;WHAT ARE THE GASTROINTESTINAL COMPLICATIONS OF CF AFTER THE NEONATAL PERIOD (EXCLUDE LIVER DISEASE AND MECONIUM ILEUS)?;490;0001
00016;WHAT ARE THE GASTROINTESTINAL COMPLICATIONS OF CF AFTER THE NEONATAL PERIOD (EXCLUDE LIVER DISEASE AND MECONIUM ILEUS)?;510;0001
00016;WHAT ARE THE GASTROINTESTINAL COMPLICATIONS OF CF AFTER THE NEONATAL PERIOD (EXCLUDE LIVER DISEASE AND MECONIUM ILEUS)?;512;0010
00016;WHAT ARE THE GASTROINTESTINAL COMPLICATIONS OF CF AFTER THE NEONATAL PERIOD (EXCLUDE LIVER DISEASE AND MECONIUM ILEUS)?;518;1011
00016;WHAT ARE THE GASTROINTESTINAL COMPLICATIONS OF CF AFTER THE NEONATAL PERIOD (EXCLUDE LIVER DISEASE AND MECONIUM ILEUS)?;522;2110
00016;WHAT ARE THE GASTROINTESTINAL COMPLICATIONS OF CF AFTER THE NEONATAL PERIOD (EXCLUDE LIVER DISEASE AND MECONIUM ILEUS)?;550;0012
00016;WHAT ARE THE GASTROINTESTINAL COMPLICATIONS OF CF AFTER THE NEONATAL PERIOD (EXCLUDE LIVER DISEASE AND MECONIUM ILEUS)?;553;0001
00016;WHAT ARE THE GASTROINTESTINAL COMPLICATIONS OF CF AFTER THE NEONATAL PERIOD (EXCLUDE LIVER DISEASE AND MECONIUM ILEUS)?;559;0001
00016;WHAT ARE THE GASTROINTESTINAL COMPLICATIONS OF CF AFTER THE NEONATAL PERIOD (EXCLUDE LIVER DISEASE AND MECONIUM ILEUS)?;581;0001
00016;WHAT ARE THE GASTROINTESTINAL COMPLICATIONS OF CF AFTER THE NEONATAL PERIOD (EXCLUDE LIVER DISEASE AND MECONIUM ILEUS)?;582;1010
00016;WHAT ARE THE GASTROINTESTINAL COMPLICATIONS OF CF AFTER THE NEONATAL PERIOD (EXCLUDE LIVER DISEASE AND MECONIUM ILEUS)?;586;0001
00016;WHAT ARE THE GASTROINTESTINAL COMPLICATIONS OF CF AFTER THE NEONATAL PERIOD (EXCLUDE LIVER DISEASE AND MECONIUM ILEUS)?;594;2220
00016;WHAT ARE THE GASTROINTESTINAL COMPLICATIONS OF CF AFTER THE NEONATAL PERIOD (EXCLUDE LIVER DISEASE AND MECONIUM ILEUS)?;615;0001
00016;WHAT ARE THE GASTROINTESTINAL COMPLICATIONS OF CF AFTER THE NEONATAL PERIOD (EXCLUDE LIVER DISEASE AND MECONIUM ILEUS)?;616;0001
00016;WHAT ARE THE GASTROINTESTINAL COMPLICATIONS OF CF AFTER THE NEONATAL PERIOD (EXCLUDE LIVER DISEASE AND MECONIUM ILEUS)?;641;1012
00016;WHAT ARE THE GASTROINTESTINAL COMPLICATIONS OF CF AFTER THE NEONATAL PERIOD (EXCLUDE LIVER DISEASE AND MECONIUM ILEUS)?;642;1102
00016;WHAT ARE THE GASTROINTESTINAL COMPLICATIONS OF CF AFTER THE NEONATAL PERIOD (EXCLUDE LIVER DISEASE AND MECONIUM ILEUS)?;643;0011
00016;WHAT ARE THE GASTROINTESTINAL COMPLICATIONS OF CF AFTER THE NEONATAL PERIOD (EXCLUDE LIVER DISEASE AND MECONIUM ILEUS)?;649;2122
00016;WHAT ARE THE GASTROINTESTINAL COMPLICATIONS OF CF AFTER THE NEONATAL PERIOD (EXCLUDE LIVER DISEASE AND MECONIUM ILEUS)?;656;0001
00016;WHAT ARE THE GASTROINTESTINAL COMPLICATIONS OF CF AFTER THE NEONATAL PERIOD (EXCLUDE LIVER DISEASE AND MECONIUM ILEUS)?;657;1001
00016;WHAT ARE THE GASTROINTESTINAL COMPLICATIONS OF CF AFTER THE NEONATAL PERIOD (EXCLUDE LIVER DISEASE AND MECONIUM ILEUS)?;658;1001
00016;WHAT ARE THE GASTROINTESTINAL COMPLICATIONS OF CF AFTER THE NEONATAL PERIOD (EXCLUDE LIVER DISEASE AND MECONIUM ILEUS)?;659;2122
00016;WHAT ARE THE GASTROINTESTINAL COMPLICATIONS OF CF AFTER THE NEONATAL PERIOD (EXCLUDE LIVER DISEASE AND MECONIUM ILEUS)?;660;1001
00016;WHAT ARE THE GASTROINTESTINAL COMPLICATIONS OF CF AFTER THE NEONATAL PERIOD (EXCLUDE LIVER DISEASE AND MECONIUM ILEUS)?;662;1001
00016;WHAT ARE THE GASTROINTESTINAL COMPLICATIONS OF CF AFTER THE NEONATAL PERIOD (EXCLUDE LIVER DISEASE AND MECONIUM ILEUS)?;673;0001
00016;WHAT ARE THE GASTROINTESTINAL COMPLICATIONS OF CF AFTER THE NEONATAL PERIOD (EXCLUDE LIVER DISEASE AND MECONIUM ILEUS)?;676;0002
00016;WHAT ARE THE GASTROINTESTINAL COMPLICATIONS OF CF AFTER THE NEONATAL PERIOD (EXCLUDE LIVER DISEASE AND MECONIUM ILEUS)?;708;1000
00016;WHAT ARE THE GASTROINTESTINAL COMPLICATIONS OF CF AFTER THE NEONATAL PERIOD (EXCLUDE LIVER DISEASE AND MECONIUM ILEUS)?;709;1000
00016;WHAT ARE THE GASTROINTESTINAL COMPLICATIONS OF CF AFTER THE NEONATAL PERIOD (EXCLUDE LIVER DISEASE AND MECONIUM ILEUS)?;711;0001
00016;WHAT ARE THE GASTROINTESTINAL COMPLICATIONS OF CF AFTER THE NEONATAL PERIOD (EXCLUDE LIVER DISEASE AND MECONIUM ILEUS)?;715;0001
00016;WHAT ARE THE GASTROINTESTINAL COMPLICATIONS OF CF AFTER THE NEONATAL PERIOD (EXCLUDE LIVER DISEASE AND MECONIUM ILEUS)?;719;1001
00016;WHAT ARE THE GASTROINTESTINAL COMPLICATIONS OF CF AFTER THE NEONATAL PERIOD (EXCLUDE LIVER DISEASE AND MECONIUM ILEUS)?;722;1122
00016;WHAT ARE THE GASTROINTESTINAL COMPLICATIONS OF CF AFTER THE NEONATAL PERIOD (EXCLUDE LIVER DISEASE AND MECONIUM ILEUS)?;723;0001
00016;WHAT ARE THE GASTROINTESTINAL COMPLICATIONS OF CF AFTER THE NEONATAL PERIOD (EXCLUDE LIVER DISEASE AND MECONIUM ILEUS)?;724;0001
00016;WHAT ARE THE GASTROINTESTINAL COMPLICATIONS OF CF AFTER THE NEONATAL PERIOD (EXCLUDE LIVER DISEASE AND MECONIUM ILEUS)?;725;0001
00016;WHAT ARE THE GASTROINTESTINAL COMPLICATIONS OF CF AFTER THE NEONATAL PERIOD (EXCLUDE LIVER DISEASE AND MECONIUM ILEUS)?;727;1222
00016;WHAT ARE THE GASTROINTESTINAL COMPLICATIONS OF CF AFTER THE NEONATAL PERIOD (EXCLUDE LIVER DISEASE AND MECONIUM ILEUS)?;729;0001
00016;WHAT ARE THE GASTROINTESTINAL COMPLICATIONS OF CF AFTER THE NEONATAL PERIOD (EXCLUDE LIVER DISEASE AND MECONIUM ILEUS)?;730;0001
00016;WHAT ARE THE GASTROINTESTINAL COMPLICATIONS OF CF AFTER THE NEONATAL PERIOD (EXCLUDE LIVER DISEASE AND MECONIUM ILEUS)?;731;0002
00016;WHAT ARE THE GASTROINTESTINAL COMPLICATIONS OF CF AFTER THE NEONATAL PERIOD (EXCLUDE LIVER DISEASE AND MECONIUM ILEUS)?;735;0001
00016;WHAT ARE THE GASTROINTESTINAL COMPLICATIONS OF CF AFTER THE NEONATAL PERIOD (EXCLUDE LIVER DISEASE AND MECONIUM ILEUS)?;755;1011
00016;WHAT ARE THE GASTROINTESTINAL COMPLICATIONS OF CF AFTER THE NEONATAL PERIOD (EXCLUDE LIVER DISEASE AND MECONIUM ILEUS)?;756;1111
00016;WHAT ARE THE GASTROINTESTINAL COMPLICATIONS OF CF AFTER THE NEONATAL PERIOD (EXCLUDE LIVER DISEASE AND MECONIUM ILEUS)?;758;0001
00016;WHAT ARE THE GASTROINTESTINAL COMPLICATIONS OF CF AFTER THE NEONATAL PERIOD (EXCLUDE LIVER DISEASE AND MECONIUM ILEUS)?;762;0010
00016;WHAT ARE THE GASTROINTESTINAL COMPLICATIONS OF CF AFTER THE NEONATAL PERIOD (EXCLUDE LIVER DISEASE AND MECONIUM ILEUS)?;763;1102
00016;WHAT ARE THE GASTROINTESTINAL COMPLICATIONS OF CF AFTER THE NEONATAL PERIOD (EXCLUDE LIVER DISEASE AND MECONIUM ILEUS)?;764;0002
00016;WHAT ARE THE GASTROINTESTINAL COMPLICATIONS OF CF AFTER THE NEONATAL PERIOD (EXCLUDE LIVER DISEASE AND MECONIUM ILEUS)?;767;0001
00016;WHAT ARE THE GASTROINTESTINAL COMPLICATIONS OF CF AFTER THE NEONATAL PERIOD (EXCLUDE LIVER DISEASE AND MECONIUM ILEUS)?;770;1100
00016;WHAT ARE THE GASTROINTESTINAL COMPLICATIONS OF CF AFTER THE NEONATAL PERIOD (EXCLUDE LIVER DISEASE AND MECONIUM ILEUS)?;772;2122
00016;WHAT ARE THE GASTROINTESTINAL COMPLICATIONS OF CF AFTER THE NEONATAL PERIOD (EXCLUDE LIVER DISEASE AND MECONIUM ILEUS)?;783;1000
00016;WHAT ARE THE GASTROINTESTINAL COMPLICATIONS OF CF AFTER THE NEONATAL PERIOD (EXCLUDE LIVER DISEASE AND MECONIUM ILEUS)?;791;1001
00016;WHAT ARE THE GASTROINTESTINAL COMPLICATIONS OF CF AFTER THE NEONATAL PERIOD (EXCLUDE LIVER DISEASE AND MECONIUM ILEUS)?;797;0001
00016;WHAT ARE THE GASTROINTESTINAL COMPLICATIONS OF CF AFTER THE NEONATAL PERIOD (EXCLUDE LIVER DISEASE AND MECONIUM ILEUS)?;799;2222
00016;WHAT ARE THE GASTROINTESTINAL COMPLICATIONS OF CF AFTER THE NEONATAL PERIOD (EXCLUDE LIVER DISEASE AND MECONIUM ILEUS)?;809;1000
00016;WHAT ARE THE GASTROINTESTINAL COMPLICATIONS OF CF AFTER THE NEONATAL PERIOD (EXCLUDE LIVER DISEASE AND MECONIUM ILEUS)?;810;0001
00016;WHAT ARE THE GASTROINTESTINAL COMPLICATIONS OF CF AFTER THE NEONATAL PERIOD (EXCLUDE LIVER DISEASE AND MECONIUM ILEUS)?;816;0011
00016;WHAT ARE THE GASTROINTESTINAL COMPLICATIONS OF CF AFTER THE NEONATAL PERIOD (EXCLUDE LIVER DISEASE AND MECONIUM ILEUS)?;822;0002
00016;WHAT ARE THE GASTROINTESTINAL COMPLICATIONS OF CF AFTER THE NEONATAL PERIOD (EXCLUDE LIVER DISEASE AND MECONIUM ILEUS)?;834;2222
00016;WHAT ARE THE GASTROINTESTINAL COMPLICATIONS OF CF AFTER THE NEONATAL PERIOD (EXCLUDE LIVER DISEASE AND MECONIUM ILEUS)?;835;0001
00016;WHAT ARE THE GASTROINTESTINAL COMPLICATIONS OF CF AFTER THE NEONATAL PERIOD (EXCLUDE LIVER DISEASE AND MECONIUM ILEUS)?;837;0001
00016;WHAT ARE THE GASTROINTESTINAL COMPLICATIONS OF CF AFTER THE NEONATAL PERIOD (EXCLUDE LIVER DISEASE AND MECONIUM ILEUS)?;844;0002
00016;WHAT ARE THE GASTROINTESTINAL COMPLICATIONS OF CF AFTER THE NEONATAL PERIOD (EXCLUDE LIVER DISEASE AND MECONIUM ILEUS)?;867;0010
00016;WHAT ARE THE GASTROINTESTINAL COMPLICATIONS OF CF AFTER THE NEONATAL PERIOD (EXCLUDE LIVER DISEASE AND MECONIUM ILEUS)?;870;0001
00016;WHAT ARE THE GASTROINTESTINAL COMPLICATIONS OF CF AFTER THE NEONATAL PERIOD (EXCLUDE LIVER DISEASE AND MECONIUM ILEUS)?;872;2210
00016;WHAT ARE THE GASTROINTESTINAL COMPLICATIONS OF CF AFTER THE NEONATAL PERIOD (EXCLUDE LIVER DISEASE AND MECONIUM ILEUS)?;875;0001
00016;WHAT ARE THE GASTROINTESTINAL COMPLICATIONS OF CF AFTER THE NEONATAL PERIOD (EXCLUDE LIVER DISEASE AND MECONIUM ILEUS)?;882;0002
00016;WHAT ARE THE GASTROINTESTINAL COMPLICATIONS OF CF AFTER THE NEONATAL PERIOD (EXCLUDE LIVER DISEASE AND MECONIUM ILEUS)?;888;0002
00016;WHAT ARE THE GASTROINTESTINAL COMPLICATIONS OF CF AFTER THE NEONATAL PERIOD (EXCLUDE LIVER DISEASE AND MECONIUM ILEUS)?;889;0002
00016;WHAT ARE THE GASTROINTESTINAL COMPLICATIONS OF CF AFTER THE NEONATAL PERIOD (EXCLUDE LIVER DISEASE AND MECONIUM ILEUS)?;893;0001
00016;WHAT ARE THE GASTROINTESTINAL COMPLICATIONS OF CF AFTER THE NEONATAL PERIOD (EXCLUDE LIVER DISEASE AND MECONIUM ILEUS)?;896;1000
00016;WHAT ARE THE GASTROINTESTINAL COMPLICATIONS OF CF AFTER THE NEONATAL PERIOD (EXCLUDE LIVER DISEASE AND MECONIUM ILEUS)?;901;2210
00016;WHAT ARE THE GASTROINTESTINAL COMPLICATIONS OF CF AFTER THE NEONATAL PERIOD (EXCLUDE LIVER DISEASE AND MECONIUM ILEUS)?;902;1010
00016;WHAT ARE THE GASTROINTESTINAL COMPLICATIONS OF CF AFTER THE NEONATAL PERIOD (EXCLUDE LIVER DISEASE AND MECONIUM ILEUS)?;919;0001
00016;WHAT ARE THE GASTROINTESTINAL COMPLICATIONS OF CF AFTER THE NEONATAL PERIOD (EXCLUDE LIVER DISEASE AND MECONIUM ILEUS)?;928;1000
00016;WHAT ARE THE GASTROINTESTINAL COMPLICATIONS OF CF AFTER THE NEONATAL PERIOD (EXCLUDE LIVER DISEASE AND MECONIUM ILEUS)?;932;0001
00016;WHAT ARE THE GASTROINTESTINAL COMPLICATIONS OF CF AFTER THE NEONATAL PERIOD (EXCLUDE LIVER DISEASE AND MECONIUM ILEUS)?;935;1111
00016;WHAT ARE THE GASTROINTESTINAL COMPLICATIONS OF CF AFTER THE NEONATAL PERIOD (EXCLUDE LIVER DISEASE AND MECONIUM ILEUS)?;937;1001
00016;WHAT ARE THE GASTROINTESTINAL COMPLICATIONS OF CF AFTER THE NEONATAL PERIOD (EXCLUDE LIVER DISEASE AND MECONIUM ILEUS)?;938;0001
00016;WHAT ARE THE GASTROINTESTINAL COMPLICATIONS OF CF AFTER THE NEONATAL PERIOD (EXCLUDE LIVER DISEASE AND MECONIUM ILEUS)?;941;0001
00016;WHAT ARE THE GASTROINTESTINAL COMPLICATIONS OF CF AFTER THE NEONATAL PERIOD (EXCLUDE LIVER DISEASE AND MECONIUM ILEUS)?;943;0011
00016;WHAT ARE THE GASTROINTESTINAL COMPLICATIONS OF CF AFTER THE NEONATAL PERIOD (EXCLUDE LIVER DISEASE AND MECONIUM ILEUS)?;944;1001
00016;WHAT ARE THE GASTROINTESTINAL COMPLICATIONS OF CF AFTER THE NEONATAL PERIOD (EXCLUDE LIVER DISEASE AND MECONIUM ILEUS)?;970;0010
00016;WHAT ARE THE GASTROINTESTINAL COMPLICATIONS OF CF AFTER THE NEONATAL PERIOD (EXCLUDE LIVER DISEASE AND MECONIUM ILEUS)?;974;0010
00016;WHAT ARE THE GASTROINTESTINAL COMPLICATIONS OF CF AFTER THE NEONATAL PERIOD (EXCLUDE LIVER DISEASE AND MECONIUM ILEUS)?;984;1010
00016;WHAT ARE THE GASTROINTESTINAL COMPLICATIONS OF CF AFTER THE NEONATAL PERIOD (EXCLUDE LIVER DISEASE AND MECONIUM ILEUS)?;990;0001
00016;WHAT ARE THE GASTROINTESTINAL COMPLICATIONS OF CF AFTER THE NEONATAL PERIOD (EXCLUDE LIVER DISEASE AND MECONIUM ILEUS)?;991;1000
00016;WHAT ARE THE GASTROINTESTINAL COMPLICATIONS OF CF AFTER THE NEONATAL PERIOD (EXCLUDE LIVER DISEASE AND MECONIUM ILEUS)?;993;1122
00016;WHAT ARE THE GASTROINTESTINAL COMPLICATIONS OF CF AFTER THE NEONATAL PERIOD (EXCLUDE LIVER DISEASE AND MECONIUM ILEUS)?;994;0010
00016;WHAT ARE THE GASTROINTESTINAL COMPLICATIONS OF CF AFTER THE NEONATAL PERIOD (EXCLUDE LIVER DISEASE AND MECONIUM ILEUS)?;1000;1002
00016;WHAT ARE THE GASTROINTESTINAL COMPLICATIONS OF CF AFTER THE NEONATAL PERIOD (EXCLUDE LIVER DISEASE AND MECONIUM ILEUS)?;1002;1010
00016;WHAT ARE THE GASTROINTESTINAL COMPLICATIONS OF CF AFTER THE NEONATAL PERIOD (EXCLUDE LIVER DISEASE AND MECONIUM ILEUS)?;1016;1011
00016;WHAT ARE THE GASTROINTESTINAL COMPLICATIONS OF CF AFTER THE NEONATAL PERIOD (EXCLUDE LIVER DISEASE AND MECONIUM ILEUS)?;1017;2211
00016;WHAT ARE THE GASTROINTESTINAL COMPLICATIONS OF CF AFTER THE NEONATAL PERIOD (EXCLUDE LIVER DISEASE AND MECONIUM ILEUS)?;1023;0002
00016;WHAT ARE THE GASTROINTESTINAL COMPLICATIONS OF CF AFTER THE NEONATAL PERIOD (EXCLUDE LIVER DISEASE AND MECONIUM ILEUS)?;1033;0001
00016;WHAT ARE THE GASTROINTESTINAL COMPLICATIONS OF CF AFTER THE NEONATAL PERIOD (EXCLUDE LIVER DISEASE AND MECONIUM ILEUS)?;1037;0001
00016;WHAT ARE THE GASTROINTESTINAL COMPLICATIONS OF CF AFTER THE NEONATAL PERIOD (EXCLUDE LIVER DISEASE AND MECONIUM ILEUS)?;1051;1000
00016;WHAT ARE THE GASTROINTESTINAL COMPLICATIONS OF CF AFTER THE NEONATAL PERIOD (EXCLUDE LIVER DISEASE AND MECONIUM ILEUS)?;1066;0001
00016;WHAT ARE THE GASTROINTESTINAL COMPLICATIONS OF CF AFTER THE NEONATAL PERIOD (EXCLUDE LIVER DISEASE AND MECONIUM ILEUS)?;1076;0001
00016;WHAT ARE THE GASTROINTESTINAL COMPLICATIONS OF CF AFTER THE NEONATAL PERIOD (EXCLUDE LIVER DISEASE AND MECONIUM ILEUS)?;1080;0002
00016;WHAT ARE THE GASTROINTESTINAL COMPLICATIONS OF CF AFTER THE NEONATAL PERIOD (EXCLUDE LIVER DISEASE AND MECONIUM ILEUS)?;1098;0002
00016;WHAT ARE THE GASTROINTESTINAL COMPLICATIONS OF CF AFTER THE NEONATAL PERIOD (EXCLUDE LIVER DISEASE AND MECONIUM ILEUS)?;1101;0002
00016;WHAT ARE THE GASTROINTESTINAL COMPLICATIONS OF CF AFTER THE NEONATAL PERIOD (EXCLUDE LIVER DISEASE AND MECONIUM ILEUS)?;1115;0002
00016;WHAT ARE THE GASTROINTESTINAL COMPLICATIONS OF CF AFTER THE NEONATAL PERIOD (EXCLUDE LIVER DISEASE AND MECONIUM ILEUS)?;1135;0001
00016;WHAT ARE THE GASTROINTESTINAL COMPLICATIONS OF CF AFTER THE NEONATAL PERIOD (EXCLUDE LIVER DISEASE AND MECONIUM ILEUS)?;1154;1012
00016;WHAT ARE THE GASTROINTESTINAL COMPLICATIONS OF CF AFTER THE NEONATAL PERIOD (EXCLUDE LIVER DISEASE AND MECONIUM ILEUS)?;1158;0001
00016;WHAT ARE THE GASTROINTESTINAL COMPLICATIONS OF CF AFTER THE NEONATAL PERIOD (EXCLUDE LIVER DISEASE AND MECONIUM ILEUS)?;1189;0001
00016;WHAT ARE THE GASTROINTESTINAL COMPLICATIONS OF CF AFTER THE NEONATAL PERIOD (EXCLUDE LIVER DISEASE AND MECONIUM ILEUS)?;1192;1111
00016;WHAT ARE THE GASTROINTESTINAL COMPLICATIONS OF CF AFTER THE NEONATAL PERIOD (EXCLUDE LIVER DISEASE AND MECONIUM ILEUS)?;1226;1220
00016;WHAT ARE THE GASTROINTESTINAL COMPLICATIONS OF CF AFTER THE NEONATAL PERIOD (EXCLUDE LIVER DISEASE AND MECONIUM ILEUS)?;1232;0001
00016;WHAT ARE THE GASTROINTESTINAL COMPLICATIONS OF CF AFTER THE NEONATAL PERIOD (EXCLUDE LIVER DISEASE AND MECONIUM ILEUS)?;1234;1001
00017;WHAT IS THE MOST EFFECTIVE REGIMEN FOR THE USE OF PANCREATIC ENZYME SUPPLEMENTS IN THE TREATMENT OF CF PATIENTS?;49;2122
00017;WHAT IS THE MOST EFFECTIVE REGIMEN FOR THE USE OF PANCREATIC ENZYME SUPPLEMENTS IN THE TREATMENT OF CF PATIENTS?;89;2120
00017;WHAT IS THE MOST EFFECTIVE REGIMEN FOR THE USE OF PANCREATIC ENZYME SUPPLEMENTS IN THE TREATMENT OF CF PATIENTS?;101;0010
00017;WHAT IS THE MOST EFFECTIVE REGIMEN FOR THE USE OF PANCREATIC ENZYME SUPPLEMENTS IN THE TREATMENT OF CF PATIENTS?;128;0001
00017;WHAT IS THE MOST EFFECTIVE REGIMEN FOR THE USE OF PANCREATIC ENZYME SUPPLEMENTS IN THE TREATMENT OF CF PATIENTS?;132;0001
00017;WHAT IS THE MOST EFFECTIVE REGIMEN FOR THE USE OF PANCREATIC ENZYME SUPPLEMENTS IN THE TREATMENT OF CF PATIENTS?;135;0001
00017;WHAT IS THE MOST EFFECTIVE REGIMEN FOR THE USE OF PANCREATIC ENZYME SUPPLEMENTS IN THE TREATMENT OF CF PATIENTS?;153;0002
00017;WHAT IS THE MOST EFFECTIVE REGIMEN FOR THE USE OF PANCREATIC ENZYME SUPPLEMENTS IN THE TREATMENT OF CF PATIENTS?;189;0001
00017;WHAT IS THE MOST EFFECTIVE REGIMEN FOR THE USE OF PANCREATIC ENZYME SUPPLEMENTS IN THE TREATMENT OF CF PATIENTS?;233;0010
00017;WHAT IS THE MOST EFFECTIVE REGIMEN FOR THE USE OF PANCREATIC ENZYME SUPPLEMENTS IN THE TREATMENT OF CF PATIENTS?;238;0001
00017;WHAT IS THE MOST EFFECTIVE REGIMEN FOR THE USE OF PANCREATIC ENZYME SUPPLEMENTS IN THE TREATMENT OF CF PATIENTS?;297;0001
00017;WHAT IS THE MOST EFFECTIVE REGIMEN FOR THE USE OF PANCREATIC ENZYME SUPPLEMENTS IN THE TREATMENT OF CF PATIENTS?;298;0001
00017;WHAT IS THE MOST EFFECTIVE REGIMEN FOR THE USE OF PANCREATIC ENZYME SUPPLEMENTS IN THE TREATMENT OF CF PATIENTS?;301;0002
00017;WHAT IS THE MOST EFFECTIVE REGIMEN FOR THE USE OF PANCREATIC ENZYME SUPPLEMENTS IN THE TREATMENT OF CF PATIENTS?;330;0001
00017;WHAT IS THE MOST EFFECTIVE REGIMEN FOR THE USE OF PANCREATIC ENZYME SUPPLEMENTS IN THE TREATMENT OF CF PATIENTS?;333;0001
00017;WHAT IS THE MOST EFFECTIVE REGIMEN FOR THE USE OF PANCREATIC ENZYME SUPPLEMENTS IN THE TREATMENT OF CF PATIENTS?;357;1111
00017;WHAT IS THE MOST EFFECTIVE REGIMEN FOR THE USE OF PANCREATIC ENZYME SUPPLEMENTS IN THE TREATMENT OF CF PATIENTS?;359;1102
00017;WHAT IS THE MOST EFFECTIVE REGIMEN FOR THE USE OF PANCREATIC ENZYME SUPPLEMENTS IN THE TREATMENT OF CF PATIENTS?;370;0111
00017;WHAT IS THE MOST EFFECTIVE REGIMEN FOR THE USE OF PANCREATIC ENZYME SUPPLEMENTS IN THE TREATMENT OF CF PATIENTS?;428;1002
00017;WHAT IS THE MOST EFFECTIVE REGIMEN FOR THE USE OF PANCREATIC ENZYME SUPPLEMENTS IN THE TREATMENT OF CF PATIENTS?;443;1100
00017;WHAT IS THE MOST EFFECTIVE REGIMEN FOR THE USE OF PANCREATIC ENZYME SUPPLEMENTS IN THE TREATMENT OF CF PATIENTS?;450;0010
00017;WHAT IS THE MOST EFFECTIVE REGIMEN FOR THE USE OF PANCREATIC ENZYME SUPPLEMENTS IN THE TREATMENT OF CF PATIENTS?;506;0010
00017;WHAT IS THE MOST EFFECTIVE REGIMEN FOR THE USE OF PANCREATIC ENZYME SUPPLEMENTS IN THE TREATMENT OF CF PATIENTS?;643;0011
00017;WHAT IS THE MOST EFFECTIVE REGIMEN FOR THE USE OF PANCREATIC ENZYME SUPPLEMENTS IN THE TREATMENT OF CF PATIENTS?;660;0010
00017;WHAT IS THE MOST EFFECTIVE REGIMEN FOR THE USE OF PANCREATIC ENZYME SUPPLEMENTS IN THE TREATMENT OF CF PATIENTS?;662;2120
00017;WHAT IS THE MOST EFFECTIVE REGIMEN FOR THE USE OF PANCREATIC ENZYME SUPPLEMENTS IN THE TREATMENT OF CF PATIENTS?;688;2221
00017;WHAT IS THE MOST EFFECTIVE REGIMEN FOR THE USE OF PANCREATIC ENZYME SUPPLEMENTS IN THE TREATMENT OF CF PATIENTS?;722;0001
00017;WHAT IS THE MOST EFFECTIVE REGIMEN FOR THE USE OF PANCREATIC ENZYME SUPPLEMENTS IN THE TREATMENT OF CF PATIENTS?;729;0001
00017;WHAT IS THE MOST EFFECTIVE REGIMEN FOR THE USE OF PANCREATIC ENZYME SUPPLEMENTS IN THE TREATMENT OF CF PATIENTS?;730;0011
00017;WHAT IS THE MOST EFFECTIVE REGIMEN FOR THE USE OF PANCREATIC ENZYME SUPPLEMENTS IN THE TREATMENT OF CF PATIENTS?;731;0002
00017;WHAT IS THE MOST EFFECTIVE REGIMEN FOR THE USE OF PANCREATIC ENZYME SUPPLEMENTS IN THE TREATMENT OF CF PATIENTS?;735;0002
00017;WHAT IS THE MOST EFFECTIVE REGIMEN FOR THE USE OF PANCREATIC ENZYME SUPPLEMENTS IN THE TREATMENT OF CF PATIENTS?;791;1122
00017;WHAT IS THE MOST EFFECTIVE REGIMEN FOR THE USE OF PANCREATIC ENZYME SUPPLEMENTS IN THE TREATMENT OF CF PATIENTS?;810;2112
00017;WHAT IS THE MOST EFFECTIVE REGIMEN FOR THE USE OF PANCREATIC ENZYME SUPPLEMENTS IN THE TREATMENT OF CF PATIENTS?;816;0012
00017;WHAT IS THE MOST EFFECTIVE REGIMEN FOR THE USE OF PANCREATIC ENZYME SUPPLEMENTS IN THE TREATMENT OF CF PATIENTS?;837;0001
00017;WHAT IS THE MOST EFFECTIVE REGIMEN FOR THE USE OF PANCREATIC ENZYME SUPPLEMENTS IN THE TREATMENT OF CF PATIENTS?;839;0001
00017;WHAT IS THE MOST EFFECTIVE REGIMEN FOR THE USE OF PANCREATIC ENZYME SUPPLEMENTS IN THE TREATMENT OF CF PATIENTS?;845;0001
00017;WHAT IS THE MOST EFFECTIVE REGIMEN FOR THE USE OF PANCREATIC ENZYME SUPPLEMENTS IN THE TREATMENT OF CF PATIENTS?;882;0002
00017;WHAT IS THE MOST EFFECTIVE REGIMEN FOR THE USE OF PANCREATIC ENZYME SUPPLEMENTS IN THE TREATMENT OF CF PATIENTS?;889;0002
00017;WHAT IS THE MOST EFFECTIVE REGIMEN FOR THE USE OF PANCREATIC ENZYME SUPPLEMENTS IN THE TREATMENT OF CF PATIENTS?;897;1000
00017;WHAT IS THE MOST EFFECTIVE REGIMEN FOR THE USE OF PANCREATIC ENZYME SUPPLEMENTS IN THE TREATMENT OF CF PATIENTS?;937;0001
00017;WHAT IS THE MOST EFFECTIVE REGIMEN FOR THE USE OF PANCREATIC ENZYME SUPPLEMENTS IN THE TREATMENT OF CF PATIENTS?;938;0001
00017;WHAT IS THE MOST EFFECTIVE REGIMEN FOR THE USE OF PANCREATIC ENZYME SUPPLEMENTS IN THE TREATMENT OF CF PATIENTS?;941;1001
00017;WHAT IS THE MOST EFFECTIVE REGIMEN FOR THE USE OF PANCREATIC ENZYME SUPPLEMENTS IN THE TREATMENT OF CF PATIENTS?;944;1001
00017;WHAT IS THE MOST EFFECTIVE REGIMEN FOR THE USE OF PANCREATIC ENZYME SUPPLEMENTS IN THE TREATMENT OF CF PATIENTS?;1000;0001
00017;WHAT IS THE MOST EFFECTIVE REGIMEN FOR THE USE OF PANCREATIC ENZYME SUPPLEMENTS IN THE TREATMENT OF CF PATIENTS?;1023;0001
00017;WHAT IS THE MOST EFFECTIVE REGIMEN FOR THE USE OF PANCREATIC ENZYME SUPPLEMENTS IN THE TREATMENT OF CF PATIENTS?;1040;0001
00017;WHAT IS THE MOST EFFECTIVE REGIMEN FOR THE USE OF PANCREATIC ENZYME SUPPLEMENTS IN THE TREATMENT OF CF PATIENTS?;1069;0001
00017;WHAT IS THE MOST EFFECTIVE REGIMEN FOR THE USE OF PANCREATIC ENZYME SUPPLEMENTS IN THE TREATMENT OF CF PATIENTS?;1080;0001
00017;WHAT IS THE MOST EFFECTIVE REGIMEN FOR THE USE OF PANCREATIC ENZYME SUPPLEMENTS IN THE TREATMENT OF CF PATIENTS?;1088;0002
00017;WHAT IS THE MOST EFFECTIVE REGIMEN FOR THE USE OF PANCREATIC ENZYME SUPPLEMENTS IN THE TREATMENT OF CF PATIENTS?;1101;2221
00017;WHAT IS THE MOST EFFECTIVE REGIMEN FOR THE USE OF PANCREATIC ENZYME SUPPLEMENTS IN THE TREATMENT OF CF PATIENTS?;1103;1120
00017;WHAT IS THE MOST EFFECTIVE REGIMEN FOR THE USE OF PANCREATIC ENZYME SUPPLEMENTS IN THE TREATMENT OF CF PATIENTS?;1115;0001
00017;WHAT IS THE MOST EFFECTIVE REGIMEN FOR THE USE OF PANCREATIC ENZYME SUPPLEMENTS IN THE TREATMENT OF CF PATIENTS?;1187;0001
00017;WHAT IS THE MOST EFFECTIVE REGIMEN FOR THE USE OF PANCREATIC ENZYME SUPPLEMENTS IN THE TREATMENT OF CF PATIENTS?;1234;0001
00018;IS DIETARY SUPPLEMENTATION WITH BILE SALTS OF THERAPEUTIC BENEFIT TO CF PATIENTS?;129;2122
00018;IS DIETARY SUPPLEMENTATION WITH BILE SALTS OF THERAPEUTIC BENEFIT TO CF PATIENTS?;153;0001
00018;IS DIETARY SUPPLEMENTATION WITH BILE SALTS OF THERAPEUTIC BENEFIT TO CF PATIENTS?;205;2120
00018;IS DIETARY SUPPLEMENTATION WITH BILE SALTS OF THERAPEUTIC BENEFIT TO CF PATIENTS?;226;0002
00018;IS DIETARY SUPPLEMENTATION WITH BILE SALTS OF THERAPEUTIC BENEFIT TO CF PATIENTS?;364;0100
00018;IS DIETARY SUPPLEMENTATION WITH BILE SALTS OF THERAPEUTIC BENEFIT TO CF PATIENTS?;370;1010
00018;IS DIETARY SUPPLEMENTATION WITH BILE SALTS OF THERAPEUTIC BENEFIT TO CF PATIENTS?;414;0002
00018;IS DIETARY SUPPLEMENTATION WITH BILE SALTS OF THERAPEUTIC BENEFIT TO CF PATIENTS?;424;1110
00018;IS DIETARY SUPPLEMENTATION WITH BILE SALTS OF THERAPEUTIC BENEFIT TO CF PATIENTS?;443;0010
00018;IS DIETARY SUPPLEMENTATION WITH BILE SALTS OF THERAPEUTIC BENEFIT TO CF PATIENTS?;642;1000
00018;IS DIETARY SUPPLEMENTATION WITH BILE SALTS OF THERAPEUTIC BENEFIT TO CF PATIENTS?;656;1001
00018;IS DIETARY SUPPLEMENTATION WITH BILE SALTS OF THERAPEUTIC BENEFIT TO CF PATIENTS?;657;1010
00018;IS DIETARY SUPPLEMENTATION WITH BILE SALTS OF THERAPEUTIC BENEFIT TO CF PATIENTS?;658;1010
00018;IS DIETARY SUPPLEMENTATION WITH BILE SALTS OF THERAPEUTIC BENEFIT TO CF PATIENTS?;660;1010
00018;IS DIETARY SUPPLEMENTATION WITH BILE SALTS OF THERAPEUTIC BENEFIT TO CF PATIENTS?;725;1110
00018;IS DIETARY SUPPLEMENTATION WITH BILE SALTS OF THERAPEUTIC BENEFIT TO CF PATIENTS?;816;1000
00018;IS DIETARY SUPPLEMENTATION WITH BILE SALTS OF THERAPEUTIC BENEFIT TO CF PATIENTS?;935;1010
00018;IS DIETARY SUPPLEMENTATION WITH BILE SALTS OF THERAPEUTIC BENEFIT TO CF PATIENTS?;993;1110
00018;IS DIETARY SUPPLEMENTATION WITH BILE SALTS OF THERAPEUTIC BENEFIT TO CF PATIENTS?;994;1000
00018;IS DIETARY SUPPLEMENTATION WITH BILE SALTS OF THERAPEUTIC BENEFIT TO CF PATIENTS?;1016;2110
00018;IS DIETARY SUPPLEMENTATION WITH BILE SALTS OF THERAPEUTIC BENEFIT TO CF PATIENTS?;1162;1100
00019;WHAT COMPLICATIONS OF PANCREATIC ENZYME THERAPY HAVE BEEN REPORTED IN CF PATIENTS?;21;2220
00019;WHAT COMPLICATIONS OF PANCREATIC ENZYME THERAPY HAVE BEEN REPORTED IN CF PATIENTS?;49;0001
00019;WHAT COMPLICATIONS OF PANCREATIC ENZYME THERAPY HAVE BEEN REPORTED IN CF PATIENTS?;359;1011
00019;WHAT COMPLICATIONS OF PANCREATIC ENZYME THERAPY HAVE BEEN REPORTED IN CF PATIENTS?;370;1100
00019;WHAT COMPLICATIONS OF PANCREATIC ENZYME THERAPY HAVE BEEN REPORTED IN CF PATIENTS?;398;0001
00019;WHAT COMPLICATIONS OF PANCREATIC ENZYME THERAPY HAVE BEEN REPORTED IN CF PATIENTS?;432;2121
00019;WHAT COMPLICATIONS OF PANCREATIC ENZYME THERAPY HAVE BEEN REPORTED IN CF PATIENTS?;455;0010
00019;WHAT COMPLICATIONS OF PANCREATIC ENZYME THERAPY HAVE BEEN REPORTED IN CF PATIENTS?;487;2222
00019;WHAT COMPLICATIONS OF PANCREATIC ENZYME THERAPY HAVE BEEN REPORTED IN CF PATIENTS?;506;2222
00019;WHAT COMPLICATIONS OF PANCREATIC ENZYME THERAPY HAVE BEEN REPORTED IN CF PATIENTS?;618;2222
00019;WHAT COMPLICATIONS OF PANCREATIC ENZYME THERAPY HAVE BEEN REPORTED IN CF PATIENTS?;626;2222
00019;WHAT COMPLICATIONS OF PANCREATIC ENZYME THERAPY HAVE BEEN REPORTED IN CF PATIENTS?;672;2212
00019;WHAT COMPLICATIONS OF PANCREATIC ENZYME THERAPY HAVE BEEN REPORTED IN CF PATIENTS?;688;2222
00019;WHAT COMPLICATIONS OF PANCREATIC ENZYME THERAPY HAVE BEEN REPORTED IN CF PATIENTS?;693;2222
00019;WHAT COMPLICATIONS OF PANCREATIC ENZYME THERAPY HAVE BEEN REPORTED IN CF PATIENTS?;897;2222
00019;WHAT COMPLICATIONS OF PANCREATIC ENZYME THERAPY HAVE BEEN REPORTED IN CF PATIENTS?;936;0010
00019;WHAT COMPLICATIONS OF PANCREATIC ENZYME THERAPY HAVE BEEN REPORTED IN CF PATIENTS?;944;0001
00019;WHAT COMPLICATIONS OF PANCREATIC ENZYME THERAPY HAVE BEEN REPORTED IN CF PATIENTS?;1000;0001
00019;WHAT COMPLICATIONS OF PANCREATIC ENZYME THERAPY HAVE BEEN REPORTED IN CF PATIENTS?;1049;2221
00019;WHAT COMPLICATIONS OF PANCREATIC ENZYME THERAPY HAVE BEEN REPORTED IN CF PATIENTS?;1103;2222
00019;WHAT COMPLICATIONS OF PANCREATIC ENZYME THERAPY HAVE BEEN REPORTED IN CF PATIENTS?;1129;0001
00019;WHAT COMPLICATIONS OF PANCREATIC ENZYME THERAPY HAVE BEEN REPORTED IN CF PATIENTS?;1205;0001
00020;WHAT IS THE EFFECT OF TREATMENT OF CF PATIENTS WITH ESSENTIAL FATTY ACID SUPPLEMENTS?;126;2112
00020;WHAT IS THE EFFECT OF TREATMENT OF CF PATIENTS WITH ESSENTIAL FATTY ACID SUPPLEMENTS?;133;0002
00020;WHAT IS THE EFFECT OF TREATMENT OF CF PATIENTS WITH ESSENTIAL FATTY ACID SUPPLEMENTS?;153;0002
00020;WHAT IS THE EFFECT OF TREATMENT OF CF PATIENTS WITH ESSENTIAL FATTY ACID SUPPLEMENTS?;181;0010
00020;WHAT IS THE EFFECT OF TREATMENT OF CF PATIENTS WITH ESSENTIAL FATTY ACID SUPPLEMENTS?;207;2122
00020;WHAT IS THE EFFECT OF TREATMENT OF CF PATIENTS WITH ESSENTIAL FATTY ACID SUPPLEMENTS?;208;2122
00020;WHAT IS THE EFFECT OF TREATMENT OF CF PATIENTS WITH ESSENTIAL FATTY ACID SUPPLEMENTS?;220;2221
00020;WHAT IS THE EFFECT OF TREATMENT OF CF PATIENTS WITH ESSENTIAL FATTY ACID SUPPLEMENTS?;278;2111
00020;WHAT IS THE EFFECT OF TREATMENT OF CF PATIENTS WITH ESSENTIAL FATTY ACID SUPPLEMENTS?;283;1100
00020;WHAT IS THE EFFECT OF TREATMENT OF CF PATIENTS WITH ESSENTIAL FATTY ACID SUPPLEMENTS?;286;2111
00020;WHAT IS THE EFFECT OF TREATMENT OF CF PATIENTS WITH ESSENTIAL FATTY ACID SUPPLEMENTS?;287;2111
00020;WHAT IS THE EFFECT OF TREATMENT OF CF PATIENTS WITH ESSENTIAL FATTY ACID SUPPLEMENTS?;288;1100
00020;WHAT IS THE EFFECT OF TREATMENT OF CF PATIENTS WITH ESSENTIAL FATTY ACID SUPPLEMENTS?;290;2111
00020;WHAT IS THE EFFECT OF TREATMENT OF CF PATIENTS WITH ESSENTIAL FATTY ACID SUPPLEMENTS?;292;2111
00020;WHAT IS THE EFFECT OF TREATMENT OF CF PATIENTS WITH ESSENTIAL FATTY ACID SUPPLEMENTS?;370;0110
00020;WHAT IS THE EFFECT OF TREATMENT OF CF PATIENTS WITH ESSENTIAL FATTY ACID SUPPLEMENTS?;443;0010
00020;WHAT IS THE EFFECT OF TREATMENT OF CF PATIENTS WITH ESSENTIAL FATTY ACID SUPPLEMENTS?;538;2122
00020;WHAT IS THE EFFECT OF TREATMENT OF CF PATIENTS WITH ESSENTIAL FATTY ACID SUPPLEMENTS?;539;2111
00020;WHAT IS THE EFFECT OF TREATMENT OF CF PATIENTS WITH ESSENTIAL FATTY ACID SUPPLEMENTS?;540;2222
00020;WHAT IS THE EFFECT OF TREATMENT OF CF PATIENTS WITH ESSENTIAL FATTY ACID SUPPLEMENTS?;544;2111
00020;WHAT IS THE EFFECT OF TREATMENT OF CF PATIENTS WITH ESSENTIAL FATTY ACID SUPPLEMENTS?;604;0100
00020;WHAT IS THE EFFECT OF TREATMENT OF CF PATIENTS WITH ESSENTIAL FATTY ACID SUPPLEMENTS?;643;0001
00020;WHAT IS THE EFFECT OF TREATMENT OF CF PATIENTS WITH ESSENTIAL FATTY ACID SUPPLEMENTS?;711;1210
00020;WHAT IS THE EFFECT OF TREATMENT OF CF PATIENTS WITH ESSENTIAL FATTY ACID SUPPLEMENTS?;715;1011
00020;WHAT IS THE EFFECT OF TREATMENT OF CF PATIENTS WITH ESSENTIAL FATTY ACID SUPPLEMENTS?;731;0001
00020;WHAT IS THE EFFECT OF TREATMENT OF CF PATIENTS WITH ESSENTIAL FATTY ACID SUPPLEMENTS?;758;2222
00020;WHAT IS THE EFFECT OF TREATMENT OF CF PATIENTS WITH ESSENTIAL FATTY ACID SUPPLEMENTS?;767;0100
00020;WHAT IS THE EFFECT OF TREATMENT OF CF PATIENTS WITH ESSENTIAL FATTY ACID SUPPLEMENTS?;791;0001
00020;WHAT IS THE EFFECT OF TREATMENT OF CF PATIENTS WITH ESSENTIAL FATTY ACID SUPPLEMENTS?;823;2222
00020;WHAT IS THE EFFECT OF TREATMENT OF CF PATIENTS WITH ESSENTIAL FATTY ACID SUPPLEMENTS?;824;1001
00020;WHAT IS THE EFFECT OF TREATMENT OF CF PATIENTS WITH ESSENTIAL FATTY ACID SUPPLEMENTS?;882;0002
00020;WHAT IS THE EFFECT OF TREATMENT OF CF PATIENTS WITH ESSENTIAL FATTY ACID SUPPLEMENTS?;919;1000
00020;WHAT IS THE EFFECT OF TREATMENT OF CF PATIENTS WITH ESSENTIAL FATTY ACID SUPPLEMENTS?;924;2222
00020;WHAT IS THE EFFECT OF TREATMENT OF CF PATIENTS WITH ESSENTIAL FATTY ACID SUPPLEMENTS?;928;1000
00020;WHAT IS THE EFFECT OF TREATMENT OF CF PATIENTS WITH ESSENTIAL FATTY ACID SUPPLEMENTS?;944;0001
00020;WHAT IS THE EFFECT OF TREATMENT OF CF PATIENTS WITH ESSENTIAL FATTY ACID SUPPLEMENTS?;962;2222
00020;WHAT IS THE EFFECT OF TREATMENT OF CF PATIENTS WITH ESSENTIAL FATTY ACID SUPPLEMENTS?;970;1001
00020;WHAT IS THE EFFECT OF TREATMENT OF CF PATIENTS WITH ESSENTIAL FATTY ACID SUPPLEMENTS?;1066;2222
00020;WHAT IS THE EFFECT OF TREATMENT OF CF PATIENTS WITH ESSENTIAL FATTY ACID SUPPLEMENTS?;1080;0010
00020;WHAT IS THE EFFECT OF TREATMENT OF CF PATIENTS WITH ESSENTIAL FATTY ACID SUPPLEMENTS?;1115;2222
00020;WHAT IS THE EFFECT OF TREATMENT OF CF PATIENTS WITH ESSENTIAL FATTY ACID SUPPLEMENTS?;1168;2222
00020;WHAT IS THE EFFECT OF TREATMENT OF CF PATIENTS WITH ESSENTIAL FATTY ACID SUPPLEMENTS?;1189;0001
00020;WHAT IS THE EFFECT OF TREATMENT OF CF PATIENTS WITH ESSENTIAL FATTY ACID SUPPLEMENTS?;1213;2222
00020;WHAT IS THE EFFECT OF TREATMENT OF CF PATIENTS WITH ESSENTIAL FATTY ACID SUPPLEMENTS?;1215;2222
00020;WHAT IS THE EFFECT OF TREATMENT OF CF PATIENTS WITH ESSENTIAL FATTY ACID SUPPLEMENTS?;1234;1001
00020;WHAT IS THE EFFECT OF TREATMENT OF CF PATIENTS WITH ESSENTIAL FATTY ACID SUPPLEMENTS?;1239;1120
00021;DOES PANCREATIC INSUFFICIENCY IN CF PATIENTS AFFECT THEIR ABILITY TO ABSORB OR METABOLIZE IRON?;68;2112
00021;DOES PANCREATIC INSUFFICIENCY IN CF PATIENTS AFFECT THEIR ABILITY TO ABSORB OR METABOLIZE IRON?;97;0002
00021;DOES PANCREATIC INSUFFICIENCY IN CF PATIENTS AFFECT THEIR ABILITY TO ABSORB OR METABOLIZE IRON?;98;0012
00021;DOES PANCREATIC INSUFFICIENCY IN CF PATIENTS AFFECT THEIR ABILITY TO ABSORB OR METABOLIZE IRON?;181;0001
00021;DOES PANCREATIC INSUFFICIENCY IN CF PATIENTS AFFECT THEIR ABILITY TO ABSORB OR METABOLIZE IRON?;251;2112
00021;DOES PANCREATIC INSUFFICIENCY IN CF PATIENTS AFFECT THEIR ABILITY TO ABSORB OR METABOLIZE IRON?;413;0001
00021;DOES PANCREATIC INSUFFICIENCY IN CF PATIENTS AFFECT THEIR ABILITY TO ABSORB OR METABOLIZE IRON?;416;0001
00021;DOES PANCREATIC INSUFFICIENCY IN CF PATIENTS AFFECT THEIR ABILITY TO ABSORB OR METABOLIZE IRON?;434;0001
00021;DOES PANCREATIC INSUFFICIENCY IN CF PATIENTS AFFECT THEIR ABILITY TO ABSORB OR METABOLIZE IRON?;443;0002
00021;DOES PANCREATIC INSUFFICIENCY IN CF PATIENTS AFFECT THEIR ABILITY TO ABSORB OR METABOLIZE IRON?;551;0100
00021;DOES PANCREATIC INSUFFICIENCY IN CF PATIENTS AFFECT THEIR ABILITY TO ABSORB OR METABOLIZE IRON?;615;0001
00021;DOES PANCREATIC INSUFFICIENCY IN CF PATIENTS AFFECT THEIR ABILITY TO ABSORB OR METABOLIZE IRON?;676;0001
00021;DOES PANCREATIC INSUFFICIENCY IN CF PATIENTS AFFECT THEIR ABILITY TO ABSORB OR METABOLIZE IRON?;708;2122
00021;DOES PANCREATIC INSUFFICIENCY IN CF PATIENTS AFFECT THEIR ABILITY TO ABSORB OR METABOLIZE IRON?;709;2222
00021;DOES PANCREATIC INSUFFICIENCY IN CF PATIENTS AFFECT THEIR ABILITY TO ABSORB OR METABOLIZE IRON?;719;1100
00021;DOES PANCREATIC INSUFFICIENCY IN CF PATIENTS AFFECT THEIR ABILITY TO ABSORB OR METABOLIZE IRON?;722;0001
00021;DOES PANCREATIC INSUFFICIENCY IN CF PATIENTS AFFECT THEIR ABILITY TO ABSORB OR METABOLIZE IRON?;751;0001
00021;DOES PANCREATIC INSUFFICIENCY IN CF PATIENTS AFFECT THEIR ABILITY TO ABSORB OR METABOLIZE IRON?;756;0010
00021;DOES PANCREATIC INSUFFICIENCY IN CF PATIENTS AFFECT THEIR ABILITY TO ABSORB OR METABOLIZE IRON?;757;0100
00021;DOES PANCREATIC INSUFFICIENCY IN CF PATIENTS AFFECT THEIR ABILITY TO ABSORB OR METABOLIZE IRON?;932;0001
00021;DOES PANCREATIC INSUFFICIENCY IN CF PATIENTS AFFECT THEIR ABILITY TO ABSORB OR METABOLIZE IRON?;941;1101
00021;DOES PANCREATIC INSUFFICIENCY IN CF PATIENTS AFFECT THEIR ABILITY TO ABSORB OR METABOLIZE IRON?;1098;0002
00021;DOES PANCREATIC INSUFFICIENCY IN CF PATIENTS AFFECT THEIR ABILITY TO ABSORB OR METABOLIZE IRON?;1115;1122
00021;DOES PANCREATIC INSUFFICIENCY IN CF PATIENTS AFFECT THEIR ABILITY TO ABSORB OR METABOLIZE IRON?;1158;2221
00021;DOES PANCREATIC INSUFFICIENCY IN CF PATIENTS AFFECT THEIR ABILITY TO ABSORB OR METABOLIZE IRON?;1189;0001
00022;WHAT IS THE FREQUENCY OF CF IN NON-CAUCASIAN POPULATIONS?;13;2222
00022;WHAT IS THE FREQUENCY OF CF IN NON-CAUCASIAN POPULATIONS?;39;0012
00022;WHAT IS THE FREQUENCY OF CF IN NON-CAUCASIAN POPULATIONS?;67;0001
00022;WHAT IS THE FREQUENCY OF CF IN NON-CAUCASIAN POPULATIONS?;69;0001
00022;WHAT IS THE FREQUENCY OF CF IN NON-CAUCASIAN POPULATIONS?;104;0001
00022;WHAT IS THE FREQUENCY OF CF IN NON-CAUCASIAN POPULATIONS?;130;2222
00022;WHAT IS THE FREQUENCY OF CF IN NON-CAUCASIAN POPULATIONS?;189;0001
00022;WHAT IS THE FREQUENCY OF CF IN NON-CAUCASIAN POPULATIONS?;197;0001
00022;WHAT IS THE FREQUENCY OF CF IN NON-CAUCASIAN POPULATIONS?;221;0001
00022;WHAT IS THE FREQUENCY OF CF IN NON-CAUCASIAN POPULATIONS?;226;0001
00022;WHAT IS THE FREQUENCY OF CF IN NON-CAUCASIAN POPULATIONS?;237;0101
00022;WHAT IS THE FREQUENCY OF CF IN NON-CAUCASIAN POPULATIONS?;247;0010
00022;WHAT IS THE FREQUENCY OF CF IN NON-CAUCASIAN POPULATIONS?;258;2221
00022;WHAT IS THE FREQUENCY OF CF IN NON-CAUCASIAN POPULATIONS?;262;2112
00022;WHAT IS THE FREQUENCY OF CF IN NON-CAUCASIAN POPULATIONS?;276;2222
00022;WHAT IS THE FREQUENCY OF CF IN NON-CAUCASIAN POPULATIONS?;322;0001
00022;WHAT IS THE FREQUENCY OF CF IN NON-CAUCASIAN POPULATIONS?;325;0001
00022;WHAT IS THE FREQUENCY OF CF IN NON-CAUCASIAN POPULATIONS?;333;0001
00022;WHAT IS THE FREQUENCY OF CF IN NON-CAUCASIAN POPULATIONS?;342;0110
00022;WHAT IS THE FREQUENCY OF CF IN NON-CAUCASIAN POPULATIONS?;343;0101
00022;WHAT IS THE FREQUENCY OF CF IN NON-CAUCASIAN POPULATIONS?;350;0100
00022;WHAT IS THE FREQUENCY OF CF IN NON-CAUCASIAN POPULATIONS?;365;0001
00022;WHAT IS THE FREQUENCY OF CF IN NON-CAUCASIAN POPULATIONS?;370;1012
00022;WHAT IS THE FREQUENCY OF CF IN NON-CAUCASIAN POPULATIONS?;392;0001
00022;WHAT IS THE FREQUENCY OF CF IN NON-CAUCASIAN POPULATIONS?;431;1121
00022;WHAT IS THE FREQUENCY OF CF IN NON-CAUCASIAN POPULATIONS?;464;0001
00022;WHAT IS THE FREQUENCY OF CF IN NON-CAUCASIAN POPULATIONS?;465;0001
00022;WHAT IS THE FREQUENCY OF CF IN NON-CAUCASIAN POPULATIONS?;473;1121
00022;WHAT IS THE FREQUENCY OF CF IN NON-CAUCASIAN POPULATIONS?;478;1121
00022;WHAT IS THE FREQUENCY OF CF IN NON-CAUCASIAN POPULATIONS?;503;1101
00022;WHAT IS THE FREQUENCY OF CF IN NON-CAUCASIAN POPULATIONS?;510;0101
00022;WHAT IS THE FREQUENCY OF CF IN NON-CAUCASIAN POPULATIONS?;512;0110
00022;WHAT IS THE FREQUENCY OF CF IN NON-CAUCASIAN POPULATIONS?;514;1001
00022;WHAT IS THE FREQUENCY OF CF IN NON-CAUCASIAN POPULATIONS?;586;0001
00022;WHAT IS THE FREQUENCY OF CF IN NON-CAUCASIAN POPULATIONS?;590;0011
00022;WHAT IS THE FREQUENCY OF CF IN NON-CAUCASIAN POPULATIONS?;654;0101
00022;WHAT IS THE FREQUENCY OF CF IN NON-CAUCASIAN POPULATIONS?;671;1101
00022;WHAT IS THE FREQUENCY OF CF IN NON-CAUCASIAN POPULATIONS?;682;0001
00022;WHAT IS THE FREQUENCY OF CF IN NON-CAUCASIAN POPULATIONS?;692;2222
00022;WHAT IS THE FREQUENCY OF CF IN NON-CAUCASIAN POPULATIONS?;704;2111
00022;WHAT IS THE FREQUENCY OF CF IN NON-CAUCASIAN POPULATIONS?;713;0001
00022;WHAT IS THE FREQUENCY OF CF IN NON-CAUCASIAN POPULATIONS?;729;0001
00022;WHAT IS THE FREQUENCY OF CF IN NON-CAUCASIAN POPULATIONS?;731;0002
00022;WHAT IS THE FREQUENCY OF CF IN NON-CAUCASIAN POPULATIONS?;735;0001
00022;WHAT IS THE FREQUENCY OF CF IN NON-CAUCASIAN POPULATIONS?;764;1212
00022;WHAT IS THE FREQUENCY OF CF IN NON-CAUCASIAN POPULATIONS?;774;0101
00022;WHAT IS THE FREQUENCY OF CF IN NON-CAUCASIAN POPULATIONS?;788;1011
00022;WHAT IS THE FREQUENCY OF CF IN NON-CAUCASIAN POPULATIONS?;843;0102
00022;WHAT IS THE FREQUENCY OF CF IN NON-CAUCASIAN POPULATIONS?;845;0002
00022;WHAT IS THE FREQUENCY OF CF IN NON-CAUCASIAN POPULATIONS?;871;1001
00022;WHAT IS THE FREQUENCY OF CF IN NON-CAUCASIAN POPULATIONS?;880;1012
00022;WHAT IS THE FREQUENCY OF CF IN NON-CAUCASIAN POPULATIONS?;881;0102
00022;WHAT IS THE FREQUENCY OF CF IN NON-CAUCASIAN POPULATIONS?;882;0002
00022;WHAT IS THE FREQUENCY OF CF IN NON-CAUCASIAN POPULATIONS?;888;0002
00022;WHAT IS THE FREQUENCY OF CF IN NON-CAUCASIAN POPULATIONS?;898;2212
00022;WHAT IS THE FREQUENCY OF CF IN NON-CAUCASIAN POPULATIONS?;908;1111
00022;WHAT IS THE FREQUENCY OF CF IN NON-CAUCASIAN POPULATIONS?;942;0001
00022;WHAT IS THE FREQUENCY OF CF IN NON-CAUCASIAN POPULATIONS?;946;0001
00022;WHAT IS THE FREQUENCY OF CF IN NON-CAUCASIAN POPULATIONS?;968;0100
00022;WHAT IS THE FREQUENCY OF CF IN NON-CAUCASIAN POPULATIONS?;1000;0002
00022;WHAT IS THE FREQUENCY OF CF IN NON-CAUCASIAN POPULATIONS?;1033;0001
00022;WHAT IS THE FREQUENCY OF CF IN NON-CAUCASIAN POPULATIONS?;1040;0001
00022;WHAT IS THE FREQUENCY OF CF IN NON-CAUCASIAN POPULATIONS?;1083;1122
00022;WHAT IS THE FREQUENCY OF CF IN NON-CAUCASIAN POPULATIONS?;1093;0001
00022;WHAT IS THE FREQUENCY OF CF IN NON-CAUCASIAN POPULATIONS?;1114;1002
00022;WHAT IS THE FREQUENCY OF CF IN NON-CAUCASIAN POPULATIONS?;1144;0100
00022;WHAT IS THE FREQUENCY OF CF IN NON-CAUCASIAN POPULATIONS?;1156;1111
00022;WHAT IS THE FREQUENCY OF CF IN NON-CAUCASIAN POPULATIONS?;1166;0110
00022;WHAT IS THE FREQUENCY OF CF IN NON-CAUCASIAN POPULATIONS?;1194;1121
00022;WHAT IS THE FREQUENCY OF CF IN NON-CAUCASIAN POPULATIONS?;1195;0001
00023;WHAT CONGENITAL OR HEREDITARY DISEASES OR CONDITIONS HAVE BEEN FOUND IN ASSOCIATION WITH CF?;9;2221
00023;WHAT CONGENITAL OR HEREDITARY DISEASES OR CONDITIONS HAVE BEEN FOUND IN ASSOCIATION WITH CF?;10;2122
00023;WHAT CONGENITAL OR HEREDITARY DISEASES OR CONDITIONS HAVE BEEN FOUND IN ASSOCIATION WITH CF?;11;1100
00023;WHAT CONGENITAL OR HEREDITARY DISEASES OR CONDITIONS HAVE BEEN FOUND IN ASSOCIATION WITH CF?;12;2212
00023;WHAT CONGENITAL OR HEREDITARY DISEASES OR CONDITIONS HAVE BEEN FOUND IN ASSOCIATION WITH CF?;34;2222
00023;WHAT CONGENITAL OR HEREDITARY DISEASES OR CONDITIONS HAVE BEEN FOUND IN ASSOCIATION WITH CF?;42;2222
00023;WHAT CONGENITAL OR HEREDITARY DISEASES OR CONDITIONS HAVE BEEN FOUND IN ASSOCIATION WITH CF?;99;1112
00023;WHAT CONGENITAL OR HEREDITARY DISEASES OR CONDITIONS HAVE BEEN FOUND IN ASSOCIATION WITH CF?;162;1000
00023;WHAT CONGENITAL OR HEREDITARY DISEASES OR CONDITIONS HAVE BEEN FOUND IN ASSOCIATION WITH CF?;163;0001
00023;WHAT CONGENITAL OR HEREDITARY DISEASES OR CONDITIONS HAVE BEEN FOUND IN ASSOCIATION WITH CF?;167;1000
00023;WHAT CONGENITAL OR HEREDITARY DISEASES OR CONDITIONS HAVE BEEN FOUND IN ASSOCIATION WITH CF?;198;1000
00023;WHAT CONGENITAL OR HEREDITARY DISEASES OR CONDITIONS HAVE BEEN FOUND IN ASSOCIATION WITH CF?;248;1000
00023;WHAT CONGENITAL OR HEREDITARY DISEASES OR CONDITIONS HAVE BEEN FOUND IN ASSOCIATION WITH CF?;285;0010
00023;WHAT CONGENITAL OR HEREDITARY DISEASES OR CONDITIONS HAVE BEEN FOUND IN ASSOCIATION WITH CF?;322;0101
00023;WHAT CONGENITAL OR HEREDITARY DISEASES OR CONDITIONS HAVE BEEN FOUND IN ASSOCIATION WITH CF?;350;1001
00023;WHAT CONGENITAL OR HEREDITARY DISEASES OR CONDITIONS HAVE BEEN FOUND IN ASSOCIATION WITH CF?;370;1002
00023;WHAT CONGENITAL OR HEREDITARY DISEASES OR CONDITIONS HAVE BEEN FOUND IN ASSOCIATION WITH CF?;426;2122
00023;WHAT CONGENITAL OR HEREDITARY DISEASES OR CONDITIONS HAVE BEEN FOUND IN ASSOCIATION WITH CF?;434;1212
00023;WHAT CONGENITAL OR HEREDITARY DISEASES OR CONDITIONS HAVE BEEN FOUND IN ASSOCIATION WITH CF?;464;1000
00023;WHAT CONGENITAL OR HEREDITARY DISEASES OR CONDITIONS HAVE BEEN FOUND IN ASSOCIATION WITH CF?;509;2222
00023;WHAT CONGENITAL OR HEREDITARY DISEASES OR CONDITIONS HAVE BEEN FOUND IN ASSOCIATION WITH CF?;541;2222
00023;WHAT CONGENITAL OR HEREDITARY DISEASES OR CONDITIONS HAVE BEEN FOUND IN ASSOCIATION WITH CF?;582;0002
00023;WHAT CONGENITAL OR HEREDITARY DISEASES OR CONDITIONS HAVE BEEN FOUND IN ASSOCIATION WITH CF?;583;1000
00023;WHAT CONGENITAL OR HEREDITARY DISEASES OR CONDITIONS HAVE BEEN FOUND IN ASSOCIATION WITH CF?;598;0002
00023;WHAT CONGENITAL OR HEREDITARY DISEASES OR CONDITIONS HAVE BEEN FOUND IN ASSOCIATION WITH CF?;716;1002
00023;WHAT CONGENITAL OR HEREDITARY DISEASES OR CONDITIONS HAVE BEEN FOUND IN ASSOCIATION WITH CF?;780;1000
00023;WHAT CONGENITAL OR HEREDITARY DISEASES OR CONDITIONS HAVE BEEN FOUND IN ASSOCIATION WITH CF?;859;2120
00023;WHAT CONGENITAL OR HEREDITARY DISEASES OR CONDITIONS HAVE BEEN FOUND IN ASSOCIATION WITH CF?;883;0001
00023;WHAT CONGENITAL OR HEREDITARY DISEASES OR CONDITIONS HAVE BEEN FOUND IN ASSOCIATION WITH CF?;888;1002
00023;WHAT CONGENITAL OR HEREDITARY DISEASES OR CONDITIONS HAVE BEEN FOUND IN ASSOCIATION WITH CF?;979;2222
00023;WHAT CONGENITAL OR HEREDITARY DISEASES OR CONDITIONS HAVE BEEN FOUND IN ASSOCIATION WITH CF?;984;0002
00023;WHAT CONGENITAL OR HEREDITARY DISEASES OR CONDITIONS HAVE BEEN FOUND IN ASSOCIATION WITH CF?;1096;0011
00023;WHAT CONGENITAL OR HEREDITARY DISEASES OR CONDITIONS HAVE BEEN FOUND IN ASSOCIATION WITH CF?;1114;2222
00023;WHAT CONGENITAL OR HEREDITARY DISEASES OR CONDITIONS HAVE BEEN FOUND IN ASSOCIATION WITH CF?;1156;0010
00023;WHAT CONGENITAL OR HEREDITARY DISEASES OR CONDITIONS HAVE BEEN FOUND IN ASSOCIATION WITH CF?;1163;1000
00024;WHAT ARE THE CHARACTERISTICS OF PATIENTS IN WHOM CF IS INCOMPLETELY MANIFESTED?;32;1100
00024;WHAT ARE THE CHARACTERISTICS OF PATIENTS IN WHOM CF IS INCOMPLETELY MANIFESTED?;72;0001
00024;WHAT ARE THE CHARACTERISTICS OF PATIENTS IN WHOM CF IS INCOMPLETELY MANIFESTED?;199;0001
00024;WHAT ARE THE CHARACTERISTICS OF PATIENTS IN WHOM CF IS INCOMPLETELY MANIFESTED?;207;0001
00024;WHAT ARE THE CHARACTERISTICS OF PATIENTS IN WHOM CF IS INCOMPLETELY MANIFESTED?;210;2220
00024;WHAT ARE THE CHARACTERISTICS OF PATIENTS IN WHOM CF IS INCOMPLETELY MANIFESTED?;240;0001
00024;WHAT ARE THE CHARACTERISTICS OF PATIENTS IN WHOM CF IS INCOMPLETELY MANIFESTED?;254;2111
00024;WHAT ARE THE CHARACTERISTICS OF PATIENTS IN WHOM CF IS INCOMPLETELY MANIFESTED?;331;0001
00024;WHAT ARE THE CHARACTERISTICS OF PATIENTS IN WHOM CF IS INCOMPLETELY MANIFESTED?;370;1000
00024;WHAT ARE THE CHARACTERISTICS OF PATIENTS IN WHOM CF IS INCOMPLETELY MANIFESTED?;377;0001
00024;WHAT ARE THE CHARACTERISTICS OF PATIENTS IN WHOM CF IS INCOMPLETELY MANIFESTED?;411;0001
00024;WHAT ARE THE CHARACTERISTICS OF PATIENTS IN WHOM CF IS INCOMPLETELY MANIFESTED?;477;0001
00024;WHAT ARE THE CHARACTERISTICS OF PATIENTS IN WHOM CF IS INCOMPLETELY MANIFESTED?;492;0001
00024;WHAT ARE THE CHARACTERISTICS OF PATIENTS IN WHOM CF IS INCOMPLETELY MANIFESTED?;522;0001
00024;WHAT ARE THE CHARACTERISTICS OF PATIENTS IN WHOM CF IS INCOMPLETELY MANIFESTED?;552;0002
00024;WHAT ARE THE CHARACTERISTICS OF PATIENTS IN WHOM CF IS INCOMPLETELY MANIFESTED?;559;0010
00024;WHAT ARE THE CHARACTERISTICS OF PATIENTS IN WHOM CF IS INCOMPLETELY MANIFESTED?;611;1001
00024;WHAT ARE THE CHARACTERISTICS OF PATIENTS IN WHOM CF IS INCOMPLETELY MANIFESTED?;647;2222
00024;WHAT ARE THE CHARACTERISTICS OF PATIENTS IN WHOM CF IS INCOMPLETELY MANIFESTED?;677;0001
00024;WHAT ARE THE CHARACTERISTICS OF PATIENTS IN WHOM CF IS INCOMPLETELY MANIFESTED?;724;0002
00024;WHAT ARE THE CHARACTERISTICS OF PATIENTS IN WHOM CF IS INCOMPLETELY MANIFESTED?;763;0001
00024;WHAT ARE THE CHARACTERISTICS OF PATIENTS IN WHOM CF IS INCOMPLETELY MANIFESTED?;858;0001
00024;WHAT ARE THE CHARACTERISTICS OF PATIENTS IN WHOM CF IS INCOMPLETELY MANIFESTED?;913;2222
00024;WHAT ARE THE CHARACTERISTICS OF PATIENTS IN WHOM CF IS INCOMPLETELY MANIFESTED?;915;2211
00024;WHAT ARE THE CHARACTERISTICS OF PATIENTS IN WHOM CF IS INCOMPLETELY MANIFESTED?;926;2121
00024;WHAT ARE THE CHARACTERISTICS OF PATIENTS IN WHOM CF IS INCOMPLETELY MANIFESTED?;934;0001
00024;WHAT ARE THE CHARACTERISTICS OF PATIENTS IN WHOM CF IS INCOMPLETELY MANIFESTED?;1000;0001
00024;WHAT ARE THE CHARACTERISTICS OF PATIENTS IN WHOM CF IS INCOMPLETELY MANIFESTED?;1031;1011
00024;WHAT ARE THE CHARACTERISTICS OF PATIENTS IN WHOM CF IS INCOMPLETELY MANIFESTED?;1109;2222
00024;WHAT ARE THE CHARACTERISTICS OF PATIENTS IN WHOM CF IS INCOMPLETELY MANIFESTED?;1195;1121
00024;WHAT ARE THE CHARACTERISTICS OF PATIENTS IN WHOM CF IS INCOMPLETELY MANIFESTED?;1232;0001
00025;WHAT EVIDENCE IS THERE THAT THE GENETIC BASIS FOR CF INVOLVES MORE THAN ONE GENE?;72;2112
00025;WHAT EVIDENCE IS THERE THAT THE GENETIC BASIS FOR CF INVOLVES MORE THAN ONE GENE?;74;2110
00025;WHAT EVIDENCE IS THERE THAT THE GENETIC BASIS FOR CF INVOLVES MORE THAN ONE GENE?;83;0111
00025;WHAT EVIDENCE IS THERE THAT THE GENETIC BASIS FOR CF INVOLVES MORE THAN ONE GENE?;84;0011
00025;WHAT EVIDENCE IS THERE THAT THE GENETIC BASIS FOR CF INVOLVES MORE THAN ONE GENE?;106;1012
00025;WHAT EVIDENCE IS THERE THAT THE GENETIC BASIS FOR CF INVOLVES MORE THAN ONE GENE?;112;0001
00025;WHAT EVIDENCE IS THERE THAT THE GENETIC BASIS FOR CF INVOLVES MORE THAN ONE GENE?;120;0102
00025;WHAT EVIDENCE IS THERE THAT THE GENETIC BASIS FOR CF INVOLVES MORE THAN ONE GENE?;141;0001
00025;WHAT EVIDENCE IS THERE THAT THE GENETIC BASIS FOR CF INVOLVES MORE THAN ONE GENE?;162;1001
00025;WHAT EVIDENCE IS THERE THAT THE GENETIC BASIS FOR CF INVOLVES MORE THAN ONE GENE?;172;0001
00025;WHAT EVIDENCE IS THERE THAT THE GENETIC BASIS FOR CF INVOLVES MORE THAN ONE GENE?;198;1012
00025;WHAT EVIDENCE IS THERE THAT THE GENETIC BASIS FOR CF INVOLVES MORE THAN ONE GENE?;221;0001
00025;WHAT EVIDENCE IS THERE THAT THE GENETIC BASIS FOR CF INVOLVES MORE THAN ONE GENE?;276;0001
00025;WHAT EVIDENCE IS THERE THAT THE GENETIC BASIS FOR CF INVOLVES MORE THAN ONE GENE?;370;1010
00025;WHAT EVIDENCE IS THERE THAT THE GENETIC BASIS FOR CF INVOLVES MORE THAN ONE GENE?;390;0010
00025;WHAT EVIDENCE IS THERE THAT THE GENETIC BASIS FOR CF INVOLVES MORE THAN ONE GENE?;392;0001
00025;WHAT EVIDENCE IS THERE THAT THE GENETIC BASIS FOR CF INVOLVES MORE THAN ONE GENE?;411;2111
00025;WHAT EVIDENCE IS THERE THAT THE GENETIC BASIS FOR CF INVOLVES MORE THAN ONE GENE?;415;1000
00025;WHAT EVIDENCE IS THERE THAT THE GENETIC BASIS FOR CF INVOLVES MORE THAN ONE GENE?;425;0001
00025;WHAT EVIDENCE IS THERE THAT THE GENETIC BASIS FOR CF INVOLVES MORE THAN ONE GENE?;431;2222
00025;WHAT EVIDENCE IS THERE THAT THE GENETIC BASIS FOR CF INVOLVES MORE THAN ONE GENE?;432;0002
00025;WHAT EVIDENCE IS THERE THAT THE GENETIC BASIS FOR CF INVOLVES MORE THAN ONE GENE?;464;0010
00025;WHAT EVIDENCE IS THERE THAT THE GENETIC BASIS FOR CF INVOLVES MORE THAN ONE GENE?;465;1102
00025;WHAT EVIDENCE IS THERE THAT THE GENETIC BASIS FOR CF INVOLVES MORE THAN ONE GENE?;503;1121
00025;WHAT EVIDENCE IS THERE THAT THE GENETIC BASIS FOR CF INVOLVES MORE THAN ONE GENE?;505;0001
00025;WHAT EVIDENCE IS THERE THAT THE GENETIC BASIS FOR CF INVOLVES MORE THAN ONE GENE?;530;0001
00025;WHAT EVIDENCE IS THERE THAT THE GENETIC BASIS FOR CF INVOLVES MORE THAN ONE GENE?;550;0001
00025;WHAT EVIDENCE IS THERE THAT THE GENETIC BASIS FOR CF INVOLVES MORE THAN ONE GENE?;559;0001
00025;WHAT EVIDENCE IS THERE THAT THE GENETIC BASIS FOR CF INVOLVES MORE THAN ONE GENE?;566;1000
00025;WHAT EVIDENCE IS THERE THAT THE GENETIC BASIS FOR CF INVOLVES MORE THAN ONE GENE?;568;1000
00025;WHAT EVIDENCE IS THERE THAT THE GENETIC BASIS FOR CF INVOLVES MORE THAN ONE GENE?;569;1011
00025;WHAT EVIDENCE IS THERE THAT THE GENETIC BASIS FOR CF INVOLVES MORE THAN ONE GENE?;622;0001
00025;WHAT EVIDENCE IS THERE THAT THE GENETIC BASIS FOR CF INVOLVES MORE THAN ONE GENE?;647;2122
00025;WHAT EVIDENCE IS THERE THAT THE GENETIC BASIS FOR CF INVOLVES MORE THAN ONE GENE?;855;0001
00025;WHAT EVIDENCE IS THERE THAT THE GENETIC BASIS FOR CF INVOLVES MORE THAN ONE GENE?;858;2111
00025;WHAT EVIDENCE IS THERE THAT THE GENETIC BASIS FOR CF INVOLVES MORE THAN ONE GENE?;875;0001
00025;WHAT EVIDENCE IS THERE THAT THE GENETIC BASIS FOR CF INVOLVES MORE THAN ONE GENE?;880;0002
00025;WHAT EVIDENCE IS THERE THAT THE GENETIC BASIS FOR CF INVOLVES MORE THAN ONE GENE?;881;1002
00025;WHAT EVIDENCE IS THERE THAT THE GENETIC BASIS FOR CF INVOLVES MORE THAN ONE GENE?;891;0001
00025;WHAT EVIDENCE IS THERE THAT THE GENETIC BASIS FOR CF INVOLVES MORE THAN ONE GENE?;913;2222
00025;WHAT EVIDENCE IS THERE THAT THE GENETIC BASIS FOR CF INVOLVES MORE THAN ONE GENE?;915;0001
00025;WHAT EVIDENCE IS THERE THAT THE GENETIC BASIS FOR CF INVOLVES MORE THAN ONE GENE?;926;2121
00025;WHAT EVIDENCE IS THERE THAT THE GENETIC BASIS FOR CF INVOLVES MORE THAN ONE GENE?;949;0001
00025;WHAT EVIDENCE IS THERE THAT THE GENETIC BASIS FOR CF INVOLVES MORE THAN ONE GENE?;977;1000
00025;WHAT EVIDENCE IS THERE THAT THE GENETIC BASIS FOR CF INVOLVES MORE THAN ONE GENE?;1027;0001
00025;WHAT EVIDENCE IS THERE THAT THE GENETIC BASIS FOR CF INVOLVES MORE THAN ONE GENE?;1031;1000
00025;WHAT EVIDENCE IS THERE THAT THE GENETIC BASIS FOR CF INVOLVES MORE THAN ONE GENE?;1083;0001
00025;WHAT EVIDENCE IS THERE THAT THE GENETIC BASIS FOR CF INVOLVES MORE THAN ONE GENE?;1156;0110
00025;WHAT EVIDENCE IS THERE THAT THE GENETIC BASIS FOR CF INVOLVES MORE THAN ONE GENE?;1194;1121
00025;WHAT EVIDENCE IS THERE THAT THE GENETIC BASIS FOR CF INVOLVES MORE THAN ONE GENE?;1195;1112
00025;WHAT EVIDENCE IS THERE THAT THE GENETIC BASIS FOR CF INVOLVES MORE THAN ONE GENE?;1210;0001
00026;WHAT IS THE HETEROZYGOTE ADVANTAGE IN CF?;74;0110
00026;WHAT IS THE HETEROZYGOTE ADVANTAGE IN CF?;104;2212
00026;WHAT IS THE HETEROZYGOTE ADVANTAGE IN CF?;199;2222
00026;WHAT IS THE HETEROZYGOTE ADVANTAGE IN CF?;221;0001
00026;WHAT IS THE HETEROZYGOTE ADVANTAGE IN CF?;281;2222
00026;WHAT IS THE HETEROZYGOTE ADVANTAGE IN CF?;285;2112
00026;WHAT IS THE HETEROZYGOTE ADVANTAGE IN CF?;328;2111
00026;WHAT IS THE HETEROZYGOTE ADVANTAGE IN CF?;333;0001
00026;WHAT IS THE HETEROZYGOTE ADVANTAGE IN CF?;342;2110
00026;WHAT IS THE HETEROZYGOTE ADVANTAGE IN CF?;343;1100
00026;WHAT IS THE HETEROZYGOTE ADVANTAGE IN CF?;370;0010
00026;WHAT IS THE HETEROZYGOTE ADVANTAGE IN CF?;392;0001
00026;WHAT IS THE HETEROZYGOTE ADVANTAGE IN CF?;431;2222
00026;WHAT IS THE HETEROZYGOTE ADVANTAGE IN CF?;434;0001
00026;WHAT IS THE HETEROZYGOTE ADVANTAGE IN CF?;442;0002
00026;WHAT IS THE HETEROZYGOTE ADVANTAGE IN CF?;465;0001
00026;WHAT IS THE HETEROZYGOTE ADVANTAGE IN CF?;485;0010
00026;WHAT IS THE HETEROZYGOTE ADVANTAGE IN CF?;488;0010
00026;WHAT IS THE HETEROZYGOTE ADVANTAGE IN CF?;490;0001
00026;WHAT IS THE HETEROZYGOTE ADVANTAGE IN CF?;610;2122
00026;WHAT IS THE HETEROZYGOTE ADVANTAGE IN CF?;617;2222
00026;WHAT IS THE HETEROZYGOTE ADVANTAGE IN CF?;665;1112
00026;WHAT IS THE HETEROZYGOTE ADVANTAGE IN CF?;713;0010
00026;WHAT IS THE HETEROZYGOTE ADVANTAGE IN CF?;774;0101
00026;WHAT IS THE HETEROZYGOTE ADVANTAGE IN CF?;807;1122
00026;WHAT IS THE HETEROZYGOTE ADVANTAGE IN CF?;855;0010
00026;WHAT IS THE HETEROZYGOTE ADVANTAGE IN CF?;881;0102
00026;WHAT IS THE HETEROZYGOTE ADVANTAGE IN CF?;942;1101
00026;WHAT IS THE HETEROZYGOTE ADVANTAGE IN CF?;1061;2222
00026;WHAT IS THE HETEROZYGOTE ADVANTAGE IN CF?;1144;2222
00026;WHAT IS THE HETEROZYGOTE ADVANTAGE IN CF?;1166;2211
00026;WHAT IS THE HETEROZYGOTE ADVANTAGE IN CF?;1194;1121
00026;WHAT IS THE HETEROZYGOTE ADVANTAGE IN CF?;1195;0001
00027;WHAT IS THE CONCORDANCE OF CLINICAL OR BIOCHEMICAL MANIFESTATIONS OF CF IN SIBLING PAIRS (BOTH OF WHOM HAVE CF)?;98;1102
00027;WHAT IS THE CONCORDANCE OF CLINICAL OR BIOCHEMICAL MANIFESTATIONS OF CF IN SIBLING PAIRS (BOTH OF WHOM HAVE CF)?;179;0001
00027;WHAT IS THE CONCORDANCE OF CLINICAL OR BIOCHEMICAL MANIFESTATIONS OF CF IN SIBLING PAIRS (BOTH OF WHOM HAVE CF)?;599;2222
00027;WHAT IS THE CONCORDANCE OF CLINICAL OR BIOCHEMICAL MANIFESTATIONS OF CF IN SIBLING PAIRS (BOTH OF WHOM HAVE CF)?;756;0002
00027;WHAT IS THE CONCORDANCE OF CLINICAL OR BIOCHEMICAL MANIFESTATIONS OF CF IN SIBLING PAIRS (BOTH OF WHOM HAVE CF)?;858;0001
00027;WHAT IS THE CONCORDANCE OF CLINICAL OR BIOCHEMICAL MANIFESTATIONS OF CF IN SIBLING PAIRS (BOTH OF WHOM HAVE CF)?;905;2122
00027;WHAT IS THE CONCORDANCE OF CLINICAL OR BIOCHEMICAL MANIFESTATIONS OF CF IN SIBLING PAIRS (BOTH OF WHOM HAVE CF)?;912;0001
00027;WHAT IS THE CONCORDANCE OF CLINICAL OR BIOCHEMICAL MANIFESTATIONS OF CF IN SIBLING PAIRS (BOTH OF WHOM HAVE CF)?;913;1001
00027;WHAT IS THE CONCORDANCE OF CLINICAL OR BIOCHEMICAL MANIFESTATIONS OF CF IN SIBLING PAIRS (BOTH OF WHOM HAVE CF)?;1000;0100
00027;WHAT IS THE CONCORDANCE OF CLINICAL OR BIOCHEMICAL MANIFESTATIONS OF CF IN SIBLING PAIRS (BOTH OF WHOM HAVE CF)?;1083;0100
00027;WHAT IS THE CONCORDANCE OF CLINICAL OR BIOCHEMICAL MANIFESTATIONS OF CF IN SIBLING PAIRS (BOTH OF WHOM HAVE CF)?;1096;0002
00028;WHAT IS THE INCIDENCE OF MALE FERTILITY IN CF?;134;0001
00028;WHAT IS THE INCIDENCE OF MALE FERTILITY IN CF?;135;0102
00028;WHAT IS THE INCIDENCE OF MALE FERTILITY IN CF?;136;0001
00028;WHAT IS THE INCIDENCE OF MALE FERTILITY IN CF?;215;1112
00028;WHAT IS THE INCIDENCE OF MALE FERTILITY IN CF?;274;1000
00028;WHAT IS THE INCIDENCE OF MALE FERTILITY IN CF?;300;0002
00028;WHAT IS THE INCIDENCE OF MALE FERTILITY IN CF?;322;0002
00028;WHAT IS THE INCIDENCE OF MALE FERTILITY IN CF?;331;0001
00028;WHAT IS THE INCIDENCE OF MALE FERTILITY IN CF?;333;0001
00028;WHAT IS THE INCIDENCE OF MALE FERTILITY IN CF?;343;0001
00028;WHAT IS THE INCIDENCE OF MALE FERTILITY IN CF?;351;2112
00028;WHAT IS THE INCIDENCE OF MALE FERTILITY IN CF?;352;2112
00028;WHAT IS THE INCIDENCE OF MALE FERTILITY IN CF?;370;1112
00028;WHAT IS THE INCIDENCE OF MALE FERTILITY IN CF?;392;0001
00028;WHAT IS THE INCIDENCE OF MALE FERTILITY IN CF?;398;0001
00028;WHAT IS THE INCIDENCE OF MALE FERTILITY IN CF?;465;0001
00028;WHAT IS THE INCIDENCE OF MALE FERTILITY IN CF?;467;0001
00028;WHAT IS THE INCIDENCE OF MALE FERTILITY IN CF?;477;2121
00028;WHAT IS THE INCIDENCE OF MALE FERTILITY IN CF?;510;0001
00028;WHAT IS THE INCIDENCE OF MALE FERTILITY IN CF?;550;0001
00028;WHAT IS THE INCIDENCE OF MALE FERTILITY IN CF?;559;0001
00028;WHAT IS THE INCIDENCE OF MALE FERTILITY IN CF?;586;0001
00028;WHAT IS THE INCIDENCE OF MALE FERTILITY IN CF?;611;0001
00028;WHAT IS THE INCIDENCE OF MALE FERTILITY IN CF?;665;0001
00028;WHAT IS THE INCIDENCE OF MALE FERTILITY IN CF?;722;1012
00028;WHAT IS THE INCIDENCE OF MALE FERTILITY IN CF?;724;0102
00028;WHAT IS THE INCIDENCE OF MALE FERTILITY IN CF?;729;0001
00028;WHAT IS THE INCIDENCE OF MALE FERTILITY IN CF?;735;0001
00028;WHAT IS THE INCIDENCE OF MALE FERTILITY IN CF?;759;2111
00028;WHAT IS THE INCIDENCE OF MALE FERTILITY IN CF?;763;0102
00028;WHAT IS THE INCIDENCE OF MALE FERTILITY IN CF?;822;1212
00028;WHAT IS THE INCIDENCE OF MALE FERTILITY IN CF?;832;0001
00028;WHAT IS THE INCIDENCE OF MALE FERTILITY IN CF?;837;0001
00028;WHAT IS THE INCIDENCE OF MALE FERTILITY IN CF?;875;0001
00028;WHAT IS THE INCIDENCE OF MALE FERTILITY IN CF?;882;0002
00028;WHAT IS THE INCIDENCE OF MALE FERTILITY IN CF?;913;0001
00028;WHAT IS THE INCIDENCE OF MALE FERTILITY IN CF?;937;0001
00028;WHAT IS THE INCIDENCE OF MALE FERTILITY IN CF?;942;0101
00028;WHAT IS THE INCIDENCE OF MALE FERTILITY IN CF?;944;0001
00028;WHAT IS THE INCIDENCE OF MALE FERTILITY IN CF?;969;0001
00028;WHAT IS THE INCIDENCE OF MALE FERTILITY IN CF?;990;0002
00028;WHAT IS THE INCIDENCE OF MALE FERTILITY IN CF?;1000;1102
00028;WHAT IS THE INCIDENCE OF MALE FERTILITY IN CF?;1033;0102
00028;WHAT IS THE INCIDENCE OF MALE FERTILITY IN CF?;1040;0102
00028;WHAT IS THE INCIDENCE OF MALE FERTILITY IN CF?;1083;1112
00028;WHAT IS THE INCIDENCE OF MALE FERTILITY IN CF?;1093;0102
00028;WHAT IS THE INCIDENCE OF MALE FERTILITY IN CF?;1187;0001
00028;WHAT IS THE INCIDENCE OF MALE FERTILITY IN CF?;1192;0102
00028;WHAT IS THE INCIDENCE OF MALE FERTILITY IN CF?;1222;0001
00028;WHAT IS THE INCIDENCE OF MALE FERTILITY IN CF?;1226;0001
00028;WHAT IS THE INCIDENCE OF MALE FERTILITY IN CF?;1234;0102
00029;WHAT IS THE PATHOLOGY OF THE REPRODUCTIVE SYSTEM (MALE OR FEMALE) IN CF?;15;1012
00029;WHAT IS THE PATHOLOGY OF THE REPRODUCTIVE SYSTEM (MALE OR FEMALE) IN CF?;100;0001
00029;WHAT IS THE PATHOLOGY OF THE REPRODUCTIVE SYSTEM (MALE OR FEMALE) IN CF?;215;2122
00029;WHAT IS THE PATHOLOGY OF THE REPRODUCTIVE SYSTEM (MALE OR FEMALE) IN CF?;274;2222
00029;WHAT IS THE PATHOLOGY OF THE REPRODUCTIVE SYSTEM (MALE OR FEMALE) IN CF?;300;2212
00029;WHAT IS THE PATHOLOGY OF THE REPRODUCTIVE SYSTEM (MALE OR FEMALE) IN CF?;322;2222
00029;WHAT IS THE PATHOLOGY OF THE REPRODUCTIVE SYSTEM (MALE OR FEMALE) IN CF?;333;0101
00029;WHAT IS THE PATHOLOGY OF THE REPRODUCTIVE SYSTEM (MALE OR FEMALE) IN CF?;343;0001
00029;WHAT IS THE PATHOLOGY OF THE REPRODUCTIVE SYSTEM (MALE OR FEMALE) IN CF?;350;0110
00029;WHAT IS THE PATHOLOGY OF THE REPRODUCTIVE SYSTEM (MALE OR FEMALE) IN CF?;351;2122
00029;WHAT IS THE PATHOLOGY OF THE REPRODUCTIVE SYSTEM (MALE OR FEMALE) IN CF?;352;2122
00029;WHAT IS THE PATHOLOGY OF THE REPRODUCTIVE SYSTEM (MALE OR FEMALE) IN CF?;353;2220
00029;WHAT IS THE PATHOLOGY OF THE REPRODUCTIVE SYSTEM (MALE OR FEMALE) IN CF?;370;1112
00029;WHAT IS THE PATHOLOGY OF THE REPRODUCTIVE SYSTEM (MALE OR FEMALE) IN CF?;385;0001
00029;WHAT IS THE PATHOLOGY OF THE REPRODUCTIVE SYSTEM (MALE OR FEMALE) IN CF?;392;0001
00029;WHAT IS THE PATHOLOGY OF THE REPRODUCTIVE SYSTEM (MALE OR FEMALE) IN CF?;434;0001
00029;WHAT IS THE PATHOLOGY OF THE REPRODUCTIVE SYSTEM (MALE OR FEMALE) IN CF?;442;0001
00029;WHAT IS THE PATHOLOGY OF THE REPRODUCTIVE SYSTEM (MALE OR FEMALE) IN CF?;477;1120
00029;WHAT IS THE PATHOLOGY OF THE REPRODUCTIVE SYSTEM (MALE OR FEMALE) IN CF?;510;0001
00029;WHAT IS THE PATHOLOGY OF THE REPRODUCTIVE SYSTEM (MALE OR FEMALE) IN CF?;553;0001
00029;WHAT IS THE PATHOLOGY OF THE REPRODUCTIVE SYSTEM (MALE OR FEMALE) IN CF?;687;0010
00029;WHAT IS THE PATHOLOGY OF THE REPRODUCTIVE SYSTEM (MALE OR FEMALE) IN CF?;714;1002
00029;WHAT IS THE PATHOLOGY OF THE REPRODUCTIVE SYSTEM (MALE OR FEMALE) IN CF?;722;1012
00029;WHAT IS THE PATHOLOGY OF THE REPRODUCTIVE SYSTEM (MALE OR FEMALE) IN CF?;724;0102
00029;WHAT IS THE PATHOLOGY OF THE REPRODUCTIVE SYSTEM (MALE OR FEMALE) IN CF?;729;0001
00029;WHAT IS THE PATHOLOGY OF THE REPRODUCTIVE SYSTEM (MALE OR FEMALE) IN CF?;759;2212
00029;WHAT IS THE PATHOLOGY OF THE REPRODUCTIVE SYSTEM (MALE OR FEMALE) IN CF?;763;1102
00029;WHAT IS THE PATHOLOGY OF THE REPRODUCTIVE SYSTEM (MALE OR FEMALE) IN CF?;764;1000
00029;WHAT IS THE PATHOLOGY OF THE REPRODUCTIVE SYSTEM (MALE OR FEMALE) IN CF?;788;1000
00029;WHAT IS THE PATHOLOGY OF THE REPRODUCTIVE SYSTEM (MALE OR FEMALE) IN CF?;822;0102
00029;WHAT IS THE PATHOLOGY OF THE REPRODUCTIVE SYSTEM (MALE OR FEMALE) IN CF?;832;1222
00029;WHAT IS THE PATHOLOGY OF THE REPRODUCTIVE SYSTEM (MALE OR FEMALE) IN CF?;837;0001
00029;WHAT IS THE PATHOLOGY OF THE REPRODUCTIVE SYSTEM (MALE OR FEMALE) IN CF?;875;0001
00029;WHAT IS THE PATHOLOGY OF THE REPRODUCTIVE SYSTEM (MALE OR FEMALE) IN CF?;937;0001
00029;WHAT IS THE PATHOLOGY OF THE REPRODUCTIVE SYSTEM (MALE OR FEMALE) IN CF?;942;0101
00029;WHAT IS THE PATHOLOGY OF THE REPRODUCTIVE SYSTEM (MALE OR FEMALE) IN CF?;944;1102
00029;WHAT IS THE PATHOLOGY OF THE REPRODUCTIVE SYSTEM (MALE OR FEMALE) IN CF?;1000;0001
00029;WHAT IS THE PATHOLOGY OF THE REPRODUCTIVE SYSTEM (MALE OR FEMALE) IN CF?;1033;0100
00029;WHAT IS THE PATHOLOGY OF THE REPRODUCTIVE SYSTEM (MALE OR FEMALE) IN CF?;1040;0101
00029;WHAT IS THE PATHOLOGY OF THE REPRODUCTIVE SYSTEM (MALE OR FEMALE) IN CF?;1083;0002
00029;WHAT IS THE PATHOLOGY OF THE REPRODUCTIVE SYSTEM (MALE OR FEMALE) IN CF?;1093;0100
00029;WHAT IS THE PATHOLOGY OF THE REPRODUCTIVE SYSTEM (MALE OR FEMALE) IN CF?;1184;0100
00029;WHAT IS THE PATHOLOGY OF THE REPRODUCTIVE SYSTEM (MALE OR FEMALE) IN CF?;1192;1122
00029;WHAT IS THE PATHOLOGY OF THE REPRODUCTIVE SYSTEM (MALE OR FEMALE) IN CF?;1234;0102
00030;WHAT ARE THE RESULTS OF GENETIC COUNSELING OF FAMILIES OF CHILDREN WITH CF?;117;0002
00030;WHAT ARE THE RESULTS OF GENETIC COUNSELING OF FAMILIES OF CHILDREN WITH CF?;328;0101
00030;WHAT ARE THE RESULTS OF GENETIC COUNSELING OF FAMILIES OF CHILDREN WITH CF?;332;0001
00030;WHAT ARE THE RESULTS OF GENETIC COUNSELING OF FAMILIES OF CHILDREN WITH CF?;433;2122
00030;WHAT ARE THE RESULTS OF GENETIC COUNSELING OF FAMILIES OF CHILDREN WITH CF?;492;0001
00030;WHAT ARE THE RESULTS OF GENETIC COUNSELING OF FAMILIES OF CHILDREN WITH CF?;557;0002
00030;WHAT ARE THE RESULTS OF GENETIC COUNSELING OF FAMILIES OF CHILDREN WITH CF?;586;2112
00030;WHAT ARE THE RESULTS OF GENETIC COUNSELING OF FAMILIES OF CHILDREN WITH CF?;687;0010
00030;WHAT ARE THE RESULTS OF GENETIC COUNSELING OF FAMILIES OF CHILDREN WITH CF?;775;0001
00030;WHAT ARE THE RESULTS OF GENETIC COUNSELING OF FAMILIES OF CHILDREN WITH CF?;880;2112
00030;WHAT ARE THE RESULTS OF GENETIC COUNSELING OF FAMILIES OF CHILDREN WITH CF?;881;0001
00030;WHAT ARE THE RESULTS OF GENETIC COUNSELING OF FAMILIES OF CHILDREN WITH CF?;911;2212
00030;WHAT ARE THE RESULTS OF GENETIC COUNSELING OF FAMILIES OF CHILDREN WITH CF?;942;1010
00030;WHAT ARE THE RESULTS OF GENETIC COUNSELING OF FAMILIES OF CHILDREN WITH CF?;1001;0011
00030;WHAT ARE THE RESULTS OF GENETIC COUNSELING OF FAMILIES OF CHILDREN WITH CF?;1084;0100
00030;WHAT ARE THE RESULTS OF GENETIC COUNSELING OF FAMILIES OF CHILDREN WITH CF?;1224;1212
00030;WHAT ARE THE RESULTS OF GENETIC COUNSELING OF FAMILIES OF CHILDREN WITH CF?;1234;0001
00031;WHAT ARE THE MAJOR PSYCHOLOGICAL OR SOCIAL EFFECTS OF CF ON PATIENTS AND THEIR FAMILIES?;43;2222
00031;WHAT ARE THE MAJOR PSYCHOLOGICAL OR SOCIAL EFFECTS OF CF ON PATIENTS AND THEIR FAMILIES?;69;0001
00031;WHAT ARE THE MAJOR PSYCHOLOGICAL OR SOCIAL EFFECTS OF CF ON PATIENTS AND THEIR FAMILIES?;127;1112
00031;WHAT ARE THE MAJOR PSYCHOLOGICAL OR SOCIAL EFFECTS OF CF ON PATIENTS AND THEIR FAMILIES?;128;1000
00031;WHAT ARE THE MAJOR PSYCHOLOGICAL OR SOCIAL EFFECTS OF CF ON PATIENTS AND THEIR FAMILIES?;136;1101
00031;WHAT ARE THE MAJOR PSYCHOLOGICAL OR SOCIAL EFFECTS OF CF ON PATIENTS AND THEIR FAMILIES?;145;0002
00031;WHAT ARE THE MAJOR PSYCHOLOGICAL OR SOCIAL EFFECTS OF CF ON PATIENTS AND THEIR FAMILIES?;168;0101
00031;WHAT ARE THE MAJOR PSYCHOLOGICAL OR SOCIAL EFFECTS OF CF ON PATIENTS AND THEIR FAMILIES?;189;1112
00031;WHAT ARE THE MAJOR PSYCHOLOGICAL OR SOCIAL EFFECTS OF CF ON PATIENTS AND THEIR FAMILIES?;213;0001
00031;WHAT ARE THE MAJOR PSYCHOLOGICAL OR SOCIAL EFFECTS OF CF ON PATIENTS AND THEIR FAMILIES?;226;1122
00031;WHAT ARE THE MAJOR PSYCHOLOGICAL OR SOCIAL EFFECTS OF CF ON PATIENTS AND THEIR FAMILIES?;239;2222
00031;WHAT ARE THE MAJOR PSYCHOLOGICAL OR SOCIAL EFFECTS OF CF ON PATIENTS AND THEIR FAMILIES?;272;0100
00031;WHAT ARE THE MAJOR PSYCHOLOGICAL OR SOCIAL EFFECTS OF CF ON PATIENTS AND THEIR FAMILIES?;330;1111
00031;WHAT ARE THE MAJOR PSYCHOLOGICAL OR SOCIAL EFFECTS OF CF ON PATIENTS AND THEIR FAMILIES?;331;1001
00031;WHAT ARE THE MAJOR PSYCHOLOGICAL OR SOCIAL EFFECTS OF CF ON PATIENTS AND THEIR FAMILIES?;332;2222
00031;WHAT ARE THE MAJOR PSYCHOLOGICAL OR SOCIAL EFFECTS OF CF ON PATIENTS AND THEIR FAMILIES?;359;0100
00031;WHAT ARE THE MAJOR PSYCHOLOGICAL OR SOCIAL EFFECTS OF CF ON PATIENTS AND THEIR FAMILIES?;370;1111
00031;WHAT ARE THE MAJOR PSYCHOLOGICAL OR SOCIAL EFFECTS OF CF ON PATIENTS AND THEIR FAMILIES?;389;1000
00031;WHAT ARE THE MAJOR PSYCHOLOGICAL OR SOCIAL EFFECTS OF CF ON PATIENTS AND THEIR FAMILIES?;433;2222
00031;WHAT ARE THE MAJOR PSYCHOLOGICAL OR SOCIAL EFFECTS OF CF ON PATIENTS AND THEIR FAMILIES?;448;2122
00031;WHAT ARE THE MAJOR PSYCHOLOGICAL OR SOCIAL EFFECTS OF CF ON PATIENTS AND THEIR FAMILIES?;467;2222
00031;WHAT ARE THE MAJOR PSYCHOLOGICAL OR SOCIAL EFFECTS OF CF ON PATIENTS AND THEIR FAMILIES?;512;0100
00031;WHAT ARE THE MAJOR PSYCHOLOGICAL OR SOCIAL EFFECTS OF CF ON PATIENTS AND THEIR FAMILIES?;550;0001
00031;WHAT ARE THE MAJOR PSYCHOLOGICAL OR SOCIAL EFFECTS OF CF ON PATIENTS AND THEIR FAMILIES?;551;0101
00031;WHAT ARE THE MAJOR PSYCHOLOGICAL OR SOCIAL EFFECTS OF CF ON PATIENTS AND THEIR FAMILIES?;557;2222
00031;WHAT ARE THE MAJOR PSYCHOLOGICAL OR SOCIAL EFFECTS OF CF ON PATIENTS AND THEIR FAMILIES?;586;2222
00031;WHAT ARE THE MAJOR PSYCHOLOGICAL OR SOCIAL EFFECTS OF CF ON PATIENTS AND THEIR FAMILIES?;620;1001
00031;WHAT ARE THE MAJOR PSYCHOLOGICAL OR SOCIAL EFFECTS OF CF ON PATIENTS AND THEIR FAMILIES?;628;0111
00031;WHAT ARE THE MAJOR PSYCHOLOGICAL OR SOCIAL EFFECTS OF CF ON PATIENTS AND THEIR FAMILIES?;651;2221
00031;WHAT ARE THE MAJOR PSYCHOLOGICAL OR SOCIAL EFFECTS OF CF ON PATIENTS AND THEIR FAMILIES?;701;1100
00031;WHAT ARE THE MAJOR PSYCHOLOGICAL OR SOCIAL EFFECTS OF CF ON PATIENTS AND THEIR FAMILIES?;722;1001
00031;WHAT ARE THE MAJOR PSYCHOLOGICAL OR SOCIAL EFFECTS OF CF ON PATIENTS AND THEIR FAMILIES?;724;1000
00031;WHAT ARE THE MAJOR PSYCHOLOGICAL OR SOCIAL EFFECTS OF CF ON PATIENTS AND THEIR FAMILIES?;729;0101
00031;WHAT ARE THE MAJOR PSYCHOLOGICAL OR SOCIAL EFFECTS OF CF ON PATIENTS AND THEIR FAMILIES?;735;0100
00031;WHAT ARE THE MAJOR PSYCHOLOGICAL OR SOCIAL EFFECTS OF CF ON PATIENTS AND THEIR FAMILIES?;760;2222
00031;WHAT ARE THE MAJOR PSYCHOLOGICAL OR SOCIAL EFFECTS OF CF ON PATIENTS AND THEIR FAMILIES?;762;1000
00031;WHAT ARE THE MAJOR PSYCHOLOGICAL OR SOCIAL EFFECTS OF CF ON PATIENTS AND THEIR FAMILIES?;764;1000
00031;WHAT ARE THE MAJOR PSYCHOLOGICAL OR SOCIAL EFFECTS OF CF ON PATIENTS AND THEIR FAMILIES?;839;1212
00031;WHAT ARE THE MAJOR PSYCHOLOGICAL OR SOCIAL EFFECTS OF CF ON PATIENTS AND THEIR FAMILIES?;845;2222
00031;WHAT ARE THE MAJOR PSYCHOLOGICAL OR SOCIAL EFFECTS OF CF ON PATIENTS AND THEIR FAMILIES?;882;1112
00031;WHAT ARE THE MAJOR PSYCHOLOGICAL OR SOCIAL EFFECTS OF CF ON PATIENTS AND THEIR FAMILIES?;937;0101
00031;WHAT ARE THE MAJOR PSYCHOLOGICAL OR SOCIAL EFFECTS OF CF ON PATIENTS AND THEIR FAMILIES?;938;1212
00031;WHAT ARE THE MAJOR PSYCHOLOGICAL OR SOCIAL EFFECTS OF CF ON PATIENTS AND THEIR FAMILIES?;940;0101
00031;WHAT ARE THE MAJOR PSYCHOLOGICAL OR SOCIAL EFFECTS OF CF ON PATIENTS AND THEIR FAMILIES?;942;1012
00031;WHAT ARE THE MAJOR PSYCHOLOGICAL OR SOCIAL EFFECTS OF CF ON PATIENTS AND THEIR FAMILIES?;944;0001
00031;WHAT ARE THE MAJOR PSYCHOLOGICAL OR SOCIAL EFFECTS OF CF ON PATIENTS AND THEIR FAMILIES?;999;2222
00031;WHAT ARE THE MAJOR PSYCHOLOGICAL OR SOCIAL EFFECTS OF CF ON PATIENTS AND THEIR FAMILIES?;1000;0101
00031;WHAT ARE THE MAJOR PSYCHOLOGICAL OR SOCIAL EFFECTS OF CF ON PATIENTS AND THEIR FAMILIES?;1020;2122
00031;WHAT ARE THE MAJOR PSYCHOLOGICAL OR SOCIAL EFFECTS OF CF ON PATIENTS AND THEIR FAMILIES?;1022;1222
00031;WHAT ARE THE MAJOR PSYCHOLOGICAL OR SOCIAL EFFECTS OF CF ON PATIENTS AND THEIR FAMILIES?;1036;2112
00031;WHAT ARE THE MAJOR PSYCHOLOGICAL OR SOCIAL EFFECTS OF CF ON PATIENTS AND THEIR FAMILIES?;1040;1102
00031;WHAT ARE THE MAJOR PSYCHOLOGICAL OR SOCIAL EFFECTS OF CF ON PATIENTS AND THEIR FAMILIES?;1084;2222
00031;WHAT ARE THE MAJOR PSYCHOLOGICAL OR SOCIAL EFFECTS OF CF ON PATIENTS AND THEIR FAMILIES?;1093;0002
00031;WHAT ARE THE MAJOR PSYCHOLOGICAL OR SOCIAL EFFECTS OF CF ON PATIENTS AND THEIR FAMILIES?;1187;0101
00031;WHAT ARE THE MAJOR PSYCHOLOGICAL OR SOCIAL EFFECTS OF CF ON PATIENTS AND THEIR FAMILIES?;1224;1120
00031;WHAT ARE THE MAJOR PSYCHOLOGICAL OR SOCIAL EFFECTS OF CF ON PATIENTS AND THEIR FAMILIES?;1232;0001
00031;WHAT ARE THE MAJOR PSYCHOLOGICAL OR SOCIAL EFFECTS OF CF ON PATIENTS AND THEIR FAMILIES?;1233;2222
00031;WHAT ARE THE MAJOR PSYCHOLOGICAL OR SOCIAL EFFECTS OF CF ON PATIENTS AND THEIR FAMILIES?;1234;0102
00032;WHAT FACTORS INFLUENCE COMPLIANCE WITH PRESCRIBED THERAPY IN CF PATIENTS?;43;1000
00032;WHAT FACTORS INFLUENCE COMPLIANCE WITH PRESCRIBED THERAPY IN CF PATIENTS?;127;0001
00032;WHAT FACTORS INFLUENCE COMPLIANCE WITH PRESCRIBED THERAPY IN CF PATIENTS?;128;1000
00032;WHAT FACTORS INFLUENCE COMPLIANCE WITH PRESCRIBED THERAPY IN CF PATIENTS?;181;0001
00032;WHAT FACTORS INFLUENCE COMPLIANCE WITH PRESCRIBED THERAPY IN CF PATIENTS?;184;2222
00032;WHAT FACTORS INFLUENCE COMPLIANCE WITH PRESCRIBED THERAPY IN CF PATIENTS?;189;0002
00032;WHAT FACTORS INFLUENCE COMPLIANCE WITH PRESCRIBED THERAPY IN CF PATIENTS?;212;0011
00032;WHAT FACTORS INFLUENCE COMPLIANCE WITH PRESCRIBED THERAPY IN CF PATIENTS?;226;0001
00032;WHAT FACTORS INFLUENCE COMPLIANCE WITH PRESCRIBED THERAPY IN CF PATIENTS?;239;0011
00032;WHAT FACTORS INFLUENCE COMPLIANCE WITH PRESCRIBED THERAPY IN CF PATIENTS?;315;1000
00032;WHAT FACTORS INFLUENCE COMPLIANCE WITH PRESCRIBED THERAPY IN CF PATIENTS?;330;0001
00032;WHAT FACTORS INFLUENCE COMPLIANCE WITH PRESCRIBED THERAPY IN CF PATIENTS?;331;0001
00032;WHAT FACTORS INFLUENCE COMPLIANCE WITH PRESCRIBED THERAPY IN CF PATIENTS?;370;1000
00032;WHAT FACTORS INFLUENCE COMPLIANCE WITH PRESCRIBED THERAPY IN CF PATIENTS?;389;1112
00032;WHAT FACTORS INFLUENCE COMPLIANCE WITH PRESCRIBED THERAPY IN CF PATIENTS?;433;1121
00032;WHAT FACTORS INFLUENCE COMPLIANCE WITH PRESCRIBED THERAPY IN CF PATIENTS?;467;1000
00032;WHAT FACTORS INFLUENCE COMPLIANCE WITH PRESCRIBED THERAPY IN CF PATIENTS?;473;0001
00032;WHAT FACTORS INFLUENCE COMPLIANCE WITH PRESCRIBED THERAPY IN CF PATIENTS?;489;1000
00032;WHAT FACTORS INFLUENCE COMPLIANCE WITH PRESCRIBED THERAPY IN CF PATIENTS?;506;0010
00032;WHAT FACTORS INFLUENCE COMPLIANCE WITH PRESCRIBED THERAPY IN CF PATIENTS?;586;1011
00032;WHAT FACTORS INFLUENCE COMPLIANCE WITH PRESCRIBED THERAPY IN CF PATIENTS?;722;1122
00032;WHAT FACTORS INFLUENCE COMPLIANCE WITH PRESCRIBED THERAPY IN CF PATIENTS?;735;0001
00032;WHAT FACTORS INFLUENCE COMPLIANCE WITH PRESCRIBED THERAPY IN CF PATIENTS?;764;0001
00032;WHAT FACTORS INFLUENCE COMPLIANCE WITH PRESCRIBED THERAPY IN CF PATIENTS?;882;0001
00032;WHAT FACTORS INFLUENCE COMPLIANCE WITH PRESCRIBED THERAPY IN CF PATIENTS?;937;0001
00032;WHAT FACTORS INFLUENCE COMPLIANCE WITH PRESCRIBED THERAPY IN CF PATIENTS?;999;1000
00032;WHAT FACTORS INFLUENCE COMPLIANCE WITH PRESCRIBED THERAPY IN CF PATIENTS?;1040;0101
00032;WHAT FACTORS INFLUENCE COMPLIANCE WITH PRESCRIBED THERAPY IN CF PATIENTS?;1093;0001
00032;WHAT FACTORS INFLUENCE COMPLIANCE WITH PRESCRIBED THERAPY IN CF PATIENTS?;1220;0001
00032;WHAT FACTORS INFLUENCE COMPLIANCE WITH PRESCRIBED THERAPY IN CF PATIENTS?;1234;1100
00033;WHAT CONDITIONS OR FACTORS LEAD TO ERRONEOUS SWEAT TESTS?;37;0101
00033;WHAT CONDITIONS OR FACTORS LEAD TO ERRONEOUS SWEAT TESTS?;65;0001
00033;WHAT CONDITIONS OR FACTORS LEAD TO ERRONEOUS SWEAT TESTS?;91;2222
00033;WHAT CONDITIONS OR FACTORS LEAD TO ERRONEOUS SWEAT TESTS?;94;2220
00033;WHAT CONDITIONS OR FACTORS LEAD TO ERRONEOUS SWEAT TESTS?;96;0001
00033;WHAT CONDITIONS OR FACTORS LEAD TO ERRONEOUS SWEAT TESTS?;210;2220
00033;WHAT CONDITIONS OR FACTORS LEAD TO ERRONEOUS SWEAT TESTS?;225;0012
00033;WHAT CONDITIONS OR FACTORS LEAD TO ERRONEOUS SWEAT TESTS?;297;0001
00033;WHAT CONDITIONS OR FACTORS LEAD TO ERRONEOUS SWEAT TESTS?;359;1011
00033;WHAT CONDITIONS OR FACTORS LEAD TO ERRONEOUS SWEAT TESTS?;370;1212
00033;WHAT CONDITIONS OR FACTORS LEAD TO ERRONEOUS SWEAT TESTS?;403;2212
00033;WHAT CONDITIONS OR FACTORS LEAD TO ERRONEOUS SWEAT TESTS?;404;0002
00033;WHAT CONDITIONS OR FACTORS LEAD TO ERRONEOUS SWEAT TESTS?;413;0002
00033;WHAT CONDITIONS OR FACTORS LEAD TO ERRONEOUS SWEAT TESTS?;465;2222
00033;WHAT CONDITIONS OR FACTORS LEAD TO ERRONEOUS SWEAT TESTS?;515;0001
00033;WHAT CONDITIONS OR FACTORS LEAD TO ERRONEOUS SWEAT TESTS?;612;2222
00033;WHAT CONDITIONS OR FACTORS LEAD TO ERRONEOUS SWEAT TESTS?;637;2220
00033;WHAT CONDITIONS OR FACTORS LEAD TO ERRONEOUS SWEAT TESTS?;638;2220
00033;WHAT CONDITIONS OR FACTORS LEAD TO ERRONEOUS SWEAT TESTS?;663;0001
00033;WHAT CONDITIONS OR FACTORS LEAD TO ERRONEOUS SWEAT TESTS?;719;0001
00033;WHAT CONDITIONS OR FACTORS LEAD TO ERRONEOUS SWEAT TESTS?;721;2222
00033;WHAT CONDITIONS OR FACTORS LEAD TO ERRONEOUS SWEAT TESTS?;731;0001
00033;WHAT CONDITIONS OR FACTORS LEAD TO ERRONEOUS SWEAT TESTS?;763;1001
00033;WHAT CONDITIONS OR FACTORS LEAD TO ERRONEOUS SWEAT TESTS?;764;0002
00033;WHAT CONDITIONS OR FACTORS LEAD TO ERRONEOUS SWEAT TESTS?;773;0001
00033;WHAT CONDITIONS OR FACTORS LEAD TO ERRONEOUS SWEAT TESTS?;793;0010
00033;WHAT CONDITIONS OR FACTORS LEAD TO ERRONEOUS SWEAT TESTS?;795;1000
00033;WHAT CONDITIONS OR FACTORS LEAD TO ERRONEOUS SWEAT TESTS?;797;2210
00033;WHAT CONDITIONS OR FACTORS LEAD TO ERRONEOUS SWEAT TESTS?;811;2222
00033;WHAT CONDITIONS OR FACTORS LEAD TO ERRONEOUS SWEAT TESTS?;818;2220
00033;WHAT CONDITIONS OR FACTORS LEAD TO ERRONEOUS SWEAT TESTS?;822;0001
00033;WHAT CONDITIONS OR FACTORS LEAD TO ERRONEOUS SWEAT TESTS?;825;2222
00033;WHAT CONDITIONS OR FACTORS LEAD TO ERRONEOUS SWEAT TESTS?;846;0001
00033;WHAT CONDITIONS OR FACTORS LEAD TO ERRONEOUS SWEAT TESTS?;882;0001
00033;WHAT CONDITIONS OR FACTORS LEAD TO ERRONEOUS SWEAT TESTS?;888;1002
00033;WHAT CONDITIONS OR FACTORS LEAD TO ERRONEOUS SWEAT TESTS?;889;0002
00033;WHAT CONDITIONS OR FACTORS LEAD TO ERRONEOUS SWEAT TESTS?;916;2222
00033;WHAT CONDITIONS OR FACTORS LEAD TO ERRONEOUS SWEAT TESTS?;920;2212
00033;WHAT CONDITIONS OR FACTORS LEAD TO ERRONEOUS SWEAT TESTS?;927;2121
00033;WHAT CONDITIONS OR FACTORS LEAD TO ERRONEOUS SWEAT TESTS?;978;2110
00033;WHAT CONDITIONS OR FACTORS LEAD TO ERRONEOUS SWEAT TESTS?;981;1000
00033;WHAT CONDITIONS OR FACTORS LEAD TO ERRONEOUS SWEAT TESTS?;995;1121
00033;WHAT CONDITIONS OR FACTORS LEAD TO ERRONEOUS SWEAT TESTS?;996;2222
00033;WHAT CONDITIONS OR FACTORS LEAD TO ERRONEOUS SWEAT TESTS?;1000;0100
00033;WHAT CONDITIONS OR FACTORS LEAD TO ERRONEOUS SWEAT TESTS?;1023;0001
00033;WHAT CONDITIONS OR FACTORS LEAD TO ERRONEOUS SWEAT TESTS?;1052;2222
00033;WHAT CONDITIONS OR FACTORS LEAD TO ERRONEOUS SWEAT TESTS?;1072;0001
00033;WHAT CONDITIONS OR FACTORS LEAD TO ERRONEOUS SWEAT TESTS?;1098;0001
00033;WHAT CONDITIONS OR FACTORS LEAD TO ERRONEOUS SWEAT TESTS?;1105;2222
00033;WHAT CONDITIONS OR FACTORS LEAD TO ERRONEOUS SWEAT TESTS?;1113;2222
00033;WHAT CONDITIONS OR FACTORS LEAD TO ERRONEOUS SWEAT TESTS?;1122;1112
00033;WHAT CONDITIONS OR FACTORS LEAD TO ERRONEOUS SWEAT TESTS?;1123;0112
00033;WHAT CONDITIONS OR FACTORS LEAD TO ERRONEOUS SWEAT TESTS?;1183;1122
00033;WHAT CONDITIONS OR FACTORS LEAD TO ERRONEOUS SWEAT TESTS?;1186;1222
00033;WHAT CONDITIONS OR FACTORS LEAD TO ERRONEOUS SWEAT TESTS?;1189;0011
00033;WHAT CONDITIONS OR FACTORS LEAD TO ERRONEOUS SWEAT TESTS?;1215;0010
00033;WHAT CONDITIONS OR FACTORS LEAD TO ERRONEOUS SWEAT TESTS?;1234;1222
00034;"WHAT ALTERNATIVE TECHNIQUES OTHER THAN THE CLASSICAL GIBSON-COOKE QUANTITATIVE PILOCARPINE IONTOPHORESIS TEST (WITH TITRIMETRIC ANALYSIS OF CHLORIDE) ARE AVAILABLE FOR SWEAT TESTING; WHAT ARE THEIR RELATIVE ADVANTAGES AND DISADVANTAGES?";37;2222
00034;"WHAT ALTERNATIVE TECHNIQUES OTHER THAN THE CLASSICAL GIBSON-COOKE QUANTITATIVE PILOCARPINE IONTOPHORESIS TEST (WITH TITRIMETRIC ANALYSIS OF CHLORIDE) ARE AVAILABLE FOR SWEAT TESTING; WHAT ARE THEIR RELATIVE ADVANTAGES AND DISADVANTAGES?";65;2212
00034;"WHAT ALTERNATIVE TECHNIQUES OTHER THAN THE CLASSICAL GIBSON-COOKE QUANTITATIVE PILOCARPINE IONTOPHORESIS TEST (WITH TITRIMETRIC ANALYSIS OF CHLORIDE) ARE AVAILABLE FOR SWEAT TESTING; WHAT ARE THEIR RELATIVE ADVANTAGES AND DISADVANTAGES?";76;0011
00034;"WHAT ALTERNATIVE TECHNIQUES OTHER THAN THE CLASSICAL GIBSON-COOKE QUANTITATIVE PILOCARPINE IONTOPHORESIS TEST (WITH TITRIMETRIC ANALYSIS OF CHLORIDE) ARE AVAILABLE FOR SWEAT TESTING; WHAT ARE THEIR RELATIVE ADVANTAGES AND DISADVANTAGES?";77;0100
00034;"WHAT ALTERNATIVE TECHNIQUES OTHER THAN THE CLASSICAL GIBSON-COOKE QUANTITATIVE PILOCARPINE IONTOPHORESIS TEST (WITH TITRIMETRIC ANALYSIS OF CHLORIDE) ARE AVAILABLE FOR SWEAT TESTING; WHAT ARE THEIR RELATIVE ADVANTAGES AND DISADVANTAGES?";94;0002
00034;"WHAT ALTERNATIVE TECHNIQUES OTHER THAN THE CLASSICAL GIBSON-COOKE QUANTITATIVE PILOCARPINE IONTOPHORESIS TEST (WITH TITRIMETRIC ANALYSIS OF CHLORIDE) ARE AVAILABLE FOR SWEAT TESTING; WHAT ARE THEIR RELATIVE ADVANTAGES AND DISADVANTAGES?";135;0001
00034;"WHAT ALTERNATIVE TECHNIQUES OTHER THAN THE CLASSICAL GIBSON-COOKE QUANTITATIVE PILOCARPINE IONTOPHORESIS TEST (WITH TITRIMETRIC ANALYSIS OF CHLORIDE) ARE AVAILABLE FOR SWEAT TESTING; WHAT ARE THEIR RELATIVE ADVANTAGES AND DISADVANTAGES?";225;0002
00034;"WHAT ALTERNATIVE TECHNIQUES OTHER THAN THE CLASSICAL GIBSON-COOKE QUANTITATIVE PILOCARPINE IONTOPHORESIS TEST (WITH TITRIMETRIC ANALYSIS OF CHLORIDE) ARE AVAILABLE FOR SWEAT TESTING; WHAT ARE THEIR RELATIVE ADVANTAGES AND DISADVANTAGES?";235;0010
00034;"WHAT ALTERNATIVE TECHNIQUES OTHER THAN THE CLASSICAL GIBSON-COOKE QUANTITATIVE PILOCARPINE IONTOPHORESIS TEST (WITH TITRIMETRIC ANALYSIS OF CHLORIDE) ARE AVAILABLE FOR SWEAT TESTING; WHAT ARE THEIR RELATIVE ADVANTAGES AND DISADVANTAGES?";236;0010
00034;"WHAT ALTERNATIVE TECHNIQUES OTHER THAN THE CLASSICAL GIBSON-COOKE QUANTITATIVE PILOCARPINE IONTOPHORESIS TEST (WITH TITRIMETRIC ANALYSIS OF CHLORIDE) ARE AVAILABLE FOR SWEAT TESTING; WHAT ARE THEIR RELATIVE ADVANTAGES AND DISADVANTAGES?";247;0010
00034;"WHAT ALTERNATIVE TECHNIQUES OTHER THAN THE CLASSICAL GIBSON-COOKE QUANTITATIVE PILOCARPINE IONTOPHORESIS TEST (WITH TITRIMETRIC ANALYSIS OF CHLORIDE) ARE AVAILABLE FOR SWEAT TESTING; WHAT ARE THEIR RELATIVE ADVANTAGES AND DISADVANTAGES?";261;2122
00034;"WHAT ALTERNATIVE TECHNIQUES OTHER THAN THE CLASSICAL GIBSON-COOKE QUANTITATIVE PILOCARPINE IONTOPHORESIS TEST (WITH TITRIMETRIC ANALYSIS OF CHLORIDE) ARE AVAILABLE FOR SWEAT TESTING; WHAT ARE THEIR RELATIVE ADVANTAGES AND DISADVANTAGES?";277;0010
00034;"WHAT ALTERNATIVE TECHNIQUES OTHER THAN THE CLASSICAL GIBSON-COOKE QUANTITATIVE PILOCARPINE IONTOPHORESIS TEST (WITH TITRIMETRIC ANALYSIS OF CHLORIDE) ARE AVAILABLE FOR SWEAT TESTING; WHAT ARE THEIR RELATIVE ADVANTAGES AND DISADVANTAGES?";297;0001
00034;"WHAT ALTERNATIVE TECHNIQUES OTHER THAN THE CLASSICAL GIBSON-COOKE QUANTITATIVE PILOCARPINE IONTOPHORESIS TEST (WITH TITRIMETRIC ANALYSIS OF CHLORIDE) ARE AVAILABLE FOR SWEAT TESTING; WHAT ARE THEIR RELATIVE ADVANTAGES AND DISADVANTAGES?";359;0010
00034;"WHAT ALTERNATIVE TECHNIQUES OTHER THAN THE CLASSICAL GIBSON-COOKE QUANTITATIVE PILOCARPINE IONTOPHORESIS TEST (WITH TITRIMETRIC ANALYSIS OF CHLORIDE) ARE AVAILABLE FOR SWEAT TESTING; WHAT ARE THEIR RELATIVE ADVANTAGES AND DISADVANTAGES?";403;2221
00034;"WHAT ALTERNATIVE TECHNIQUES OTHER THAN THE CLASSICAL GIBSON-COOKE QUANTITATIVE PILOCARPINE IONTOPHORESIS TEST (WITH TITRIMETRIC ANALYSIS OF CHLORIDE) ARE AVAILABLE FOR SWEAT TESTING; WHAT ARE THEIR RELATIVE ADVANTAGES AND DISADVANTAGES?";404;2222
00034;"WHAT ALTERNATIVE TECHNIQUES OTHER THAN THE CLASSICAL GIBSON-COOKE QUANTITATIVE PILOCARPINE IONTOPHORESIS TEST (WITH TITRIMETRIC ANALYSIS OF CHLORIDE) ARE AVAILABLE FOR SWEAT TESTING; WHAT ARE THEIR RELATIVE ADVANTAGES AND DISADVANTAGES?";465;2222
00034;"WHAT ALTERNATIVE TECHNIQUES OTHER THAN THE CLASSICAL GIBSON-COOKE QUANTITATIVE PILOCARPINE IONTOPHORESIS TEST (WITH TITRIMETRIC ANALYSIS OF CHLORIDE) ARE AVAILABLE FOR SWEAT TESTING; WHAT ARE THEIR RELATIVE ADVANTAGES AND DISADVANTAGES?";471;2221
00034;"WHAT ALTERNATIVE TECHNIQUES OTHER THAN THE CLASSICAL GIBSON-COOKE QUANTITATIVE PILOCARPINE IONTOPHORESIS TEST (WITH TITRIMETRIC ANALYSIS OF CHLORIDE) ARE AVAILABLE FOR SWEAT TESTING; WHAT ARE THEIR RELATIVE ADVANTAGES AND DISADVANTAGES?";552;0001
00034;"WHAT ALTERNATIVE TECHNIQUES OTHER THAN THE CLASSICAL GIBSON-COOKE QUANTITATIVE PILOCARPINE IONTOPHORESIS TEST (WITH TITRIMETRIC ANALYSIS OF CHLORIDE) ARE AVAILABLE FOR SWEAT TESTING; WHAT ARE THEIR RELATIVE ADVANTAGES AND DISADVANTAGES?";627;0001
00034;"WHAT ALTERNATIVE TECHNIQUES OTHER THAN THE CLASSICAL GIBSON-COOKE QUANTITATIVE PILOCARPINE IONTOPHORESIS TEST (WITH TITRIMETRIC ANALYSIS OF CHLORIDE) ARE AVAILABLE FOR SWEAT TESTING; WHAT ARE THEIR RELATIVE ADVANTAGES AND DISADVANTAGES?";637;2222
00034;"WHAT ALTERNATIVE TECHNIQUES OTHER THAN THE CLASSICAL GIBSON-COOKE QUANTITATIVE PILOCARPINE IONTOPHORESIS TEST (WITH TITRIMETRIC ANALYSIS OF CHLORIDE) ARE AVAILABLE FOR SWEAT TESTING; WHAT ARE THEIR RELATIVE ADVANTAGES AND DISADVANTAGES?";638;2222
00034;"WHAT ALTERNATIVE TECHNIQUES OTHER THAN THE CLASSICAL GIBSON-COOKE QUANTITATIVE PILOCARPINE IONTOPHORESIS TEST (WITH TITRIMETRIC ANALYSIS OF CHLORIDE) ARE AVAILABLE FOR SWEAT TESTING; WHAT ARE THEIR RELATIVE ADVANTAGES AND DISADVANTAGES?";721;2222
00034;"WHAT ALTERNATIVE TECHNIQUES OTHER THAN THE CLASSICAL GIBSON-COOKE QUANTITATIVE PILOCARPINE IONTOPHORESIS TEST (WITH TITRIMETRIC ANALYSIS OF CHLORIDE) ARE AVAILABLE FOR SWEAT TESTING; WHAT ARE THEIR RELATIVE ADVANTAGES AND DISADVANTAGES?";773;2211
00034;"WHAT ALTERNATIVE TECHNIQUES OTHER THAN THE CLASSICAL GIBSON-COOKE QUANTITATIVE PILOCARPINE IONTOPHORESIS TEST (WITH TITRIMETRIC ANALYSIS OF CHLORIDE) ARE AVAILABLE FOR SWEAT TESTING; WHAT ARE THEIR RELATIVE ADVANTAGES AND DISADVANTAGES?";795;2222
00034;"WHAT ALTERNATIVE TECHNIQUES OTHER THAN THE CLASSICAL GIBSON-COOKE QUANTITATIVE PILOCARPINE IONTOPHORESIS TEST (WITH TITRIMETRIC ANALYSIS OF CHLORIDE) ARE AVAILABLE FOR SWEAT TESTING; WHAT ARE THEIR RELATIVE ADVANTAGES AND DISADVANTAGES?";817;2222
00034;"WHAT ALTERNATIVE TECHNIQUES OTHER THAN THE CLASSICAL GIBSON-COOKE QUANTITATIVE PILOCARPINE IONTOPHORESIS TEST (WITH TITRIMETRIC ANALYSIS OF CHLORIDE) ARE AVAILABLE FOR SWEAT TESTING; WHAT ARE THEIR RELATIVE ADVANTAGES AND DISADVANTAGES?";818;0001
00034;"WHAT ALTERNATIVE TECHNIQUES OTHER THAN THE CLASSICAL GIBSON-COOKE QUANTITATIVE PILOCARPINE IONTOPHORESIS TEST (WITH TITRIMETRIC ANALYSIS OF CHLORIDE) ARE AVAILABLE FOR SWEAT TESTING; WHAT ARE THEIR RELATIVE ADVANTAGES AND DISADVANTAGES?";825;0100
00034;"WHAT ALTERNATIVE TECHNIQUES OTHER THAN THE CLASSICAL GIBSON-COOKE QUANTITATIVE PILOCARPINE IONTOPHORESIS TEST (WITH TITRIMETRIC ANALYSIS OF CHLORIDE) ARE AVAILABLE FOR SWEAT TESTING; WHAT ARE THEIR RELATIVE ADVANTAGES AND DISADVANTAGES?";846;2222
00034;"WHAT ALTERNATIVE TECHNIQUES OTHER THAN THE CLASSICAL GIBSON-COOKE QUANTITATIVE PILOCARPINE IONTOPHORESIS TEST (WITH TITRIMETRIC ANALYSIS OF CHLORIDE) ARE AVAILABLE FOR SWEAT TESTING; WHAT ARE THEIR RELATIVE ADVANTAGES AND DISADVANTAGES?";916;2221
00034;"WHAT ALTERNATIVE TECHNIQUES OTHER THAN THE CLASSICAL GIBSON-COOKE QUANTITATIVE PILOCARPINE IONTOPHORESIS TEST (WITH TITRIMETRIC ANALYSIS OF CHLORIDE) ARE AVAILABLE FOR SWEAT TESTING; WHAT ARE THEIR RELATIVE ADVANTAGES AND DISADVANTAGES?";933;0001
00034;"WHAT ALTERNATIVE TECHNIQUES OTHER THAN THE CLASSICAL GIBSON-COOKE QUANTITATIVE PILOCARPINE IONTOPHORESIS TEST (WITH TITRIMETRIC ANALYSIS OF CHLORIDE) ARE AVAILABLE FOR SWEAT TESTING; WHAT ARE THEIR RELATIVE ADVANTAGES AND DISADVANTAGES?";941;0100
00034;"WHAT ALTERNATIVE TECHNIQUES OTHER THAN THE CLASSICAL GIBSON-COOKE QUANTITATIVE PILOCARPINE IONTOPHORESIS TEST (WITH TITRIMETRIC ANALYSIS OF CHLORIDE) ARE AVAILABLE FOR SWEAT TESTING; WHAT ARE THEIR RELATIVE ADVANTAGES AND DISADVANTAGES?";944;0001
00034;"WHAT ALTERNATIVE TECHNIQUES OTHER THAN THE CLASSICAL GIBSON-COOKE QUANTITATIVE PILOCARPINE IONTOPHORESIS TEST (WITH TITRIMETRIC ANALYSIS OF CHLORIDE) ARE AVAILABLE FOR SWEAT TESTING; WHAT ARE THEIR RELATIVE ADVANTAGES AND DISADVANTAGES?";995;2222
00034;"WHAT ALTERNATIVE TECHNIQUES OTHER THAN THE CLASSICAL GIBSON-COOKE QUANTITATIVE PILOCARPINE IONTOPHORESIS TEST (WITH TITRIMETRIC ANALYSIS OF CHLORIDE) ARE AVAILABLE FOR SWEAT TESTING; WHAT ARE THEIR RELATIVE ADVANTAGES AND DISADVANTAGES?";1000;0100
00034;"WHAT ALTERNATIVE TECHNIQUES OTHER THAN THE CLASSICAL GIBSON-COOKE QUANTITATIVE PILOCARPINE IONTOPHORESIS TEST (WITH TITRIMETRIC ANALYSIS OF CHLORIDE) ARE AVAILABLE FOR SWEAT TESTING; WHAT ARE THEIR RELATIVE ADVANTAGES AND DISADVANTAGES?";1023;0001
00034;"WHAT ALTERNATIVE TECHNIQUES OTHER THAN THE CLASSICAL GIBSON-COOKE QUANTITATIVE PILOCARPINE IONTOPHORESIS TEST (WITH TITRIMETRIC ANALYSIS OF CHLORIDE) ARE AVAILABLE FOR SWEAT TESTING; WHAT ARE THEIR RELATIVE ADVANTAGES AND DISADVANTAGES?";1052;0101
00034;"WHAT ALTERNATIVE TECHNIQUES OTHER THAN THE CLASSICAL GIBSON-COOKE QUANTITATIVE PILOCARPINE IONTOPHORESIS TEST (WITH TITRIMETRIC ANALYSIS OF CHLORIDE) ARE AVAILABLE FOR SWEAT TESTING; WHAT ARE THEIR RELATIVE ADVANTAGES AND DISADVANTAGES?";1186;0001
00034;"WHAT ALTERNATIVE TECHNIQUES OTHER THAN THE CLASSICAL GIBSON-COOKE QUANTITATIVE PILOCARPINE IONTOPHORESIS TEST (WITH TITRIMETRIC ANALYSIS OF CHLORIDE) ARE AVAILABLE FOR SWEAT TESTING; WHAT ARE THEIR RELATIVE ADVANTAGES AND DISADVANTAGES?";1234;0001
00035;HAS ANY CF PATIENT BEEN FOUND TO HAVE CONSISTENTLY NORMAL SWEAT TESTS?;32;1000
00035;HAS ANY CF PATIENT BEEN FOUND TO HAVE CONSISTENTLY NORMAL SWEAT TESTS?;120;0100
00035;HAS ANY CF PATIENT BEEN FOUND TO HAVE CONSISTENTLY NORMAL SWEAT TESTS?;210;2222
00035;HAS ANY CF PATIENT BEEN FOUND TO HAVE CONSISTENTLY NORMAL SWEAT TESTS?;811;1120
00035;HAS ANY CF PATIENT BEEN FOUND TO HAVE CONSISTENTLY NORMAL SWEAT TESTS?;825;0100
00035;HAS ANY CF PATIENT BEEN FOUND TO HAVE CONSISTENTLY NORMAL SWEAT TESTS?;888;0001
00035;HAS ANY CF PATIENT BEEN FOUND TO HAVE CONSISTENTLY NORMAL SWEAT TESTS?;913;2110
00035;HAS ANY CF PATIENT BEEN FOUND TO HAVE CONSISTENTLY NORMAL SWEAT TESTS?;915;2120
00035;HAS ANY CF PATIENT BEEN FOUND TO HAVE CONSISTENTLY NORMAL SWEAT TESTS?;920;0100
00035;HAS ANY CF PATIENT BEEN FOUND TO HAVE CONSISTENTLY NORMAL SWEAT TESTS?;926;0010
00035;HAS ANY CF PATIENT BEEN FOUND TO HAVE CONSISTENTLY NORMAL SWEAT TESTS?;948;0010
00035;HAS ANY CF PATIENT BEEN FOUND TO HAVE CONSISTENTLY NORMAL SWEAT TESTS?;1105;0001
00035;HAS ANY CF PATIENT BEEN FOUND TO HAVE CONSISTENTLY NORMAL SWEAT TESTS?;1109;2222
00035;HAS ANY CF PATIENT BEEN FOUND TO HAVE CONSISTENTLY NORMAL SWEAT TESTS?;1119;0001
00036;WHAT IS THE CONCENTRATION OF POTASSIUM IN SWEAT FROM CF PATIENTS?;66;1000
00036;WHAT IS THE CONCENTRATION OF POTASSIUM IN SWEAT FROM CF PATIENTS?;325;0001
00036;WHAT IS THE CONCENTRATION OF POTASSIUM IN SWEAT FROM CF PATIENTS?;370;0002
00036;WHAT IS THE CONCENTRATION OF POTASSIUM IN SWEAT FROM CF PATIENTS?;403;1100
00036;WHAT IS THE CONCENTRATION OF POTASSIUM IN SWEAT FROM CF PATIENTS?;612;2120
00036;WHAT IS THE CONCENTRATION OF POTASSIUM IN SWEAT FROM CF PATIENTS?;721;1000
00036;WHAT IS THE CONCENTRATION OF POTASSIUM IN SWEAT FROM CF PATIENTS?;722;2220
00036;WHAT IS THE CONCENTRATION OF POTASSIUM IN SWEAT FROM CF PATIENTS?;724;0001
00036;WHAT IS THE CONCENTRATION OF POTASSIUM IN SWEAT FROM CF PATIENTS?;1052;2220
00037;WHAT TECHNIQUES ARE AVAILABLE FOR SCREENING OF NEWBORN INFANTS FOR CF, AND WHAT FACTORS CONTRIBUTE TO ERRONEOUS RESULTS OF THESE TESTS?;3;2112
00037;WHAT TECHNIQUES ARE AVAILABLE FOR SCREENING OF NEWBORN INFANTS FOR CF, AND WHAT FACTORS CONTRIBUTE TO ERRONEOUS RESULTS OF THESE TESTS?;4;1000
00037;WHAT TECHNIQUES ARE AVAILABLE FOR SCREENING OF NEWBORN INFANTS FOR CF, AND WHAT FACTORS CONTRIBUTE TO ERRONEOUS RESULTS OF THESE TESTS?;28;2120
00037;WHAT TECHNIQUES ARE AVAILABLE FOR SCREENING OF NEWBORN INFANTS FOR CF, AND WHAT FACTORS CONTRIBUTE TO ERRONEOUS RESULTS OF THESE TESTS?;33;2222
00037;WHAT TECHNIQUES ARE AVAILABLE FOR SCREENING OF NEWBORN INFANTS FOR CF, AND WHAT FACTORS CONTRIBUTE TO ERRONEOUS RESULTS OF THESE TESTS?;35;2122
00037;WHAT TECHNIQUES ARE AVAILABLE FOR SCREENING OF NEWBORN INFANTS FOR CF, AND WHAT FACTORS CONTRIBUTE TO ERRONEOUS RESULTS OF THESE TESTS?;38;2222
00037;WHAT TECHNIQUES ARE AVAILABLE FOR SCREENING OF NEWBORN INFANTS FOR CF, AND WHAT FACTORS CONTRIBUTE TO ERRONEOUS RESULTS OF THESE TESTS?;65;1001
00037;WHAT TECHNIQUES ARE AVAILABLE FOR SCREENING OF NEWBORN INFANTS FOR CF, AND WHAT FACTORS CONTRIBUTE TO ERRONEOUS RESULTS OF THESE TESTS?;71;1111
00037;WHAT TECHNIQUES ARE AVAILABLE FOR SCREENING OF NEWBORN INFANTS FOR CF, AND WHAT FACTORS CONTRIBUTE TO ERRONEOUS RESULTS OF THESE TESTS?;76;1002
00037;WHAT TECHNIQUES ARE AVAILABLE FOR SCREENING OF NEWBORN INFANTS FOR CF, AND WHAT FACTORS CONTRIBUTE TO ERRONEOUS RESULTS OF THESE TESTS?;116;0001
00037;WHAT TECHNIQUES ARE AVAILABLE FOR SCREENING OF NEWBORN INFANTS FOR CF, AND WHAT FACTORS CONTRIBUTE TO ERRONEOUS RESULTS OF THESE TESTS?;119;0001
00037;WHAT TECHNIQUES ARE AVAILABLE FOR SCREENING OF NEWBORN INFANTS FOR CF, AND WHAT FACTORS CONTRIBUTE TO ERRONEOUS RESULTS OF THESE TESTS?;120;1222
00037;WHAT TECHNIQUES ARE AVAILABLE FOR SCREENING OF NEWBORN INFANTS FOR CF, AND WHAT FACTORS CONTRIBUTE TO ERRONEOUS RESULTS OF THESE TESTS?;131;2222
00037;WHAT TECHNIQUES ARE AVAILABLE FOR SCREENING OF NEWBORN INFANTS FOR CF, AND WHAT FACTORS CONTRIBUTE TO ERRONEOUS RESULTS OF THESE TESTS?;148;0001
00037;WHAT TECHNIQUES ARE AVAILABLE FOR SCREENING OF NEWBORN INFANTS FOR CF, AND WHAT FACTORS CONTRIBUTE TO ERRONEOUS RESULTS OF THESE TESTS?;150;0001
00037;WHAT TECHNIQUES ARE AVAILABLE FOR SCREENING OF NEWBORN INFANTS FOR CF, AND WHAT FACTORS CONTRIBUTE TO ERRONEOUS RESULTS OF THESE TESTS?;158;2222
00037;WHAT TECHNIQUES ARE AVAILABLE FOR SCREENING OF NEWBORN INFANTS FOR CF, AND WHAT FACTORS CONTRIBUTE TO ERRONEOUS RESULTS OF THESE TESTS?;175;2222
00037;WHAT TECHNIQUES ARE AVAILABLE FOR SCREENING OF NEWBORN INFANTS FOR CF, AND WHAT FACTORS CONTRIBUTE TO ERRONEOUS RESULTS OF THESE TESTS?;203;2122
00037;WHAT TECHNIQUES ARE AVAILABLE FOR SCREENING OF NEWBORN INFANTS FOR CF, AND WHAT FACTORS CONTRIBUTE TO ERRONEOUS RESULTS OF THESE TESTS?;220;0001
00037;WHAT TECHNIQUES ARE AVAILABLE FOR SCREENING OF NEWBORN INFANTS FOR CF, AND WHAT FACTORS CONTRIBUTE TO ERRONEOUS RESULTS OF THESE TESTS?;225;2222
00037;WHAT TECHNIQUES ARE AVAILABLE FOR SCREENING OF NEWBORN INFANTS FOR CF, AND WHAT FACTORS CONTRIBUTE TO ERRONEOUS RESULTS OF THESE TESTS?;231;0012
00037;WHAT TECHNIQUES ARE AVAILABLE FOR SCREENING OF NEWBORN INFANTS FOR CF, AND WHAT FACTORS CONTRIBUTE TO ERRONEOUS RESULTS OF THESE TESTS?;233;0010
00037;WHAT TECHNIQUES ARE AVAILABLE FOR SCREENING OF NEWBORN INFANTS FOR CF, AND WHAT FACTORS CONTRIBUTE TO ERRONEOUS RESULTS OF THESE TESTS?;234;2222
00037;WHAT TECHNIQUES ARE AVAILABLE FOR SCREENING OF NEWBORN INFANTS FOR CF, AND WHAT FACTORS CONTRIBUTE TO ERRONEOUS RESULTS OF THESE TESTS?;238;0011
00037;WHAT TECHNIQUES ARE AVAILABLE FOR SCREENING OF NEWBORN INFANTS FOR CF, AND WHAT FACTORS CONTRIBUTE TO ERRONEOUS RESULTS OF THESE TESTS?;247;2112
00037;WHAT TECHNIQUES ARE AVAILABLE FOR SCREENING OF NEWBORN INFANTS FOR CF, AND WHAT FACTORS CONTRIBUTE TO ERRONEOUS RESULTS OF THESE TESTS?;280;1212
00037;WHAT TECHNIQUES ARE AVAILABLE FOR SCREENING OF NEWBORN INFANTS FOR CF, AND WHAT FACTORS CONTRIBUTE TO ERRONEOUS RESULTS OF THESE TESTS?;291;0001
00037;WHAT TECHNIQUES ARE AVAILABLE FOR SCREENING OF NEWBORN INFANTS FOR CF, AND WHAT FACTORS CONTRIBUTE TO ERRONEOUS RESULTS OF THESE TESTS?;294;1000
00037;WHAT TECHNIQUES ARE AVAILABLE FOR SCREENING OF NEWBORN INFANTS FOR CF, AND WHAT FACTORS CONTRIBUTE TO ERRONEOUS RESULTS OF THESE TESTS?;318;2222
00037;WHAT TECHNIQUES ARE AVAILABLE FOR SCREENING OF NEWBORN INFANTS FOR CF, AND WHAT FACTORS CONTRIBUTE TO ERRONEOUS RESULTS OF THESE TESTS?;319;2111
00037;WHAT TECHNIQUES ARE AVAILABLE FOR SCREENING OF NEWBORN INFANTS FOR CF, AND WHAT FACTORS CONTRIBUTE TO ERRONEOUS RESULTS OF THESE TESTS?;333;1012
00037;WHAT TECHNIQUES ARE AVAILABLE FOR SCREENING OF NEWBORN INFANTS FOR CF, AND WHAT FACTORS CONTRIBUTE TO ERRONEOUS RESULTS OF THESE TESTS?;334;1001
00037;WHAT TECHNIQUES ARE AVAILABLE FOR SCREENING OF NEWBORN INFANTS FOR CF, AND WHAT FACTORS CONTRIBUTE TO ERRONEOUS RESULTS OF THESE TESTS?;342;0001
00037;WHAT TECHNIQUES ARE AVAILABLE FOR SCREENING OF NEWBORN INFANTS FOR CF, AND WHAT FACTORS CONTRIBUTE TO ERRONEOUS RESULTS OF THESE TESTS?;345;0001
00037;WHAT TECHNIQUES ARE AVAILABLE FOR SCREENING OF NEWBORN INFANTS FOR CF, AND WHAT FACTORS CONTRIBUTE TO ERRONEOUS RESULTS OF THESE TESTS?;370;0012
00037;WHAT TECHNIQUES ARE AVAILABLE FOR SCREENING OF NEWBORN INFANTS FOR CF, AND WHAT FACTORS CONTRIBUTE TO ERRONEOUS RESULTS OF THESE TESTS?;378;2122
00037;WHAT TECHNIQUES ARE AVAILABLE FOR SCREENING OF NEWBORN INFANTS FOR CF, AND WHAT FACTORS CONTRIBUTE TO ERRONEOUS RESULTS OF THESE TESTS?;379;2222
00037;WHAT TECHNIQUES ARE AVAILABLE FOR SCREENING OF NEWBORN INFANTS FOR CF, AND WHAT FACTORS CONTRIBUTE TO ERRONEOUS RESULTS OF THESE TESTS?;380;2222
00037;WHAT TECHNIQUES ARE AVAILABLE FOR SCREENING OF NEWBORN INFANTS FOR CF, AND WHAT FACTORS CONTRIBUTE TO ERRONEOUS RESULTS OF THESE TESTS?;392;0001
00037;WHAT TECHNIQUES ARE AVAILABLE FOR SCREENING OF NEWBORN INFANTS FOR CF, AND WHAT FACTORS CONTRIBUTE TO ERRONEOUS RESULTS OF THESE TESTS?;403;0001
00037;WHAT TECHNIQUES ARE AVAILABLE FOR SCREENING OF NEWBORN INFANTS FOR CF, AND WHAT FACTORS CONTRIBUTE TO ERRONEOUS RESULTS OF THESE TESTS?;428;1001
00037;WHAT TECHNIQUES ARE AVAILABLE FOR SCREENING OF NEWBORN INFANTS FOR CF, AND WHAT FACTORS CONTRIBUTE TO ERRONEOUS RESULTS OF THESE TESTS?;433;1000
00037;WHAT TECHNIQUES ARE AVAILABLE FOR SCREENING OF NEWBORN INFANTS FOR CF, AND WHAT FACTORS CONTRIBUTE TO ERRONEOUS RESULTS OF THESE TESTS?;443;0001
00037;WHAT TECHNIQUES ARE AVAILABLE FOR SCREENING OF NEWBORN INFANTS FOR CF, AND WHAT FACTORS CONTRIBUTE TO ERRONEOUS RESULTS OF THESE TESTS?;465;2222
00037;WHAT TECHNIQUES ARE AVAILABLE FOR SCREENING OF NEWBORN INFANTS FOR CF, AND WHAT FACTORS CONTRIBUTE TO ERRONEOUS RESULTS OF THESE TESTS?;470;2121
00037;WHAT TECHNIQUES ARE AVAILABLE FOR SCREENING OF NEWBORN INFANTS FOR CF, AND WHAT FACTORS CONTRIBUTE TO ERRONEOUS RESULTS OF THESE TESTS?;476;1122
00037;WHAT TECHNIQUES ARE AVAILABLE FOR SCREENING OF NEWBORN INFANTS FOR CF, AND WHAT FACTORS CONTRIBUTE TO ERRONEOUS RESULTS OF THESE TESTS?;482;2222
00037;WHAT TECHNIQUES ARE AVAILABLE FOR SCREENING OF NEWBORN INFANTS FOR CF, AND WHAT FACTORS CONTRIBUTE TO ERRONEOUS RESULTS OF THESE TESTS?;483;2222
00037;WHAT TECHNIQUES ARE AVAILABLE FOR SCREENING OF NEWBORN INFANTS FOR CF, AND WHAT FACTORS CONTRIBUTE TO ERRONEOUS RESULTS OF THESE TESTS?;491;2222
00037;WHAT TECHNIQUES ARE AVAILABLE FOR SCREENING OF NEWBORN INFANTS FOR CF, AND WHAT FACTORS CONTRIBUTE TO ERRONEOUS RESULTS OF THESE TESTS?;492;2222
00037;WHAT TECHNIQUES ARE AVAILABLE FOR SCREENING OF NEWBORN INFANTS FOR CF, AND WHAT FACTORS CONTRIBUTE TO ERRONEOUS RESULTS OF THESE TESTS?;510;0001
00037;WHAT TECHNIQUES ARE AVAILABLE FOR SCREENING OF NEWBORN INFANTS FOR CF, AND WHAT FACTORS CONTRIBUTE TO ERRONEOUS RESULTS OF THESE TESTS?;512;0001
00037;WHAT TECHNIQUES ARE AVAILABLE FOR SCREENING OF NEWBORN INFANTS FOR CF, AND WHAT FACTORS CONTRIBUTE TO ERRONEOUS RESULTS OF THESE TESTS?;514;0001
00037;WHAT TECHNIQUES ARE AVAILABLE FOR SCREENING OF NEWBORN INFANTS FOR CF, AND WHAT FACTORS CONTRIBUTE TO ERRONEOUS RESULTS OF THESE TESTS?;596;0001
00037;WHAT TECHNIQUES ARE AVAILABLE FOR SCREENING OF NEWBORN INFANTS FOR CF, AND WHAT FACTORS CONTRIBUTE TO ERRONEOUS RESULTS OF THESE TESTS?;600;2222
00037;WHAT TECHNIQUES ARE AVAILABLE FOR SCREENING OF NEWBORN INFANTS FOR CF, AND WHAT FACTORS CONTRIBUTE TO ERRONEOUS RESULTS OF THESE TESTS?;627;1112
00037;WHAT TECHNIQUES ARE AVAILABLE FOR SCREENING OF NEWBORN INFANTS FOR CF, AND WHAT FACTORS CONTRIBUTE TO ERRONEOUS RESULTS OF THESE TESTS?;671;0001
00037;WHAT TECHNIQUES ARE AVAILABLE FOR SCREENING OF NEWBORN INFANTS FOR CF, AND WHAT FACTORS CONTRIBUTE TO ERRONEOUS RESULTS OF THESE TESTS?;697;2222
00037;WHAT TECHNIQUES ARE AVAILABLE FOR SCREENING OF NEWBORN INFANTS FOR CF, AND WHAT FACTORS CONTRIBUTE TO ERRONEOUS RESULTS OF THESE TESTS?;711;0010
00037;WHAT TECHNIQUES ARE AVAILABLE FOR SCREENING OF NEWBORN INFANTS FOR CF, AND WHAT FACTORS CONTRIBUTE TO ERRONEOUS RESULTS OF THESE TESTS?;712;2122
00037;WHAT TECHNIQUES ARE AVAILABLE FOR SCREENING OF NEWBORN INFANTS FOR CF, AND WHAT FACTORS CONTRIBUTE TO ERRONEOUS RESULTS OF THESE TESTS?;717;2222
00037;WHAT TECHNIQUES ARE AVAILABLE FOR SCREENING OF NEWBORN INFANTS FOR CF, AND WHAT FACTORS CONTRIBUTE TO ERRONEOUS RESULTS OF THESE TESTS?;721;1000
00037;WHAT TECHNIQUES ARE AVAILABLE FOR SCREENING OF NEWBORN INFANTS FOR CF, AND WHAT FACTORS CONTRIBUTE TO ERRONEOUS RESULTS OF THESE TESTS?;731;0002
00037;WHAT TECHNIQUES ARE AVAILABLE FOR SCREENING OF NEWBORN INFANTS FOR CF, AND WHAT FACTORS CONTRIBUTE TO ERRONEOUS RESULTS OF THESE TESTS?;774;1011
00037;WHAT TECHNIQUES ARE AVAILABLE FOR SCREENING OF NEWBORN INFANTS FOR CF, AND WHAT FACTORS CONTRIBUTE TO ERRONEOUS RESULTS OF THESE TESTS?;776;0001
00037;WHAT TECHNIQUES ARE AVAILABLE FOR SCREENING OF NEWBORN INFANTS FOR CF, AND WHAT FACTORS CONTRIBUTE TO ERRONEOUS RESULTS OF THESE TESTS?;815;2222
00037;WHAT TECHNIQUES ARE AVAILABLE FOR SCREENING OF NEWBORN INFANTS FOR CF, AND WHAT FACTORS CONTRIBUTE TO ERRONEOUS RESULTS OF THESE TESTS?;817;2122
00037;WHAT TECHNIQUES ARE AVAILABLE FOR SCREENING OF NEWBORN INFANTS FOR CF, AND WHAT FACTORS CONTRIBUTE TO ERRONEOUS RESULTS OF THESE TESTS?;818;0001
00037;WHAT TECHNIQUES ARE AVAILABLE FOR SCREENING OF NEWBORN INFANTS FOR CF, AND WHAT FACTORS CONTRIBUTE TO ERRONEOUS RESULTS OF THESE TESTS?;831;2221
00037;WHAT TECHNIQUES ARE AVAILABLE FOR SCREENING OF NEWBORN INFANTS FOR CF, AND WHAT FACTORS CONTRIBUTE TO ERRONEOUS RESULTS OF THESE TESTS?;835;2122
00037;WHAT TECHNIQUES ARE AVAILABLE FOR SCREENING OF NEWBORN INFANTS FOR CF, AND WHAT FACTORS CONTRIBUTE TO ERRONEOUS RESULTS OF THESE TESTS?;849;2222
00037;WHAT TECHNIQUES ARE AVAILABLE FOR SCREENING OF NEWBORN INFANTS FOR CF, AND WHAT FACTORS CONTRIBUTE TO ERRONEOUS RESULTS OF THESE TESTS?;866;1012
00037;WHAT TECHNIQUES ARE AVAILABLE FOR SCREENING OF NEWBORN INFANTS FOR CF, AND WHAT FACTORS CONTRIBUTE TO ERRONEOUS RESULTS OF THESE TESTS?;871;0012
00037;WHAT TECHNIQUES ARE AVAILABLE FOR SCREENING OF NEWBORN INFANTS FOR CF, AND WHAT FACTORS CONTRIBUTE TO ERRONEOUS RESULTS OF THESE TESTS?;877;2222
00037;WHAT TECHNIQUES ARE AVAILABLE FOR SCREENING OF NEWBORN INFANTS FOR CF, AND WHAT FACTORS CONTRIBUTE TO ERRONEOUS RESULTS OF THESE TESTS?;888;0001
00037;WHAT TECHNIQUES ARE AVAILABLE FOR SCREENING OF NEWBORN INFANTS FOR CF, AND WHAT FACTORS CONTRIBUTE TO ERRONEOUS RESULTS OF THESE TESTS?;930;2122
00037;WHAT TECHNIQUES ARE AVAILABLE FOR SCREENING OF NEWBORN INFANTS FOR CF, AND WHAT FACTORS CONTRIBUTE TO ERRONEOUS RESULTS OF THESE TESTS?;933;1111
00037;WHAT TECHNIQUES ARE AVAILABLE FOR SCREENING OF NEWBORN INFANTS FOR CF, AND WHAT FACTORS CONTRIBUTE TO ERRONEOUS RESULTS OF THESE TESTS?;941;1000
00037;WHAT TECHNIQUES ARE AVAILABLE FOR SCREENING OF NEWBORN INFANTS FOR CF, AND WHAT FACTORS CONTRIBUTE TO ERRONEOUS RESULTS OF THESE TESTS?;942;1211
00037;WHAT TECHNIQUES ARE AVAILABLE FOR SCREENING OF NEWBORN INFANTS FOR CF, AND WHAT FACTORS CONTRIBUTE TO ERRONEOUS RESULTS OF THESE TESTS?;944;0100
00037;WHAT TECHNIQUES ARE AVAILABLE FOR SCREENING OF NEWBORN INFANTS FOR CF, AND WHAT FACTORS CONTRIBUTE TO ERRONEOUS RESULTS OF THESE TESTS?;946;2222
00037;WHAT TECHNIQUES ARE AVAILABLE FOR SCREENING OF NEWBORN INFANTS FOR CF, AND WHAT FACTORS CONTRIBUTE TO ERRONEOUS RESULTS OF THESE TESTS?;991;2212
00037;WHAT TECHNIQUES ARE AVAILABLE FOR SCREENING OF NEWBORN INFANTS FOR CF, AND WHAT FACTORS CONTRIBUTE TO ERRONEOUS RESULTS OF THESE TESTS?;1008;2222
00037;WHAT TECHNIQUES ARE AVAILABLE FOR SCREENING OF NEWBORN INFANTS FOR CF, AND WHAT FACTORS CONTRIBUTE TO ERRONEOUS RESULTS OF THESE TESTS?;1011;1011
00037;WHAT TECHNIQUES ARE AVAILABLE FOR SCREENING OF NEWBORN INFANTS FOR CF, AND WHAT FACTORS CONTRIBUTE TO ERRONEOUS RESULTS OF THESE TESTS?;1014;2222
00037;WHAT TECHNIQUES ARE AVAILABLE FOR SCREENING OF NEWBORN INFANTS FOR CF, AND WHAT FACTORS CONTRIBUTE TO ERRONEOUS RESULTS OF THESE TESTS?;1028;2222
00037;WHAT TECHNIQUES ARE AVAILABLE FOR SCREENING OF NEWBORN INFANTS FOR CF, AND WHAT FACTORS CONTRIBUTE TO ERRONEOUS RESULTS OF THESE TESTS?;1080;0001
00037;WHAT TECHNIQUES ARE AVAILABLE FOR SCREENING OF NEWBORN INFANTS FOR CF, AND WHAT FACTORS CONTRIBUTE TO ERRONEOUS RESULTS OF THESE TESTS?;1126;2222
00037;WHAT TECHNIQUES ARE AVAILABLE FOR SCREENING OF NEWBORN INFANTS FOR CF, AND WHAT FACTORS CONTRIBUTE TO ERRONEOUS RESULTS OF THESE TESTS?;1128;1222
00037;WHAT TECHNIQUES ARE AVAILABLE FOR SCREENING OF NEWBORN INFANTS FOR CF, AND WHAT FACTORS CONTRIBUTE TO ERRONEOUS RESULTS OF THESE TESTS?;1130;0001
00037;WHAT TECHNIQUES ARE AVAILABLE FOR SCREENING OF NEWBORN INFANTS FOR CF, AND WHAT FACTORS CONTRIBUTE TO ERRONEOUS RESULTS OF THESE TESTS?;1131;1122
00037;WHAT TECHNIQUES ARE AVAILABLE FOR SCREENING OF NEWBORN INFANTS FOR CF, AND WHAT FACTORS CONTRIBUTE TO ERRONEOUS RESULTS OF THESE TESTS?;1133;2222
00037;WHAT TECHNIQUES ARE AVAILABLE FOR SCREENING OF NEWBORN INFANTS FOR CF, AND WHAT FACTORS CONTRIBUTE TO ERRONEOUS RESULTS OF THESE TESTS?;1135;0111
00037;WHAT TECHNIQUES ARE AVAILABLE FOR SCREENING OF NEWBORN INFANTS FOR CF, AND WHAT FACTORS CONTRIBUTE TO ERRONEOUS RESULTS OF THESE TESTS?;1174;1222
00037;WHAT TECHNIQUES ARE AVAILABLE FOR SCREENING OF NEWBORN INFANTS FOR CF, AND WHAT FACTORS CONTRIBUTE TO ERRONEOUS RESULTS OF THESE TESTS?;1176;2222
00037;WHAT TECHNIQUES ARE AVAILABLE FOR SCREENING OF NEWBORN INFANTS FOR CF, AND WHAT FACTORS CONTRIBUTE TO ERRONEOUS RESULTS OF THESE TESTS?;1178;2122
00037;WHAT TECHNIQUES ARE AVAILABLE FOR SCREENING OF NEWBORN INFANTS FOR CF, AND WHAT FACTORS CONTRIBUTE TO ERRONEOUS RESULTS OF THESE TESTS?;1182;1222
00037;WHAT TECHNIQUES ARE AVAILABLE FOR SCREENING OF NEWBORN INFANTS FOR CF, AND WHAT FACTORS CONTRIBUTE TO ERRONEOUS RESULTS OF THESE TESTS?;1234;1212
00038;CAN CF BE DIAGNOSED PRENATALLY?;14;2122
00038;CAN CF BE DIAGNOSED PRENATALLY?;76;0001
00038;CAN CF BE DIAGNOSED PRENATALLY?;117;1010
00038;CAN CF BE DIAGNOSED PRENATALLY?;142;0001
00038;CAN CF BE DIAGNOSED PRENATALLY?;252;0100
00038;CAN CF BE DIAGNOSED PRENATALLY?;360;2212
00038;CAN CF BE DIAGNOSED PRENATALLY?;370;0001
00038;CAN CF BE DIAGNOSED PRENATALLY?;390;2222
00038;CAN CF BE DIAGNOSED PRENATALLY?;392;0001
00038;CAN CF BE DIAGNOSED PRENATALLY?;444;0001
00038;CAN CF BE DIAGNOSED PRENATALLY?;465;1212
00038;CAN CF BE DIAGNOSED PRENATALLY?;503;0001
00038;CAN CF BE DIAGNOSED PRENATALLY?;505;0010
00038;CAN CF BE DIAGNOSED PRENATALLY?;510;0001
00038;CAN CF BE DIAGNOSED PRENATALLY?;572;0010
00038;CAN CF BE DIAGNOSED PRENATALLY?;573;0010
00038;CAN CF BE DIAGNOSED PRENATALLY?;621;0001
00038;CAN CF BE DIAGNOSED PRENATALLY?;622;0002
00038;CAN CF BE DIAGNOSED PRENATALLY?;627;0001
00038;CAN CF BE DIAGNOSED PRENATALLY?;634;2112
00038;CAN CF BE DIAGNOSED PRENATALLY?;644;1121
00038;CAN CF BE DIAGNOSED PRENATALLY?;646;1001
00038;CAN CF BE DIAGNOSED PRENATALLY?;666;1010
00038;CAN CF BE DIAGNOSED PRENATALLY?;702;0002
00038;CAN CF BE DIAGNOSED PRENATALLY?;729;0001
00038;CAN CF BE DIAGNOSED PRENATALLY?;776;0001
00038;CAN CF BE DIAGNOSED PRENATALLY?;786;1000
00038;CAN CF BE DIAGNOSED PRENATALLY?;856;0001
00038;CAN CF BE DIAGNOSED PRENATALLY?;862;0001
00038;CAN CF BE DIAGNOSED PRENATALLY?;866;0100
00038;CAN CF BE DIAGNOSED PRENATALLY?;873;1002
00038;CAN CF BE DIAGNOSED PRENATALLY?;881;1000
00038;CAN CF BE DIAGNOSED PRENATALLY?;882;0002
00038;CAN CF BE DIAGNOSED PRENATALLY?;888;0001
00038;CAN CF BE DIAGNOSED PRENATALLY?;971;1122
00038;CAN CF BE DIAGNOSED PRENATALLY?;990;0002
00038;CAN CF BE DIAGNOSED PRENATALLY?;1001;1000
00038;CAN CF BE DIAGNOSED PRENATALLY?;1024;1001
00038;CAN CF BE DIAGNOSED PRENATALLY?;1027;1000
00038;CAN CF BE DIAGNOSED PRENATALLY?;1029;1000
00038;CAN CF BE DIAGNOSED PRENATALLY?;1059;1000
00038;CAN CF BE DIAGNOSED PRENATALLY?;1066;0001
00038;CAN CF BE DIAGNOSED PRENATALLY?;1068;1222
00038;CAN CF BE DIAGNOSED PRENATALLY?;1072;0001
00038;CAN CF BE DIAGNOSED PRENATALLY?;1075;1000
00038;CAN CF BE DIAGNOSED PRENATALLY?;1130;1222
00038;CAN CF BE DIAGNOSED PRENATALLY?;1136;1222
00038;CAN CF BE DIAGNOSED PRENATALLY?;1140;1122
00038;CAN CF BE DIAGNOSED PRENATALLY?;1146;0011
00038;CAN CF BE DIAGNOSED PRENATALLY?;1148;0011
00038;CAN CF BE DIAGNOSED PRENATALLY?;1160;0011
00038;CAN CF BE DIAGNOSED PRENATALLY?;1230;1000
00038;CAN CF BE DIAGNOSED PRENATALLY?;1234;1210
00039;HOW MAY HETEROZYGOTES FOR CF BE IDENTIFIED?;3;1000
00039;HOW MAY HETEROZYGOTES FOR CF BE IDENTIFIED?;67;0001
00039;HOW MAY HETEROZYGOTES FOR CF BE IDENTIFIED?;74;0001
00039;HOW MAY HETEROZYGOTES FOR CF BE IDENTIFIED?;76;0001
00039;HOW MAY HETEROZYGOTES FOR CF BE IDENTIFIED?;83;2121
00039;HOW MAY HETEROZYGOTES FOR CF BE IDENTIFIED?;84;0001
00039;HOW MAY HETEROZYGOTES FOR CF BE IDENTIFIED?;85;2122
00039;HOW MAY HETEROZYGOTES FOR CF BE IDENTIFIED?;102;1000
00039;HOW MAY HETEROZYGOTES FOR CF BE IDENTIFIED?;107;0001
00039;HOW MAY HETEROZYGOTES FOR CF BE IDENTIFIED?;108;0002
00039;HOW MAY HETEROZYGOTES FOR CF BE IDENTIFIED?;112;0011
00039;HOW MAY HETEROZYGOTES FOR CF BE IDENTIFIED?;135;0001
00039;HOW MAY HETEROZYGOTES FOR CF BE IDENTIFIED?;143;1000
00039;HOW MAY HETEROZYGOTES FOR CF BE IDENTIFIED?;216;2122
00039;HOW MAY HETEROZYGOTES FOR CF BE IDENTIFIED?;217;2122
00039;HOW MAY HETEROZYGOTES FOR CF BE IDENTIFIED?;218;2122
00039;HOW MAY HETEROZYGOTES FOR CF BE IDENTIFIED?;219;2122
00039;HOW MAY HETEROZYGOTES FOR CF BE IDENTIFIED?;221;2122
00039;HOW MAY HETEROZYGOTES FOR CF BE IDENTIFIED?;222;2121
00039;HOW MAY HETEROZYGOTES FOR CF BE IDENTIFIED?;225;2222
00039;HOW MAY HETEROZYGOTES FOR CF BE IDENTIFIED?;226;0001
00039;HOW MAY HETEROZYGOTES FOR CF BE IDENTIFIED?;230;1002
00039;HOW MAY HETEROZYGOTES FOR CF BE IDENTIFIED?;233;0010
00039;HOW MAY HETEROZYGOTES FOR CF BE IDENTIFIED?;235;2122
00039;HOW MAY HETEROZYGOTES FOR CF BE IDENTIFIED?;236;2122
00039;HOW MAY HETEROZYGOTES FOR CF BE IDENTIFIED?;244;0010
00039;HOW MAY HETEROZYGOTES FOR CF BE IDENTIFIED?;248;0010
00039;HOW MAY HETEROZYGOTES FOR CF BE IDENTIFIED?;249;2112
00039;HOW MAY HETEROZYGOTES FOR CF BE IDENTIFIED?;252;1011
00039;HOW MAY HETEROZYGOTES FOR CF BE IDENTIFIED?;254;1010
00039;HOW MAY HETEROZYGOTES FOR CF BE IDENTIFIED?;263;1011
00039;HOW MAY HETEROZYGOTES FOR CF BE IDENTIFIED?;276;0001
00039;HOW MAY HETEROZYGOTES FOR CF BE IDENTIFIED?;277;2122
00039;HOW MAY HETEROZYGOTES FOR CF BE IDENTIFIED?;289;2112
00039;HOW MAY HETEROZYGOTES FOR CF BE IDENTIFIED?;293;2112
00039;HOW MAY HETEROZYGOTES FOR CF BE IDENTIFIED?;297;0001
00039;HOW MAY HETEROZYGOTES FOR CF BE IDENTIFIED?;301;0001
00039;HOW MAY HETEROZYGOTES FOR CF BE IDENTIFIED?;304;1122
00039;HOW MAY HETEROZYGOTES FOR CF BE IDENTIFIED?;306;0001
00039;HOW MAY HETEROZYGOTES FOR CF BE IDENTIFIED?;307;1001
00039;HOW MAY HETEROZYGOTES FOR CF BE IDENTIFIED?;308;0002
00039;HOW MAY HETEROZYGOTES FOR CF BE IDENTIFIED?;338;2122
00039;HOW MAY HETEROZYGOTES FOR CF BE IDENTIFIED?;342;0002
00039;HOW MAY HETEROZYGOTES FOR CF BE IDENTIFIED?;343;0002
00039;HOW MAY HETEROZYGOTES FOR CF BE IDENTIFIED?;356;1101
00039;HOW MAY HETEROZYGOTES FOR CF BE IDENTIFIED?;360;0010
00039;HOW MAY HETEROZYGOTES FOR CF BE IDENTIFIED?;365;0001
00039;HOW MAY HETEROZYGOTES FOR CF BE IDENTIFIED?;366;1000
00039;HOW MAY HETEROZYGOTES FOR CF BE IDENTIFIED?;370;0001
00039;HOW MAY HETEROZYGOTES FOR CF BE IDENTIFIED?;392;0001
00039;HOW MAY HETEROZYGOTES FOR CF BE IDENTIFIED?;404;0002
00039;HOW MAY HETEROZYGOTES FOR CF BE IDENTIFIED?;407;2122
00039;HOW MAY HETEROZYGOTES FOR CF BE IDENTIFIED?;412;2110
00039;HOW MAY HETEROZYGOTES FOR CF BE IDENTIFIED?;420;2112
00039;HOW MAY HETEROZYGOTES FOR CF BE IDENTIFIED?;433;1002
00039;HOW MAY HETEROZYGOTES FOR CF BE IDENTIFIED?;453;1000
00039;HOW MAY HETEROZYGOTES FOR CF BE IDENTIFIED?;465;0002
00039;HOW MAY HETEROZYGOTES FOR CF BE IDENTIFIED?;470;2121
00039;HOW MAY HETEROZYGOTES FOR CF BE IDENTIFIED?;488;0011
00039;HOW MAY HETEROZYGOTES FOR CF BE IDENTIFIED?;490;0001
00039;HOW MAY HETEROZYGOTES FOR CF BE IDENTIFIED?;494;0002
00039;HOW MAY HETEROZYGOTES FOR CF BE IDENTIFIED?;503;0001
00039;HOW MAY HETEROZYGOTES FOR CF BE IDENTIFIED?;505;0012
00039;HOW MAY HETEROZYGOTES FOR CF BE IDENTIFIED?;508;0101
00039;HOW MAY HETEROZYGOTES FOR CF BE IDENTIFIED?;510;1001
00039;HOW MAY HETEROZYGOTES FOR CF BE IDENTIFIED?;529;0012
00039;HOW MAY HETEROZYGOTES FOR CF BE IDENTIFIED?;530;0001
00039;HOW MAY HETEROZYGOTES FOR CF BE IDENTIFIED?;532;0001
00039;HOW MAY HETEROZYGOTES FOR CF BE IDENTIFIED?;534;0011
00039;HOW MAY HETEROZYGOTES FOR CF BE IDENTIFIED?;535;0001
00039;HOW MAY HETEROZYGOTES FOR CF BE IDENTIFIED?;553;1012
00039;HOW MAY HETEROZYGOTES FOR CF BE IDENTIFIED?;560;2122
00039;HOW MAY HETEROZYGOTES FOR CF BE IDENTIFIED?;563;0002
00039;HOW MAY HETEROZYGOTES FOR CF BE IDENTIFIED?;564;1001
00039;HOW MAY HETEROZYGOTES FOR CF BE IDENTIFIED?;565;0001
00039;HOW MAY HETEROZYGOTES FOR CF BE IDENTIFIED?;566;0001
00039;HOW MAY HETEROZYGOTES FOR CF BE IDENTIFIED?;567;1001
00039;HOW MAY HETEROZYGOTES FOR CF BE IDENTIFIED?;568;0001
00039;HOW MAY HETEROZYGOTES FOR CF BE IDENTIFIED?;569;0001
00039;HOW MAY HETEROZYGOTES FOR CF BE IDENTIFIED?;570;0011
00039;HOW MAY HETEROZYGOTES FOR CF BE IDENTIFIED?;571;0011
00039;HOW MAY HETEROZYGOTES FOR CF BE IDENTIFIED?;572;0001
00039;HOW MAY HETEROZYGOTES FOR CF BE IDENTIFIED?;573;1011
00039;HOW MAY HETEROZYGOTES FOR CF BE IDENTIFIED?;576;1000
00039;HOW MAY HETEROZYGOTES FOR CF BE IDENTIFIED?;584;1122
00039;HOW MAY HETEROZYGOTES FOR CF BE IDENTIFIED?;586;0001
00039;HOW MAY HETEROZYGOTES FOR CF BE IDENTIFIED?;608;0011
00039;HOW MAY HETEROZYGOTES FOR CF BE IDENTIFIED?;610;0001
00039;HOW MAY HETEROZYGOTES FOR CF BE IDENTIFIED?;619;2121
00039;HOW MAY HETEROZYGOTES FOR CF BE IDENTIFIED?;621;0001
00039;HOW MAY HETEROZYGOTES FOR CF BE IDENTIFIED?;622;0002
00039;HOW MAY HETEROZYGOTES FOR CF BE IDENTIFIED?;627;0001
00039;HOW MAY HETEROZYGOTES FOR CF BE IDENTIFIED?;639;2221
00039;HOW MAY HETEROZYGOTES FOR CF BE IDENTIFIED?;645;2111
00039;HOW MAY HETEROZYGOTES FOR CF BE IDENTIFIED?;646;1001
00039;HOW MAY HETEROZYGOTES FOR CF BE IDENTIFIED?;647;0010
00039;HOW MAY HETEROZYGOTES FOR CF BE IDENTIFIED?;652;0001
00039;HOW MAY HETEROZYGOTES FOR CF BE IDENTIFIED?;654;2121
00039;HOW MAY HETEROZYGOTES FOR CF BE IDENTIFIED?;702;0002
00039;HOW MAY HETEROZYGOTES FOR CF BE IDENTIFIED?;716;0111
00039;HOW MAY HETEROZYGOTES FOR CF BE IDENTIFIED?;729;0001
00039;HOW MAY HETEROZYGOTES FOR CF BE IDENTIFIED?;738;0002
00039;HOW MAY HETEROZYGOTES FOR CF BE IDENTIFIED?;739;0002
00039;HOW MAY HETEROZYGOTES FOR CF BE IDENTIFIED?;740;0002
00039;HOW MAY HETEROZYGOTES FOR CF BE IDENTIFIED?;744;0001
00039;HOW MAY HETEROZYGOTES FOR CF BE IDENTIFIED?;746;0002
00039;HOW MAY HETEROZYGOTES FOR CF BE IDENTIFIED?;749;0001
00039;HOW MAY HETEROZYGOTES FOR CF BE IDENTIFIED?;776;0001
00039;HOW MAY HETEROZYGOTES FOR CF BE IDENTIFIED?;777;0011
00039;HOW MAY HETEROZYGOTES FOR CF BE IDENTIFIED?;786;0011
00039;HOW MAY HETEROZYGOTES FOR CF BE IDENTIFIED?;845;0001
00039;HOW MAY HETEROZYGOTES FOR CF BE IDENTIFIED?;849;0001
00039;HOW MAY HETEROZYGOTES FOR CF BE IDENTIFIED?;851;2121
00039;HOW MAY HETEROZYGOTES FOR CF BE IDENTIFIED?;862;0001
00039;HOW MAY HETEROZYGOTES FOR CF BE IDENTIFIED?;869;1002
00039;HOW MAY HETEROZYGOTES FOR CF BE IDENTIFIED?;873;1122
00039;HOW MAY HETEROZYGOTES FOR CF BE IDENTIFIED?;881;1001
00039;HOW MAY HETEROZYGOTES FOR CF BE IDENTIFIED?;882;0002
00039;HOW MAY HETEROZYGOTES FOR CF BE IDENTIFIED?;888;0001
00039;HOW MAY HETEROZYGOTES FOR CF BE IDENTIFIED?;889;0001
00039;HOW MAY HETEROZYGOTES FOR CF BE IDENTIFIED?;892;0001
00039;HOW MAY HETEROZYGOTES FOR CF BE IDENTIFIED?;902;0001
00039;HOW MAY HETEROZYGOTES FOR CF BE IDENTIFIED?;918;0002
00039;HOW MAY HETEROZYGOTES FOR CF BE IDENTIFIED?;942;0001
00039;HOW MAY HETEROZYGOTES FOR CF BE IDENTIFIED?;944;0001
00039;HOW MAY HETEROZYGOTES FOR CF BE IDENTIFIED?;949;1002
00039;HOW MAY HETEROZYGOTES FOR CF BE IDENTIFIED?;966;0012
00039;HOW MAY HETEROZYGOTES FOR CF BE IDENTIFIED?;971;2122
00039;HOW MAY HETEROZYGOTES FOR CF BE IDENTIFIED?;990;0002
00039;HOW MAY HETEROZYGOTES FOR CF BE IDENTIFIED?;1001;1001
00039;HOW MAY HETEROZYGOTES FOR CF BE IDENTIFIED?;1026;0001
00039;HOW MAY HETEROZYGOTES FOR CF BE IDENTIFIED?;1027;1001
00039;HOW MAY HETEROZYGOTES FOR CF BE IDENTIFIED?;1029;1001
00039;HOW MAY HETEROZYGOTES FOR CF BE IDENTIFIED?;1044;0001
00039;HOW MAY HETEROZYGOTES FOR CF BE IDENTIFIED?;1066;0001
00039;HOW MAY HETEROZYGOTES FOR CF BE IDENTIFIED?;1070;0001
00039;HOW MAY HETEROZYGOTES FOR CF BE IDENTIFIED?;1072;0001
00039;HOW MAY HETEROZYGOTES FOR CF BE IDENTIFIED?;1076;0001
00039;HOW MAY HETEROZYGOTES FOR CF BE IDENTIFIED?;1096;0100
00039;HOW MAY HETEROZYGOTES FOR CF BE IDENTIFIED?;1127;1011
00039;HOW MAY HETEROZYGOTES FOR CF BE IDENTIFIED?;1135;0001
00039;HOW MAY HETEROZYGOTES FOR CF BE IDENTIFIED?;1136;1000
00039;HOW MAY HETEROZYGOTES FOR CF BE IDENTIFIED?;1137;1221
00039;HOW MAY HETEROZYGOTES FOR CF BE IDENTIFIED?;1139;1222
00039;HOW MAY HETEROZYGOTES FOR CF BE IDENTIFIED?;1140;0010
00039;HOW MAY HETEROZYGOTES FOR CF BE IDENTIFIED?;1141;1122
00039;HOW MAY HETEROZYGOTES FOR CF BE IDENTIFIED?;1146;0011
00039;HOW MAY HETEROZYGOTES FOR CF BE IDENTIFIED?;1148;0011
00039;HOW MAY HETEROZYGOTES FOR CF BE IDENTIFIED?;1160;0010
00039;HOW MAY HETEROZYGOTES FOR CF BE IDENTIFIED?;1161;0001
00039;HOW MAY HETEROZYGOTES FOR CF BE IDENTIFIED?;1185;0001
00039;HOW MAY HETEROZYGOTES FOR CF BE IDENTIFIED?;1194;0001
00039;HOW MAY HETEROZYGOTES FOR CF BE IDENTIFIED?;1209;0001
00039;HOW MAY HETEROZYGOTES FOR CF BE IDENTIFIED?;1210;0001
00039;HOW MAY HETEROZYGOTES FOR CF BE IDENTIFIED?;1211;1002
00039;HOW MAY HETEROZYGOTES FOR CF BE IDENTIFIED?;1222;0001
00039;HOW MAY HETEROZYGOTES FOR CF BE IDENTIFIED?;1224;0001
00039;HOW MAY HETEROZYGOTES FOR CF BE IDENTIFIED?;1225;1112
00039;HOW MAY HETEROZYGOTES FOR CF BE IDENTIFIED?;1230;1002
00039;HOW MAY HETEROZYGOTES FOR CF BE IDENTIFIED?;1234;1211
00039;HOW MAY HETEROZYGOTES FOR CF BE IDENTIFIED?;1236;0001
00039;HOW MAY HETEROZYGOTES FOR CF BE IDENTIFIED?;1238;0002
00040;OTHER THAN THE SWEAT TEST, WHAT TECHNIQUES MAY BE USEFUL (BEYOND THE NEONATAL PERIOD) FOR THE DIAGNOSIS OF CF?;2;0100
00040;OTHER THAN THE SWEAT TEST, WHAT TECHNIQUES MAY BE USEFUL (BEYOND THE NEONATAL PERIOD) FOR THE DIAGNOSIS OF CF?;3;2122
00040;OTHER THAN THE SWEAT TEST, WHAT TECHNIQUES MAY BE USEFUL (BEYOND THE NEONATAL PERIOD) FOR THE DIAGNOSIS OF CF?;4;2122
00040;OTHER THAN THE SWEAT TEST, WHAT TECHNIQUES MAY BE USEFUL (BEYOND THE NEONATAL PERIOD) FOR THE DIAGNOSIS OF CF?;5;0100
00040;OTHER THAN THE SWEAT TEST, WHAT TECHNIQUES MAY BE USEFUL (BEYOND THE NEONATAL PERIOD) FOR THE DIAGNOSIS OF CF?;9;0001
00040;OTHER THAN THE SWEAT TEST, WHAT TECHNIQUES MAY BE USEFUL (BEYOND THE NEONATAL PERIOD) FOR THE DIAGNOSIS OF CF?;10;0001
00040;OTHER THAN THE SWEAT TEST, WHAT TECHNIQUES MAY BE USEFUL (BEYOND THE NEONATAL PERIOD) FOR THE DIAGNOSIS OF CF?;17;0001
00040;OTHER THAN THE SWEAT TEST, WHAT TECHNIQUES MAY BE USEFUL (BEYOND THE NEONATAL PERIOD) FOR THE DIAGNOSIS OF CF?;28;2212
00040;OTHER THAN THE SWEAT TEST, WHAT TECHNIQUES MAY BE USEFUL (BEYOND THE NEONATAL PERIOD) FOR THE DIAGNOSIS OF CF?;32;0001
00040;OTHER THAN THE SWEAT TEST, WHAT TECHNIQUES MAY BE USEFUL (BEYOND THE NEONATAL PERIOD) FOR THE DIAGNOSIS OF CF?;35;0100
00040;OTHER THAN THE SWEAT TEST, WHAT TECHNIQUES MAY BE USEFUL (BEYOND THE NEONATAL PERIOD) FOR THE DIAGNOSIS OF CF?;76;0001
00040;OTHER THAN THE SWEAT TEST, WHAT TECHNIQUES MAY BE USEFUL (BEYOND THE NEONATAL PERIOD) FOR THE DIAGNOSIS OF CF?;77;1122
00040;OTHER THAN THE SWEAT TEST, WHAT TECHNIQUES MAY BE USEFUL (BEYOND THE NEONATAL PERIOD) FOR THE DIAGNOSIS OF CF?;95;2110
00040;OTHER THAN THE SWEAT TEST, WHAT TECHNIQUES MAY BE USEFUL (BEYOND THE NEONATAL PERIOD) FOR THE DIAGNOSIS OF CF?;103;0010
00040;OTHER THAN THE SWEAT TEST, WHAT TECHNIQUES MAY BE USEFUL (BEYOND THE NEONATAL PERIOD) FOR THE DIAGNOSIS OF CF?;105;0010
00040;OTHER THAN THE SWEAT TEST, WHAT TECHNIQUES MAY BE USEFUL (BEYOND THE NEONATAL PERIOD) FOR THE DIAGNOSIS OF CF?;108;0010
00040;OTHER THAN THE SWEAT TEST, WHAT TECHNIQUES MAY BE USEFUL (BEYOND THE NEONATAL PERIOD) FOR THE DIAGNOSIS OF CF?;109;1010
00040;OTHER THAN THE SWEAT TEST, WHAT TECHNIQUES MAY BE USEFUL (BEYOND THE NEONATAL PERIOD) FOR THE DIAGNOSIS OF CF?;112;0010
00040;OTHER THAN THE SWEAT TEST, WHAT TECHNIQUES MAY BE USEFUL (BEYOND THE NEONATAL PERIOD) FOR THE DIAGNOSIS OF CF?;115;0010
00040;OTHER THAN THE SWEAT TEST, WHAT TECHNIQUES MAY BE USEFUL (BEYOND THE NEONATAL PERIOD) FOR THE DIAGNOSIS OF CF?;116;1122
00040;OTHER THAN THE SWEAT TEST, WHAT TECHNIQUES MAY BE USEFUL (BEYOND THE NEONATAL PERIOD) FOR THE DIAGNOSIS OF CF?;119;1001
00040;OTHER THAN THE SWEAT TEST, WHAT TECHNIQUES MAY BE USEFUL (BEYOND THE NEONATAL PERIOD) FOR THE DIAGNOSIS OF CF?;120;0001
00040;OTHER THAN THE SWEAT TEST, WHAT TECHNIQUES MAY BE USEFUL (BEYOND THE NEONATAL PERIOD) FOR THE DIAGNOSIS OF CF?;132;0001
00040;OTHER THAN THE SWEAT TEST, WHAT TECHNIQUES MAY BE USEFUL (BEYOND THE NEONATAL PERIOD) FOR THE DIAGNOSIS OF CF?;142;0001
00040;OTHER THAN THE SWEAT TEST, WHAT TECHNIQUES MAY BE USEFUL (BEYOND THE NEONATAL PERIOD) FOR THE DIAGNOSIS OF CF?;144;0001
00040;OTHER THAN THE SWEAT TEST, WHAT TECHNIQUES MAY BE USEFUL (BEYOND THE NEONATAL PERIOD) FOR THE DIAGNOSIS OF CF?;150;0102
00040;OTHER THAN THE SWEAT TEST, WHAT TECHNIQUES MAY BE USEFUL (BEYOND THE NEONATAL PERIOD) FOR THE DIAGNOSIS OF CF?;151;0002
00040;OTHER THAN THE SWEAT TEST, WHAT TECHNIQUES MAY BE USEFUL (BEYOND THE NEONATAL PERIOD) FOR THE DIAGNOSIS OF CF?;169;1000
00040;OTHER THAN THE SWEAT TEST, WHAT TECHNIQUES MAY BE USEFUL (BEYOND THE NEONATAL PERIOD) FOR THE DIAGNOSIS OF CF?;173;0001
00040;OTHER THAN THE SWEAT TEST, WHAT TECHNIQUES MAY BE USEFUL (BEYOND THE NEONATAL PERIOD) FOR THE DIAGNOSIS OF CF?;189;0001
00040;OTHER THAN THE SWEAT TEST, WHAT TECHNIQUES MAY BE USEFUL (BEYOND THE NEONATAL PERIOD) FOR THE DIAGNOSIS OF CF?;198;0010
00040;OTHER THAN THE SWEAT TEST, WHAT TECHNIQUES MAY BE USEFUL (BEYOND THE NEONATAL PERIOD) FOR THE DIAGNOSIS OF CF?;210;0001
00040;OTHER THAN THE SWEAT TEST, WHAT TECHNIQUES MAY BE USEFUL (BEYOND THE NEONATAL PERIOD) FOR THE DIAGNOSIS OF CF?;225;2122
00040;OTHER THAN THE SWEAT TEST, WHAT TECHNIQUES MAY BE USEFUL (BEYOND THE NEONATAL PERIOD) FOR THE DIAGNOSIS OF CF?;231;2122
00040;OTHER THAN THE SWEAT TEST, WHAT TECHNIQUES MAY BE USEFUL (BEYOND THE NEONATAL PERIOD) FOR THE DIAGNOSIS OF CF?;233;2222
00040;OTHER THAN THE SWEAT TEST, WHAT TECHNIQUES MAY BE USEFUL (BEYOND THE NEONATAL PERIOD) FOR THE DIAGNOSIS OF CF?;235;0010
00040;OTHER THAN THE SWEAT TEST, WHAT TECHNIQUES MAY BE USEFUL (BEYOND THE NEONATAL PERIOD) FOR THE DIAGNOSIS OF CF?;236;0010
00040;OTHER THAN THE SWEAT TEST, WHAT TECHNIQUES MAY BE USEFUL (BEYOND THE NEONATAL PERIOD) FOR THE DIAGNOSIS OF CF?;240;2110
00040;OTHER THAN THE SWEAT TEST, WHAT TECHNIQUES MAY BE USEFUL (BEYOND THE NEONATAL PERIOD) FOR THE DIAGNOSIS OF CF?;248;1000
00040;OTHER THAN THE SWEAT TEST, WHAT TECHNIQUES MAY BE USEFUL (BEYOND THE NEONATAL PERIOD) FOR THE DIAGNOSIS OF CF?;249;0010
00040;OTHER THAN THE SWEAT TEST, WHAT TECHNIQUES MAY BE USEFUL (BEYOND THE NEONATAL PERIOD) FOR THE DIAGNOSIS OF CF?;252;1002
00040;OTHER THAN THE SWEAT TEST, WHAT TECHNIQUES MAY BE USEFUL (BEYOND THE NEONATAL PERIOD) FOR THE DIAGNOSIS OF CF?;254;1122
00040;OTHER THAN THE SWEAT TEST, WHAT TECHNIQUES MAY BE USEFUL (BEYOND THE NEONATAL PERIOD) FOR THE DIAGNOSIS OF CF?;261;0010
00040;OTHER THAN THE SWEAT TEST, WHAT TECHNIQUES MAY BE USEFUL (BEYOND THE NEONATAL PERIOD) FOR THE DIAGNOSIS OF CF?;263;0001
00040;OTHER THAN THE SWEAT TEST, WHAT TECHNIQUES MAY BE USEFUL (BEYOND THE NEONATAL PERIOD) FOR THE DIAGNOSIS OF CF?;277;1122
00040;OTHER THAN THE SWEAT TEST, WHAT TECHNIQUES MAY BE USEFUL (BEYOND THE NEONATAL PERIOD) FOR THE DIAGNOSIS OF CF?;279;0010
00040;OTHER THAN THE SWEAT TEST, WHAT TECHNIQUES MAY BE USEFUL (BEYOND THE NEONATAL PERIOD) FOR THE DIAGNOSIS OF CF?;289;0010
00040;OTHER THAN THE SWEAT TEST, WHAT TECHNIQUES MAY BE USEFUL (BEYOND THE NEONATAL PERIOD) FOR THE DIAGNOSIS OF CF?;291;0001
00040;OTHER THAN THE SWEAT TEST, WHAT TECHNIQUES MAY BE USEFUL (BEYOND THE NEONATAL PERIOD) FOR THE DIAGNOSIS OF CF?;293;0011
00040;OTHER THAN THE SWEAT TEST, WHAT TECHNIQUES MAY BE USEFUL (BEYOND THE NEONATAL PERIOD) FOR THE DIAGNOSIS OF CF?;294;1011
00040;OTHER THAN THE SWEAT TEST, WHAT TECHNIQUES MAY BE USEFUL (BEYOND THE NEONATAL PERIOD) FOR THE DIAGNOSIS OF CF?;297;0001
00040;OTHER THAN THE SWEAT TEST, WHAT TECHNIQUES MAY BE USEFUL (BEYOND THE NEONATAL PERIOD) FOR THE DIAGNOSIS OF CF?;298;0001
00040;OTHER THAN THE SWEAT TEST, WHAT TECHNIQUES MAY BE USEFUL (BEYOND THE NEONATAL PERIOD) FOR THE DIAGNOSIS OF CF?;304;0010
00040;OTHER THAN THE SWEAT TEST, WHAT TECHNIQUES MAY BE USEFUL (BEYOND THE NEONATAL PERIOD) FOR THE DIAGNOSIS OF CF?;308;0010
00040;OTHER THAN THE SWEAT TEST, WHAT TECHNIQUES MAY BE USEFUL (BEYOND THE NEONATAL PERIOD) FOR THE DIAGNOSIS OF CF?;333;0001
00040;OTHER THAN THE SWEAT TEST, WHAT TECHNIQUES MAY BE USEFUL (BEYOND THE NEONATAL PERIOD) FOR THE DIAGNOSIS OF CF?;338;0001
00040;OTHER THAN THE SWEAT TEST, WHAT TECHNIQUES MAY BE USEFUL (BEYOND THE NEONATAL PERIOD) FOR THE DIAGNOSIS OF CF?;344;0011
00040;OTHER THAN THE SWEAT TEST, WHAT TECHNIQUES MAY BE USEFUL (BEYOND THE NEONATAL PERIOD) FOR THE DIAGNOSIS OF CF?;345;0001
00040;OTHER THAN THE SWEAT TEST, WHAT TECHNIQUES MAY BE USEFUL (BEYOND THE NEONATAL PERIOD) FOR THE DIAGNOSIS OF CF?;351;1000
00040;OTHER THAN THE SWEAT TEST, WHAT TECHNIQUES MAY BE USEFUL (BEYOND THE NEONATAL PERIOD) FOR THE DIAGNOSIS OF CF?;352;1000
00040;OTHER THAN THE SWEAT TEST, WHAT TECHNIQUES MAY BE USEFUL (BEYOND THE NEONATAL PERIOD) FOR THE DIAGNOSIS OF CF?;370;1001
00040;OTHER THAN THE SWEAT TEST, WHAT TECHNIQUES MAY BE USEFUL (BEYOND THE NEONATAL PERIOD) FOR THE DIAGNOSIS OF CF?;392;0001
00040;OTHER THAN THE SWEAT TEST, WHAT TECHNIQUES MAY BE USEFUL (BEYOND THE NEONATAL PERIOD) FOR THE DIAGNOSIS OF CF?;404;2122
00040;OTHER THAN THE SWEAT TEST, WHAT TECHNIQUES MAY BE USEFUL (BEYOND THE NEONATAL PERIOD) FOR THE DIAGNOSIS OF CF?;405;2122
00040;OTHER THAN THE SWEAT TEST, WHAT TECHNIQUES MAY BE USEFUL (BEYOND THE NEONATAL PERIOD) FOR THE DIAGNOSIS OF CF?;407;0010
00040;OTHER THAN THE SWEAT TEST, WHAT TECHNIQUES MAY BE USEFUL (BEYOND THE NEONATAL PERIOD) FOR THE DIAGNOSIS OF CF?;413;0001
00040;OTHER THAN THE SWEAT TEST, WHAT TECHNIQUES MAY BE USEFUL (BEYOND THE NEONATAL PERIOD) FOR THE DIAGNOSIS OF CF?;417;0102
00040;OTHER THAN THE SWEAT TEST, WHAT TECHNIQUES MAY BE USEFUL (BEYOND THE NEONATAL PERIOD) FOR THE DIAGNOSIS OF CF?;420;0012
00040;OTHER THAN THE SWEAT TEST, WHAT TECHNIQUES MAY BE USEFUL (BEYOND THE NEONATAL PERIOD) FOR THE DIAGNOSIS OF CF?;434;0001
00040;OTHER THAN THE SWEAT TEST, WHAT TECHNIQUES MAY BE USEFUL (BEYOND THE NEONATAL PERIOD) FOR THE DIAGNOSIS OF CF?;465;2222
00040;OTHER THAN THE SWEAT TEST, WHAT TECHNIQUES MAY BE USEFUL (BEYOND THE NEONATAL PERIOD) FOR THE DIAGNOSIS OF CF?;478;0001
00040;OTHER THAN THE SWEAT TEST, WHAT TECHNIQUES MAY BE USEFUL (BEYOND THE NEONATAL PERIOD) FOR THE DIAGNOSIS OF CF?;479;2111
00040;OTHER THAN THE SWEAT TEST, WHAT TECHNIQUES MAY BE USEFUL (BEYOND THE NEONATAL PERIOD) FOR THE DIAGNOSIS OF CF?;508;0002
00040;OTHER THAN THE SWEAT TEST, WHAT TECHNIQUES MAY BE USEFUL (BEYOND THE NEONATAL PERIOD) FOR THE DIAGNOSIS OF CF?;510;0010
00040;OTHER THAN THE SWEAT TEST, WHAT TECHNIQUES MAY BE USEFUL (BEYOND THE NEONATAL PERIOD) FOR THE DIAGNOSIS OF CF?;515;0001
00040;OTHER THAN THE SWEAT TEST, WHAT TECHNIQUES MAY BE USEFUL (BEYOND THE NEONATAL PERIOD) FOR THE DIAGNOSIS OF CF?;526;0010
00040;OTHER THAN THE SWEAT TEST, WHAT TECHNIQUES MAY BE USEFUL (BEYOND THE NEONATAL PERIOD) FOR THE DIAGNOSIS OF CF?;529;0010
00040;OTHER THAN THE SWEAT TEST, WHAT TECHNIQUES MAY BE USEFUL (BEYOND THE NEONATAL PERIOD) FOR THE DIAGNOSIS OF CF?;532;0010
00040;OTHER THAN THE SWEAT TEST, WHAT TECHNIQUES MAY BE USEFUL (BEYOND THE NEONATAL PERIOD) FOR THE DIAGNOSIS OF CF?;535;0001
00040;OTHER THAN THE SWEAT TEST, WHAT TECHNIQUES MAY BE USEFUL (BEYOND THE NEONATAL PERIOD) FOR THE DIAGNOSIS OF CF?;553;0010
00040;OTHER THAN THE SWEAT TEST, WHAT TECHNIQUES MAY BE USEFUL (BEYOND THE NEONATAL PERIOD) FOR THE DIAGNOSIS OF CF?;560;1010
00040;OTHER THAN THE SWEAT TEST, WHAT TECHNIQUES MAY BE USEFUL (BEYOND THE NEONATAL PERIOD) FOR THE DIAGNOSIS OF CF?;571;0010
00040;OTHER THAN THE SWEAT TEST, WHAT TECHNIQUES MAY BE USEFUL (BEYOND THE NEONATAL PERIOD) FOR THE DIAGNOSIS OF CF?;572;0010
00040;OTHER THAN THE SWEAT TEST, WHAT TECHNIQUES MAY BE USEFUL (BEYOND THE NEONATAL PERIOD) FOR THE DIAGNOSIS OF CF?;573;1010
00040;OTHER THAN THE SWEAT TEST, WHAT TECHNIQUES MAY BE USEFUL (BEYOND THE NEONATAL PERIOD) FOR THE DIAGNOSIS OF CF?;576;1000
00040;OTHER THAN THE SWEAT TEST, WHAT TECHNIQUES MAY BE USEFUL (BEYOND THE NEONATAL PERIOD) FOR THE DIAGNOSIS OF CF?;583;0001
00040;OTHER THAN THE SWEAT TEST, WHAT TECHNIQUES MAY BE USEFUL (BEYOND THE NEONATAL PERIOD) FOR THE DIAGNOSIS OF CF?;613;0001
00040;OTHER THAN THE SWEAT TEST, WHAT TECHNIQUES MAY BE USEFUL (BEYOND THE NEONATAL PERIOD) FOR THE DIAGNOSIS OF CF?;616;0001
00040;OTHER THAN THE SWEAT TEST, WHAT TECHNIQUES MAY BE USEFUL (BEYOND THE NEONATAL PERIOD) FOR THE DIAGNOSIS OF CF?;619;0010
00040;OTHER THAN THE SWEAT TEST, WHAT TECHNIQUES MAY BE USEFUL (BEYOND THE NEONATAL PERIOD) FOR THE DIAGNOSIS OF CF?;645;0010
00040;OTHER THAN THE SWEAT TEST, WHAT TECHNIQUES MAY BE USEFUL (BEYOND THE NEONATAL PERIOD) FOR THE DIAGNOSIS OF CF?;646;0010
00040;OTHER THAN THE SWEAT TEST, WHAT TECHNIQUES MAY BE USEFUL (BEYOND THE NEONATAL PERIOD) FOR THE DIAGNOSIS OF CF?;654;0010
00040;OTHER THAN THE SWEAT TEST, WHAT TECHNIQUES MAY BE USEFUL (BEYOND THE NEONATAL PERIOD) FOR THE DIAGNOSIS OF CF?;673;0001
00040;OTHER THAN THE SWEAT TEST, WHAT TECHNIQUES MAY BE USEFUL (BEYOND THE NEONATAL PERIOD) FOR THE DIAGNOSIS OF CF?;677;0001
00040;OTHER THAN THE SWEAT TEST, WHAT TECHNIQUES MAY BE USEFUL (BEYOND THE NEONATAL PERIOD) FOR THE DIAGNOSIS OF CF?;731;0001
00040;OTHER THAN THE SWEAT TEST, WHAT TECHNIQUES MAY BE USEFUL (BEYOND THE NEONATAL PERIOD) FOR THE DIAGNOSIS OF CF?;735;0001
00040;OTHER THAN THE SWEAT TEST, WHAT TECHNIQUES MAY BE USEFUL (BEYOND THE NEONATAL PERIOD) FOR THE DIAGNOSIS OF CF?;763;0001
00040;OTHER THAN THE SWEAT TEST, WHAT TECHNIQUES MAY BE USEFUL (BEYOND THE NEONATAL PERIOD) FOR THE DIAGNOSIS OF CF?;780;0010
00040;OTHER THAN THE SWEAT TEST, WHAT TECHNIQUES MAY BE USEFUL (BEYOND THE NEONATAL PERIOD) FOR THE DIAGNOSIS OF CF?;785;2122
00040;OTHER THAN THE SWEAT TEST, WHAT TECHNIQUES MAY BE USEFUL (BEYOND THE NEONATAL PERIOD) FOR THE DIAGNOSIS OF CF?;786;2122
00040;OTHER THAN THE SWEAT TEST, WHAT TECHNIQUES MAY BE USEFUL (BEYOND THE NEONATAL PERIOD) FOR THE DIAGNOSIS OF CF?;815;1221
00040;OTHER THAN THE SWEAT TEST, WHAT TECHNIQUES MAY BE USEFUL (BEYOND THE NEONATAL PERIOD) FOR THE DIAGNOSIS OF CF?;849;0100
00040;OTHER THAN THE SWEAT TEST, WHAT TECHNIQUES MAY BE USEFUL (BEYOND THE NEONATAL PERIOD) FOR THE DIAGNOSIS OF CF?;851;0001
00040;OTHER THAN THE SWEAT TEST, WHAT TECHNIQUES MAY BE USEFUL (BEYOND THE NEONATAL PERIOD) FOR THE DIAGNOSIS OF CF?;852;0001
00040;OTHER THAN THE SWEAT TEST, WHAT TECHNIQUES MAY BE USEFUL (BEYOND THE NEONATAL PERIOD) FOR THE DIAGNOSIS OF CF?;869;1000
00040;OTHER THAN THE SWEAT TEST, WHAT TECHNIQUES MAY BE USEFUL (BEYOND THE NEONATAL PERIOD) FOR THE DIAGNOSIS OF CF?;882;0001
00040;OTHER THAN THE SWEAT TEST, WHAT TECHNIQUES MAY BE USEFUL (BEYOND THE NEONATAL PERIOD) FOR THE DIAGNOSIS OF CF?;888;0100
00040;OTHER THAN THE SWEAT TEST, WHAT TECHNIQUES MAY BE USEFUL (BEYOND THE NEONATAL PERIOD) FOR THE DIAGNOSIS OF CF?;899;1210
00040;OTHER THAN THE SWEAT TEST, WHAT TECHNIQUES MAY BE USEFUL (BEYOND THE NEONATAL PERIOD) FOR THE DIAGNOSIS OF CF?;931;0010
00040;OTHER THAN THE SWEAT TEST, WHAT TECHNIQUES MAY BE USEFUL (BEYOND THE NEONATAL PERIOD) FOR THE DIAGNOSIS OF CF?;941;1111
00040;OTHER THAN THE SWEAT TEST, WHAT TECHNIQUES MAY BE USEFUL (BEYOND THE NEONATAL PERIOD) FOR THE DIAGNOSIS OF CF?;942;0001
00040;OTHER THAN THE SWEAT TEST, WHAT TECHNIQUES MAY BE USEFUL (BEYOND THE NEONATAL PERIOD) FOR THE DIAGNOSIS OF CF?;949;1000
00040;OTHER THAN THE SWEAT TEST, WHAT TECHNIQUES MAY BE USEFUL (BEYOND THE NEONATAL PERIOD) FOR THE DIAGNOSIS OF CF?;954;0101
00040;OTHER THAN THE SWEAT TEST, WHAT TECHNIQUES MAY BE USEFUL (BEYOND THE NEONATAL PERIOD) FOR THE DIAGNOSIS OF CF?;956;0100
00040;OTHER THAN THE SWEAT TEST, WHAT TECHNIQUES MAY BE USEFUL (BEYOND THE NEONATAL PERIOD) FOR THE DIAGNOSIS OF CF?;959;0100
00040;OTHER THAN THE SWEAT TEST, WHAT TECHNIQUES MAY BE USEFUL (BEYOND THE NEONATAL PERIOD) FOR THE DIAGNOSIS OF CF?;1000;0001
00040;OTHER THAN THE SWEAT TEST, WHAT TECHNIQUES MAY BE USEFUL (BEYOND THE NEONATAL PERIOD) FOR THE DIAGNOSIS OF CF?;1008;1222
00040;OTHER THAN THE SWEAT TEST, WHAT TECHNIQUES MAY BE USEFUL (BEYOND THE NEONATAL PERIOD) FOR THE DIAGNOSIS OF CF?;1024;1000
00040;OTHER THAN THE SWEAT TEST, WHAT TECHNIQUES MAY BE USEFUL (BEYOND THE NEONATAL PERIOD) FOR THE DIAGNOSIS OF CF?;1027;0001
00040;OTHER THAN THE SWEAT TEST, WHAT TECHNIQUES MAY BE USEFUL (BEYOND THE NEONATAL PERIOD) FOR THE DIAGNOSIS OF CF?;1029;0001
00040;OTHER THAN THE SWEAT TEST, WHAT TECHNIQUES MAY BE USEFUL (BEYOND THE NEONATAL PERIOD) FOR THE DIAGNOSIS OF CF?;1052;0011
00040;OTHER THAN THE SWEAT TEST, WHAT TECHNIQUES MAY BE USEFUL (BEYOND THE NEONATAL PERIOD) FOR THE DIAGNOSIS OF CF?;1080;0101
00040;OTHER THAN THE SWEAT TEST, WHAT TECHNIQUES MAY BE USEFUL (BEYOND THE NEONATAL PERIOD) FOR THE DIAGNOSIS OF CF?;1100;1212
00040;OTHER THAN THE SWEAT TEST, WHAT TECHNIQUES MAY BE USEFUL (BEYOND THE NEONATAL PERIOD) FOR THE DIAGNOSIS OF CF?;1105;0002
00040;OTHER THAN THE SWEAT TEST, WHAT TECHNIQUES MAY BE USEFUL (BEYOND THE NEONATAL PERIOD) FOR THE DIAGNOSIS OF CF?;1109;0010
00040;OTHER THAN THE SWEAT TEST, WHAT TECHNIQUES MAY BE USEFUL (BEYOND THE NEONATAL PERIOD) FOR THE DIAGNOSIS OF CF?;1117;1212
00040;OTHER THAN THE SWEAT TEST, WHAT TECHNIQUES MAY BE USEFUL (BEYOND THE NEONATAL PERIOD) FOR THE DIAGNOSIS OF CF?;1124;2210
00040;OTHER THAN THE SWEAT TEST, WHAT TECHNIQUES MAY BE USEFUL (BEYOND THE NEONATAL PERIOD) FOR THE DIAGNOSIS OF CF?;1126;0010
00040;OTHER THAN THE SWEAT TEST, WHAT TECHNIQUES MAY BE USEFUL (BEYOND THE NEONATAL PERIOD) FOR THE DIAGNOSIS OF CF?;1127;0012
00040;OTHER THAN THE SWEAT TEST, WHAT TECHNIQUES MAY BE USEFUL (BEYOND THE NEONATAL PERIOD) FOR THE DIAGNOSIS OF CF?;1128;0010
00040;OTHER THAN THE SWEAT TEST, WHAT TECHNIQUES MAY BE USEFUL (BEYOND THE NEONATAL PERIOD) FOR THE DIAGNOSIS OF CF?;1130;0001
00040;OTHER THAN THE SWEAT TEST, WHAT TECHNIQUES MAY BE USEFUL (BEYOND THE NEONATAL PERIOD) FOR THE DIAGNOSIS OF CF?;1131;0002
00040;OTHER THAN THE SWEAT TEST, WHAT TECHNIQUES MAY BE USEFUL (BEYOND THE NEONATAL PERIOD) FOR THE DIAGNOSIS OF CF?;1132;0001
00040;OTHER THAN THE SWEAT TEST, WHAT TECHNIQUES MAY BE USEFUL (BEYOND THE NEONATAL PERIOD) FOR THE DIAGNOSIS OF CF?;1133;0011
00040;OTHER THAN THE SWEAT TEST, WHAT TECHNIQUES MAY BE USEFUL (BEYOND THE NEONATAL PERIOD) FOR THE DIAGNOSIS OF CF?;1135;1122
00040;OTHER THAN THE SWEAT TEST, WHAT TECHNIQUES MAY BE USEFUL (BEYOND THE NEONATAL PERIOD) FOR THE DIAGNOSIS OF CF?;1137;1121
00040;OTHER THAN THE SWEAT TEST, WHAT TECHNIQUES MAY BE USEFUL (BEYOND THE NEONATAL PERIOD) FOR THE DIAGNOSIS OF CF?;1139;1220
00040;OTHER THAN THE SWEAT TEST, WHAT TECHNIQUES MAY BE USEFUL (BEYOND THE NEONATAL PERIOD) FOR THE DIAGNOSIS OF CF?;1141;1120
00040;OTHER THAN THE SWEAT TEST, WHAT TECHNIQUES MAY BE USEFUL (BEYOND THE NEONATAL PERIOD) FOR THE DIAGNOSIS OF CF?;1146;0010
00040;OTHER THAN THE SWEAT TEST, WHAT TECHNIQUES MAY BE USEFUL (BEYOND THE NEONATAL PERIOD) FOR THE DIAGNOSIS OF CF?;1148;0010
00040;OTHER THAN THE SWEAT TEST, WHAT TECHNIQUES MAY BE USEFUL (BEYOND THE NEONATAL PERIOD) FOR THE DIAGNOSIS OF CF?;1160;0011
00040;OTHER THAN THE SWEAT TEST, WHAT TECHNIQUES MAY BE USEFUL (BEYOND THE NEONATAL PERIOD) FOR THE DIAGNOSIS OF CF?;1161;0010
00040;OTHER THAN THE SWEAT TEST, WHAT TECHNIQUES MAY BE USEFUL (BEYOND THE NEONATAL PERIOD) FOR THE DIAGNOSIS OF CF?;1192;0001
00040;OTHER THAN THE SWEAT TEST, WHAT TECHNIQUES MAY BE USEFUL (BEYOND THE NEONATAL PERIOD) FOR THE DIAGNOSIS OF CF?;1193;1121
00040;OTHER THAN THE SWEAT TEST, WHAT TECHNIQUES MAY BE USEFUL (BEYOND THE NEONATAL PERIOD) FOR THE DIAGNOSIS OF CF?;1230;1120
00040;OTHER THAN THE SWEAT TEST, WHAT TECHNIQUES MAY BE USEFUL (BEYOND THE NEONATAL PERIOD) FOR THE DIAGNOSIS OF CF?;1234;2222
00041;IS VITAMIN D METABOLISM NORMAL IN CF PATIENTS?;46;0100
00041;IS VITAMIN D METABOLISM NORMAL IN CF PATIENTS?;296;0100
00041;IS VITAMIN D METABOLISM NORMAL IN CF PATIENTS?;301;0100
00041;IS VITAMIN D METABOLISM NORMAL IN CF PATIENTS?;322;0010
00041;IS VITAMIN D METABOLISM NORMAL IN CF PATIENTS?;370;0100
00041;IS VITAMIN D METABOLISM NORMAL IN CF PATIENTS?;392;1000
00041;IS VITAMIN D METABOLISM NORMAL IN CF PATIENTS?;603;2221
00041;IS VITAMIN D METABOLISM NORMAL IN CF PATIENTS?;941;0001
00041;IS VITAMIN D METABOLISM NORMAL IN CF PATIENTS?;998;1010
00041;IS VITAMIN D METABOLISM NORMAL IN CF PATIENTS?;1106;2222
00041;IS VITAMIN D METABOLISM NORMAL IN CF PATIENTS?;1107;2222
00041;IS VITAMIN D METABOLISM NORMAL IN CF PATIENTS?;1108;2222
00041;IS VITAMIN D METABOLISM NORMAL IN CF PATIENTS?;1115;1122
00041;IS VITAMIN D METABOLISM NORMAL IN CF PATIENTS?;1184;0010
00041;IS VITAMIN D METABOLISM NORMAL IN CF PATIENTS?;1190;2222
00042;WHAT ABNORMALITIES OF INSULIN SECRETION OR INSULIN METABOLISM OCCUR IN CF PATIENTS?;5;0001
00042;WHAT ABNORMALITIES OF INSULIN SECRETION OR INSULIN METABOLISM OCCUR IN CF PATIENTS?;46;0100
00042;WHAT ABNORMALITIES OF INSULIN SECRETION OR INSULIN METABOLISM OCCUR IN CF PATIENTS?;57;2222
00042;WHAT ABNORMALITIES OF INSULIN SECRETION OR INSULIN METABOLISM OCCUR IN CF PATIENTS?;92;2212
00042;WHAT ABNORMALITIES OF INSULIN SECRETION OR INSULIN METABOLISM OCCUR IN CF PATIENTS?;135;0001
00042;WHAT ABNORMALITIES OF INSULIN SECRETION OR INSULIN METABOLISM OCCUR IN CF PATIENTS?;209;2222
00042;WHAT ABNORMALITIES OF INSULIN SECRETION OR INSULIN METABOLISM OCCUR IN CF PATIENTS?;245;1011
00042;WHAT ABNORMALITIES OF INSULIN SECRETION OR INSULIN METABOLISM OCCUR IN CF PATIENTS?;297;0001
00042;WHAT ABNORMALITIES OF INSULIN SECRETION OR INSULIN METABOLISM OCCUR IN CF PATIENTS?;301;1112
00042;WHAT ABNORMALITIES OF INSULIN SECRETION OR INSULIN METABOLISM OCCUR IN CF PATIENTS?;314;0100
00042;WHAT ABNORMALITIES OF INSULIN SECRETION OR INSULIN METABOLISM OCCUR IN CF PATIENTS?;317;2222
00042;WHAT ABNORMALITIES OF INSULIN SECRETION OR INSULIN METABOLISM OCCUR IN CF PATIENTS?;322;0001
00042;WHAT ABNORMALITIES OF INSULIN SECRETION OR INSULIN METABOLISM OCCUR IN CF PATIENTS?;337;1212
00042;WHAT ABNORMALITIES OF INSULIN SECRETION OR INSULIN METABOLISM OCCUR IN CF PATIENTS?;339;0100
00042;WHAT ABNORMALITIES OF INSULIN SECRETION OR INSULIN METABOLISM OCCUR IN CF PATIENTS?;370;0011
00042;WHAT ABNORMALITIES OF INSULIN SECRETION OR INSULIN METABOLISM OCCUR IN CF PATIENTS?;416;2212
00042;WHAT ABNORMALITIES OF INSULIN SECRETION OR INSULIN METABOLISM OCCUR IN CF PATIENTS?;434;0001
00042;WHAT ABNORMALITIES OF INSULIN SECRETION OR INSULIN METABOLISM OCCUR IN CF PATIENTS?;443;2220
00042;WHAT ABNORMALITIES OF INSULIN SECRETION OR INSULIN METABOLISM OCCUR IN CF PATIENTS?;489;0001
00042;WHAT ABNORMALITIES OF INSULIN SECRETION OR INSULIN METABOLISM OCCUR IN CF PATIENTS?;505;2221
00042;WHAT ABNORMALITIES OF INSULIN SECRETION OR INSULIN METABOLISM OCCUR IN CF PATIENTS?;509;1000
00042;WHAT ABNORMALITIES OF INSULIN SECRETION OR INSULIN METABOLISM OCCUR IN CF PATIENTS?;550;0001
00042;WHAT ABNORMALITIES OF INSULIN SECRETION OR INSULIN METABOLISM OCCUR IN CF PATIENTS?;585;2222
00042;WHAT ABNORMALITIES OF INSULIN SECRETION OR INSULIN METABOLISM OCCUR IN CF PATIENTS?;586;0001
00042;WHAT ABNORMALITIES OF INSULIN SECRETION OR INSULIN METABOLISM OCCUR IN CF PATIENTS?;601;0001
00042;WHAT ABNORMALITIES OF INSULIN SECRETION OR INSULIN METABOLISM OCCUR IN CF PATIENTS?;695;2222
00042;WHAT ABNORMALITIES OF INSULIN SECRETION OR INSULIN METABOLISM OCCUR IN CF PATIENTS?;719;0001
00042;WHAT ABNORMALITIES OF INSULIN SECRETION OR INSULIN METABOLISM OCCUR IN CF PATIENTS?;722;0002
00042;WHAT ABNORMALITIES OF INSULIN SECRETION OR INSULIN METABOLISM OCCUR IN CF PATIENTS?;724;0001
00042;WHAT ABNORMALITIES OF INSULIN SECRETION OR INSULIN METABOLISM OCCUR IN CF PATIENTS?;731;0001
00042;WHAT ABNORMALITIES OF INSULIN SECRETION OR INSULIN METABOLISM OCCUR IN CF PATIENTS?;763;0001
00042;WHAT ABNORMALITIES OF INSULIN SECRETION OR INSULIN METABOLISM OCCUR IN CF PATIENTS?;764;0001
00042;WHAT ABNORMALITIES OF INSULIN SECRETION OR INSULIN METABOLISM OCCUR IN CF PATIENTS?;770;0001
00042;WHAT ABNORMALITIES OF INSULIN SECRETION OR INSULIN METABOLISM OCCUR IN CF PATIENTS?;822;0001
00042;WHAT ABNORMALITIES OF INSULIN SECRETION OR INSULIN METABOLISM OCCUR IN CF PATIENTS?;837;0001
00042;WHAT ABNORMALITIES OF INSULIN SECRETION OR INSULIN METABOLISM OCCUR IN CF PATIENTS?;888;0001
00042;WHAT ABNORMALITIES OF INSULIN SECRETION OR INSULIN METABOLISM OCCUR IN CF PATIENTS?;931;1011
00042;WHAT ABNORMALITIES OF INSULIN SECRETION OR INSULIN METABOLISM OCCUR IN CF PATIENTS?;944;0001
00042;WHAT ABNORMALITIES OF INSULIN SECRETION OR INSULIN METABOLISM OCCUR IN CF PATIENTS?;1000;0001
00042;WHAT ABNORMALITIES OF INSULIN SECRETION OR INSULIN METABOLISM OCCUR IN CF PATIENTS?;1033;0001
00042;WHAT ABNORMALITIES OF INSULIN SECRETION OR INSULIN METABOLISM OCCUR IN CF PATIENTS?;1040;0001
00042;WHAT ABNORMALITIES OF INSULIN SECRETION OR INSULIN METABOLISM OCCUR IN CF PATIENTS?;1085;1011
00042;WHAT ABNORMALITIES OF INSULIN SECRETION OR INSULIN METABOLISM OCCUR IN CF PATIENTS?;1093;0001
00042;WHAT ABNORMALITIES OF INSULIN SECRETION OR INSULIN METABOLISM OCCUR IN CF PATIENTS?;1187;0001
00042;WHAT ABNORMALITIES OF INSULIN SECRETION OR INSULIN METABOLISM OCCUR IN CF PATIENTS?;1192;0001
00042;WHAT ABNORMALITIES OF INSULIN SECRETION OR INSULIN METABOLISM OCCUR IN CF PATIENTS?;1232;0001
00042;WHAT ABNORMALITIES OF INSULIN SECRETION OR INSULIN METABOLISM OCCUR IN CF PATIENTS?;1234;1001
00043;IS SALT (SODIUM AND/OR CHLORIDE) TRANSPORT/PERMEABILITY ABNORMAL IN CF?;3;0100
00043;IS SALT (SODIUM AND/OR CHLORIDE) TRANSPORT/PERMEABILITY ABNORMAL IN CF?;4;0100
00043;IS SALT (SODIUM AND/OR CHLORIDE) TRANSPORT/PERMEABILITY ABNORMAL IN CF?;28;0100
00043;IS SALT (SODIUM AND/OR CHLORIDE) TRANSPORT/PERMEABILITY ABNORMAL IN CF?;54;1121
00043;IS SALT (SODIUM AND/OR CHLORIDE) TRANSPORT/PERMEABILITY ABNORMAL IN CF?;65;0100
00043;IS SALT (SODIUM AND/OR CHLORIDE) TRANSPORT/PERMEABILITY ABNORMAL IN CF?;66;2221
00043;IS SALT (SODIUM AND/OR CHLORIDE) TRANSPORT/PERMEABILITY ABNORMAL IN CF?;91;0100
00043;IS SALT (SODIUM AND/OR CHLORIDE) TRANSPORT/PERMEABILITY ABNORMAL IN CF?;94;0100
00043;IS SALT (SODIUM AND/OR CHLORIDE) TRANSPORT/PERMEABILITY ABNORMAL IN CF?;119;0012
00043;IS SALT (SODIUM AND/OR CHLORIDE) TRANSPORT/PERMEABILITY ABNORMAL IN CF?;124;1212
00043;IS SALT (SODIUM AND/OR CHLORIDE) TRANSPORT/PERMEABILITY ABNORMAL IN CF?;125;2222
00043;IS SALT (SODIUM AND/OR CHLORIDE) TRANSPORT/PERMEABILITY ABNORMAL IN CF?;135;0001
00043;IS SALT (SODIUM AND/OR CHLORIDE) TRANSPORT/PERMEABILITY ABNORMAL IN CF?;137;0002
00043;IS SALT (SODIUM AND/OR CHLORIDE) TRANSPORT/PERMEABILITY ABNORMAL IN CF?;140;2222
00043;IS SALT (SODIUM AND/OR CHLORIDE) TRANSPORT/PERMEABILITY ABNORMAL IN CF?;147;0010
00043;IS SALT (SODIUM AND/OR CHLORIDE) TRANSPORT/PERMEABILITY ABNORMAL IN CF?;172;2222
00043;IS SALT (SODIUM AND/OR CHLORIDE) TRANSPORT/PERMEABILITY ABNORMAL IN CF?;173;1220
00043;IS SALT (SODIUM AND/OR CHLORIDE) TRANSPORT/PERMEABILITY ABNORMAL IN CF?;199;0001
00043;IS SALT (SODIUM AND/OR CHLORIDE) TRANSPORT/PERMEABILITY ABNORMAL IN CF?;221;0001
00043;IS SALT (SODIUM AND/OR CHLORIDE) TRANSPORT/PERMEABILITY ABNORMAL IN CF?;261;1100
00043;IS SALT (SODIUM AND/OR CHLORIDE) TRANSPORT/PERMEABILITY ABNORMAL IN CF?;294;0100
00043;IS SALT (SODIUM AND/OR CHLORIDE) TRANSPORT/PERMEABILITY ABNORMAL IN CF?;301;0001
00043;IS SALT (SODIUM AND/OR CHLORIDE) TRANSPORT/PERMEABILITY ABNORMAL IN CF?;302;1100
00043;IS SALT (SODIUM AND/OR CHLORIDE) TRANSPORT/PERMEABILITY ABNORMAL IN CF?;303;2120
00043;IS SALT (SODIUM AND/OR CHLORIDE) TRANSPORT/PERMEABILITY ABNORMAL IN CF?;307;0001
00043;IS SALT (SODIUM AND/OR CHLORIDE) TRANSPORT/PERMEABILITY ABNORMAL IN CF?;308;0100
00043;IS SALT (SODIUM AND/OR CHLORIDE) TRANSPORT/PERMEABILITY ABNORMAL IN CF?;311;0100
00043;IS SALT (SODIUM AND/OR CHLORIDE) TRANSPORT/PERMEABILITY ABNORMAL IN CF?;324;0100
00043;IS SALT (SODIUM AND/OR CHLORIDE) TRANSPORT/PERMEABILITY ABNORMAL IN CF?;334;0100
00043;IS SALT (SODIUM AND/OR CHLORIDE) TRANSPORT/PERMEABILITY ABNORMAL IN CF?;361;0100
00043;IS SALT (SODIUM AND/OR CHLORIDE) TRANSPORT/PERMEABILITY ABNORMAL IN CF?;370;1112
00043;IS SALT (SODIUM AND/OR CHLORIDE) TRANSPORT/PERMEABILITY ABNORMAL IN CF?;386;1000
00043;IS SALT (SODIUM AND/OR CHLORIDE) TRANSPORT/PERMEABILITY ABNORMAL IN CF?;392;0011
00043;IS SALT (SODIUM AND/OR CHLORIDE) TRANSPORT/PERMEABILITY ABNORMAL IN CF?;404;0100
00043;IS SALT (SODIUM AND/OR CHLORIDE) TRANSPORT/PERMEABILITY ABNORMAL IN CF?;418;2212
00043;IS SALT (SODIUM AND/OR CHLORIDE) TRANSPORT/PERMEABILITY ABNORMAL IN CF?;430;0001
00043;IS SALT (SODIUM AND/OR CHLORIDE) TRANSPORT/PERMEABILITY ABNORMAL IN CF?;440;2222
00043;IS SALT (SODIUM AND/OR CHLORIDE) TRANSPORT/PERMEABILITY ABNORMAL IN CF?;441;2222
00043;IS SALT (SODIUM AND/OR CHLORIDE) TRANSPORT/PERMEABILITY ABNORMAL IN CF?;461;1210
00043;IS SALT (SODIUM AND/OR CHLORIDE) TRANSPORT/PERMEABILITY ABNORMAL IN CF?;471;0001
00043;IS SALT (SODIUM AND/OR CHLORIDE) TRANSPORT/PERMEABILITY ABNORMAL IN CF?;484;0110
00043;IS SALT (SODIUM AND/OR CHLORIDE) TRANSPORT/PERMEABILITY ABNORMAL IN CF?;490;0001
00043;IS SALT (SODIUM AND/OR CHLORIDE) TRANSPORT/PERMEABILITY ABNORMAL IN CF?;493;0001
00043;IS SALT (SODIUM AND/OR CHLORIDE) TRANSPORT/PERMEABILITY ABNORMAL IN CF?;504;2222
00043;IS SALT (SODIUM AND/OR CHLORIDE) TRANSPORT/PERMEABILITY ABNORMAL IN CF?;505;0001
00043;IS SALT (SODIUM AND/OR CHLORIDE) TRANSPORT/PERMEABILITY ABNORMAL IN CF?;522;0101
00043;IS SALT (SODIUM AND/OR CHLORIDE) TRANSPORT/PERMEABILITY ABNORMAL IN CF?;526;1100
00043;IS SALT (SODIUM AND/OR CHLORIDE) TRANSPORT/PERMEABILITY ABNORMAL IN CF?;527;0100
00043;IS SALT (SODIUM AND/OR CHLORIDE) TRANSPORT/PERMEABILITY ABNORMAL IN CF?;560;0100
00043;IS SALT (SODIUM AND/OR CHLORIDE) TRANSPORT/PERMEABILITY ABNORMAL IN CF?;562;0100
00043;IS SALT (SODIUM AND/OR CHLORIDE) TRANSPORT/PERMEABILITY ABNORMAL IN CF?;563;0001
00043;IS SALT (SODIUM AND/OR CHLORIDE) TRANSPORT/PERMEABILITY ABNORMAL IN CF?;568;2222
00043;IS SALT (SODIUM AND/OR CHLORIDE) TRANSPORT/PERMEABILITY ABNORMAL IN CF?;570;0001
00043;IS SALT (SODIUM AND/OR CHLORIDE) TRANSPORT/PERMEABILITY ABNORMAL IN CF?;571;0001
00043;IS SALT (SODIUM AND/OR CHLORIDE) TRANSPORT/PERMEABILITY ABNORMAL IN CF?;575;0001
00043;IS SALT (SODIUM AND/OR CHLORIDE) TRANSPORT/PERMEABILITY ABNORMAL IN CF?;636;1000
00043;IS SALT (SODIUM AND/OR CHLORIDE) TRANSPORT/PERMEABILITY ABNORMAL IN CF?;655;0010
00043;IS SALT (SODIUM AND/OR CHLORIDE) TRANSPORT/PERMEABILITY ABNORMAL IN CF?;693;0001
00043;IS SALT (SODIUM AND/OR CHLORIDE) TRANSPORT/PERMEABILITY ABNORMAL IN CF?;694;0100
00043;IS SALT (SODIUM AND/OR CHLORIDE) TRANSPORT/PERMEABILITY ABNORMAL IN CF?;707;0001
00043;IS SALT (SODIUM AND/OR CHLORIDE) TRANSPORT/PERMEABILITY ABNORMAL IN CF?;714;1100
00043;IS SALT (SODIUM AND/OR CHLORIDE) TRANSPORT/PERMEABILITY ABNORMAL IN CF?;733;0001
00043;IS SALT (SODIUM AND/OR CHLORIDE) TRANSPORT/PERMEABILITY ABNORMAL IN CF?;737;0001
00043;IS SALT (SODIUM AND/OR CHLORIDE) TRANSPORT/PERMEABILITY ABNORMAL IN CF?;741;0001
00043;IS SALT (SODIUM AND/OR CHLORIDE) TRANSPORT/PERMEABILITY ABNORMAL IN CF?;758;0001
00043;IS SALT (SODIUM AND/OR CHLORIDE) TRANSPORT/PERMEABILITY ABNORMAL IN CF?;793;0100
00043;IS SALT (SODIUM AND/OR CHLORIDE) TRANSPORT/PERMEABILITY ABNORMAL IN CF?;795;0100
00043;IS SALT (SODIUM AND/OR CHLORIDE) TRANSPORT/PERMEABILITY ABNORMAL IN CF?;817;0100
00043;IS SALT (SODIUM AND/OR CHLORIDE) TRANSPORT/PERMEABILITY ABNORMAL IN CF?;818;0100
00043;IS SALT (SODIUM AND/OR CHLORIDE) TRANSPORT/PERMEABILITY ABNORMAL IN CF?;864;0001
00043;IS SALT (SODIUM AND/OR CHLORIDE) TRANSPORT/PERMEABILITY ABNORMAL IN CF?;889;0001
00043;IS SALT (SODIUM AND/OR CHLORIDE) TRANSPORT/PERMEABILITY ABNORMAL IN CF?;891;0011
00043;IS SALT (SODIUM AND/OR CHLORIDE) TRANSPORT/PERMEABILITY ABNORMAL IN CF?;913;0100
00043;IS SALT (SODIUM AND/OR CHLORIDE) TRANSPORT/PERMEABILITY ABNORMAL IN CF?;916;0100
00043;IS SALT (SODIUM AND/OR CHLORIDE) TRANSPORT/PERMEABILITY ABNORMAL IN CF?;918;1011
00043;IS SALT (SODIUM AND/OR CHLORIDE) TRANSPORT/PERMEABILITY ABNORMAL IN CF?;921;1102
00043;IS SALT (SODIUM AND/OR CHLORIDE) TRANSPORT/PERMEABILITY ABNORMAL IN CF?;944;0001
00043;IS SALT (SODIUM AND/OR CHLORIDE) TRANSPORT/PERMEABILITY ABNORMAL IN CF?;958;1002
00043;IS SALT (SODIUM AND/OR CHLORIDE) TRANSPORT/PERMEABILITY ABNORMAL IN CF?;960;2222
00043;IS SALT (SODIUM AND/OR CHLORIDE) TRANSPORT/PERMEABILITY ABNORMAL IN CF?;966;1001
00043;IS SALT (SODIUM AND/OR CHLORIDE) TRANSPORT/PERMEABILITY ABNORMAL IN CF?;967;1001
00043;IS SALT (SODIUM AND/OR CHLORIDE) TRANSPORT/PERMEABILITY ABNORMAL IN CF?;975;0002
00043;IS SALT (SODIUM AND/OR CHLORIDE) TRANSPORT/PERMEABILITY ABNORMAL IN CF?;982;0001
00043;IS SALT (SODIUM AND/OR CHLORIDE) TRANSPORT/PERMEABILITY ABNORMAL IN CF?;997;0010
00043;IS SALT (SODIUM AND/OR CHLORIDE) TRANSPORT/PERMEABILITY ABNORMAL IN CF?;1000;0002
00043;IS SALT (SODIUM AND/OR CHLORIDE) TRANSPORT/PERMEABILITY ABNORMAL IN CF?;1080;0001
00043;IS SALT (SODIUM AND/OR CHLORIDE) TRANSPORT/PERMEABILITY ABNORMAL IN CF?;1093;0001
00043;IS SALT (SODIUM AND/OR CHLORIDE) TRANSPORT/PERMEABILITY ABNORMAL IN CF?;1094;0001
00043;IS SALT (SODIUM AND/OR CHLORIDE) TRANSPORT/PERMEABILITY ABNORMAL IN CF?;1121;0001
00043;IS SALT (SODIUM AND/OR CHLORIDE) TRANSPORT/PERMEABILITY ABNORMAL IN CF?;1156;0001
00043;IS SALT (SODIUM AND/OR CHLORIDE) TRANSPORT/PERMEABILITY ABNORMAL IN CF?;1167;0011
00043;IS SALT (SODIUM AND/OR CHLORIDE) TRANSPORT/PERMEABILITY ABNORMAL IN CF?;1172;0011
00043;IS SALT (SODIUM AND/OR CHLORIDE) TRANSPORT/PERMEABILITY ABNORMAL IN CF?;1184;0010
00043;IS SALT (SODIUM AND/OR CHLORIDE) TRANSPORT/PERMEABILITY ABNORMAL IN CF?;1185;0001
00043;IS SALT (SODIUM AND/OR CHLORIDE) TRANSPORT/PERMEABILITY ABNORMAL IN CF?;1199;1002
00043;IS SALT (SODIUM AND/OR CHLORIDE) TRANSPORT/PERMEABILITY ABNORMAL IN CF?;1200;2211
00043;IS SALT (SODIUM AND/OR CHLORIDE) TRANSPORT/PERMEABILITY ABNORMAL IN CF?;1209;0001
00043;IS SALT (SODIUM AND/OR CHLORIDE) TRANSPORT/PERMEABILITY ABNORMAL IN CF?;1216;0010
00044;WHAT STRUCTURAL OR ENZYMATIC DIFFERENCES ARE THERE BETWEEN FIBROBLASTS FROM CF PATIENTS AND NON-CF PATIENTS?;44;2222
00044;WHAT STRUCTURAL OR ENZYMATIC DIFFERENCES ARE THERE BETWEEN FIBROBLASTS FROM CF PATIENTS AND NON-CF PATIENTS?;45;1000
00044;WHAT STRUCTURAL OR ENZYMATIC DIFFERENCES ARE THERE BETWEEN FIBROBLASTS FROM CF PATIENTS AND NON-CF PATIENTS?;53;2222
00044;WHAT STRUCTURAL OR ENZYMATIC DIFFERENCES ARE THERE BETWEEN FIBROBLASTS FROM CF PATIENTS AND NON-CF PATIENTS?;67;1211
00044;WHAT STRUCTURAL OR ENZYMATIC DIFFERENCES ARE THERE BETWEEN FIBROBLASTS FROM CF PATIENTS AND NON-CF PATIENTS?;72;2112
00044;WHAT STRUCTURAL OR ENZYMATIC DIFFERENCES ARE THERE BETWEEN FIBROBLASTS FROM CF PATIENTS AND NON-CF PATIENTS?;74;2222
00044;WHAT STRUCTURAL OR ENZYMATIC DIFFERENCES ARE THERE BETWEEN FIBROBLASTS FROM CF PATIENTS AND NON-CF PATIENTS?;83;1001
00044;WHAT STRUCTURAL OR ENZYMATIC DIFFERENCES ARE THERE BETWEEN FIBROBLASTS FROM CF PATIENTS AND NON-CF PATIENTS?;84;1112
00044;WHAT STRUCTURAL OR ENZYMATIC DIFFERENCES ARE THERE BETWEEN FIBROBLASTS FROM CF PATIENTS AND NON-CF PATIENTS?;106;1001
00044;WHAT STRUCTURAL OR ENZYMATIC DIFFERENCES ARE THERE BETWEEN FIBROBLASTS FROM CF PATIENTS AND NON-CF PATIENTS?;108;1000
00044;WHAT STRUCTURAL OR ENZYMATIC DIFFERENCES ARE THERE BETWEEN FIBROBLASTS FROM CF PATIENTS AND NON-CF PATIENTS?;118;1000
00044;WHAT STRUCTURAL OR ENZYMATIC DIFFERENCES ARE THERE BETWEEN FIBROBLASTS FROM CF PATIENTS AND NON-CF PATIENTS?;121;1000
00044;WHAT STRUCTURAL OR ENZYMATIC DIFFERENCES ARE THERE BETWEEN FIBROBLASTS FROM CF PATIENTS AND NON-CF PATIENTS?;122;0011
00044;WHAT STRUCTURAL OR ENZYMATIC DIFFERENCES ARE THERE BETWEEN FIBROBLASTS FROM CF PATIENTS AND NON-CF PATIENTS?;124;2222
00044;WHAT STRUCTURAL OR ENZYMATIC DIFFERENCES ARE THERE BETWEEN FIBROBLASTS FROM CF PATIENTS AND NON-CF PATIENTS?;125;0100
00044;WHAT STRUCTURAL OR ENZYMATIC DIFFERENCES ARE THERE BETWEEN FIBROBLASTS FROM CF PATIENTS AND NON-CF PATIENTS?;135;0001
00044;WHAT STRUCTURAL OR ENZYMATIC DIFFERENCES ARE THERE BETWEEN FIBROBLASTS FROM CF PATIENTS AND NON-CF PATIENTS?;138;0002
00044;WHAT STRUCTURAL OR ENZYMATIC DIFFERENCES ARE THERE BETWEEN FIBROBLASTS FROM CF PATIENTS AND NON-CF PATIENTS?;142;0010
00044;WHAT STRUCTURAL OR ENZYMATIC DIFFERENCES ARE THERE BETWEEN FIBROBLASTS FROM CF PATIENTS AND NON-CF PATIENTS?;143;2212
00044;WHAT STRUCTURAL OR ENZYMATIC DIFFERENCES ARE THERE BETWEEN FIBROBLASTS FROM CF PATIENTS AND NON-CF PATIENTS?;154;2212
00044;WHAT STRUCTURAL OR ENZYMATIC DIFFERENCES ARE THERE BETWEEN FIBROBLASTS FROM CF PATIENTS AND NON-CF PATIENTS?;166;1000
00044;WHAT STRUCTURAL OR ENZYMATIC DIFFERENCES ARE THERE BETWEEN FIBROBLASTS FROM CF PATIENTS AND NON-CF PATIENTS?;171;2212
00044;WHAT STRUCTURAL OR ENZYMATIC DIFFERENCES ARE THERE BETWEEN FIBROBLASTS FROM CF PATIENTS AND NON-CF PATIENTS?;172;1000
00044;WHAT STRUCTURAL OR ENZYMATIC DIFFERENCES ARE THERE BETWEEN FIBROBLASTS FROM CF PATIENTS AND NON-CF PATIENTS?;190;2222
00044;WHAT STRUCTURAL OR ENZYMATIC DIFFERENCES ARE THERE BETWEEN FIBROBLASTS FROM CF PATIENTS AND NON-CF PATIENTS?;235;2210
00044;WHAT STRUCTURAL OR ENZYMATIC DIFFERENCES ARE THERE BETWEEN FIBROBLASTS FROM CF PATIENTS AND NON-CF PATIENTS?;236;2211
00044;WHAT STRUCTURAL OR ENZYMATIC DIFFERENCES ARE THERE BETWEEN FIBROBLASTS FROM CF PATIENTS AND NON-CF PATIENTS?;242;2210
00044;WHAT STRUCTURAL OR ENZYMATIC DIFFERENCES ARE THERE BETWEEN FIBROBLASTS FROM CF PATIENTS AND NON-CF PATIENTS?;243;2210
00044;WHAT STRUCTURAL OR ENZYMATIC DIFFERENCES ARE THERE BETWEEN FIBROBLASTS FROM CF PATIENTS AND NON-CF PATIENTS?;244;2220
00044;WHAT STRUCTURAL OR ENZYMATIC DIFFERENCES ARE THERE BETWEEN FIBROBLASTS FROM CF PATIENTS AND NON-CF PATIENTS?;257;1001
00044;WHAT STRUCTURAL OR ENZYMATIC DIFFERENCES ARE THERE BETWEEN FIBROBLASTS FROM CF PATIENTS AND NON-CF PATIENTS?;264;2110
00044;WHAT STRUCTURAL OR ENZYMATIC DIFFERENCES ARE THERE BETWEEN FIBROBLASTS FROM CF PATIENTS AND NON-CF PATIENTS?;269;2212
00044;WHAT STRUCTURAL OR ENZYMATIC DIFFERENCES ARE THERE BETWEEN FIBROBLASTS FROM CF PATIENTS AND NON-CF PATIENTS?;276;0001
00044;WHAT STRUCTURAL OR ENZYMATIC DIFFERENCES ARE THERE BETWEEN FIBROBLASTS FROM CF PATIENTS AND NON-CF PATIENTS?;297;0001
00044;WHAT STRUCTURAL OR ENZYMATIC DIFFERENCES ARE THERE BETWEEN FIBROBLASTS FROM CF PATIENTS AND NON-CF PATIENTS?;310;0100
00044;WHAT STRUCTURAL OR ENZYMATIC DIFFERENCES ARE THERE BETWEEN FIBROBLASTS FROM CF PATIENTS AND NON-CF PATIENTS?;312;2222
00044;WHAT STRUCTURAL OR ENZYMATIC DIFFERENCES ARE THERE BETWEEN FIBROBLASTS FROM CF PATIENTS AND NON-CF PATIENTS?;325;1111
00044;WHAT STRUCTURAL OR ENZYMATIC DIFFERENCES ARE THERE BETWEEN FIBROBLASTS FROM CF PATIENTS AND NON-CF PATIENTS?;336;2111
00044;WHAT STRUCTURAL OR ENZYMATIC DIFFERENCES ARE THERE BETWEEN FIBROBLASTS FROM CF PATIENTS AND NON-CF PATIENTS?;360;1001
00044;WHAT STRUCTURAL OR ENZYMATIC DIFFERENCES ARE THERE BETWEEN FIBROBLASTS FROM CF PATIENTS AND NON-CF PATIENTS?;370;1000
00044;WHAT STRUCTURAL OR ENZYMATIC DIFFERENCES ARE THERE BETWEEN FIBROBLASTS FROM CF PATIENTS AND NON-CF PATIENTS?;371;0001
00044;WHAT STRUCTURAL OR ENZYMATIC DIFFERENCES ARE THERE BETWEEN FIBROBLASTS FROM CF PATIENTS AND NON-CF PATIENTS?;381;0001
00044;WHAT STRUCTURAL OR ENZYMATIC DIFFERENCES ARE THERE BETWEEN FIBROBLASTS FROM CF PATIENTS AND NON-CF PATIENTS?;386;2212
00044;WHAT STRUCTURAL OR ENZYMATIC DIFFERENCES ARE THERE BETWEEN FIBROBLASTS FROM CF PATIENTS AND NON-CF PATIENTS?;390;2212
00044;WHAT STRUCTURAL OR ENZYMATIC DIFFERENCES ARE THERE BETWEEN FIBROBLASTS FROM CF PATIENTS AND NON-CF PATIENTS?;392;0001
00044;WHAT STRUCTURAL OR ENZYMATIC DIFFERENCES ARE THERE BETWEEN FIBROBLASTS FROM CF PATIENTS AND NON-CF PATIENTS?;399;1211
00044;WHAT STRUCTURAL OR ENZYMATIC DIFFERENCES ARE THERE BETWEEN FIBROBLASTS FROM CF PATIENTS AND NON-CF PATIENTS?;409;0001
00044;WHAT STRUCTURAL OR ENZYMATIC DIFFERENCES ARE THERE BETWEEN FIBROBLASTS FROM CF PATIENTS AND NON-CF PATIENTS?;411;2222
00044;WHAT STRUCTURAL OR ENZYMATIC DIFFERENCES ARE THERE BETWEEN FIBROBLASTS FROM CF PATIENTS AND NON-CF PATIENTS?;415;2120
00044;WHAT STRUCTURAL OR ENZYMATIC DIFFERENCES ARE THERE BETWEEN FIBROBLASTS FROM CF PATIENTS AND NON-CF PATIENTS?;430;1001
00044;WHAT STRUCTURAL OR ENZYMATIC DIFFERENCES ARE THERE BETWEEN FIBROBLASTS FROM CF PATIENTS AND NON-CF PATIENTS?;435;0001
00044;WHAT STRUCTURAL OR ENZYMATIC DIFFERENCES ARE THERE BETWEEN FIBROBLASTS FROM CF PATIENTS AND NON-CF PATIENTS?;436;2220
00044;WHAT STRUCTURAL OR ENZYMATIC DIFFERENCES ARE THERE BETWEEN FIBROBLASTS FROM CF PATIENTS AND NON-CF PATIENTS?;453;2222
00044;WHAT STRUCTURAL OR ENZYMATIC DIFFERENCES ARE THERE BETWEEN FIBROBLASTS FROM CF PATIENTS AND NON-CF PATIENTS?;465;0001
00044;WHAT STRUCTURAL OR ENZYMATIC DIFFERENCES ARE THERE BETWEEN FIBROBLASTS FROM CF PATIENTS AND NON-CF PATIENTS?;493;0101
00044;WHAT STRUCTURAL OR ENZYMATIC DIFFERENCES ARE THERE BETWEEN FIBROBLASTS FROM CF PATIENTS AND NON-CF PATIENTS?;495;2222
00044;WHAT STRUCTURAL OR ENZYMATIC DIFFERENCES ARE THERE BETWEEN FIBROBLASTS FROM CF PATIENTS AND NON-CF PATIENTS?;503;0001
00044;WHAT STRUCTURAL OR ENZYMATIC DIFFERENCES ARE THERE BETWEEN FIBROBLASTS FROM CF PATIENTS AND NON-CF PATIENTS?;504;2222
00044;WHAT STRUCTURAL OR ENZYMATIC DIFFERENCES ARE THERE BETWEEN FIBROBLASTS FROM CF PATIENTS AND NON-CF PATIENTS?;523;1001
00044;WHAT STRUCTURAL OR ENZYMATIC DIFFERENCES ARE THERE BETWEEN FIBROBLASTS FROM CF PATIENTS AND NON-CF PATIENTS?;528;2212
00044;WHAT STRUCTURAL OR ENZYMATIC DIFFERENCES ARE THERE BETWEEN FIBROBLASTS FROM CF PATIENTS AND NON-CF PATIENTS?;538;0001
00044;WHAT STRUCTURAL OR ENZYMATIC DIFFERENCES ARE THERE BETWEEN FIBROBLASTS FROM CF PATIENTS AND NON-CF PATIENTS?;548;2222
00044;WHAT STRUCTURAL OR ENZYMATIC DIFFERENCES ARE THERE BETWEEN FIBROBLASTS FROM CF PATIENTS AND NON-CF PATIENTS?;561;2212
00044;WHAT STRUCTURAL OR ENZYMATIC DIFFERENCES ARE THERE BETWEEN FIBROBLASTS FROM CF PATIENTS AND NON-CF PATIENTS?;563;0001
00044;WHAT STRUCTURAL OR ENZYMATIC DIFFERENCES ARE THERE BETWEEN FIBROBLASTS FROM CF PATIENTS AND NON-CF PATIENTS?;566;2222
00044;WHAT STRUCTURAL OR ENZYMATIC DIFFERENCES ARE THERE BETWEEN FIBROBLASTS FROM CF PATIENTS AND NON-CF PATIENTS?;567;2222
00044;WHAT STRUCTURAL OR ENZYMATIC DIFFERENCES ARE THERE BETWEEN FIBROBLASTS FROM CF PATIENTS AND NON-CF PATIENTS?;568;2222
00044;WHAT STRUCTURAL OR ENZYMATIC DIFFERENCES ARE THERE BETWEEN FIBROBLASTS FROM CF PATIENTS AND NON-CF PATIENTS?;569;2220
00044;WHAT STRUCTURAL OR ENZYMATIC DIFFERENCES ARE THERE BETWEEN FIBROBLASTS FROM CF PATIENTS AND NON-CF PATIENTS?;570;1120
00044;WHAT STRUCTURAL OR ENZYMATIC DIFFERENCES ARE THERE BETWEEN FIBROBLASTS FROM CF PATIENTS AND NON-CF PATIENTS?;572;1210
00044;WHAT STRUCTURAL OR ENZYMATIC DIFFERENCES ARE THERE BETWEEN FIBROBLASTS FROM CF PATIENTS AND NON-CF PATIENTS?;574;2222
00044;WHAT STRUCTURAL OR ENZYMATIC DIFFERENCES ARE THERE BETWEEN FIBROBLASTS FROM CF PATIENTS AND NON-CF PATIENTS?;575;2222
00044;WHAT STRUCTURAL OR ENZYMATIC DIFFERENCES ARE THERE BETWEEN FIBROBLASTS FROM CF PATIENTS AND NON-CF PATIENTS?;576;0010
00044;WHAT STRUCTURAL OR ENZYMATIC DIFFERENCES ARE THERE BETWEEN FIBROBLASTS FROM CF PATIENTS AND NON-CF PATIENTS?;590;0001
00044;WHAT STRUCTURAL OR ENZYMATIC DIFFERENCES ARE THERE BETWEEN FIBROBLASTS FROM CF PATIENTS AND NON-CF PATIENTS?;608;0001
00044;WHAT STRUCTURAL OR ENZYMATIC DIFFERENCES ARE THERE BETWEEN FIBROBLASTS FROM CF PATIENTS AND NON-CF PATIENTS?;621;2222
00044;WHAT STRUCTURAL OR ENZYMATIC DIFFERENCES ARE THERE BETWEEN FIBROBLASTS FROM CF PATIENTS AND NON-CF PATIENTS?;622;2222
00044;WHAT STRUCTURAL OR ENZYMATIC DIFFERENCES ARE THERE BETWEEN FIBROBLASTS FROM CF PATIENTS AND NON-CF PATIENTS?;623;2222
00044;WHAT STRUCTURAL OR ENZYMATIC DIFFERENCES ARE THERE BETWEEN FIBROBLASTS FROM CF PATIENTS AND NON-CF PATIENTS?;624;2212
00044;WHAT STRUCTURAL OR ENZYMATIC DIFFERENCES ARE THERE BETWEEN FIBROBLASTS FROM CF PATIENTS AND NON-CF PATIENTS?;625;2222
00044;WHAT STRUCTURAL OR ENZYMATIC DIFFERENCES ARE THERE BETWEEN FIBROBLASTS FROM CF PATIENTS AND NON-CF PATIENTS?;634;2222
00044;WHAT STRUCTURAL OR ENZYMATIC DIFFERENCES ARE THERE BETWEEN FIBROBLASTS FROM CF PATIENTS AND NON-CF PATIENTS?;636;2222
00044;WHAT STRUCTURAL OR ENZYMATIC DIFFERENCES ARE THERE BETWEEN FIBROBLASTS FROM CF PATIENTS AND NON-CF PATIENTS?;645;0101
00044;WHAT STRUCTURAL OR ENZYMATIC DIFFERENCES ARE THERE BETWEEN FIBROBLASTS FROM CF PATIENTS AND NON-CF PATIENTS?;647;1212
00044;WHAT STRUCTURAL OR ENZYMATIC DIFFERENCES ARE THERE BETWEEN FIBROBLASTS FROM CF PATIENTS AND NON-CF PATIENTS?;655;2222
00044;WHAT STRUCTURAL OR ENZYMATIC DIFFERENCES ARE THERE BETWEEN FIBROBLASTS FROM CF PATIENTS AND NON-CF PATIENTS?;666;1211
00044;WHAT STRUCTURAL OR ENZYMATIC DIFFERENCES ARE THERE BETWEEN FIBROBLASTS FROM CF PATIENTS AND NON-CF PATIENTS?;691;2222
00044;WHAT STRUCTURAL OR ENZYMATIC DIFFERENCES ARE THERE BETWEEN FIBROBLASTS FROM CF PATIENTS AND NON-CF PATIENTS?;702;2222
00044;WHAT STRUCTURAL OR ENZYMATIC DIFFERENCES ARE THERE BETWEEN FIBROBLASTS FROM CF PATIENTS AND NON-CF PATIENTS?;737;2222
00044;WHAT STRUCTURAL OR ENZYMATIC DIFFERENCES ARE THERE BETWEEN FIBROBLASTS FROM CF PATIENTS AND NON-CF PATIENTS?;743;2222
00044;WHAT STRUCTURAL OR ENZYMATIC DIFFERENCES ARE THERE BETWEEN FIBROBLASTS FROM CF PATIENTS AND NON-CF PATIENTS?;747;0001
00044;WHAT STRUCTURAL OR ENZYMATIC DIFFERENCES ARE THERE BETWEEN FIBROBLASTS FROM CF PATIENTS AND NON-CF PATIENTS?;750;2222
00044;WHAT STRUCTURAL OR ENZYMATIC DIFFERENCES ARE THERE BETWEEN FIBROBLASTS FROM CF PATIENTS AND NON-CF PATIENTS?;765;2222
00044;WHAT STRUCTURAL OR ENZYMATIC DIFFERENCES ARE THERE BETWEEN FIBROBLASTS FROM CF PATIENTS AND NON-CF PATIENTS?;766;2222
00044;WHAT STRUCTURAL OR ENZYMATIC DIFFERENCES ARE THERE BETWEEN FIBROBLASTS FROM CF PATIENTS AND NON-CF PATIENTS?;767;0001
00044;WHAT STRUCTURAL OR ENZYMATIC DIFFERENCES ARE THERE BETWEEN FIBROBLASTS FROM CF PATIENTS AND NON-CF PATIENTS?;786;2222
00044;WHAT STRUCTURAL OR ENZYMATIC DIFFERENCES ARE THERE BETWEEN FIBROBLASTS FROM CF PATIENTS AND NON-CF PATIENTS?;840;2222
00044;WHAT STRUCTURAL OR ENZYMATIC DIFFERENCES ARE THERE BETWEEN FIBROBLASTS FROM CF PATIENTS AND NON-CF PATIENTS?;841;1101
00044;WHAT STRUCTURAL OR ENZYMATIC DIFFERENCES ARE THERE BETWEEN FIBROBLASTS FROM CF PATIENTS AND NON-CF PATIENTS?;847;2222
00044;WHAT STRUCTURAL OR ENZYMATIC DIFFERENCES ARE THERE BETWEEN FIBROBLASTS FROM CF PATIENTS AND NON-CF PATIENTS?;850;2222
00044;WHAT STRUCTURAL OR ENZYMATIC DIFFERENCES ARE THERE BETWEEN FIBROBLASTS FROM CF PATIENTS AND NON-CF PATIENTS?;856;0001
00044;WHAT STRUCTURAL OR ENZYMATIC DIFFERENCES ARE THERE BETWEEN FIBROBLASTS FROM CF PATIENTS AND NON-CF PATIENTS?;858;2121
00044;WHAT STRUCTURAL OR ENZYMATIC DIFFERENCES ARE THERE BETWEEN FIBROBLASTS FROM CF PATIENTS AND NON-CF PATIENTS?;862;0001
00044;WHAT STRUCTURAL OR ENZYMATIC DIFFERENCES ARE THERE BETWEEN FIBROBLASTS FROM CF PATIENTS AND NON-CF PATIENTS?;873;2222
00044;WHAT STRUCTURAL OR ENZYMATIC DIFFERENCES ARE THERE BETWEEN FIBROBLASTS FROM CF PATIENTS AND NON-CF PATIENTS?;875;0001
00044;WHAT STRUCTURAL OR ENZYMATIC DIFFERENCES ARE THERE BETWEEN FIBROBLASTS FROM CF PATIENTS AND NON-CF PATIENTS?;951;2222
00044;WHAT STRUCTURAL OR ENZYMATIC DIFFERENCES ARE THERE BETWEEN FIBROBLASTS FROM CF PATIENTS AND NON-CF PATIENTS?;953;2222
00044;WHAT STRUCTURAL OR ENZYMATIC DIFFERENCES ARE THERE BETWEEN FIBROBLASTS FROM CF PATIENTS AND NON-CF PATIENTS?;961;1000
00044;WHAT STRUCTURAL OR ENZYMATIC DIFFERENCES ARE THERE BETWEEN FIBROBLASTS FROM CF PATIENTS AND NON-CF PATIENTS?;967;2222
00044;WHAT STRUCTURAL OR ENZYMATIC DIFFERENCES ARE THERE BETWEEN FIBROBLASTS FROM CF PATIENTS AND NON-CF PATIENTS?;971;1221
00044;WHAT STRUCTURAL OR ENZYMATIC DIFFERENCES ARE THERE BETWEEN FIBROBLASTS FROM CF PATIENTS AND NON-CF PATIENTS?;973;2222
00044;WHAT STRUCTURAL OR ENZYMATIC DIFFERENCES ARE THERE BETWEEN FIBROBLASTS FROM CF PATIENTS AND NON-CF PATIENTS?;1024;2222
00044;WHAT STRUCTURAL OR ENZYMATIC DIFFERENCES ARE THERE BETWEEN FIBROBLASTS FROM CF PATIENTS AND NON-CF PATIENTS?;1029;2222
00044;WHAT STRUCTURAL OR ENZYMATIC DIFFERENCES ARE THERE BETWEEN FIBROBLASTS FROM CF PATIENTS AND NON-CF PATIENTS?;1030;2222
00044;WHAT STRUCTURAL OR ENZYMATIC DIFFERENCES ARE THERE BETWEEN FIBROBLASTS FROM CF PATIENTS AND NON-CF PATIENTS?;1053;2222
00044;WHAT STRUCTURAL OR ENZYMATIC DIFFERENCES ARE THERE BETWEEN FIBROBLASTS FROM CF PATIENTS AND NON-CF PATIENTS?;1054;0001
00044;WHAT STRUCTURAL OR ENZYMATIC DIFFERENCES ARE THERE BETWEEN FIBROBLASTS FROM CF PATIENTS AND NON-CF PATIENTS?;1055;2222
00044;WHAT STRUCTURAL OR ENZYMATIC DIFFERENCES ARE THERE BETWEEN FIBROBLASTS FROM CF PATIENTS AND NON-CF PATIENTS?;1057;1012
00044;WHAT STRUCTURAL OR ENZYMATIC DIFFERENCES ARE THERE BETWEEN FIBROBLASTS FROM CF PATIENTS AND NON-CF PATIENTS?;1059;2222
00044;WHAT STRUCTURAL OR ENZYMATIC DIFFERENCES ARE THERE BETWEEN FIBROBLASTS FROM CF PATIENTS AND NON-CF PATIENTS?;1070;0001
00044;WHAT STRUCTURAL OR ENZYMATIC DIFFERENCES ARE THERE BETWEEN FIBROBLASTS FROM CF PATIENTS AND NON-CF PATIENTS?;1072;1212
00044;WHAT STRUCTURAL OR ENZYMATIC DIFFERENCES ARE THERE BETWEEN FIBROBLASTS FROM CF PATIENTS AND NON-CF PATIENTS?;1130;0002
00044;WHAT STRUCTURAL OR ENZYMATIC DIFFERENCES ARE THERE BETWEEN FIBROBLASTS FROM CF PATIENTS AND NON-CF PATIENTS?;1136;0001
00044;WHAT STRUCTURAL OR ENZYMATIC DIFFERENCES ARE THERE BETWEEN FIBROBLASTS FROM CF PATIENTS AND NON-CF PATIENTS?;1139;0001
00044;WHAT STRUCTURAL OR ENZYMATIC DIFFERENCES ARE THERE BETWEEN FIBROBLASTS FROM CF PATIENTS AND NON-CF PATIENTS?;1142;1002
00044;WHAT STRUCTURAL OR ENZYMATIC DIFFERENCES ARE THERE BETWEEN FIBROBLASTS FROM CF PATIENTS AND NON-CF PATIENTS?;1144;0001
00044;WHAT STRUCTURAL OR ENZYMATIC DIFFERENCES ARE THERE BETWEEN FIBROBLASTS FROM CF PATIENTS AND NON-CF PATIENTS?;1146;1220
00044;WHAT STRUCTURAL OR ENZYMATIC DIFFERENCES ARE THERE BETWEEN FIBROBLASTS FROM CF PATIENTS AND NON-CF PATIENTS?;1148;1222
00044;WHAT STRUCTURAL OR ENZYMATIC DIFFERENCES ARE THERE BETWEEN FIBROBLASTS FROM CF PATIENTS AND NON-CF PATIENTS?;1156;1221
00044;WHAT STRUCTURAL OR ENZYMATIC DIFFERENCES ARE THERE BETWEEN FIBROBLASTS FROM CF PATIENTS AND NON-CF PATIENTS?;1157;0001
00044;WHAT STRUCTURAL OR ENZYMATIC DIFFERENCES ARE THERE BETWEEN FIBROBLASTS FROM CF PATIENTS AND NON-CF PATIENTS?;1160;2122
00044;WHAT STRUCTURAL OR ENZYMATIC DIFFERENCES ARE THERE BETWEEN FIBROBLASTS FROM CF PATIENTS AND NON-CF PATIENTS?;1185;2221
00044;WHAT STRUCTURAL OR ENZYMATIC DIFFERENCES ARE THERE BETWEEN FIBROBLASTS FROM CF PATIENTS AND NON-CF PATIENTS?;1196;0001
00044;WHAT STRUCTURAL OR ENZYMATIC DIFFERENCES ARE THERE BETWEEN FIBROBLASTS FROM CF PATIENTS AND NON-CF PATIENTS?;1201;2222
00044;WHAT STRUCTURAL OR ENZYMATIC DIFFERENCES ARE THERE BETWEEN FIBROBLASTS FROM CF PATIENTS AND NON-CF PATIENTS?;1202;2222
00044;WHAT STRUCTURAL OR ENZYMATIC DIFFERENCES ARE THERE BETWEEN FIBROBLASTS FROM CF PATIENTS AND NON-CF PATIENTS?;1210;0001
00044;WHAT STRUCTURAL OR ENZYMATIC DIFFERENCES ARE THERE BETWEEN FIBROBLASTS FROM CF PATIENTS AND NON-CF PATIENTS?;1212;0001
00044;WHAT STRUCTURAL OR ENZYMATIC DIFFERENCES ARE THERE BETWEEN FIBROBLASTS FROM CF PATIENTS AND NON-CF PATIENTS?;1222;2222
00044;WHAT STRUCTURAL OR ENZYMATIC DIFFERENCES ARE THERE BETWEEN FIBROBLASTS FROM CF PATIENTS AND NON-CF PATIENTS?;1230;2211
00044;WHAT STRUCTURAL OR ENZYMATIC DIFFERENCES ARE THERE BETWEEN FIBROBLASTS FROM CF PATIENTS AND NON-CF PATIENTS?;1231;1101
00045;WHAT ABNORMALITIES OF PROSTAGLANDIN METABOLISM HAVE BEEN DESCRIBED IN CF PATIENTS?;278;0100
00045;WHAT ABNORMALITIES OF PROSTAGLANDIN METABOLISM HAVE BEEN DESCRIBED IN CF PATIENTS?;283;0100
00045;WHAT ABNORMALITIES OF PROSTAGLANDIN METABOLISM HAVE BEEN DESCRIBED IN CF PATIENTS?;286;0100
00045;WHAT ABNORMALITIES OF PROSTAGLANDIN METABOLISM HAVE BEEN DESCRIBED IN CF PATIENTS?;287;0101
00045;WHAT ABNORMALITIES OF PROSTAGLANDIN METABOLISM HAVE BEEN DESCRIBED IN CF PATIENTS?;288;0100
00045;WHAT ABNORMALITIES OF PROSTAGLANDIN METABOLISM HAVE BEEN DESCRIBED IN CF PATIENTS?;289;1220
00045;WHAT ABNORMALITIES OF PROSTAGLANDIN METABOLISM HAVE BEEN DESCRIBED IN CF PATIENTS?;290;1110
00045;WHAT ABNORMALITIES OF PROSTAGLANDIN METABOLISM HAVE BEEN DESCRIBED IN CF PATIENTS?;292;2210
00045;WHAT ABNORMALITIES OF PROSTAGLANDIN METABOLISM HAVE BEEN DESCRIBED IN CF PATIENTS?;293;1220
00045;WHAT ABNORMALITIES OF PROSTAGLANDIN METABOLISM HAVE BEEN DESCRIBED IN CF PATIENTS?;338;1212
00045;WHAT ABNORMALITIES OF PROSTAGLANDIN METABOLISM HAVE BEEN DESCRIBED IN CF PATIENTS?;538;2210
00045;WHAT ABNORMALITIES OF PROSTAGLANDIN METABOLISM HAVE BEEN DESCRIBED IN CF PATIENTS?;540;1000
00045;WHAT ABNORMALITIES OF PROSTAGLANDIN METABOLISM HAVE BEEN DESCRIBED IN CF PATIENTS?;715;0100
00045;WHAT ABNORMALITIES OF PROSTAGLANDIN METABOLISM HAVE BEEN DESCRIBED IN CF PATIENTS?;758;1010
00045;WHAT ABNORMALITIES OF PROSTAGLANDIN METABOLISM HAVE BEEN DESCRIBED IN CF PATIENTS?;803;2212
00045;WHAT ABNORMALITIES OF PROSTAGLANDIN METABOLISM HAVE BEEN DESCRIBED IN CF PATIENTS?;919;2212
00045;WHAT ABNORMALITIES OF PROSTAGLANDIN METABOLISM HAVE BEEN DESCRIBED IN CF PATIENTS?;924;2212
00045;WHAT ABNORMALITIES OF PROSTAGLANDIN METABOLISM HAVE BEEN DESCRIBED IN CF PATIENTS?;1050;0010
00045;WHAT ABNORMALITIES OF PROSTAGLANDIN METABOLISM HAVE BEEN DESCRIBED IN CF PATIENTS?;1159;2222
00045;WHAT ABNORMALITIES OF PROSTAGLANDIN METABOLISM HAVE BEEN DESCRIBED IN CF PATIENTS?;1168;0010
00046;WHAT ARE THE PROPERTIES AND ACTIVITY OF GALACTOSYLTRANSFERASE ENZYMES FROM CF PATIENTS?;51;2222
00046;WHAT ARE THE PROPERTIES AND ACTIVITY OF GALACTOSYLTRANSFERASE ENZYMES FROM CF PATIENTS?;53;2222
00046;WHAT ARE THE PROPERTIES AND ACTIVITY OF GALACTOSYLTRANSFERASE ENZYMES FROM CF PATIENTS?;370;0010
00046;WHAT ARE THE PROPERTIES AND ACTIVITY OF GALACTOSYLTRANSFERASE ENZYMES FROM CF PATIENTS?;410;0011
00046;WHAT ARE THE PROPERTIES AND ACTIVITY OF GALACTOSYLTRANSFERASE ENZYMES FROM CF PATIENTS?;430;0001
00046;WHAT ARE THE PROPERTIES AND ACTIVITY OF GALACTOSYLTRANSFERASE ENZYMES FROM CF PATIENTS?;500;0100
00046;WHAT ARE THE PROPERTIES AND ACTIVITY OF GALACTOSYLTRANSFERASE ENZYMES FROM CF PATIENTS?;503;2221
00046;WHAT ARE THE PROPERTIES AND ACTIVITY OF GALACTOSYLTRANSFERASE ENZYMES FROM CF PATIENTS?;516;2111
00046;WHAT ARE THE PROPERTIES AND ACTIVITY OF GALACTOSYLTRANSFERASE ENZYMES FROM CF PATIENTS?;553;1002
00046;WHAT ARE THE PROPERTIES AND ACTIVITY OF GALACTOSYLTRANSFERASE ENZYMES FROM CF PATIENTS?;568;1000
00046;WHAT ARE THE PROPERTIES AND ACTIVITY OF GALACTOSYLTRANSFERASE ENZYMES FROM CF PATIENTS?;623;0010
00046;WHAT ARE THE PROPERTIES AND ACTIVITY OF GALACTOSYLTRANSFERASE ENZYMES FROM CF PATIENTS?;702;2122
00046;WHAT ARE THE PROPERTIES AND ACTIVITY OF GALACTOSYLTRANSFERASE ENZYMES FROM CF PATIENTS?;737;2222
00046;WHAT ARE THE PROPERTIES AND ACTIVITY OF GALACTOSYLTRANSFERASE ENZYMES FROM CF PATIENTS?;854;1111
00046;WHAT ARE THE PROPERTIES AND ACTIVITY OF GALACTOSYLTRANSFERASE ENZYMES FROM CF PATIENTS?;856;2111
00046;WHAT ARE THE PROPERTIES AND ACTIVITY OF GALACTOSYLTRANSFERASE ENZYMES FROM CF PATIENTS?;857;0002
00046;WHAT ARE THE PROPERTIES AND ACTIVITY OF GALACTOSYLTRANSFERASE ENZYMES FROM CF PATIENTS?;1196;0001
00046;WHAT ARE THE PROPERTIES AND ACTIVITY OF GALACTOSYLTRANSFERASE ENZYMES FROM CF PATIENTS?;1212;1121
00047;WHAT DIFFERENCES BETWEEN NORMAL SUBJECTS AND CF PATIENTS HAVE BEEN DESCRIBED IN THE FUNCTION OR METABOLISM OF HORMONES?;15;0002
00047;WHAT DIFFERENCES BETWEEN NORMAL SUBJECTS AND CF PATIENTS HAVE BEEN DESCRIBED IN THE FUNCTION OR METABOLISM OF HORMONES?;57;1000
00047;WHAT DIFFERENCES BETWEEN NORMAL SUBJECTS AND CF PATIENTS HAVE BEEN DESCRIBED IN THE FUNCTION OR METABOLISM OF HORMONES?;92;2220
00047;WHAT DIFFERENCES BETWEEN NORMAL SUBJECTS AND CF PATIENTS HAVE BEEN DESCRIBED IN THE FUNCTION OR METABOLISM OF HORMONES?;118;0010
00047;WHAT DIFFERENCES BETWEEN NORMAL SUBJECTS AND CF PATIENTS HAVE BEEN DESCRIBED IN THE FUNCTION OR METABOLISM OF HORMONES?;121;0010
00047;WHAT DIFFERENCES BETWEEN NORMAL SUBJECTS AND CF PATIENTS HAVE BEEN DESCRIBED IN THE FUNCTION OR METABOLISM OF HORMONES?;125;0001
00047;WHAT DIFFERENCES BETWEEN NORMAL SUBJECTS AND CF PATIENTS HAVE BEEN DESCRIBED IN THE FUNCTION OR METABOLISM OF HORMONES?;163;2222
00047;WHAT DIFFERENCES BETWEEN NORMAL SUBJECTS AND CF PATIENTS HAVE BEEN DESCRIBED IN THE FUNCTION OR METABOLISM OF HORMONES?;165;0002
00047;WHAT DIFFERENCES BETWEEN NORMAL SUBJECTS AND CF PATIENTS HAVE BEEN DESCRIBED IN THE FUNCTION OR METABOLISM OF HORMONES?;172;0012
00047;WHAT DIFFERENCES BETWEEN NORMAL SUBJECTS AND CF PATIENTS HAVE BEEN DESCRIBED IN THE FUNCTION OR METABOLISM OF HORMONES?;183;0010
00047;WHAT DIFFERENCES BETWEEN NORMAL SUBJECTS AND CF PATIENTS HAVE BEEN DESCRIBED IN THE FUNCTION OR METABOLISM OF HORMONES?;208;0001
00047;WHAT DIFFERENCES BETWEEN NORMAL SUBJECTS AND CF PATIENTS HAVE BEEN DESCRIBED IN THE FUNCTION OR METABOLISM OF HORMONES?;209;2220
00047;WHAT DIFFERENCES BETWEEN NORMAL SUBJECTS AND CF PATIENTS HAVE BEEN DESCRIBED IN THE FUNCTION OR METABOLISM OF HORMONES?;245;1000
00047;WHAT DIFFERENCES BETWEEN NORMAL SUBJECTS AND CF PATIENTS HAVE BEEN DESCRIBED IN THE FUNCTION OR METABOLISM OF HORMONES?;259;0010
00047;WHAT DIFFERENCES BETWEEN NORMAL SUBJECTS AND CF PATIENTS HAVE BEEN DESCRIBED IN THE FUNCTION OR METABOLISM OF HORMONES?;278;0010
00047;WHAT DIFFERENCES BETWEEN NORMAL SUBJECTS AND CF PATIENTS HAVE BEEN DESCRIBED IN THE FUNCTION OR METABOLISM OF HORMONES?;279;0010
00047;WHAT DIFFERENCES BETWEEN NORMAL SUBJECTS AND CF PATIENTS HAVE BEEN DESCRIBED IN THE FUNCTION OR METABOLISM OF HORMONES?;283;0010
00047;WHAT DIFFERENCES BETWEEN NORMAL SUBJECTS AND CF PATIENTS HAVE BEEN DESCRIBED IN THE FUNCTION OR METABOLISM OF HORMONES?;286;0010
00047;WHAT DIFFERENCES BETWEEN NORMAL SUBJECTS AND CF PATIENTS HAVE BEEN DESCRIBED IN THE FUNCTION OR METABOLISM OF HORMONES?;287;0010
00047;WHAT DIFFERENCES BETWEEN NORMAL SUBJECTS AND CF PATIENTS HAVE BEEN DESCRIBED IN THE FUNCTION OR METABOLISM OF HORMONES?;295;2211
00047;WHAT DIFFERENCES BETWEEN NORMAL SUBJECTS AND CF PATIENTS HAVE BEEN DESCRIBED IN THE FUNCTION OR METABOLISM OF HORMONES?;296;0100
00047;WHAT DIFFERENCES BETWEEN NORMAL SUBJECTS AND CF PATIENTS HAVE BEEN DESCRIBED IN THE FUNCTION OR METABOLISM OF HORMONES?;301;1210
00047;WHAT DIFFERENCES BETWEEN NORMAL SUBJECTS AND CF PATIENTS HAVE BEEN DESCRIBED IN THE FUNCTION OR METABOLISM OF HORMONES?;302;0100
00047;WHAT DIFFERENCES BETWEEN NORMAL SUBJECTS AND CF PATIENTS HAVE BEEN DESCRIBED IN THE FUNCTION OR METABOLISM OF HORMONES?;317;2220
00047;WHAT DIFFERENCES BETWEEN NORMAL SUBJECTS AND CF PATIENTS HAVE BEEN DESCRIBED IN THE FUNCTION OR METABOLISM OF HORMONES?;337;1000
00047;WHAT DIFFERENCES BETWEEN NORMAL SUBJECTS AND CF PATIENTS HAVE BEEN DESCRIBED IN THE FUNCTION OR METABOLISM OF HORMONES?;361;1000
00047;WHAT DIFFERENCES BETWEEN NORMAL SUBJECTS AND CF PATIENTS HAVE BEEN DESCRIBED IN THE FUNCTION OR METABOLISM OF HORMONES?;370;1000
00047;WHAT DIFFERENCES BETWEEN NORMAL SUBJECTS AND CF PATIENTS HAVE BEEN DESCRIBED IN THE FUNCTION OR METABOLISM OF HORMONES?;406;2212
00047;WHAT DIFFERENCES BETWEEN NORMAL SUBJECTS AND CF PATIENTS HAVE BEEN DESCRIBED IN THE FUNCTION OR METABOLISM OF HORMONES?;416;1000
00047;WHAT DIFFERENCES BETWEEN NORMAL SUBJECTS AND CF PATIENTS HAVE BEEN DESCRIBED IN THE FUNCTION OR METABOLISM OF HORMONES?;436;0001
00047;WHAT DIFFERENCES BETWEEN NORMAL SUBJECTS AND CF PATIENTS HAVE BEEN DESCRIBED IN THE FUNCTION OR METABOLISM OF HORMONES?;505;2221
00047;WHAT DIFFERENCES BETWEEN NORMAL SUBJECTS AND CF PATIENTS HAVE BEEN DESCRIBED IN THE FUNCTION OR METABOLISM OF HORMONES?;508;2210
00047;WHAT DIFFERENCES BETWEEN NORMAL SUBJECTS AND CF PATIENTS HAVE BEEN DESCRIBED IN THE FUNCTION OR METABOLISM OF HORMONES?;525;0010
00047;WHAT DIFFERENCES BETWEEN NORMAL SUBJECTS AND CF PATIENTS HAVE BEEN DESCRIBED IN THE FUNCTION OR METABOLISM OF HORMONES?;585;2220
00047;WHAT DIFFERENCES BETWEEN NORMAL SUBJECTS AND CF PATIENTS HAVE BEEN DESCRIBED IN THE FUNCTION OR METABOLISM OF HORMONES?;613;2210
00047;WHAT DIFFERENCES BETWEEN NORMAL SUBJECTS AND CF PATIENTS HAVE BEEN DESCRIBED IN THE FUNCTION OR METABOLISM OF HORMONES?;684;2222
00047;WHAT DIFFERENCES BETWEEN NORMAL SUBJECTS AND CF PATIENTS HAVE BEEN DESCRIBED IN THE FUNCTION OR METABOLISM OF HORMONES?;694;2212
00047;WHAT DIFFERENCES BETWEEN NORMAL SUBJECTS AND CF PATIENTS HAVE BEEN DESCRIBED IN THE FUNCTION OR METABOLISM OF HORMONES?;695;2210
00047;WHAT DIFFERENCES BETWEEN NORMAL SUBJECTS AND CF PATIENTS HAVE BEEN DESCRIBED IN THE FUNCTION OR METABOLISM OF HORMONES?;707;0110
00047;WHAT DIFFERENCES BETWEEN NORMAL SUBJECTS AND CF PATIENTS HAVE BEEN DESCRIBED IN THE FUNCTION OR METABOLISM OF HORMONES?;781;0001
00047;WHAT DIFFERENCES BETWEEN NORMAL SUBJECTS AND CF PATIENTS HAVE BEEN DESCRIBED IN THE FUNCTION OR METABOLISM OF HORMONES?;862;0010
00047;WHAT DIFFERENCES BETWEEN NORMAL SUBJECTS AND CF PATIENTS HAVE BEEN DESCRIBED IN THE FUNCTION OR METABOLISM OF HORMONES?;868;0010
00047;WHAT DIFFERENCES BETWEEN NORMAL SUBJECTS AND CF PATIENTS HAVE BEEN DESCRIBED IN THE FUNCTION OR METABOLISM OF HORMONES?;906;2221
00047;WHAT DIFFERENCES BETWEEN NORMAL SUBJECTS AND CF PATIENTS HAVE BEEN DESCRIBED IN THE FUNCTION OR METABOLISM OF HORMONES?;928;0010
00047;WHAT DIFFERENCES BETWEEN NORMAL SUBJECTS AND CF PATIENTS HAVE BEEN DESCRIBED IN THE FUNCTION OR METABOLISM OF HORMONES?;931;1000
00047;WHAT DIFFERENCES BETWEEN NORMAL SUBJECTS AND CF PATIENTS HAVE BEEN DESCRIBED IN THE FUNCTION OR METABOLISM OF HORMONES?;971;0100
00047;WHAT DIFFERENCES BETWEEN NORMAL SUBJECTS AND CF PATIENTS HAVE BEEN DESCRIBED IN THE FUNCTION OR METABOLISM OF HORMONES?;998;1010
00047;WHAT DIFFERENCES BETWEEN NORMAL SUBJECTS AND CF PATIENTS HAVE BEEN DESCRIBED IN THE FUNCTION OR METABOLISM OF HORMONES?;1000;1001
00047;WHAT DIFFERENCES BETWEEN NORMAL SUBJECTS AND CF PATIENTS HAVE BEEN DESCRIBED IN THE FUNCTION OR METABOLISM OF HORMONES?;1013;1000
00047;WHAT DIFFERENCES BETWEEN NORMAL SUBJECTS AND CF PATIENTS HAVE BEEN DESCRIBED IN THE FUNCTION OR METABOLISM OF HORMONES?;1058;2220
00047;WHAT DIFFERENCES BETWEEN NORMAL SUBJECTS AND CF PATIENTS HAVE BEEN DESCRIBED IN THE FUNCTION OR METABOLISM OF HORMONES?;1075;0010
00047;WHAT DIFFERENCES BETWEEN NORMAL SUBJECTS AND CF PATIENTS HAVE BEEN DESCRIBED IN THE FUNCTION OR METABOLISM OF HORMONES?;1106;1000
00047;WHAT DIFFERENCES BETWEEN NORMAL SUBJECTS AND CF PATIENTS HAVE BEEN DESCRIBED IN THE FUNCTION OR METABOLISM OF HORMONES?;1107;1000
00047;WHAT DIFFERENCES BETWEEN NORMAL SUBJECTS AND CF PATIENTS HAVE BEEN DESCRIBED IN THE FUNCTION OR METABOLISM OF HORMONES?;1108;1000
00047;WHAT DIFFERENCES BETWEEN NORMAL SUBJECTS AND CF PATIENTS HAVE BEEN DESCRIBED IN THE FUNCTION OR METABOLISM OF HORMONES?;1129;0010
00047;WHAT DIFFERENCES BETWEEN NORMAL SUBJECTS AND CF PATIENTS HAVE BEEN DESCRIBED IN THE FUNCTION OR METABOLISM OF HORMONES?;1132;0010
00047;WHAT DIFFERENCES BETWEEN NORMAL SUBJECTS AND CF PATIENTS HAVE BEEN DESCRIBED IN THE FUNCTION OR METABOLISM OF HORMONES?;1165;2222
00047;WHAT DIFFERENCES BETWEEN NORMAL SUBJECTS AND CF PATIENTS HAVE BEEN DESCRIBED IN THE FUNCTION OR METABOLISM OF HORMONES?;1192;1000
00047;WHAT DIFFERENCES BETWEEN NORMAL SUBJECTS AND CF PATIENTS HAVE BEEN DESCRIBED IN THE FUNCTION OR METABOLISM OF HORMONES?;1194;0010
00047;WHAT DIFFERENCES BETWEEN NORMAL SUBJECTS AND CF PATIENTS HAVE BEEN DESCRIBED IN THE FUNCTION OR METABOLISM OF HORMONES?;1206;0010
00048;DO FIBROBLASTS FROM CF PATIENTS GROW AT A NORMAL RATE?;44;0110
00048;DO FIBROBLASTS FROM CF PATIENTS GROW AT A NORMAL RATE?;72;0100
00048;DO FIBROBLASTS FROM CF PATIENTS GROW AT A NORMAL RATE?;74;0100
00048;DO FIBROBLASTS FROM CF PATIENTS GROW AT A NORMAL RATE?;124;2220
00048;DO FIBROBLASTS FROM CF PATIENTS GROW AT A NORMAL RATE?;143;0002
00048;DO FIBROBLASTS FROM CF PATIENTS GROW AT A NORMAL RATE?;154;2222
00048;DO FIBROBLASTS FROM CF PATIENTS GROW AT A NORMAL RATE?;190;0010
00048;DO FIBROBLASTS FROM CF PATIENTS GROW AT A NORMAL RATE?;257;0011
00048;DO FIBROBLASTS FROM CF PATIENTS GROW AT A NORMAL RATE?;312;0100
00048;DO FIBROBLASTS FROM CF PATIENTS GROW AT A NORMAL RATE?;336;2222
00048;DO FIBROBLASTS FROM CF PATIENTS GROW AT A NORMAL RATE?;386;0100
00048;DO FIBROBLASTS FROM CF PATIENTS GROW AT A NORMAL RATE?;422;0001
00048;DO FIBROBLASTS FROM CF PATIENTS GROW AT A NORMAL RATE?;436;2222
00048;DO FIBROBLASTS FROM CF PATIENTS GROW AT A NORMAL RATE?;453;2222
00048;DO FIBROBLASTS FROM CF PATIENTS GROW AT A NORMAL RATE?;493;0101
00048;DO FIBROBLASTS FROM CF PATIENTS GROW AT A NORMAL RATE?;495;2220
00048;DO FIBROBLASTS FROM CF PATIENTS GROW AT A NORMAL RATE?;523;2220
00048;DO FIBROBLASTS FROM CF PATIENTS GROW AT A NORMAL RATE?;548;2220
00048;DO FIBROBLASTS FROM CF PATIENTS GROW AT A NORMAL RATE?;566;1000
00048;DO FIBROBLASTS FROM CF PATIENTS GROW AT A NORMAL RATE?;568;2222
00048;DO FIBROBLASTS FROM CF PATIENTS GROW AT A NORMAL RATE?;576;2222
00048;DO FIBROBLASTS FROM CF PATIENTS GROW AT A NORMAL RATE?;691;0001
00048;DO FIBROBLASTS FROM CF PATIENTS GROW AT A NORMAL RATE?;765;0010
00048;DO FIBROBLASTS FROM CF PATIENTS GROW AT A NORMAL RATE?;766;0010
00048;DO FIBROBLASTS FROM CF PATIENTS GROW AT A NORMAL RATE?;786;0010
00048;DO FIBROBLASTS FROM CF PATIENTS GROW AT A NORMAL RATE?;850;2222
00048;DO FIBROBLASTS FROM CF PATIENTS GROW AT A NORMAL RATE?;967;0011
00048;DO FIBROBLASTS FROM CF PATIENTS GROW AT A NORMAL RATE?;1142;2220
00048;DO FIBROBLASTS FROM CF PATIENTS GROW AT A NORMAL RATE?;1201;0001
00048;DO FIBROBLASTS FROM CF PATIENTS GROW AT A NORMAL RATE?;1231;2122
00049;IS RNA METHYLATION OR POLYAMINE METABOLISM NORMAL IN CF PATIENTS?;72;0100
00049;IS RNA METHYLATION OR POLYAMINE METABOLISM NORMAL IN CF PATIENTS?;84;0010
00049;IS RNA METHYLATION OR POLYAMINE METABOLISM NORMAL IN CF PATIENTS?;138;2222
00049;IS RNA METHYLATION OR POLYAMINE METABOLISM NORMAL IN CF PATIENTS?;143;2222
00049;IS RNA METHYLATION OR POLYAMINE METABOLISM NORMAL IN CF PATIENTS?;230;2220
00049;IS RNA METHYLATION OR POLYAMINE METABOLISM NORMAL IN CF PATIENTS?;313;2222
00049;IS RNA METHYLATION OR POLYAMINE METABOLISM NORMAL IN CF PATIENTS?;370;0010
00049;IS RNA METHYLATION OR POLYAMINE METABOLISM NORMAL IN CF PATIENTS?;392;1010
00049;IS RNA METHYLATION OR POLYAMINE METABOLISM NORMAL IN CF PATIENTS?;393;2220
00049;IS RNA METHYLATION OR POLYAMINE METABOLISM NORMAL IN CF PATIENTS?;430;0010
00049;IS RNA METHYLATION OR POLYAMINE METABOLISM NORMAL IN CF PATIENTS?;436;2222
00049;IS RNA METHYLATION OR POLYAMINE METABOLISM NORMAL IN CF PATIENTS?;440;1000
00049;IS RNA METHYLATION OR POLYAMINE METABOLISM NORMAL IN CF PATIENTS?;465;0001
00049;IS RNA METHYLATION OR POLYAMINE METABOLISM NORMAL IN CF PATIENTS?;493;2222
00049;IS RNA METHYLATION OR POLYAMINE METABOLISM NORMAL IN CF PATIENTS?;503;0001
00049;IS RNA METHYLATION OR POLYAMINE METABOLISM NORMAL IN CF PATIENTS?;504;1222
00049;IS RNA METHYLATION OR POLYAMINE METABOLISM NORMAL IN CF PATIENTS?;505;0001
00049;IS RNA METHYLATION OR POLYAMINE METABOLISM NORMAL IN CF PATIENTS?;523;2220
00049;IS RNA METHYLATION OR POLYAMINE METABOLISM NORMAL IN CF PATIENTS?;530;0001
00049;IS RNA METHYLATION OR POLYAMINE METABOLISM NORMAL IN CF PATIENTS?;553;0010
00049;IS RNA METHYLATION OR POLYAMINE METABOLISM NORMAL IN CF PATIENTS?;562;2220
00049;IS RNA METHYLATION OR POLYAMINE METABOLISM NORMAL IN CF PATIENTS?;563;2220
00049;IS RNA METHYLATION OR POLYAMINE METABOLISM NORMAL IN CF PATIENTS?;566;1000
00049;IS RNA METHYLATION OR POLYAMINE METABOLISM NORMAL IN CF PATIENTS?;568;1212
00049;IS RNA METHYLATION OR POLYAMINE METABOLISM NORMAL IN CF PATIENTS?;570;1001
00049;IS RNA METHYLATION OR POLYAMINE METABOLISM NORMAL IN CF PATIENTS?;586;0001
00049;IS RNA METHYLATION OR POLYAMINE METABOLISM NORMAL IN CF PATIENTS?;608;0001
00049;IS RNA METHYLATION OR POLYAMINE METABOLISM NORMAL IN CF PATIENTS?;624;2222
00049;IS RNA METHYLATION OR POLYAMINE METABOLISM NORMAL IN CF PATIENTS?;625;1221
00049;IS RNA METHYLATION OR POLYAMINE METABOLISM NORMAL IN CF PATIENTS?;691;2220
00049;IS RNA METHYLATION OR POLYAMINE METABOLISM NORMAL IN CF PATIENTS?;726;0100
00049;IS RNA METHYLATION OR POLYAMINE METABOLISM NORMAL IN CF PATIENTS?;743;2220
00049;IS RNA METHYLATION OR POLYAMINE METABOLISM NORMAL IN CF PATIENTS?;749;0011
00049;IS RNA METHYLATION OR POLYAMINE METABOLISM NORMAL IN CF PATIENTS?;953;1222
00049;IS RNA METHYLATION OR POLYAMINE METABOLISM NORMAL IN CF PATIENTS?;972;2222
00049;IS RNA METHYLATION OR POLYAMINE METABOLISM NORMAL IN CF PATIENTS?;1198;2222
00050;WHAT DEFECTS IN THE SYNTHESIS OR METABOLISM OF CYCLIC NUCLEOTIDES HAVE BEEN DESCRIBED IN CF PATIENTS?;44;0100
00050;WHAT DEFECTS IN THE SYNTHESIS OR METABOLISM OF CYCLIC NUCLEOTIDES HAVE BEEN DESCRIBED IN CF PATIENTS?;259;2222
00050;WHAT DEFECTS IN THE SYNTHESIS OR METABOLISM OF CYCLIC NUCLEOTIDES HAVE BEEN DESCRIBED IN CF PATIENTS?;309;0100
00050;WHAT DEFECTS IN THE SYNTHESIS OR METABOLISM OF CYCLIC NUCLEOTIDES HAVE BEEN DESCRIBED IN CF PATIENTS?;347;0001
00050;WHAT DEFECTS IN THE SYNTHESIS OR METABOLISM OF CYCLIC NUCLEOTIDES HAVE BEEN DESCRIBED IN CF PATIENTS?;435;2222
00050;WHAT DEFECTS IN THE SYNTHESIS OR METABOLISM OF CYCLIC NUCLEOTIDES HAVE BEEN DESCRIBED IN CF PATIENTS?;440;1001
00050;WHAT DEFECTS IN THE SYNTHESIS OR METABOLISM OF CYCLIC NUCLEOTIDES HAVE BEEN DESCRIBED IN CF PATIENTS?;495;2222
00050;WHAT DEFECTS IN THE SYNTHESIS OR METABOLISM OF CYCLIC NUCLEOTIDES HAVE BEEN DESCRIBED IN CF PATIENTS?;505;0001
00050;WHAT DEFECTS IN THE SYNTHESIS OR METABOLISM OF CYCLIC NUCLEOTIDES HAVE BEEN DESCRIBED IN CF PATIENTS?;543;0100
00050;WHAT DEFECTS IN THE SYNTHESIS OR METABOLISM OF CYCLIC NUCLEOTIDES HAVE BEEN DESCRIBED IN CF PATIENTS?;548;2222
00050;WHAT DEFECTS IN THE SYNTHESIS OR METABOLISM OF CYCLIC NUCLEOTIDES HAVE BEEN DESCRIBED IN CF PATIENTS?;568;1001
00050;WHAT DEFECTS IN THE SYNTHESIS OR METABOLISM OF CYCLIC NUCLEOTIDES HAVE BEEN DESCRIBED IN CF PATIENTS?;570;0001
00050;WHAT DEFECTS IN THE SYNTHESIS OR METABOLISM OF CYCLIC NUCLEOTIDES HAVE BEEN DESCRIBED IN CF PATIENTS?;575;0001
00050;WHAT DEFECTS IN THE SYNTHESIS OR METABOLISM OF CYCLIC NUCLEOTIDES HAVE BEEN DESCRIBED IN CF PATIENTS?;601;0001
00050;WHAT DEFECTS IN THE SYNTHESIS OR METABOLISM OF CYCLIC NUCLEOTIDES HAVE BEEN DESCRIBED IN CF PATIENTS?;634;0001
00050;WHAT DEFECTS IN THE SYNTHESIS OR METABOLISM OF CYCLIC NUCLEOTIDES HAVE BEEN DESCRIBED IN CF PATIENTS?;829;0001
00050;WHAT DEFECTS IN THE SYNTHESIS OR METABOLISM OF CYCLIC NUCLEOTIDES HAVE BEEN DESCRIBED IN CF PATIENTS?;848;2222
00050;WHAT DEFECTS IN THE SYNTHESIS OR METABOLISM OF CYCLIC NUCLEOTIDES HAVE BEEN DESCRIBED IN CF PATIENTS?;953;1222
00050;WHAT DEFECTS IN THE SYNTHESIS OR METABOLISM OF CYCLIC NUCLEOTIDES HAVE BEEN DESCRIBED IN CF PATIENTS?;961;2222
00050;WHAT DEFECTS IN THE SYNTHESIS OR METABOLISM OF CYCLIC NUCLEOTIDES HAVE BEEN DESCRIBED IN CF PATIENTS?;973;1220
00050;WHAT DEFECTS IN THE SYNTHESIS OR METABOLISM OF CYCLIC NUCLEOTIDES HAVE BEEN DESCRIBED IN CF PATIENTS?;1058;0100
00050;WHAT DEFECTS IN THE SYNTHESIS OR METABOLISM OF CYCLIC NUCLEOTIDES HAVE BEEN DESCRIBED IN CF PATIENTS?;1156;1121
00050;WHAT DEFECTS IN THE SYNTHESIS OR METABOLISM OF CYCLIC NUCLEOTIDES HAVE BEEN DESCRIBED IN CF PATIENTS?;1157;2222
00050;WHAT DEFECTS IN THE SYNTHESIS OR METABOLISM OF CYCLIC NUCLEOTIDES HAVE BEEN DESCRIBED IN CF PATIENTS?;1159;1121
00050;WHAT DEFECTS IN THE SYNTHESIS OR METABOLISM OF CYCLIC NUCLEOTIDES HAVE BEEN DESCRIBED IN CF PATIENTS?;1160;0001
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";1;0100
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";11;0100
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";14;0100
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";18;1120
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";19;1210
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";26;2221
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";44;1120
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";51;0100
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";55;0100
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";62;0100
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";63;0100
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";66;0001
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";67;1112
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";72;1112
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";83;0001
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";84;1112
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";85;2222
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";102;1100
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";107;1102
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";108;0001
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";112;2212
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";114;2211
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";122;2222
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";124;0002
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";135;0001
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";137;2221
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";141;2222
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";142;2212
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";177;0001
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";190;0001
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";191;2121
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";196;0011
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";200;0001
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";201;2222
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";214;2222
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";216;0100
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";217;0100
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";218;0100
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";219;0100
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";221;0100
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";222;0100
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";225;2222
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";230;0001
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";235;2212
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";236;2211
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";245;0100
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";249;2222
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";252;0100
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";254;2111
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";263;0100
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";264;1100
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";270;2212
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";276;0001
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";277;2210
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";279;0012
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";281;0011
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";289;0100
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";297;1001
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";302;2212
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";303;2212
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";304;2221
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";305;2212
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";306;2222
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";307;0102
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";308;2111
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";311;0001
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";322;0001
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";325;1211
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";333;1101
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";337;1001
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";343;0001
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";345;0100
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";355;0100
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";360;1002
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";365;1212
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";366;1211
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";370;1112
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";382;0001
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";383;1012
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";386;1222
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";391;0011
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";392;1122
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";400;2112
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";402;0001
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";407;2221
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";415;1101
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";417;0002
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";418;1211
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";419;2111
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";430;1011
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";435;0001
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";437;0001
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";440;0001
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";442;2122
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";444;2222
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";445;2222
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";465;1222
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";481;2222
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";484;2211
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";488;0001
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";490;2222
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";493;0101
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";494;2122
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";495;0001
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";498;1122
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";501;2221
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";502;0001
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";503;0011
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";504;2222
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";505;0001
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";510;0001
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";511;1011
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";517;0011
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";521;1210
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";526;0001
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";528;2211
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";529;2211
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";530;2211
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";531;2211
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";532;2221
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";534;2211
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";535;2222
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";548;0001
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";553;2211
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";560;2222
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";562;0102
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";563;2211
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";564;2222
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";565;2222
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";566;2221
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";568;1222
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";569;2222
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";570;1222
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";571;1000
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";572;2222
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";573;2222
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";574;2222
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";575;2222
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";576;0001
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";589;0010
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";590;0101
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";605;1122
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";608;1222
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";625;0001
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";627;0001
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";636;1002
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";639;1100
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";643;0001
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";646;2222
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";675;1100
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";681;2112
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";685;2222
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";707;1000
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";726;2222
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";733;0001
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";737;0010
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";738;2222
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";739;2222
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";740;2222
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";741;2222
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";744;2222
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";745;0001
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";746;2222
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";747;0001
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";748;2222
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";749;2222
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";779;1001
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";789;2210
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";790;0100
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";793;0001
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";827;2222
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";828;0100
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";829;2211
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";847;0001
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";852;0100
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";856;0101
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";857;0100
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";858;0001
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";861;0001
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";864;1211
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";865;0002
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";866;0001
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";868;1000
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";869;2112
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";875;0001
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";881;0001
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";889;0001
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";891;1001
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";892;2212
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";905;0001
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";918;2222
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";921;2222
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";925;1001
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";926;1000
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";933;0001
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";936;0100
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";949;2222
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";950;2222
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";954;1220
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";956;1001
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";957;2222
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";958;2211
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";966;2221
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";990;0001
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";991;0001
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";1001;0001
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";1024;1210
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";1026;2222
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";1027;0100
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";1044;1221
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";1057;0100
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";1065;0001
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";1070;1100
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";1074;0102
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";1076;2222
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";1079;0001
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";1091;0002
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";1120;1112
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";1127;0100
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";1135;0100
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";1137;0100
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";1139;0100
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";1141;0100
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";1156;1221
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";1167;1222
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";1196;1211
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";1198;0001
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";1199;1000
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";1200;2221
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";1202;0010
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";1203;2122
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";1204;2221
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";1207;2122
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";1208;2222
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";1209;2222
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";1210;1121
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";1211;1222
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";1212;2122
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";1234;0002
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";1236;1222
00051;"WHAT CIRCULATING OR SECRETED ""FACTORS"" HAVE BEEN DESCRIBED IN CF PATIENTS? (""FACTORS"" ARE UNIDENTIFIED BIOLOGICALLY ACTIVE MOLECULES THOUGHT TO PLAY SOME PATHOGENETIC ROLE IN CYSTIC FIBROSIS).";1238;1220
00052;WHAT IS KNOWN ABOUT PROLACTIN IN CF PATIENTS?;406;2222
00052;WHAT IS KNOWN ABOUT PROLACTIN IN CF PATIENTS?;505;0010
00053;DOES SECRETORY IGA PROTECT CF PATIENTS AGAINST BACTERIAL COLONIZATION OR INFECTION?;1;1000
00053;DOES SECRETORY IGA PROTECT CF PATIENTS AGAINST BACTERIAL COLONIZATION OR INFECTION?;11;0002
00053;DOES SECRETORY IGA PROTECT CF PATIENTS AGAINST BACTERIAL COLONIZATION OR INFECTION?;55;1000
00053;DOES SECRETORY IGA PROTECT CF PATIENTS AGAINST BACTERIAL COLONIZATION OR INFECTION?;81;1000
00053;DOES SECRETORY IGA PROTECT CF PATIENTS AGAINST BACTERIAL COLONIZATION OR INFECTION?;160;0001
00053;DOES SECRETORY IGA PROTECT CF PATIENTS AGAINST BACTERIAL COLONIZATION OR INFECTION?;188;1000
00053;DOES SECRETORY IGA PROTECT CF PATIENTS AGAINST BACTERIAL COLONIZATION OR INFECTION?;223;1000
00053;DOES SECRETORY IGA PROTECT CF PATIENTS AGAINST BACTERIAL COLONIZATION OR INFECTION?;228;1000
00053;DOES SECRETORY IGA PROTECT CF PATIENTS AGAINST BACTERIAL COLONIZATION OR INFECTION?;347;1100
00053;DOES SECRETORY IGA PROTECT CF PATIENTS AGAINST BACTERIAL COLONIZATION OR INFECTION?;370;0010
00053;DOES SECRETORY IGA PROTECT CF PATIENTS AGAINST BACTERIAL COLONIZATION OR INFECTION?;401;2210
00053;DOES SECRETORY IGA PROTECT CF PATIENTS AGAINST BACTERIAL COLONIZATION OR INFECTION?;432;1212
00053;DOES SECRETORY IGA PROTECT CF PATIENTS AGAINST BACTERIAL COLONIZATION OR INFECTION?;447;2220
00053;DOES SECRETORY IGA PROTECT CF PATIENTS AGAINST BACTERIAL COLONIZATION OR INFECTION?;505;1000
00053;DOES SECRETORY IGA PROTECT CF PATIENTS AGAINST BACTERIAL COLONIZATION OR INFECTION?;509;1000
00053;DOES SECRETORY IGA PROTECT CF PATIENTS AGAINST BACTERIAL COLONIZATION OR INFECTION?;577;1110
00053;DOES SECRETORY IGA PROTECT CF PATIENTS AGAINST BACTERIAL COLONIZATION OR INFECTION?;590;1010
00053;DOES SECRETORY IGA PROTECT CF PATIENTS AGAINST BACTERIAL COLONIZATION OR INFECTION?;767;1001
00053;DOES SECRETORY IGA PROTECT CF PATIENTS AGAINST BACTERIAL COLONIZATION OR INFECTION?;917;0100
00053;DOES SECRETORY IGA PROTECT CF PATIENTS AGAINST BACTERIAL COLONIZATION OR INFECTION?;987;2221
00053;DOES SECRETORY IGA PROTECT CF PATIENTS AGAINST BACTERIAL COLONIZATION OR INFECTION?;1170;1210
00053;DOES SECRETORY IGA PROTECT CF PATIENTS AGAINST BACTERIAL COLONIZATION OR INFECTION?;1228;0111
00053;DOES SECRETORY IGA PROTECT CF PATIENTS AGAINST BACTERIAL COLONIZATION OR INFECTION?;1229;0111
00054;WHAT IS THE RELATIONSHIP OF ALLERGY OR HYPERSENSITIVITY TO LUNG DISEASE IN CF PATIENTS?;11;2222
00054;WHAT IS THE RELATIONSHIP OF ALLERGY OR HYPERSENSITIVITY TO LUNG DISEASE IN CF PATIENTS?;23;0100
00054;WHAT IS THE RELATIONSHIP OF ALLERGY OR HYPERSENSITIVITY TO LUNG DISEASE IN CF PATIENTS?;55;1010
00054;WHAT IS THE RELATIONSHIP OF ALLERGY OR HYPERSENSITIVITY TO LUNG DISEASE IN CF PATIENTS?;187;1011
00054;WHAT IS THE RELATIONSHIP OF ALLERGY OR HYPERSENSITIVITY TO LUNG DISEASE IN CF PATIENTS?;206;0100
00054;WHAT IS THE RELATIONSHIP OF ALLERGY OR HYPERSENSITIVITY TO LUNG DISEASE IN CF PATIENTS?;211;2222
00054;WHAT IS THE RELATIONSHIP OF ALLERGY OR HYPERSENSITIVITY TO LUNG DISEASE IN CF PATIENTS?;223;1122
00054;WHAT IS THE RELATIONSHIP OF ALLERGY OR HYPERSENSITIVITY TO LUNG DISEASE IN CF PATIENTS?;228;2222
00054;WHAT IS THE RELATIONSHIP OF ALLERGY OR HYPERSENSITIVITY TO LUNG DISEASE IN CF PATIENTS?;229;2222
00054;WHAT IS THE RELATIONSHIP OF ALLERGY OR HYPERSENSITIVITY TO LUNG DISEASE IN CF PATIENTS?;333;0011
00054;WHAT IS THE RELATIONSHIP OF ALLERGY OR HYPERSENSITIVITY TO LUNG DISEASE IN CF PATIENTS?;341;0012
00054;WHAT IS THE RELATIONSHIP OF ALLERGY OR HYPERSENSITIVITY TO LUNG DISEASE IN CF PATIENTS?;347;0012
00054;WHAT IS THE RELATIONSHIP OF ALLERGY OR HYPERSENSITIVITY TO LUNG DISEASE IN CF PATIENTS?;358;2222
00054;WHAT IS THE RELATIONSHIP OF ALLERGY OR HYPERSENSITIVITY TO LUNG DISEASE IN CF PATIENTS?;369;2121
00054;WHAT IS THE RELATIONSHIP OF ALLERGY OR HYPERSENSITIVITY TO LUNG DISEASE IN CF PATIENTS?;382;2222
00054;WHAT IS THE RELATIONSHIP OF ALLERGY OR HYPERSENSITIVITY TO LUNG DISEASE IN CF PATIENTS?;394;2120
00054;WHAT IS THE RELATIONSHIP OF ALLERGY OR HYPERSENSITIVITY TO LUNG DISEASE IN CF PATIENTS?;401;2111
00054;WHAT IS THE RELATIONSHIP OF ALLERGY OR HYPERSENSITIVITY TO LUNG DISEASE IN CF PATIENTS?;402;2122
00054;WHAT IS THE RELATIONSHIP OF ALLERGY OR HYPERSENSITIVITY TO LUNG DISEASE IN CF PATIENTS?;432;2222
00054;WHAT IS THE RELATIONSHIP OF ALLERGY OR HYPERSENSITIVITY TO LUNG DISEASE IN CF PATIENTS?;485;2121
00054;WHAT IS THE RELATIONSHIP OF ALLERGY OR HYPERSENSITIVITY TO LUNG DISEASE IN CF PATIENTS?;488;2120
00054;WHAT IS THE RELATIONSHIP OF ALLERGY OR HYPERSENSITIVITY TO LUNG DISEASE IN CF PATIENTS?;505;0011
00054;WHAT IS THE RELATIONSHIP OF ALLERGY OR HYPERSENSITIVITY TO LUNG DISEASE IN CF PATIENTS?;513;1002
00054;WHAT IS THE RELATIONSHIP OF ALLERGY OR HYPERSENSITIVITY TO LUNG DISEASE IN CF PATIENTS?;547;0001
00054;WHAT IS THE RELATIONSHIP OF ALLERGY OR HYPERSENSITIVITY TO LUNG DISEASE IN CF PATIENTS?;550;0001
00054;WHAT IS THE RELATIONSHIP OF ALLERGY OR HYPERSENSITIVITY TO LUNG DISEASE IN CF PATIENTS?;552;0101
00054;WHAT IS THE RELATIONSHIP OF ALLERGY OR HYPERSENSITIVITY TO LUNG DISEASE IN CF PATIENTS?;577;2110
00054;WHAT IS THE RELATIONSHIP OF ALLERGY OR HYPERSENSITIVITY TO LUNG DISEASE IN CF PATIENTS?;590;0011
00054;WHAT IS THE RELATIONSHIP OF ALLERGY OR HYPERSENSITIVITY TO LUNG DISEASE IN CF PATIENTS?;607;0100
00054;WHAT IS THE RELATIONSHIP OF ALLERGY OR HYPERSENSITIVITY TO LUNG DISEASE IN CF PATIENTS?;613;1000
00054;WHAT IS THE RELATIONSHIP OF ALLERGY OR HYPERSENSITIVITY TO LUNG DISEASE IN CF PATIENTS?;626;0101
00054;WHAT IS THE RELATIONSHIP OF ALLERGY OR HYPERSENSITIVITY TO LUNG DISEASE IN CF PATIENTS?;631;2212
00054;WHAT IS THE RELATIONSHIP OF ALLERGY OR HYPERSENSITIVITY TO LUNG DISEASE IN CF PATIENTS?;632;1122
00054;WHAT IS THE RELATIONSHIP OF ALLERGY OR HYPERSENSITIVITY TO LUNG DISEASE IN CF PATIENTS?;716;1101
00054;WHAT IS THE RELATIONSHIP OF ALLERGY OR HYPERSENSITIVITY TO LUNG DISEASE IN CF PATIENTS?;767;1001
00054;WHAT IS THE RELATIONSHIP OF ALLERGY OR HYPERSENSITIVITY TO LUNG DISEASE IN CF PATIENTS?;771;0100
00054;WHAT IS THE RELATIONSHIP OF ALLERGY OR HYPERSENSITIVITY TO LUNG DISEASE IN CF PATIENTS?;790;0001
00054;WHAT IS THE RELATIONSHIP OF ALLERGY OR HYPERSENSITIVITY TO LUNG DISEASE IN CF PATIENTS?;793;0001
00054;WHAT IS THE RELATIONSHIP OF ALLERGY OR HYPERSENSITIVITY TO LUNG DISEASE IN CF PATIENTS?;806;0001
00054;WHAT IS THE RELATIONSHIP OF ALLERGY OR HYPERSENSITIVITY TO LUNG DISEASE IN CF PATIENTS?;812;2122
00054;WHAT IS THE RELATIONSHIP OF ALLERGY OR HYPERSENSITIVITY TO LUNG DISEASE IN CF PATIENTS?;819;2222
00054;WHAT IS THE RELATIONSHIP OF ALLERGY OR HYPERSENSITIVITY TO LUNG DISEASE IN CF PATIENTS?;860;0002
00054;WHAT IS THE RELATIONSHIP OF ALLERGY OR HYPERSENSITIVITY TO LUNG DISEASE IN CF PATIENTS?;904;2212
00054;WHAT IS THE RELATIONSHIP OF ALLERGY OR HYPERSENSITIVITY TO LUNG DISEASE IN CF PATIENTS?;905;0100
00054;WHAT IS THE RELATIONSHIP OF ALLERGY OR HYPERSENSITIVITY TO LUNG DISEASE IN CF PATIENTS?;917;2210
00054;WHAT IS THE RELATIONSHIP OF ALLERGY OR HYPERSENSITIVITY TO LUNG DISEASE IN CF PATIENTS?;941;1001
00054;WHAT IS THE RELATIONSHIP OF ALLERGY OR HYPERSENSITIVITY TO LUNG DISEASE IN CF PATIENTS?;964;2222
00054;WHAT IS THE RELATIONSHIP OF ALLERGY OR HYPERSENSITIVITY TO LUNG DISEASE IN CF PATIENTS?;990;1001
00054;WHAT IS THE RELATIONSHIP OF ALLERGY OR HYPERSENSITIVITY TO LUNG DISEASE IN CF PATIENTS?;1003;0002
00054;WHAT IS THE RELATIONSHIP OF ALLERGY OR HYPERSENSITIVITY TO LUNG DISEASE IN CF PATIENTS?;1005;2221
00054;WHAT IS THE RELATIONSHIP OF ALLERGY OR HYPERSENSITIVITY TO LUNG DISEASE IN CF PATIENTS?;1007;2122
00054;WHAT IS THE RELATIONSHIP OF ALLERGY OR HYPERSENSITIVITY TO LUNG DISEASE IN CF PATIENTS?;1013;1001
00054;WHAT IS THE RELATIONSHIP OF ALLERGY OR HYPERSENSITIVITY TO LUNG DISEASE IN CF PATIENTS?;1048;2122
00054;WHAT IS THE RELATIONSHIP OF ALLERGY OR HYPERSENSITIVITY TO LUNG DISEASE IN CF PATIENTS?;1060;2222
00054;WHAT IS THE RELATIONSHIP OF ALLERGY OR HYPERSENSITIVITY TO LUNG DISEASE IN CF PATIENTS?;1099;0100
00054;WHAT IS THE RELATIONSHIP OF ALLERGY OR HYPERSENSITIVITY TO LUNG DISEASE IN CF PATIENTS?;1134;2112
00054;WHAT IS THE RELATIONSHIP OF ALLERGY OR HYPERSENSITIVITY TO LUNG DISEASE IN CF PATIENTS?;1163;2212
00054;WHAT IS THE RELATIONSHIP OF ALLERGY OR HYPERSENSITIVITY TO LUNG DISEASE IN CF PATIENTS?;1164;0112
00054;WHAT IS THE RELATIONSHIP OF ALLERGY OR HYPERSENSITIVITY TO LUNG DISEASE IN CF PATIENTS?;1169;1222
00054;WHAT IS THE RELATIONSHIP OF ALLERGY OR HYPERSENSITIVITY TO LUNG DISEASE IN CF PATIENTS?;1171;0100
00054;WHAT IS THE RELATIONSHIP OF ALLERGY OR HYPERSENSITIVITY TO LUNG DISEASE IN CF PATIENTS?;1192;0001
00054;WHAT IS THE RELATIONSHIP OF ALLERGY OR HYPERSENSITIVITY TO LUNG DISEASE IN CF PATIENTS?;1237;0100
00055;WHAT ARE THE INTERACTIONS BETWEEN PROTEASES (ENDOGENOUS OR BACTERIAL ORIGIN) AND ANTIPROTEASES IN THE LUNGS OF CF PATIENTS?;70;0100
00055;WHAT ARE THE INTERACTIONS BETWEEN PROTEASES (ENDOGENOUS OR BACTERIAL ORIGIN) AND ANTIPROTEASES IN THE LUNGS OF CF PATIENTS?;232;1100
00055;WHAT ARE THE INTERACTIONS BETWEEN PROTEASES (ENDOGENOUS OR BACTERIAL ORIGIN) AND ANTIPROTEASES IN THE LUNGS OF CF PATIENTS?;305;0100
00055;WHAT ARE THE INTERACTIONS BETWEEN PROTEASES (ENDOGENOUS OR BACTERIAL ORIGIN) AND ANTIPROTEASES IN THE LUNGS OF CF PATIENTS?;347;1000
00055;WHAT ARE THE INTERACTIONS BETWEEN PROTEASES (ENDOGENOUS OR BACTERIAL ORIGIN) AND ANTIPROTEASES IN THE LUNGS OF CF PATIENTS?;358;0002
00055;WHAT ARE THE INTERACTIONS BETWEEN PROTEASES (ENDOGENOUS OR BACTERIAL ORIGIN) AND ANTIPROTEASES IN THE LUNGS OF CF PATIENTS?;391;2110
00055;WHAT ARE THE INTERACTIONS BETWEEN PROTEASES (ENDOGENOUS OR BACTERIAL ORIGIN) AND ANTIPROTEASES IN THE LUNGS OF CF PATIENTS?;430;0001
00055;WHAT ARE THE INTERACTIONS BETWEEN PROTEASES (ENDOGENOUS OR BACTERIAL ORIGIN) AND ANTIPROTEASES IN THE LUNGS OF CF PATIENTS?;432;2122
00055;WHAT ARE THE INTERACTIONS BETWEEN PROTEASES (ENDOGENOUS OR BACTERIAL ORIGIN) AND ANTIPROTEASES IN THE LUNGS OF CF PATIENTS?;463;1100
00055;WHAT ARE THE INTERACTIONS BETWEEN PROTEASES (ENDOGENOUS OR BACTERIAL ORIGIN) AND ANTIPROTEASES IN THE LUNGS OF CF PATIENTS?;505;1001
00055;WHAT ARE THE INTERACTIONS BETWEEN PROTEASES (ENDOGENOUS OR BACTERIAL ORIGIN) AND ANTIPROTEASES IN THE LUNGS OF CF PATIENTS?;521;2222
00055;WHAT ARE THE INTERACTIONS BETWEEN PROTEASES (ENDOGENOUS OR BACTERIAL ORIGIN) AND ANTIPROTEASES IN THE LUNGS OF CF PATIENTS?;530;2122
00055;WHAT ARE THE INTERACTIONS BETWEEN PROTEASES (ENDOGENOUS OR BACTERIAL ORIGIN) AND ANTIPROTEASES IN THE LUNGS OF CF PATIENTS?;640;1010
00055;WHAT ARE THE INTERACTIONS BETWEEN PROTEASES (ENDOGENOUS OR BACTERIAL ORIGIN) AND ANTIPROTEASES IN THE LUNGS OF CF PATIENTS?;675;1000
00055;WHAT ARE THE INTERACTIONS BETWEEN PROTEASES (ENDOGENOUS OR BACTERIAL ORIGIN) AND ANTIPROTEASES IN THE LUNGS OF CF PATIENTS?;749;0010
00055;WHAT ARE THE INTERACTIONS BETWEEN PROTEASES (ENDOGENOUS OR BACTERIAL ORIGIN) AND ANTIPROTEASES IN THE LUNGS OF CF PATIENTS?;779;1010
00055;WHAT ARE THE INTERACTIONS BETWEEN PROTEASES (ENDOGENOUS OR BACTERIAL ORIGIN) AND ANTIPROTEASES IN THE LUNGS OF CF PATIENTS?;820;1122
00055;WHAT ARE THE INTERACTIONS BETWEEN PROTEASES (ENDOGENOUS OR BACTERIAL ORIGIN) AND ANTIPROTEASES IN THE LUNGS OF CF PATIENTS?;828;1210
00055;WHAT ARE THE INTERACTIONS BETWEEN PROTEASES (ENDOGENOUS OR BACTERIAL ORIGIN) AND ANTIPROTEASES IN THE LUNGS OF CF PATIENTS?;847;0010
00055;WHAT ARE THE INTERACTIONS BETWEEN PROTEASES (ENDOGENOUS OR BACTERIAL ORIGIN) AND ANTIPROTEASES IN THE LUNGS OF CF PATIENTS?;890;1001
00055;WHAT ARE THE INTERACTIONS BETWEEN PROTEASES (ENDOGENOUS OR BACTERIAL ORIGIN) AND ANTIPROTEASES IN THE LUNGS OF CF PATIENTS?;1056;1000
00055;WHAT ARE THE INTERACTIONS BETWEEN PROTEASES (ENDOGENOUS OR BACTERIAL ORIGIN) AND ANTIPROTEASES IN THE LUNGS OF CF PATIENTS?;1070;1100
00055;WHAT ARE THE INTERACTIONS BETWEEN PROTEASES (ENDOGENOUS OR BACTERIAL ORIGIN) AND ANTIPROTEASES IN THE LUNGS OF CF PATIENTS?;1156;0001
00055;WHAT ARE THE INTERACTIONS BETWEEN PROTEASES (ENDOGENOUS OR BACTERIAL ORIGIN) AND ANTIPROTEASES IN THE LUNGS OF CF PATIENTS?;1205;2110
00056;WHAT IS THE RELATIONSHIP BETWEEN NUTRITION AND PULMONARY HOST DEFENSES AGAINST BACTERIAL INFECTION IN CF PATIENTS?;55;1000
00056;WHAT IS THE RELATIONSHIP BETWEEN NUTRITION AND PULMONARY HOST DEFENSES AGAINST BACTERIAL INFECTION IN CF PATIENTS?;89;0110
00056;WHAT IS THE RELATIONSHIP BETWEEN NUTRITION AND PULMONARY HOST DEFENSES AGAINST BACTERIAL INFECTION IN CF PATIENTS?;123;0001
00056;WHAT IS THE RELATIONSHIP BETWEEN NUTRITION AND PULMONARY HOST DEFENSES AGAINST BACTERIAL INFECTION IN CF PATIENTS?;135;0001
00056;WHAT IS THE RELATIONSHIP BETWEEN NUTRITION AND PULMONARY HOST DEFENSES AGAINST BACTERIAL INFECTION IN CF PATIENTS?;181;1012
00056;WHAT IS THE RELATIONSHIP BETWEEN NUTRITION AND PULMONARY HOST DEFENSES AGAINST BACTERIAL INFECTION IN CF PATIENTS?;185;1001
00056;WHAT IS THE RELATIONSHIP BETWEEN NUTRITION AND PULMONARY HOST DEFENSES AGAINST BACTERIAL INFECTION IN CF PATIENTS?;212;1012
00056;WHAT IS THE RELATIONSHIP BETWEEN NUTRITION AND PULMONARY HOST DEFENSES AGAINST BACTERIAL INFECTION IN CF PATIENTS?;288;0110
00056;WHAT IS THE RELATIONSHIP BETWEEN NUTRITION AND PULMONARY HOST DEFENSES AGAINST BACTERIAL INFECTION IN CF PATIENTS?;290;0110
00056;WHAT IS THE RELATIONSHIP BETWEEN NUTRITION AND PULMONARY HOST DEFENSES AGAINST BACTERIAL INFECTION IN CF PATIENTS?;292;0110
00056;WHAT IS THE RELATIONSHIP BETWEEN NUTRITION AND PULMONARY HOST DEFENSES AGAINST BACTERIAL INFECTION IN CF PATIENTS?;414;0100
00056;WHAT IS THE RELATIONSHIP BETWEEN NUTRITION AND PULMONARY HOST DEFENSES AGAINST BACTERIAL INFECTION IN CF PATIENTS?;424;0100
00056;WHAT IS THE RELATIONSHIP BETWEEN NUTRITION AND PULMONARY HOST DEFENSES AGAINST BACTERIAL INFECTION IN CF PATIENTS?;432;0100
00056;WHAT IS THE RELATIONSHIP BETWEEN NUTRITION AND PULMONARY HOST DEFENSES AGAINST BACTERIAL INFECTION IN CF PATIENTS?;443;0100
00056;WHAT IS THE RELATIONSHIP BETWEEN NUTRITION AND PULMONARY HOST DEFENSES AGAINST BACTERIAL INFECTION IN CF PATIENTS?;450;0002
00056;WHAT IS THE RELATIONSHIP BETWEEN NUTRITION AND PULMONARY HOST DEFENSES AGAINST BACTERIAL INFECTION IN CF PATIENTS?;758;0100
00056;WHAT IS THE RELATIONSHIP BETWEEN NUTRITION AND PULMONARY HOST DEFENSES AGAINST BACTERIAL INFECTION IN CF PATIENTS?;767;2222
00056;WHAT IS THE RELATIONSHIP BETWEEN NUTRITION AND PULMONARY HOST DEFENSES AGAINST BACTERIAL INFECTION IN CF PATIENTS?;783;1000
00056;WHAT IS THE RELATIONSHIP BETWEEN NUTRITION AND PULMONARY HOST DEFENSES AGAINST BACTERIAL INFECTION IN CF PATIENTS?;794;0100
00056;WHAT IS THE RELATIONSHIP BETWEEN NUTRITION AND PULMONARY HOST DEFENSES AGAINST BACTERIAL INFECTION IN CF PATIENTS?;919;0100
00056;WHAT IS THE RELATIONSHIP BETWEEN NUTRITION AND PULMONARY HOST DEFENSES AGAINST BACTERIAL INFECTION IN CF PATIENTS?;924;0100
00056;WHAT IS THE RELATIONSHIP BETWEEN NUTRITION AND PULMONARY HOST DEFENSES AGAINST BACTERIAL INFECTION IN CF PATIENTS?;925;0100
00056;WHAT IS THE RELATIONSHIP BETWEEN NUTRITION AND PULMONARY HOST DEFENSES AGAINST BACTERIAL INFECTION IN CF PATIENTS?;928;0100
00056;WHAT IS THE RELATIONSHIP BETWEEN NUTRITION AND PULMONARY HOST DEFENSES AGAINST BACTERIAL INFECTION IN CF PATIENTS?;970;0100
00056;WHAT IS THE RELATIONSHIP BETWEEN NUTRITION AND PULMONARY HOST DEFENSES AGAINST BACTERIAL INFECTION IN CF PATIENTS?;972;0100
00056;WHAT IS THE RELATIONSHIP BETWEEN NUTRITION AND PULMONARY HOST DEFENSES AGAINST BACTERIAL INFECTION IN CF PATIENTS?;1066;0100
00056;WHAT IS THE RELATIONSHIP BETWEEN NUTRITION AND PULMONARY HOST DEFENSES AGAINST BACTERIAL INFECTION IN CF PATIENTS?;1091;0012
00056;WHAT IS THE RELATIONSHIP BETWEEN NUTRITION AND PULMONARY HOST DEFENSES AGAINST BACTERIAL INFECTION IN CF PATIENTS?;1093;0001
00056;WHAT IS THE RELATIONSHIP BETWEEN NUTRITION AND PULMONARY HOST DEFENSES AGAINST BACTERIAL INFECTION IN CF PATIENTS?;1102;0100
00056;WHAT IS THE RELATIONSHIP BETWEEN NUTRITION AND PULMONARY HOST DEFENSES AGAINST BACTERIAL INFECTION IN CF PATIENTS?;1115;0100
00056;WHAT IS THE RELATIONSHIP BETWEEN NUTRITION AND PULMONARY HOST DEFENSES AGAINST BACTERIAL INFECTION IN CF PATIENTS?;1234;0001
00056;WHAT IS THE RELATIONSHIP BETWEEN NUTRITION AND PULMONARY HOST DEFENSES AGAINST BACTERIAL INFECTION IN CF PATIENTS?;1239;0100
00057;WHAT IS THE PATHOPHYSIOLOGIC ROLE OF CIRCULATING ANTIBODIES TO PSEUDOMONAS AERUGINOSA IN CF PATIENTS?;1;1222
00057;WHAT IS THE PATHOPHYSIOLOGIC ROLE OF CIRCULATING ANTIBODIES TO PSEUDOMONAS AERUGINOSA IN CF PATIENTS?;6;0001
00057;WHAT IS THE PATHOPHYSIOLOGIC ROLE OF CIRCULATING ANTIBODIES TO PSEUDOMONAS AERUGINOSA IN CF PATIENTS?;8;0100
00057;WHAT IS THE PATHOPHYSIOLOGIC ROLE OF CIRCULATING ANTIBODIES TO PSEUDOMONAS AERUGINOSA IN CF PATIENTS?;11;0001
00057;WHAT IS THE PATHOPHYSIOLOGIC ROLE OF CIRCULATING ANTIBODIES TO PSEUDOMONAS AERUGINOSA IN CF PATIENTS?;62;0010
00057;WHAT IS THE PATHOPHYSIOLOGIC ROLE OF CIRCULATING ANTIBODIES TO PSEUDOMONAS AERUGINOSA IN CF PATIENTS?;79;0100
00057;WHAT IS THE PATHOPHYSIOLOGIC ROLE OF CIRCULATING ANTIBODIES TO PSEUDOMONAS AERUGINOSA IN CF PATIENTS?;80;0010
00057;WHAT IS THE PATHOPHYSIOLOGIC ROLE OF CIRCULATING ANTIBODIES TO PSEUDOMONAS AERUGINOSA IN CF PATIENTS?;81;0010
00057;WHAT IS THE PATHOPHYSIOLOGIC ROLE OF CIRCULATING ANTIBODIES TO PSEUDOMONAS AERUGINOSA IN CF PATIENTS?;160;1001
00057;WHAT IS THE PATHOPHYSIOLOGIC ROLE OF CIRCULATING ANTIBODIES TO PSEUDOMONAS AERUGINOSA IN CF PATIENTS?;177;0100
00057;WHAT IS THE PATHOPHYSIOLOGIC ROLE OF CIRCULATING ANTIBODIES TO PSEUDOMONAS AERUGINOSA IN CF PATIENTS?;178;1110
00057;WHAT IS THE PATHOPHYSIOLOGIC ROLE OF CIRCULATING ANTIBODIES TO PSEUDOMONAS AERUGINOSA IN CF PATIENTS?;188;1010
00057;WHAT IS THE PATHOPHYSIOLOGIC ROLE OF CIRCULATING ANTIBODIES TO PSEUDOMONAS AERUGINOSA IN CF PATIENTS?;200;0100
00057;WHAT IS THE PATHOPHYSIOLOGIC ROLE OF CIRCULATING ANTIBODIES TO PSEUDOMONAS AERUGINOSA IN CF PATIENTS?;223;2211
00057;WHAT IS THE PATHOPHYSIOLOGIC ROLE OF CIRCULATING ANTIBODIES TO PSEUDOMONAS AERUGINOSA IN CF PATIENTS?;228;1000
00057;WHAT IS THE PATHOPHYSIOLOGIC ROLE OF CIRCULATING ANTIBODIES TO PSEUDOMONAS AERUGINOSA IN CF PATIENTS?;282;0012
00057;WHAT IS THE PATHOPHYSIOLOGIC ROLE OF CIRCULATING ANTIBODIES TO PSEUDOMONAS AERUGINOSA IN CF PATIENTS?;346;2120
00057;WHAT IS THE PATHOPHYSIOLOGIC ROLE OF CIRCULATING ANTIBODIES TO PSEUDOMONAS AERUGINOSA IN CF PATIENTS?;369;1000
00057;WHAT IS THE PATHOPHYSIOLOGIC ROLE OF CIRCULATING ANTIBODIES TO PSEUDOMONAS AERUGINOSA IN CF PATIENTS?;370;1110
00057;WHAT IS THE PATHOPHYSIOLOGIC ROLE OF CIRCULATING ANTIBODIES TO PSEUDOMONAS AERUGINOSA IN CF PATIENTS?;394;1220
00057;WHAT IS THE PATHOPHYSIOLOGIC ROLE OF CIRCULATING ANTIBODIES TO PSEUDOMONAS AERUGINOSA IN CF PATIENTS?;397;0100
00057;WHAT IS THE PATHOPHYSIOLOGIC ROLE OF CIRCULATING ANTIBODIES TO PSEUDOMONAS AERUGINOSA IN CF PATIENTS?;415;1000
00057;WHAT IS THE PATHOPHYSIOLOGIC ROLE OF CIRCULATING ANTIBODIES TO PSEUDOMONAS AERUGINOSA IN CF PATIENTS?;432;2120
00057;WHAT IS THE PATHOPHYSIOLOGIC ROLE OF CIRCULATING ANTIBODIES TO PSEUDOMONAS AERUGINOSA IN CF PATIENTS?;447;0100
00057;WHAT IS THE PATHOPHYSIOLOGIC ROLE OF CIRCULATING ANTIBODIES TO PSEUDOMONAS AERUGINOSA IN CF PATIENTS?;513;1000
00057;WHAT IS THE PATHOPHYSIOLOGIC ROLE OF CIRCULATING ANTIBODIES TO PSEUDOMONAS AERUGINOSA IN CF PATIENTS?;577;0010
00057;WHAT IS THE PATHOPHYSIOLOGIC ROLE OF CIRCULATING ANTIBODIES TO PSEUDOMONAS AERUGINOSA IN CF PATIENTS?;588;2220
00057;WHAT IS THE PATHOPHYSIOLOGIC ROLE OF CIRCULATING ANTIBODIES TO PSEUDOMONAS AERUGINOSA IN CF PATIENTS?;590;2222
00057;WHAT IS THE PATHOPHYSIOLOGIC ROLE OF CIRCULATING ANTIBODIES TO PSEUDOMONAS AERUGINOSA IN CF PATIENTS?;668;0010
00057;WHAT IS THE PATHOPHYSIOLOGIC ROLE OF CIRCULATING ANTIBODIES TO PSEUDOMONAS AERUGINOSA IN CF PATIENTS?;778;1210
00057;WHAT IS THE PATHOPHYSIOLOGIC ROLE OF CIRCULATING ANTIBODIES TO PSEUDOMONAS AERUGINOSA IN CF PATIENTS?;784;1000
00057;WHAT IS THE PATHOPHYSIOLOGIC ROLE OF CIRCULATING ANTIBODIES TO PSEUDOMONAS AERUGINOSA IN CF PATIENTS?;790;2220
00057;WHAT IS THE PATHOPHYSIOLOGIC ROLE OF CIRCULATING ANTIBODIES TO PSEUDOMONAS AERUGINOSA IN CF PATIENTS?;812;0101
00057;WHAT IS THE PATHOPHYSIOLOGIC ROLE OF CIRCULATING ANTIBODIES TO PSEUDOMONAS AERUGINOSA IN CF PATIENTS?;833;1000
00057;WHAT IS THE PATHOPHYSIOLOGIC ROLE OF CIRCULATING ANTIBODIES TO PSEUDOMONAS AERUGINOSA IN CF PATIENTS?;860;1120
00057;WHAT IS THE PATHOPHYSIOLOGIC ROLE OF CIRCULATING ANTIBODIES TO PSEUDOMONAS AERUGINOSA IN CF PATIENTS?;865;2110
00057;WHAT IS THE PATHOPHYSIOLOGIC ROLE OF CIRCULATING ANTIBODIES TO PSEUDOMONAS AERUGINOSA IN CF PATIENTS?;890;0101
00057;WHAT IS THE PATHOPHYSIOLOGIC ROLE OF CIRCULATING ANTIBODIES TO PSEUDOMONAS AERUGINOSA IN CF PATIENTS?;905;1210
00057;WHAT IS THE PATHOPHYSIOLOGIC ROLE OF CIRCULATING ANTIBODIES TO PSEUDOMONAS AERUGINOSA IN CF PATIENTS?;983;1220
00057;WHAT IS THE PATHOPHYSIOLOGIC ROLE OF CIRCULATING ANTIBODIES TO PSEUDOMONAS AERUGINOSA IN CF PATIENTS?;986;1120
00057;WHAT IS THE PATHOPHYSIOLOGIC ROLE OF CIRCULATING ANTIBODIES TO PSEUDOMONAS AERUGINOSA IN CF PATIENTS?;987;1121
00057;WHAT IS THE PATHOPHYSIOLOGIC ROLE OF CIRCULATING ANTIBODIES TO PSEUDOMONAS AERUGINOSA IN CF PATIENTS?;988;2220
00057;WHAT IS THE PATHOPHYSIOLOGIC ROLE OF CIRCULATING ANTIBODIES TO PSEUDOMONAS AERUGINOSA IN CF PATIENTS?;989;1010
00057;WHAT IS THE PATHOPHYSIOLOGIC ROLE OF CIRCULATING ANTIBODIES TO PSEUDOMONAS AERUGINOSA IN CF PATIENTS?;1086;0100
00057;WHAT IS THE PATHOPHYSIOLOGIC ROLE OF CIRCULATING ANTIBODIES TO PSEUDOMONAS AERUGINOSA IN CF PATIENTS?;1090;0100
00057;WHAT IS THE PATHOPHYSIOLOGIC ROLE OF CIRCULATING ANTIBODIES TO PSEUDOMONAS AERUGINOSA IN CF PATIENTS?;1091;0011
00057;WHAT IS THE PATHOPHYSIOLOGIC ROLE OF CIRCULATING ANTIBODIES TO PSEUDOMONAS AERUGINOSA IN CF PATIENTS?;1095;2110
00057;WHAT IS THE PATHOPHYSIOLOGIC ROLE OF CIRCULATING ANTIBODIES TO PSEUDOMONAS AERUGINOSA IN CF PATIENTS?;1170;0002
00057;WHAT IS THE PATHOPHYSIOLOGIC ROLE OF CIRCULATING ANTIBODIES TO PSEUDOMONAS AERUGINOSA IN CF PATIENTS?;1171;0002
00057;WHAT IS THE PATHOPHYSIOLOGIC ROLE OF CIRCULATING ANTIBODIES TO PSEUDOMONAS AERUGINOSA IN CF PATIENTS?;1173;1120
00057;WHAT IS THE PATHOPHYSIOLOGIC ROLE OF CIRCULATING ANTIBODIES TO PSEUDOMONAS AERUGINOSA IN CF PATIENTS?;1203;1100
00058;WHAT IS THE IMMUNOLOGIC RESPONSE TO PULMONARY INFECTION IN CF PATIENTS?;1;2222
00058;WHAT IS THE IMMUNOLOGIC RESPONSE TO PULMONARY INFECTION IN CF PATIENTS?;6;2222
00058;WHAT IS THE IMMUNOLOGIC RESPONSE TO PULMONARY INFECTION IN CF PATIENTS?;7;2222
00058;WHAT IS THE IMMUNOLOGIC RESPONSE TO PULMONARY INFECTION IN CF PATIENTS?;43;0100
00058;WHAT IS THE IMMUNOLOGIC RESPONSE TO PULMONARY INFECTION IN CF PATIENTS?;48;1010
00058;WHAT IS THE IMMUNOLOGIC RESPONSE TO PULMONARY INFECTION IN CF PATIENTS?;55;2210
00058;WHAT IS THE IMMUNOLOGIC RESPONSE TO PULMONARY INFECTION IN CF PATIENTS?;60;0100
00058;WHAT IS THE IMMUNOLOGIC RESPONSE TO PULMONARY INFECTION IN CF PATIENTS?;62;2112
00058;WHAT IS THE IMMUNOLOGIC RESPONSE TO PULMONARY INFECTION IN CF PATIENTS?;63;2110
00058;WHAT IS THE IMMUNOLOGIC RESPONSE TO PULMONARY INFECTION IN CF PATIENTS?;80;2212
00058;WHAT IS THE IMMUNOLOGIC RESPONSE TO PULMONARY INFECTION IN CF PATIENTS?;81;0002
00058;WHAT IS THE IMMUNOLOGIC RESPONSE TO PULMONARY INFECTION IN CF PATIENTS?;82;2210
00058;WHAT IS THE IMMUNOLOGIC RESPONSE TO PULMONARY INFECTION IN CF PATIENTS?;102;0001
00058;WHAT IS THE IMMUNOLOGIC RESPONSE TO PULMONARY INFECTION IN CF PATIENTS?;111;0010
00058;WHAT IS THE IMMUNOLOGIC RESPONSE TO PULMONARY INFECTION IN CF PATIENTS?;160;2222
00058;WHAT IS THE IMMUNOLOGIC RESPONSE TO PULMONARY INFECTION IN CF PATIENTS?;164;0001
00058;WHAT IS THE IMMUNOLOGIC RESPONSE TO PULMONARY INFECTION IN CF PATIENTS?;178;2122
00058;WHAT IS THE IMMUNOLOGIC RESPONSE TO PULMONARY INFECTION IN CF PATIENTS?;179;2110
00058;WHAT IS THE IMMUNOLOGIC RESPONSE TO PULMONARY INFECTION IN CF PATIENTS?;187;2120
00058;WHAT IS THE IMMUNOLOGIC RESPONSE TO PULMONARY INFECTION IN CF PATIENTS?;188;2121
00058;WHAT IS THE IMMUNOLOGIC RESPONSE TO PULMONARY INFECTION IN CF PATIENTS?;200;1002
00058;WHAT IS THE IMMUNOLOGIC RESPONSE TO PULMONARY INFECTION IN CF PATIENTS?;223;2221
00058;WHAT IS THE IMMUNOLOGIC RESPONSE TO PULMONARY INFECTION IN CF PATIENTS?;228;2120
00058;WHAT IS THE IMMUNOLOGIC RESPONSE TO PULMONARY INFECTION IN CF PATIENTS?;229;1220
00058;WHAT IS THE IMMUNOLOGIC RESPONSE TO PULMONARY INFECTION IN CF PATIENTS?;271;2210
00058;WHAT IS THE IMMUNOLOGIC RESPONSE TO PULMONARY INFECTION IN CF PATIENTS?;282;1001
00058;WHAT IS THE IMMUNOLOGIC RESPONSE TO PULMONARY INFECTION IN CF PATIENTS?;335;1001
00058;WHAT IS THE IMMUNOLOGIC RESPONSE TO PULMONARY INFECTION IN CF PATIENTS?;346;2122
00058;WHAT IS THE IMMUNOLOGIC RESPONSE TO PULMONARY INFECTION IN CF PATIENTS?;347;2121
00058;WHAT IS THE IMMUNOLOGIC RESPONSE TO PULMONARY INFECTION IN CF PATIENTS?;366;0010
00058;WHAT IS THE IMMUNOLOGIC RESPONSE TO PULMONARY INFECTION IN CF PATIENTS?;369;2220
00058;WHAT IS THE IMMUNOLOGIC RESPONSE TO PULMONARY INFECTION IN CF PATIENTS?;370;1100
00058;WHAT IS THE IMMUNOLOGIC RESPONSE TO PULMONARY INFECTION IN CF PATIENTS?;384;1000
00058;WHAT IS THE IMMUNOLOGIC RESPONSE TO PULMONARY INFECTION IN CF PATIENTS?;392;0010
00058;WHAT IS THE IMMUNOLOGIC RESPONSE TO PULMONARY INFECTION IN CF PATIENTS?;394;2211
00058;WHAT IS THE IMMUNOLOGIC RESPONSE TO PULMONARY INFECTION IN CF PATIENTS?;397;0100
00058;WHAT IS THE IMMUNOLOGIC RESPONSE TO PULMONARY INFECTION IN CF PATIENTS?;402;0001
00058;WHAT IS THE IMMUNOLOGIC RESPONSE TO PULMONARY INFECTION IN CF PATIENTS?;415;1001
00058;WHAT IS THE IMMUNOLOGIC RESPONSE TO PULMONARY INFECTION IN CF PATIENTS?;427;0001
00058;WHAT IS THE IMMUNOLOGIC RESPONSE TO PULMONARY INFECTION IN CF PATIENTS?;429;0100
00058;WHAT IS THE IMMUNOLOGIC RESPONSE TO PULMONARY INFECTION IN CF PATIENTS?;432;2122
00058;WHAT IS THE IMMUNOLOGIC RESPONSE TO PULMONARY INFECTION IN CF PATIENTS?;447;2122
00058;WHAT IS THE IMMUNOLOGIC RESPONSE TO PULMONARY INFECTION IN CF PATIENTS?;457;0001
00058;WHAT IS THE IMMUNOLOGIC RESPONSE TO PULMONARY INFECTION IN CF PATIENTS?;463;0010
00058;WHAT IS THE IMMUNOLOGIC RESPONSE TO PULMONARY INFECTION IN CF PATIENTS?;485;0001
00058;WHAT IS THE IMMUNOLOGIC RESPONSE TO PULMONARY INFECTION IN CF PATIENTS?;505;1120
00058;WHAT IS THE IMMUNOLOGIC RESPONSE TO PULMONARY INFECTION IN CF PATIENTS?;511;0100
00058;WHAT IS THE IMMUNOLOGIC RESPONSE TO PULMONARY INFECTION IN CF PATIENTS?;513;0111
00058;WHAT IS THE IMMUNOLOGIC RESPONSE TO PULMONARY INFECTION IN CF PATIENTS?;517;0010
00058;WHAT IS THE IMMUNOLOGIC RESPONSE TO PULMONARY INFECTION IN CF PATIENTS?;550;0001
00058;WHAT IS THE IMMUNOLOGIC RESPONSE TO PULMONARY INFECTION IN CF PATIENTS?;577;2122
00058;WHAT IS THE IMMUNOLOGIC RESPONSE TO PULMONARY INFECTION IN CF PATIENTS?;588;2122
00058;WHAT IS THE IMMUNOLOGIC RESPONSE TO PULMONARY INFECTION IN CF PATIENTS?;589;2110
00058;WHAT IS THE IMMUNOLOGIC RESPONSE TO PULMONARY INFECTION IN CF PATIENTS?;590;2222
00058;WHAT IS THE IMMUNOLOGIC RESPONSE TO PULMONARY INFECTION IN CF PATIENTS?;591;2222
00058;WHAT IS THE IMMUNOLOGIC RESPONSE TO PULMONARY INFECTION IN CF PATIENTS?;609;0010
00058;WHAT IS THE IMMUNOLOGIC RESPONSE TO PULMONARY INFECTION IN CF PATIENTS?;614;2121
00058;WHAT IS THE IMMUNOLOGIC RESPONSE TO PULMONARY INFECTION IN CF PATIENTS?;631;2120
00058;WHAT IS THE IMMUNOLOGIC RESPONSE TO PULMONARY INFECTION IN CF PATIENTS?;668;1021
00058;WHAT IS THE IMMUNOLOGIC RESPONSE TO PULMONARY INFECTION IN CF PATIENTS?;748;0010
00058;WHAT IS THE IMMUNOLOGIC RESPONSE TO PULMONARY INFECTION IN CF PATIENTS?;749;0010
00058;WHAT IS THE IMMUNOLOGIC RESPONSE TO PULMONARY INFECTION IN CF PATIENTS?;769;1121
00058;WHAT IS THE IMMUNOLOGIC RESPONSE TO PULMONARY INFECTION IN CF PATIENTS?;778;2212
00058;WHAT IS THE IMMUNOLOGIC RESPONSE TO PULMONARY INFECTION IN CF PATIENTS?;784;1002
00058;WHAT IS THE IMMUNOLOGIC RESPONSE TO PULMONARY INFECTION IN CF PATIENTS?;790;2222
00058;WHAT IS THE IMMUNOLOGIC RESPONSE TO PULMONARY INFECTION IN CF PATIENTS?;805;0001
00058;WHAT IS THE IMMUNOLOGIC RESPONSE TO PULMONARY INFECTION IN CF PATIENTS?;812;2212
00058;WHAT IS THE IMMUNOLOGIC RESPONSE TO PULMONARY INFECTION IN CF PATIENTS?;820;0001
00058;WHAT IS THE IMMUNOLOGIC RESPONSE TO PULMONARY INFECTION IN CF PATIENTS?;860;2222
00058;WHAT IS THE IMMUNOLOGIC RESPONSE TO PULMONARY INFECTION IN CF PATIENTS?;865;2122
00058;WHAT IS THE IMMUNOLOGIC RESPONSE TO PULMONARY INFECTION IN CF PATIENTS?;874;1112
00058;WHAT IS THE IMMUNOLOGIC RESPONSE TO PULMONARY INFECTION IN CF PATIENTS?;890;2122
00058;WHAT IS THE IMMUNOLOGIC RESPONSE TO PULMONARY INFECTION IN CF PATIENTS?;903;0110
00058;WHAT IS THE IMMUNOLOGIC RESPONSE TO PULMONARY INFECTION IN CF PATIENTS?;905;2220
00058;WHAT IS THE IMMUNOLOGIC RESPONSE TO PULMONARY INFECTION IN CF PATIENTS?;912;0001
00058;WHAT IS THE IMMUNOLOGIC RESPONSE TO PULMONARY INFECTION IN CF PATIENTS?;917;2211
00058;WHAT IS THE IMMUNOLOGIC RESPONSE TO PULMONARY INFECTION IN CF PATIENTS?;964;0100
00058;WHAT IS THE IMMUNOLOGIC RESPONSE TO PULMONARY INFECTION IN CF PATIENTS?;983;2222
00058;WHAT IS THE IMMUNOLOGIC RESPONSE TO PULMONARY INFECTION IN CF PATIENTS?;986;2222
00058;WHAT IS THE IMMUNOLOGIC RESPONSE TO PULMONARY INFECTION IN CF PATIENTS?;987;2222
00058;WHAT IS THE IMMUNOLOGIC RESPONSE TO PULMONARY INFECTION IN CF PATIENTS?;988;2222
00058;WHAT IS THE IMMUNOLOGIC RESPONSE TO PULMONARY INFECTION IN CF PATIENTS?;989;2222
00058;WHAT IS THE IMMUNOLOGIC RESPONSE TO PULMONARY INFECTION IN CF PATIENTS?;990;0001
00058;WHAT IS THE IMMUNOLOGIC RESPONSE TO PULMONARY INFECTION IN CF PATIENTS?;1005;0001
00058;WHAT IS THE IMMUNOLOGIC RESPONSE TO PULMONARY INFECTION IN CF PATIENTS?;1025;1100
00058;WHAT IS THE IMMUNOLOGIC RESPONSE TO PULMONARY INFECTION IN CF PATIENTS?;1077;2220
00058;WHAT IS THE IMMUNOLOGIC RESPONSE TO PULMONARY INFECTION IN CF PATIENTS?;1086;0100
00058;WHAT IS THE IMMUNOLOGIC RESPONSE TO PULMONARY INFECTION IN CF PATIENTS?;1090;0100
00058;WHAT IS THE IMMUNOLOGIC RESPONSE TO PULMONARY INFECTION IN CF PATIENTS?;1091;0011
00058;WHAT IS THE IMMUNOLOGIC RESPONSE TO PULMONARY INFECTION IN CF PATIENTS?;1134;0002
00058;WHAT IS THE IMMUNOLOGIC RESPONSE TO PULMONARY INFECTION IN CF PATIENTS?;1170;2221
00058;WHAT IS THE IMMUNOLOGIC RESPONSE TO PULMONARY INFECTION IN CF PATIENTS?;1171;1122
00058;WHAT IS THE IMMUNOLOGIC RESPONSE TO PULMONARY INFECTION IN CF PATIENTS?;1173;2222
00058;WHAT IS THE IMMUNOLOGIC RESPONSE TO PULMONARY INFECTION IN CF PATIENTS?;1228;1000
00058;WHAT IS THE IMMUNOLOGIC RESPONSE TO PULMONARY INFECTION IN CF PATIENTS?;1234;0001
00059;WHAT IMMUNOLOGIC ABNORMALITIES HAVE BEEN FOUND IN CF PATIENTS?;1;0002
00059;WHAT IMMUNOLOGIC ABNORMALITIES HAVE BEEN FOUND IN CF PATIENTS?;6;0001
00059;WHAT IMMUNOLOGIC ABNORMALITIES HAVE BEEN FOUND IN CF PATIENTS?;11;0001
00059;WHAT IMMUNOLOGIC ABNORMALITIES HAVE BEEN FOUND IN CF PATIENTS?;18;0101
00059;WHAT IMMUNOLOGIC ABNORMALITIES HAVE BEEN FOUND IN CF PATIENTS?;45;0010
00059;WHAT IMMUNOLOGIC ABNORMALITIES HAVE BEEN FOUND IN CF PATIENTS?;48;0112
00059;WHAT IMMUNOLOGIC ABNORMALITIES HAVE BEEN FOUND IN CF PATIENTS?;55;2222
00059;WHAT IMMUNOLOGIC ABNORMALITIES HAVE BEEN FOUND IN CF PATIENTS?;62;0002
00059;WHAT IMMUNOLOGIC ABNORMALITIES HAVE BEEN FOUND IN CF PATIENTS?;63;0002
00059;WHAT IMMUNOLOGIC ABNORMALITIES HAVE BEEN FOUND IN CF PATIENTS?;67;0001
00059;WHAT IMMUNOLOGIC ABNORMALITIES HAVE BEEN FOUND IN CF PATIENTS?;79;1000
00059;WHAT IMMUNOLOGIC ABNORMALITIES HAVE BEEN FOUND IN CF PATIENTS?;80;0002
00059;WHAT IMMUNOLOGIC ABNORMALITIES HAVE BEEN FOUND IN CF PATIENTS?;81;1002
00059;WHAT IMMUNOLOGIC ABNORMALITIES HAVE BEEN FOUND IN CF PATIENTS?;84;1012
00059;WHAT IMMUNOLOGIC ABNORMALITIES HAVE BEEN FOUND IN CF PATIENTS?;102;2111
00059;WHAT IMMUNOLOGIC ABNORMALITIES HAVE BEEN FOUND IN CF PATIENTS?;107;1012
00059;WHAT IMMUNOLOGIC ABNORMALITIES HAVE BEEN FOUND IN CF PATIENTS?;110;0001
00059;WHAT IMMUNOLOGIC ABNORMALITIES HAVE BEEN FOUND IN CF PATIENTS?;111;0100
00059;WHAT IMMUNOLOGIC ABNORMALITIES HAVE BEEN FOUND IN CF PATIENTS?;122;1100
00059;WHAT IMMUNOLOGIC ABNORMALITIES HAVE BEEN FOUND IN CF PATIENTS?;160;0101
00059;WHAT IMMUNOLOGIC ABNORMALITIES HAVE BEEN FOUND IN CF PATIENTS?;164;0001
00059;WHAT IMMUNOLOGIC ABNORMALITIES HAVE BEEN FOUND IN CF PATIENTS?;166;0110
00059;WHAT IMMUNOLOGIC ABNORMALITIES HAVE BEEN FOUND IN CF PATIENTS?;177;0001
00059;WHAT IMMUNOLOGIC ABNORMALITIES HAVE BEEN FOUND IN CF PATIENTS?;179;0001
00059;WHAT IMMUNOLOGIC ABNORMALITIES HAVE BEEN FOUND IN CF PATIENTS?;187;0002
00059;WHAT IMMUNOLOGIC ABNORMALITIES HAVE BEEN FOUND IN CF PATIENTS?;188;0001
00059;WHAT IMMUNOLOGIC ABNORMALITIES HAVE BEEN FOUND IN CF PATIENTS?;191;1102
00059;WHAT IMMUNOLOGIC ABNORMALITIES HAVE BEEN FOUND IN CF PATIENTS?;200;0001
00059;WHAT IMMUNOLOGIC ABNORMALITIES HAVE BEEN FOUND IN CF PATIENTS?;214;2111
00059;WHAT IMMUNOLOGIC ABNORMALITIES HAVE BEEN FOUND IN CF PATIENTS?;223;2222
00059;WHAT IMMUNOLOGIC ABNORMALITIES HAVE BEEN FOUND IN CF PATIENTS?;228;1112
00059;WHAT IMMUNOLOGIC ABNORMALITIES HAVE BEEN FOUND IN CF PATIENTS?;229;1222
00059;WHAT IMMUNOLOGIC ABNORMALITIES HAVE BEEN FOUND IN CF PATIENTS?;245;0010
00059;WHAT IMMUNOLOGIC ABNORMALITIES HAVE BEEN FOUND IN CF PATIENTS?;275;1011
00059;WHAT IMMUNOLOGIC ABNORMALITIES HAVE BEEN FOUND IN CF PATIENTS?;279;2111
00059;WHAT IMMUNOLOGIC ABNORMALITIES HAVE BEEN FOUND IN CF PATIENTS?;281;0001
00059;WHAT IMMUNOLOGIC ABNORMALITIES HAVE BEEN FOUND IN CF PATIENTS?;284;2112
00059;WHAT IMMUNOLOGIC ABNORMALITIES HAVE BEEN FOUND IN CF PATIENTS?;306;0001
00059;WHAT IMMUNOLOGIC ABNORMALITIES HAVE BEEN FOUND IN CF PATIENTS?;333;0001
00059;WHAT IMMUNOLOGIC ABNORMALITIES HAVE BEEN FOUND IN CF PATIENTS?;335;0111
00059;WHAT IMMUNOLOGIC ABNORMALITIES HAVE BEEN FOUND IN CF PATIENTS?;346;0101
00059;WHAT IMMUNOLOGIC ABNORMALITIES HAVE BEEN FOUND IN CF PATIENTS?;347;1002
00059;WHAT IMMUNOLOGIC ABNORMALITIES HAVE BEEN FOUND IN CF PATIENTS?;365;2111
00059;WHAT IMMUNOLOGIC ABNORMALITIES HAVE BEEN FOUND IN CF PATIENTS?;366;2111
00059;WHAT IMMUNOLOGIC ABNORMALITIES HAVE BEEN FOUND IN CF PATIENTS?;369;0001
00059;WHAT IMMUNOLOGIC ABNORMALITIES HAVE BEEN FOUND IN CF PATIENTS?;370;1011
00059;WHAT IMMUNOLOGIC ABNORMALITIES HAVE BEEN FOUND IN CF PATIENTS?;382;0001
00059;WHAT IMMUNOLOGIC ABNORMALITIES HAVE BEEN FOUND IN CF PATIENTS?;386;1001
00059;WHAT IMMUNOLOGIC ABNORMALITIES HAVE BEEN FOUND IN CF PATIENTS?;392;0011
00059;WHAT IMMUNOLOGIC ABNORMALITIES HAVE BEEN FOUND IN CF PATIENTS?;394;2212
00059;WHAT IMMUNOLOGIC ABNORMALITIES HAVE BEEN FOUND IN CF PATIENTS?;397;2121
00059;WHAT IMMUNOLOGIC ABNORMALITIES HAVE BEEN FOUND IN CF PATIENTS?;401;2122
00059;WHAT IMMUNOLOGIC ABNORMALITIES HAVE BEEN FOUND IN CF PATIENTS?;402;2222
00059;WHAT IMMUNOLOGIC ABNORMALITIES HAVE BEEN FOUND IN CF PATIENTS?;415;0002
00059;WHAT IMMUNOLOGIC ABNORMALITIES HAVE BEEN FOUND IN CF PATIENTS?;425;0010
00059;WHAT IMMUNOLOGIC ABNORMALITIES HAVE BEEN FOUND IN CF PATIENTS?;427;0001
00059;WHAT IMMUNOLOGIC ABNORMALITIES HAVE BEEN FOUND IN CF PATIENTS?;430;0001
00059;WHAT IMMUNOLOGIC ABNORMALITIES HAVE BEEN FOUND IN CF PATIENTS?;432;2122
00059;WHAT IMMUNOLOGIC ABNORMALITIES HAVE BEEN FOUND IN CF PATIENTS?;442;0001
00059;WHAT IMMUNOLOGIC ABNORMALITIES HAVE BEEN FOUND IN CF PATIENTS?;444;0001
00059;WHAT IMMUNOLOGIC ABNORMALITIES HAVE BEEN FOUND IN CF PATIENTS?;447;0002
00059;WHAT IMMUNOLOGIC ABNORMALITIES HAVE BEEN FOUND IN CF PATIENTS?;452;0001
00059;WHAT IMMUNOLOGIC ABNORMALITIES HAVE BEEN FOUND IN CF PATIENTS?;465;0001
00059;WHAT IMMUNOLOGIC ABNORMALITIES HAVE BEEN FOUND IN CF PATIENTS?;485;1001
00059;WHAT IMMUNOLOGIC ABNORMALITIES HAVE BEEN FOUND IN CF PATIENTS?;504;0001
00059;WHAT IMMUNOLOGIC ABNORMALITIES HAVE BEEN FOUND IN CF PATIENTS?;505;1122
00059;WHAT IMMUNOLOGIC ABNORMALITIES HAVE BEEN FOUND IN CF PATIENTS?;509;2112
00059;WHAT IMMUNOLOGIC ABNORMALITIES HAVE BEEN FOUND IN CF PATIENTS?;513;1112
00059;WHAT IMMUNOLOGIC ABNORMALITIES HAVE BEEN FOUND IN CF PATIENTS?;521;0002
00059;WHAT IMMUNOLOGIC ABNORMALITIES HAVE BEEN FOUND IN CF PATIENTS?;524;0001
00059;WHAT IMMUNOLOGIC ABNORMALITIES HAVE BEEN FOUND IN CF PATIENTS?;530;0002
00059;WHAT IMMUNOLOGIC ABNORMALITIES HAVE BEEN FOUND IN CF PATIENTS?;565;1121
00059;WHAT IMMUNOLOGIC ABNORMALITIES HAVE BEEN FOUND IN CF PATIENTS?;572;1011
00059;WHAT IMMUNOLOGIC ABNORMALITIES HAVE BEEN FOUND IN CF PATIENTS?;574;1011
00059;WHAT IMMUNOLOGIC ABNORMALITIES HAVE BEEN FOUND IN CF PATIENTS?;577;2222
00059;WHAT IMMUNOLOGIC ABNORMALITIES HAVE BEEN FOUND IN CF PATIENTS?;588;0112
00059;WHAT IMMUNOLOGIC ABNORMALITIES HAVE BEEN FOUND IN CF PATIENTS?;590;1012
00059;WHAT IMMUNOLOGIC ABNORMALITIES HAVE BEEN FOUND IN CF PATIENTS?;591;0002
00059;WHAT IMMUNOLOGIC ABNORMALITIES HAVE BEEN FOUND IN CF PATIENTS?;607;0001
00059;WHAT IMMUNOLOGIC ABNORMALITIES HAVE BEEN FOUND IN CF PATIENTS?;608;1220
00059;WHAT IMMUNOLOGIC ABNORMALITIES HAVE BEEN FOUND IN CF PATIENTS?;609;0100
00059;WHAT IMMUNOLOGIC ABNORMALITIES HAVE BEEN FOUND IN CF PATIENTS?;614;0002
00059;WHAT IMMUNOLOGIC ABNORMALITIES HAVE BEEN FOUND IN CF PATIENTS?;631;0101
00059;WHAT IMMUNOLOGIC ABNORMALITIES HAVE BEEN FOUND IN CF PATIENTS?;668;2222
00059;WHAT IMMUNOLOGIC ABNORMALITIES HAVE BEEN FOUND IN CF PATIENTS?;670;1122
00059;WHAT IMMUNOLOGIC ABNORMALITIES HAVE BEEN FOUND IN CF PATIENTS?;678;0001
00059;WHAT IMMUNOLOGIC ABNORMALITIES HAVE BEEN FOUND IN CF PATIENTS?;679;0001
00059;WHAT IMMUNOLOGIC ABNORMALITIES HAVE BEEN FOUND IN CF PATIENTS?;685;0010
00059;WHAT IMMUNOLOGIC ABNORMALITIES HAVE BEEN FOUND IN CF PATIENTS?;689;2111
00059;WHAT IMMUNOLOGIC ABNORMALITIES HAVE BEEN FOUND IN CF PATIENTS?;738;0001
00059;WHAT IMMUNOLOGIC ABNORMALITIES HAVE BEEN FOUND IN CF PATIENTS?;748;0001
00059;WHAT IMMUNOLOGIC ABNORMALITIES HAVE BEEN FOUND IN CF PATIENTS?;767;2212
00059;WHAT IMMUNOLOGIC ABNORMALITIES HAVE BEEN FOUND IN CF PATIENTS?;769;0001
00059;WHAT IMMUNOLOGIC ABNORMALITIES HAVE BEEN FOUND IN CF PATIENTS?;778;0101
00059;WHAT IMMUNOLOGIC ABNORMALITIES HAVE BEEN FOUND IN CF PATIENTS?;784;2122
00059;WHAT IMMUNOLOGIC ABNORMALITIES HAVE BEEN FOUND IN CF PATIENTS?;790;2120
00059;WHAT IMMUNOLOGIC ABNORMALITIES HAVE BEEN FOUND IN CF PATIENTS?;812;2222
00059;WHAT IMMUNOLOGIC ABNORMALITIES HAVE BEEN FOUND IN CF PATIENTS?;820;0001
00059;WHAT IMMUNOLOGIC ABNORMALITIES HAVE BEEN FOUND IN CF PATIENTS?;827;1001
00059;WHAT IMMUNOLOGIC ABNORMALITIES HAVE BEEN FOUND IN CF PATIENTS?;828;0001
00059;WHAT IMMUNOLOGIC ABNORMALITIES HAVE BEEN FOUND IN CF PATIENTS?;833;2121
00059;WHAT IMMUNOLOGIC ABNORMALITIES HAVE BEEN FOUND IN CF PATIENTS?;860;0102
00059;WHAT IMMUNOLOGIC ABNORMALITIES HAVE BEEN FOUND IN CF PATIENTS?;865;2122
00059;WHAT IMMUNOLOGIC ABNORMALITIES HAVE BEEN FOUND IN CF PATIENTS?;869;0100
00059;WHAT IMMUNOLOGIC ABNORMALITIES HAVE BEEN FOUND IN CF PATIENTS?;874;0102
00059;WHAT IMMUNOLOGIC ABNORMALITIES HAVE BEEN FOUND IN CF PATIENTS?;882;0001
00059;WHAT IMMUNOLOGIC ABNORMALITIES HAVE BEEN FOUND IN CF PATIENTS?;903;1111
00059;WHAT IMMUNOLOGIC ABNORMALITIES HAVE BEEN FOUND IN CF PATIENTS?;905;2221
00059;WHAT IMMUNOLOGIC ABNORMALITIES HAVE BEEN FOUND IN CF PATIENTS?;912;0001
00059;WHAT IMMUNOLOGIC ABNORMALITIES HAVE BEEN FOUND IN CF PATIENTS?;917;0101
00059;WHAT IMMUNOLOGIC ABNORMALITIES HAVE BEEN FOUND IN CF PATIENTS?;936;2112
00059;WHAT IMMUNOLOGIC ABNORMALITIES HAVE BEEN FOUND IN CF PATIENTS?;937;0001
00059;WHAT IMMUNOLOGIC ABNORMALITIES HAVE BEEN FOUND IN CF PATIENTS?;964;0100
00059;WHAT IMMUNOLOGIC ABNORMALITIES HAVE BEEN FOUND IN CF PATIENTS?;977;0010
00059;WHAT IMMUNOLOGIC ABNORMALITIES HAVE BEEN FOUND IN CF PATIENTS?;983;0102
00059;WHAT IMMUNOLOGIC ABNORMALITIES HAVE BEEN FOUND IN CF PATIENTS?;986;0102
00059;WHAT IMMUNOLOGIC ABNORMALITIES HAVE BEEN FOUND IN CF PATIENTS?;987;0002
00059;WHAT IMMUNOLOGIC ABNORMALITIES HAVE BEEN FOUND IN CF PATIENTS?;988;0102
00059;WHAT IMMUNOLOGIC ABNORMALITIES HAVE BEEN FOUND IN CF PATIENTS?;989;2222
00059;WHAT IMMUNOLOGIC ABNORMALITIES HAVE BEEN FOUND IN CF PATIENTS?;990;0001
00059;WHAT IMMUNOLOGIC ABNORMALITIES HAVE BEEN FOUND IN CF PATIENTS?;1005;0001
00059;WHAT IMMUNOLOGIC ABNORMALITIES HAVE BEEN FOUND IN CF PATIENTS?;1007;0001
00059;WHAT IMMUNOLOGIC ABNORMALITIES HAVE BEEN FOUND IN CF PATIENTS?;1025;2121
00059;WHAT IMMUNOLOGIC ABNORMALITIES HAVE BEEN FOUND IN CF PATIENTS?;1044;1100
00059;WHAT IMMUNOLOGIC ABNORMALITIES HAVE BEEN FOUND IN CF PATIENTS?;1056;0010
00059;WHAT IMMUNOLOGIC ABNORMALITIES HAVE BEEN FOUND IN CF PATIENTS?;1060;0012
00059;WHAT IMMUNOLOGIC ABNORMALITIES HAVE BEEN FOUND IN CF PATIENTS?;1071;0001
00059;WHAT IMMUNOLOGIC ABNORMALITIES HAVE BEEN FOUND IN CF PATIENTS?;1074;2122
00059;WHAT IMMUNOLOGIC ABNORMALITIES HAVE BEEN FOUND IN CF PATIENTS?;1075;0001
00059;WHAT IMMUNOLOGIC ABNORMALITIES HAVE BEEN FOUND IN CF PATIENTS?;1077;2222
00059;WHAT IMMUNOLOGIC ABNORMALITIES HAVE BEEN FOUND IN CF PATIENTS?;1091;0011
00059;WHAT IMMUNOLOGIC ABNORMALITIES HAVE BEEN FOUND IN CF PATIENTS?;1095;1122
00059;WHAT IMMUNOLOGIC ABNORMALITIES HAVE BEEN FOUND IN CF PATIENTS?;1097;0001
00059;WHAT IMMUNOLOGIC ABNORMALITIES HAVE BEEN FOUND IN CF PATIENTS?;1102;2121
00059;WHAT IMMUNOLOGIC ABNORMALITIES HAVE BEEN FOUND IN CF PATIENTS?;1134;0002
00059;WHAT IMMUNOLOGIC ABNORMALITIES HAVE BEEN FOUND IN CF PATIENTS?;1143;0010
00059;WHAT IMMUNOLOGIC ABNORMALITIES HAVE BEEN FOUND IN CF PATIENTS?;1163;1121
00059;WHAT IMMUNOLOGIC ABNORMALITIES HAVE BEEN FOUND IN CF PATIENTS?;1170;0001
00059;WHAT IMMUNOLOGIC ABNORMALITIES HAVE BEEN FOUND IN CF PATIENTS?;1171;1112
00059;WHAT IMMUNOLOGIC ABNORMALITIES HAVE BEEN FOUND IN CF PATIENTS?;1172;0012
00059;WHAT IMMUNOLOGIC ABNORMALITIES HAVE BEEN FOUND IN CF PATIENTS?;1173;1210
00059;WHAT IMMUNOLOGIC ABNORMALITIES HAVE BEEN FOUND IN CF PATIENTS?;1203;1000
00059;WHAT IMMUNOLOGIC ABNORMALITIES HAVE BEEN FOUND IN CF PATIENTS?;1205;1111
00059;WHAT IMMUNOLOGIC ABNORMALITIES HAVE BEEN FOUND IN CF PATIENTS?;1228;0002
00059;WHAT IMMUNOLOGIC ABNORMALITIES HAVE BEEN FOUND IN CF PATIENTS?;1232;0001
00060;WHAT ARE THE EFFECTS OF CF ON THE PULMONARY CIRCULATION?;17;0101
00060;WHAT ARE THE EFFECTS OF CF ON THE PULMONARY CIRCULATION?;87;0100
00060;WHAT ARE THE EFFECTS OF CF ON THE PULMONARY CIRCULATION?;100;2222
00060;WHAT ARE THE EFFECTS OF CF ON THE PULMONARY CIRCULATION?;155;1220
00060;WHAT ARE THE EFFECTS OF CF ON THE PULMONARY CIRCULATION?;241;2112
00060;WHAT ARE THE EFFECTS OF CF ON THE PULMONARY CIRCULATION?;267;0111
00060;WHAT ARE THE EFFECTS OF CF ON THE PULMONARY CIRCULATION?;322;1210
00060;WHAT ARE THE EFFECTS OF CF ON THE PULMONARY CIRCULATION?;340;0002
00060;WHAT ARE THE EFFECTS OF CF ON THE PULMONARY CIRCULATION?;348;2222
00060;WHAT ARE THE EFFECTS OF CF ON THE PULMONARY CIRCULATION?;354;1000
00060;WHAT ARE THE EFFECTS OF CF ON THE PULMONARY CIRCULATION?;370;1000
00060;WHAT ARE THE EFFECTS OF CF ON THE PULMONARY CIRCULATION?;446;2220
00060;WHAT ARE THE EFFECTS OF CF ON THE PULMONARY CIRCULATION?;519;1010
00060;WHAT ARE THE EFFECTS OF CF ON THE PULMONARY CIRCULATION?;550;1000
00060;WHAT ARE THE EFFECTS OF CF ON THE PULMONARY CIRCULATION?;587;2120
00060;WHAT ARE THE EFFECTS OF CF ON THE PULMONARY CIRCULATION?;597;2120
00060;WHAT ARE THE EFFECTS OF CF ON THE PULMONARY CIRCULATION?;653;1010
00060;WHAT ARE THE EFFECTS OF CF ON THE PULMONARY CIRCULATION?;698;2122
00060;WHAT ARE THE EFFECTS OF CF ON THE PULMONARY CIRCULATION?;722;0001
00060;WHAT ARE THE EFFECTS OF CF ON THE PULMONARY CIRCULATION?;724;0001
00060;WHAT ARE THE EFFECTS OF CF ON THE PULMONARY CIRCULATION?;751;0010
00060;WHAT ARE THE EFFECTS OF CF ON THE PULMONARY CIRCULATION?;764;0001
00060;WHAT ARE THE EFFECTS OF CF ON THE PULMONARY CIRCULATION?;990;1002
00060;WHAT ARE THE EFFECTS OF CF ON THE PULMONARY CIRCULATION?;1000;0001
00060;WHAT ARE THE EFFECTS OF CF ON THE PULMONARY CIRCULATION?;1004;2222
00060;WHAT ARE THE EFFECTS OF CF ON THE PULMONARY CIRCULATION?;1040;0001
00060;WHAT ARE THE EFFECTS OF CF ON THE PULMONARY CIRCULATION?;1041;1110
00060;WHAT ARE THE EFFECTS OF CF ON THE PULMONARY CIRCULATION?;1043;1110
00060;WHAT ARE THE EFFECTS OF CF ON THE PULMONARY CIRCULATION?;1046;0002
00060;WHAT ARE THE EFFECTS OF CF ON THE PULMONARY CIRCULATION?;1047;1110
00060;WHAT ARE THE EFFECTS OF CF ON THE PULMONARY CIRCULATION?;1104;0001
00060;WHAT ARE THE EFFECTS OF CF ON THE PULMONARY CIRCULATION?;1110;0012
00060;WHAT ARE THE EFFECTS OF CF ON THE PULMONARY CIRCULATION?;1192;1100
00060;WHAT ARE THE EFFECTS OF CF ON THE PULMONARY CIRCULATION?;1194;0001
00061;IS THERE A DEFECT IN MUCOCILIARY TRANSPORT (CLEARANCE) IN THE RESPIRATORY TRACT OF CF PATIENTS?;10;1010
00061;IS THERE A DEFECT IN MUCOCILIARY TRANSPORT (CLEARANCE) IN THE RESPIRATORY TRACT OF CF PATIENTS?;56;0001
00061;IS THERE A DEFECT IN MUCOCILIARY TRANSPORT (CLEARANCE) IN THE RESPIRATORY TRACT OF CF PATIENTS?;62;0100
00061;IS THERE A DEFECT IN MUCOCILIARY TRANSPORT (CLEARANCE) IN THE RESPIRATORY TRACT OF CF PATIENTS?;63;0100
00061;IS THERE A DEFECT IN MUCOCILIARY TRANSPORT (CLEARANCE) IN THE RESPIRATORY TRACT OF CF PATIENTS?;114;0100
00061;IS THERE A DEFECT IN MUCOCILIARY TRANSPORT (CLEARANCE) IN THE RESPIRATORY TRACT OF CF PATIENTS?;132;0001
00061;IS THERE A DEFECT IN MUCOCILIARY TRANSPORT (CLEARANCE) IN THE RESPIRATORY TRACT OF CF PATIENTS?;187;0001
00061;IS THERE A DEFECT IN MUCOCILIARY TRANSPORT (CLEARANCE) IN THE RESPIRATORY TRACT OF CF PATIENTS?;195;2222
00061;IS THERE A DEFECT IN MUCOCILIARY TRANSPORT (CLEARANCE) IN THE RESPIRATORY TRACT OF CF PATIENTS?;196;2222
00061;IS THERE A DEFECT IN MUCOCILIARY TRANSPORT (CLEARANCE) IN THE RESPIRATORY TRACT OF CF PATIENTS?;197;0100
00061;IS THERE A DEFECT IN MUCOCILIARY TRANSPORT (CLEARANCE) IN THE RESPIRATORY TRACT OF CF PATIENTS?;200;0002
00061;IS THERE A DEFECT IN MUCOCILIARY TRANSPORT (CLEARANCE) IN THE RESPIRATORY TRACT OF CF PATIENTS?;226;0001
00061;IS THERE A DEFECT IN MUCOCILIARY TRANSPORT (CLEARANCE) IN THE RESPIRATORY TRACT OF CF PATIENTS?;298;0001
00061;IS THERE A DEFECT IN MUCOCILIARY TRANSPORT (CLEARANCE) IN THE RESPIRATORY TRACT OF CF PATIENTS?;347;0001
00061;IS THERE A DEFECT IN MUCOCILIARY TRANSPORT (CLEARANCE) IN THE RESPIRATORY TRACT OF CF PATIENTS?;358;0100
00061;IS THERE A DEFECT IN MUCOCILIARY TRANSPORT (CLEARANCE) IN THE RESPIRATORY TRACT OF CF PATIENTS?;370;1012
00061;IS THERE A DEFECT IN MUCOCILIARY TRANSPORT (CLEARANCE) IN THE RESPIRATORY TRACT OF CF PATIENTS?;383;2222
00061;IS THERE A DEFECT IN MUCOCILIARY TRANSPORT (CLEARANCE) IN THE RESPIRATORY TRACT OF CF PATIENTS?;427;0001
00061;IS THERE A DEFECT IN MUCOCILIARY TRANSPORT (CLEARANCE) IN THE RESPIRATORY TRACT OF CF PATIENTS?;432;1002
00061;IS THERE A DEFECT IN MUCOCILIARY TRANSPORT (CLEARANCE) IN THE RESPIRATORY TRACT OF CF PATIENTS?;434;0001
00061;IS THERE A DEFECT IN MUCOCILIARY TRANSPORT (CLEARANCE) IN THE RESPIRATORY TRACT OF CF PATIENTS?;437;2222
00061;IS THERE A DEFECT IN MUCOCILIARY TRANSPORT (CLEARANCE) IN THE RESPIRATORY TRACT OF CF PATIENTS?;439;0100
00061;IS THERE A DEFECT IN MUCOCILIARY TRANSPORT (CLEARANCE) IN THE RESPIRATORY TRACT OF CF PATIENTS?;465;0112
00061;IS THERE A DEFECT IN MUCOCILIARY TRANSPORT (CLEARANCE) IN THE RESPIRATORY TRACT OF CF PATIENTS?;481;1101
00061;IS THERE A DEFECT IN MUCOCILIARY TRANSPORT (CLEARANCE) IN THE RESPIRATORY TRACT OF CF PATIENTS?;490;1120
00061;IS THERE A DEFECT IN MUCOCILIARY TRANSPORT (CLEARANCE) IN THE RESPIRATORY TRACT OF CF PATIENTS?;498;0102
00061;IS THERE A DEFECT IN MUCOCILIARY TRANSPORT (CLEARANCE) IN THE RESPIRATORY TRACT OF CF PATIENTS?;500;0100
00061;IS THERE A DEFECT IN MUCOCILIARY TRANSPORT (CLEARANCE) IN THE RESPIRATORY TRACT OF CF PATIENTS?;501;2222
00061;IS THERE A DEFECT IN MUCOCILIARY TRANSPORT (CLEARANCE) IN THE RESPIRATORY TRACT OF CF PATIENTS?;502;2222
00061;IS THERE A DEFECT IN MUCOCILIARY TRANSPORT (CLEARANCE) IN THE RESPIRATORY TRACT OF CF PATIENTS?;505;2222
00061;IS THERE A DEFECT IN MUCOCILIARY TRANSPORT (CLEARANCE) IN THE RESPIRATORY TRACT OF CF PATIENTS?;511;1001
00061;IS THERE A DEFECT IN MUCOCILIARY TRANSPORT (CLEARANCE) IN THE RESPIRATORY TRACT OF CF PATIENTS?;517;0001
00061;IS THERE A DEFECT IN MUCOCILIARY TRANSPORT (CLEARANCE) IN THE RESPIRATORY TRACT OF CF PATIENTS?;531;2121
00061;IS THERE A DEFECT IN MUCOCILIARY TRANSPORT (CLEARANCE) IN THE RESPIRATORY TRACT OF CF PATIENTS?;532;0010
00061;IS THERE A DEFECT IN MUCOCILIARY TRANSPORT (CLEARANCE) IN THE RESPIRATORY TRACT OF CF PATIENTS?;535;0010
00061;IS THERE A DEFECT IN MUCOCILIARY TRANSPORT (CLEARANCE) IN THE RESPIRATORY TRACT OF CF PATIENTS?;565;0010
00061;IS THERE A DEFECT IN MUCOCILIARY TRANSPORT (CLEARANCE) IN THE RESPIRATORY TRACT OF CF PATIENTS?;570;1001
00061;IS THERE A DEFECT IN MUCOCILIARY TRANSPORT (CLEARANCE) IN THE RESPIRATORY TRACT OF CF PATIENTS?;590;1001
00061;IS THERE A DEFECT IN MUCOCILIARY TRANSPORT (CLEARANCE) IN THE RESPIRATORY TRACT OF CF PATIENTS?;605;2222
00061;IS THERE A DEFECT IN MUCOCILIARY TRANSPORT (CLEARANCE) IN THE RESPIRATORY TRACT OF CF PATIENTS?;668;0001
00061;IS THERE A DEFECT IN MUCOCILIARY TRANSPORT (CLEARANCE) IN THE RESPIRATORY TRACT OF CF PATIENTS?;685;2222
00061;IS THERE A DEFECT IN MUCOCILIARY TRANSPORT (CLEARANCE) IN THE RESPIRATORY TRACT OF CF PATIENTS?;726;0010
00061;IS THERE A DEFECT IN MUCOCILIARY TRANSPORT (CLEARANCE) IN THE RESPIRATORY TRACT OF CF PATIENTS?;735;0001
00061;IS THERE A DEFECT IN MUCOCILIARY TRANSPORT (CLEARANCE) IN THE RESPIRATORY TRACT OF CF PATIENTS?;738;0010
00061;IS THERE A DEFECT IN MUCOCILIARY TRANSPORT (CLEARANCE) IN THE RESPIRATORY TRACT OF CF PATIENTS?;739;0010
00061;IS THERE A DEFECT IN MUCOCILIARY TRANSPORT (CLEARANCE) IN THE RESPIRATORY TRACT OF CF PATIENTS?;741;0010
00061;IS THERE A DEFECT IN MUCOCILIARY TRANSPORT (CLEARANCE) IN THE RESPIRATORY TRACT OF CF PATIENTS?;754;2212
00061;IS THERE A DEFECT IN MUCOCILIARY TRANSPORT (CLEARANCE) IN THE RESPIRATORY TRACT OF CF PATIENTS?;763;0001
00061;IS THERE A DEFECT IN MUCOCILIARY TRANSPORT (CLEARANCE) IN THE RESPIRATORY TRACT OF CF PATIENTS?;767;0001
00061;IS THERE A DEFECT IN MUCOCILIARY TRANSPORT (CLEARANCE) IN THE RESPIRATORY TRACT OF CF PATIENTS?;827;0100
00061;IS THERE A DEFECT IN MUCOCILIARY TRANSPORT (CLEARANCE) IN THE RESPIRATORY TRACT OF CF PATIENTS?;847;0010
00061;IS THERE A DEFECT IN MUCOCILIARY TRANSPORT (CLEARANCE) IN THE RESPIRATORY TRACT OF CF PATIENTS?;864;0001
00061;IS THERE A DEFECT IN MUCOCILIARY TRANSPORT (CLEARANCE) IN THE RESPIRATORY TRACT OF CF PATIENTS?;865;0001
00061;IS THERE A DEFECT IN MUCOCILIARY TRANSPORT (CLEARANCE) IN THE RESPIRATORY TRACT OF CF PATIENTS?;875;0100
00061;IS THERE A DEFECT IN MUCOCILIARY TRANSPORT (CLEARANCE) IN THE RESPIRATORY TRACT OF CF PATIENTS?;882;0002
00061;IS THERE A DEFECT IN MUCOCILIARY TRANSPORT (CLEARANCE) IN THE RESPIRATORY TRACT OF CF PATIENTS?;912;0001
00061;IS THERE A DEFECT IN MUCOCILIARY TRANSPORT (CLEARANCE) IN THE RESPIRATORY TRACT OF CF PATIENTS?;944;0001
00061;IS THERE A DEFECT IN MUCOCILIARY TRANSPORT (CLEARANCE) IN THE RESPIRATORY TRACT OF CF PATIENTS?;969;2122
00061;IS THERE A DEFECT IN MUCOCILIARY TRANSPORT (CLEARANCE) IN THE RESPIRATORY TRACT OF CF PATIENTS?;980;0100
00061;IS THERE A DEFECT IN MUCOCILIARY TRANSPORT (CLEARANCE) IN THE RESPIRATORY TRACT OF CF PATIENTS?;990;0002
00061;IS THERE A DEFECT IN MUCOCILIARY TRANSPORT (CLEARANCE) IN THE RESPIRATORY TRACT OF CF PATIENTS?;1040;0001
00061;IS THERE A DEFECT IN MUCOCILIARY TRANSPORT (CLEARANCE) IN THE RESPIRATORY TRACT OF CF PATIENTS?;1079;1122
00061;IS THERE A DEFECT IN MUCOCILIARY TRANSPORT (CLEARANCE) IN THE RESPIRATORY TRACT OF CF PATIENTS?;1092;0002
00061;IS THERE A DEFECT IN MUCOCILIARY TRANSPORT (CLEARANCE) IN THE RESPIRATORY TRACT OF CF PATIENTS?;1093;0002
00061;IS THERE A DEFECT IN MUCOCILIARY TRANSPORT (CLEARANCE) IN THE RESPIRATORY TRACT OF CF PATIENTS?;1098;0001
00061;IS THERE A DEFECT IN MUCOCILIARY TRANSPORT (CLEARANCE) IN THE RESPIRATORY TRACT OF CF PATIENTS?;1188;0001
00061;IS THERE A DEFECT IN MUCOCILIARY TRANSPORT (CLEARANCE) IN THE RESPIRATORY TRACT OF CF PATIENTS?;1207;0010
00061;IS THERE A DEFECT IN MUCOCILIARY TRANSPORT (CLEARANCE) IN THE RESPIRATORY TRACT OF CF PATIENTS?;1208;0010
00061;IS THERE A DEFECT IN MUCOCILIARY TRANSPORT (CLEARANCE) IN THE RESPIRATORY TRACT OF CF PATIENTS?;1234;0001
00061;IS THERE A DEFECT IN MUCOCILIARY TRANSPORT (CLEARANCE) IN THE RESPIRATORY TRACT OF CF PATIENTS?;1236;0001
00062;WHAT ARE THE CLINICAL FEATURES OF LUNG DISEASE IN CF PATIENTS?;10;0001
00062;WHAT ARE THE CLINICAL FEATURES OF LUNG DISEASE IN CF PATIENTS?;17;2211
00062;WHAT ARE THE CLINICAL FEATURES OF LUNG DISEASE IN CF PATIENTS?;24;0001
00062;WHAT ARE THE CLINICAL FEATURES OF LUNG DISEASE IN CF PATIENTS?;43;0100
00062;WHAT ARE THE CLINICAL FEATURES OF LUNG DISEASE IN CF PATIENTS?;56;1010
00062;WHAT ARE THE CLINICAL FEATURES OF LUNG DISEASE IN CF PATIENTS?;60;0010
00062;WHAT ARE THE CLINICAL FEATURES OF LUNG DISEASE IN CF PATIENTS?;62;0100
00062;WHAT ARE THE CLINICAL FEATURES OF LUNG DISEASE IN CF PATIENTS?;63;1101
00062;WHAT ARE THE CLINICAL FEATURES OF LUNG DISEASE IN CF PATIENTS?;64;1220
00062;WHAT ARE THE CLINICAL FEATURES OF LUNG DISEASE IN CF PATIENTS?;69;1000
00062;WHAT ARE THE CLINICAL FEATURES OF LUNG DISEASE IN CF PATIENTS?;72;0001
00062;WHAT ARE THE CLINICAL FEATURES OF LUNG DISEASE IN CF PATIENTS?;88;0010
00062;WHAT ARE THE CLINICAL FEATURES OF LUNG DISEASE IN CF PATIENTS?;94;0001
00062;WHAT ARE THE CLINICAL FEATURES OF LUNG DISEASE IN CF PATIENTS?;110;0100
00062;WHAT ARE THE CLINICAL FEATURES OF LUNG DISEASE IN CF PATIENTS?;144;1001
00062;WHAT ARE THE CLINICAL FEATURES OF LUNG DISEASE IN CF PATIENTS?;148;2222
00062;WHAT ARE THE CLINICAL FEATURES OF LUNG DISEASE IN CF PATIENTS?;155;2111
00062;WHAT ARE THE CLINICAL FEATURES OF LUNG DISEASE IN CF PATIENTS?;160;0001
00062;WHAT ARE THE CLINICAL FEATURES OF LUNG DISEASE IN CF PATIENTS?;182;0100
00062;WHAT ARE THE CLINICAL FEATURES OF LUNG DISEASE IN CF PATIENTS?;192;2210
00062;WHAT ARE THE CLINICAL FEATURES OF LUNG DISEASE IN CF PATIENTS?;193;2211
00062;WHAT ARE THE CLINICAL FEATURES OF LUNG DISEASE IN CF PATIENTS?;194;2210
00062;WHAT ARE THE CLINICAL FEATURES OF LUNG DISEASE IN CF PATIENTS?;197;1110
00062;WHAT ARE THE CLINICAL FEATURES OF LUNG DISEASE IN CF PATIENTS?;200;1001
00062;WHAT ARE THE CLINICAL FEATURES OF LUNG DISEASE IN CF PATIENTS?;211;0100
00062;WHAT ARE THE CLINICAL FEATURES OF LUNG DISEASE IN CF PATIENTS?;224;0100
00062;WHAT ARE THE CLINICAL FEATURES OF LUNG DISEASE IN CF PATIENTS?;226;1112
00062;WHAT ARE THE CLINICAL FEATURES OF LUNG DISEASE IN CF PATIENTS?;237;0001
00062;WHAT ARE THE CLINICAL FEATURES OF LUNG DISEASE IN CF PATIENTS?;238;0011
00062;WHAT ARE THE CLINICAL FEATURES OF LUNG DISEASE IN CF PATIENTS?;244;1000
00062;WHAT ARE THE CLINICAL FEATURES OF LUNG DISEASE IN CF PATIENTS?;267;0002
00062;WHAT ARE THE CLINICAL FEATURES OF LUNG DISEASE IN CF PATIENTS?;297;1001
00062;WHAT ARE THE CLINICAL FEATURES OF LUNG DISEASE IN CF PATIENTS?;321;1000
00062;WHAT ARE THE CLINICAL FEATURES OF LUNG DISEASE IN CF PATIENTS?;322;0001
00062;WHAT ARE THE CLINICAL FEATURES OF LUNG DISEASE IN CF PATIENTS?;330;1000
00062;WHAT ARE THE CLINICAL FEATURES OF LUNG DISEASE IN CF PATIENTS?;331;1011
00062;WHAT ARE THE CLINICAL FEATURES OF LUNG DISEASE IN CF PATIENTS?;333;1001
00062;WHAT ARE THE CLINICAL FEATURES OF LUNG DISEASE IN CF PATIENTS?;340;1000
00062;WHAT ARE THE CLINICAL FEATURES OF LUNG DISEASE IN CF PATIENTS?;348;1002
00062;WHAT ARE THE CLINICAL FEATURES OF LUNG DISEASE IN CF PATIENTS?;349;1000
00062;WHAT ARE THE CLINICAL FEATURES OF LUNG DISEASE IN CF PATIENTS?;354;1001
00062;WHAT ARE THE CLINICAL FEATURES OF LUNG DISEASE IN CF PATIENTS?;358;1000
00062;WHAT ARE THE CLINICAL FEATURES OF LUNG DISEASE IN CF PATIENTS?;359;0012
00062;WHAT ARE THE CLINICAL FEATURES OF LUNG DISEASE IN CF PATIENTS?;370;2212
00062;WHAT ARE THE CLINICAL FEATURES OF LUNG DISEASE IN CF PATIENTS?;372;1000
00062;WHAT ARE THE CLINICAL FEATURES OF LUNG DISEASE IN CF PATIENTS?;382;1001
00062;WHAT ARE THE CLINICAL FEATURES OF LUNG DISEASE IN CF PATIENTS?;383;1000
00062;WHAT ARE THE CLINICAL FEATURES OF LUNG DISEASE IN CF PATIENTS?;427;1000
00062;WHAT ARE THE CLINICAL FEATURES OF LUNG DISEASE IN CF PATIENTS?;429;1000
00062;WHAT ARE THE CLINICAL FEATURES OF LUNG DISEASE IN CF PATIENTS?;434;0001
00062;WHAT ARE THE CLINICAL FEATURES OF LUNG DISEASE IN CF PATIENTS?;437;2220
00062;WHAT ARE THE CLINICAL FEATURES OF LUNG DISEASE IN CF PATIENTS?;438;2221
00062;WHAT ARE THE CLINICAL FEATURES OF LUNG DISEASE IN CF PATIENTS?;446;1000
00062;WHAT ARE THE CLINICAL FEATURES OF LUNG DISEASE IN CF PATIENTS?;458;0100
00062;WHAT ARE THE CLINICAL FEATURES OF LUNG DISEASE IN CF PATIENTS?;459;0100
00062;WHAT ARE THE CLINICAL FEATURES OF LUNG DISEASE IN CF PATIENTS?;460;0100
00062;WHAT ARE THE CLINICAL FEATURES OF LUNG DISEASE IN CF PATIENTS?;465;0100
00062;WHAT ARE THE CLINICAL FEATURES OF LUNG DISEASE IN CF PATIENTS?;472;1000
00062;WHAT ARE THE CLINICAL FEATURES OF LUNG DISEASE IN CF PATIENTS?;473;1210
00062;WHAT ARE THE CLINICAL FEATURES OF LUNG DISEASE IN CF PATIENTS?;479;0100
00062;WHAT ARE THE CLINICAL FEATURES OF LUNG DISEASE IN CF PATIENTS?;486;0010
00062;WHAT ARE THE CLINICAL FEATURES OF LUNG DISEASE IN CF PATIENTS?;505;0100
00062;WHAT ARE THE CLINICAL FEATURES OF LUNG DISEASE IN CF PATIENTS?;537;1000
00062;WHAT ARE THE CLINICAL FEATURES OF LUNG DISEASE IN CF PATIENTS?;539;0100
00062;WHAT ARE THE CLINICAL FEATURES OF LUNG DISEASE IN CF PATIENTS?;550;2112
00062;WHAT ARE THE CLINICAL FEATURES OF LUNG DISEASE IN CF PATIENTS?;551;0001
00062;WHAT ARE THE CLINICAL FEATURES OF LUNG DISEASE IN CF PATIENTS?;558;1010
00062;WHAT ARE THE CLINICAL FEATURES OF LUNG DISEASE IN CF PATIENTS?;559;0001
00062;WHAT ARE THE CLINICAL FEATURES OF LUNG DISEASE IN CF PATIENTS?;580;0001
00062;WHAT ARE THE CLINICAL FEATURES OF LUNG DISEASE IN CF PATIENTS?;586;0001
00062;WHAT ARE THE CLINICAL FEATURES OF LUNG DISEASE IN CF PATIENTS?;590;0010
00062;WHAT ARE THE CLINICAL FEATURES OF LUNG DISEASE IN CF PATIENTS?;607;2220
00062;WHAT ARE THE CLINICAL FEATURES OF LUNG DISEASE IN CF PATIENTS?;643;0001
00062;WHAT ARE THE CLINICAL FEATURES OF LUNG DISEASE IN CF PATIENTS?;663;1010
00062;WHAT ARE THE CLINICAL FEATURES OF LUNG DISEASE IN CF PATIENTS?;677;0010
00062;WHAT ARE THE CLINICAL FEATURES OF LUNG DISEASE IN CF PATIENTS?;698;1101
00062;WHAT ARE THE CLINICAL FEATURES OF LUNG DISEASE IN CF PATIENTS?;703;1100
00062;WHAT ARE THE CLINICAL FEATURES OF LUNG DISEASE IN CF PATIENTS?;704;0001
00062;WHAT ARE THE CLINICAL FEATURES OF LUNG DISEASE IN CF PATIENTS?;722;1122
00062;WHAT ARE THE CLINICAL FEATURES OF LUNG DISEASE IN CF PATIENTS?;724;1002
00062;WHAT ARE THE CLINICAL FEATURES OF LUNG DISEASE IN CF PATIENTS?;729;0001
00062;WHAT ARE THE CLINICAL FEATURES OF LUNG DISEASE IN CF PATIENTS?;731;0001
00062;WHAT ARE THE CLINICAL FEATURES OF LUNG DISEASE IN CF PATIENTS?;734;1000
00062;WHAT ARE THE CLINICAL FEATURES OF LUNG DISEASE IN CF PATIENTS?;735;0001
00062;WHAT ARE THE CLINICAL FEATURES OF LUNG DISEASE IN CF PATIENTS?;736;1120
00062;WHAT ARE THE CLINICAL FEATURES OF LUNG DISEASE IN CF PATIENTS?;761;1001
00062;WHAT ARE THE CLINICAL FEATURES OF LUNG DISEASE IN CF PATIENTS?;763;1102
00062;WHAT ARE THE CLINICAL FEATURES OF LUNG DISEASE IN CF PATIENTS?;764;1001
00062;WHAT ARE THE CLINICAL FEATURES OF LUNG DISEASE IN CF PATIENTS?;767;0001
00062;WHAT ARE THE CLINICAL FEATURES OF LUNG DISEASE IN CF PATIENTS?;768;1011
00062;WHAT ARE THE CLINICAL FEATURES OF LUNG DISEASE IN CF PATIENTS?;783;0010
00062;WHAT ARE THE CLINICAL FEATURES OF LUNG DISEASE IN CF PATIENTS?;787;1000
00062;WHAT ARE THE CLINICAL FEATURES OF LUNG DISEASE IN CF PATIENTS?;803;0111
00062;WHAT ARE THE CLINICAL FEATURES OF LUNG DISEASE IN CF PATIENTS?;804;0100
00062;WHAT ARE THE CLINICAL FEATURES OF LUNG DISEASE IN CF PATIENTS?;806;2122
00062;WHAT ARE THE CLINICAL FEATURES OF LUNG DISEASE IN CF PATIENTS?;819;1000
00062;WHAT ARE THE CLINICAL FEATURES OF LUNG DISEASE IN CF PATIENTS?;821;0001
00062;WHAT ARE THE CLINICAL FEATURES OF LUNG DISEASE IN CF PATIENTS?;822;0002
00062;WHAT ARE THE CLINICAL FEATURES OF LUNG DISEASE IN CF PATIENTS?;837;1120
00062;WHAT ARE THE CLINICAL FEATURES OF LUNG DISEASE IN CF PATIENTS?;842;2221
00062;WHAT ARE THE CLINICAL FEATURES OF LUNG DISEASE IN CF PATIENTS?;843;0001
00062;WHAT ARE THE CLINICAL FEATURES OF LUNG DISEASE IN CF PATIENTS?;844;0002
00062;WHAT ARE THE CLINICAL FEATURES OF LUNG DISEASE IN CF PATIENTS?;845;0002
00062;WHAT ARE THE CLINICAL FEATURES OF LUNG DISEASE IN CF PATIENTS?;870;0001
00062;WHAT ARE THE CLINICAL FEATURES OF LUNG DISEASE IN CF PATIENTS?;879;1000
00062;WHAT ARE THE CLINICAL FEATURES OF LUNG DISEASE IN CF PATIENTS?;880;0001
00062;WHAT ARE THE CLINICAL FEATURES OF LUNG DISEASE IN CF PATIENTS?;882;1002
00062;WHAT ARE THE CLINICAL FEATURES OF LUNG DISEASE IN CF PATIENTS?;885;1000
00062;WHAT ARE THE CLINICAL FEATURES OF LUNG DISEASE IN CF PATIENTS?;886;1000
00062;WHAT ARE THE CLINICAL FEATURES OF LUNG DISEASE IN CF PATIENTS?;888;1002
00062;WHAT ARE THE CLINICAL FEATURES OF LUNG DISEASE IN CF PATIENTS?;889;0002
00062;WHAT ARE THE CLINICAL FEATURES OF LUNG DISEASE IN CF PATIENTS?;904;1101
00062;WHAT ARE THE CLINICAL FEATURES OF LUNG DISEASE IN CF PATIENTS?;907;2110
00062;WHAT ARE THE CLINICAL FEATURES OF LUNG DISEASE IN CF PATIENTS?;912;1000
00062;WHAT ARE THE CLINICAL FEATURES OF LUNG DISEASE IN CF PATIENTS?;913;1000
00062;WHAT ARE THE CLINICAL FEATURES OF LUNG DISEASE IN CF PATIENTS?;914;0100
00062;WHAT ARE THE CLINICAL FEATURES OF LUNG DISEASE IN CF PATIENTS?;920;0001
00062;WHAT ARE THE CLINICAL FEATURES OF LUNG DISEASE IN CF PATIENTS?;937;1000
00062;WHAT ARE THE CLINICAL FEATURES OF LUNG DISEASE IN CF PATIENTS?;941;1011
00062;WHAT ARE THE CLINICAL FEATURES OF LUNG DISEASE IN CF PATIENTS?;944;1000
00062;WHAT ARE THE CLINICAL FEATURES OF LUNG DISEASE IN CF PATIENTS?;945;0001
00062;WHAT ARE THE CLINICAL FEATURES OF LUNG DISEASE IN CF PATIENTS?;964;1000
00062;WHAT ARE THE CLINICAL FEATURES OF LUNG DISEASE IN CF PATIENTS?;969;0100
00062;WHAT ARE THE CLINICAL FEATURES OF LUNG DISEASE IN CF PATIENTS?;990;1002
00062;WHAT ARE THE CLINICAL FEATURES OF LUNG DISEASE IN CF PATIENTS?;1000;1002
00062;WHAT ARE THE CLINICAL FEATURES OF LUNG DISEASE IN CF PATIENTS?;1022;0001
00062;WHAT ARE THE CLINICAL FEATURES OF LUNG DISEASE IN CF PATIENTS?;1023;1002
00062;WHAT ARE THE CLINICAL FEATURES OF LUNG DISEASE IN CF PATIENTS?;1032;1000
00062;WHAT ARE THE CLINICAL FEATURES OF LUNG DISEASE IN CF PATIENTS?;1033;0001
00062;WHAT ARE THE CLINICAL FEATURES OF LUNG DISEASE IN CF PATIENTS?;1038;1000
00062;WHAT ARE THE CLINICAL FEATURES OF LUNG DISEASE IN CF PATIENTS?;1039;1000
00062;WHAT ARE THE CLINICAL FEATURES OF LUNG DISEASE IN CF PATIENTS?;1040;0002
00062;WHAT ARE THE CLINICAL FEATURES OF LUNG DISEASE IN CF PATIENTS?;1042;0001
00062;WHAT ARE THE CLINICAL FEATURES OF LUNG DISEASE IN CF PATIENTS?;1071;1000
00062;WHAT ARE THE CLINICAL FEATURES OF LUNG DISEASE IN CF PATIENTS?;1073;2122
00062;WHAT ARE THE CLINICAL FEATURES OF LUNG DISEASE IN CF PATIENTS?;1080;0002
00062;WHAT ARE THE CLINICAL FEATURES OF LUNG DISEASE IN CF PATIENTS?;1093;0001
00062;WHAT ARE THE CLINICAL FEATURES OF LUNG DISEASE IN CF PATIENTS?;1104;0001
00062;WHAT ARE THE CLINICAL FEATURES OF LUNG DISEASE IN CF PATIENTS?;1151;1121
00062;WHAT ARE THE CLINICAL FEATURES OF LUNG DISEASE IN CF PATIENTS?;1192;0001
00062;WHAT ARE THE CLINICAL FEATURES OF LUNG DISEASE IN CF PATIENTS?;1195;1000
00062;WHAT ARE THE CLINICAL FEATURES OF LUNG DISEASE IN CF PATIENTS?;1214;1210
00062;WHAT ARE THE CLINICAL FEATURES OF LUNG DISEASE IN CF PATIENTS?;1232;0001
00062;WHAT ARE THE CLINICAL FEATURES OF LUNG DISEASE IN CF PATIENTS?;1234;0101
00063;WHAT ARE THE BIOCHEMICAL OR MICROSCOPIC CHARACTERISTICS OF AIRWAY INFLAMMATION IN CF PATIENTS?;1;0001
00063;WHAT ARE THE BIOCHEMICAL OR MICROSCOPIC CHARACTERISTICS OF AIRWAY INFLAMMATION IN CF PATIENTS?;23;0100
00063;WHAT ARE THE BIOCHEMICAL OR MICROSCOPIC CHARACTERISTICS OF AIRWAY INFLAMMATION IN CF PATIENTS?;62;0100
00063;WHAT ARE THE BIOCHEMICAL OR MICROSCOPIC CHARACTERISTICS OF AIRWAY INFLAMMATION IN CF PATIENTS?;63;0100
00063;WHAT ARE THE BIOCHEMICAL OR MICROSCOPIC CHARACTERISTICS OF AIRWAY INFLAMMATION IN CF PATIENTS?;166;0001
00063;WHAT ARE THE BIOCHEMICAL OR MICROSCOPIC CHARACTERISTICS OF AIRWAY INFLAMMATION IN CF PATIENTS?;322;1010
00063;WHAT ARE THE BIOCHEMICAL OR MICROSCOPIC CHARACTERISTICS OF AIRWAY INFLAMMATION IN CF PATIENTS?;347;2220
00063;WHAT ARE THE BIOCHEMICAL OR MICROSCOPIC CHARACTERISTICS OF AIRWAY INFLAMMATION IN CF PATIENTS?;370;0010
00063;WHAT ARE THE BIOCHEMICAL OR MICROSCOPIC CHARACTERISTICS OF AIRWAY INFLAMMATION IN CF PATIENTS?;374;0100
00063;WHAT ARE THE BIOCHEMICAL OR MICROSCOPIC CHARACTERISTICS OF AIRWAY INFLAMMATION IN CF PATIENTS?;429;2222
00063;WHAT ARE THE BIOCHEMICAL OR MICROSCOPIC CHARACTERISTICS OF AIRWAY INFLAMMATION IN CF PATIENTS?;434;2110
00063;WHAT ARE THE BIOCHEMICAL OR MICROSCOPIC CHARACTERISTICS OF AIRWAY INFLAMMATION IN CF PATIENTS?;437;0100
00063;WHAT ARE THE BIOCHEMICAL OR MICROSCOPIC CHARACTERISTICS OF AIRWAY INFLAMMATION IN CF PATIENTS?;438;0001
00063;WHAT ARE THE BIOCHEMICAL OR MICROSCOPIC CHARACTERISTICS OF AIRWAY INFLAMMATION IN CF PATIENTS?;463;2222
00063;WHAT ARE THE BIOCHEMICAL OR MICROSCOPIC CHARACTERISTICS OF AIRWAY INFLAMMATION IN CF PATIENTS?;490;0100
00063;WHAT ARE THE BIOCHEMICAL OR MICROSCOPIC CHARACTERISTICS OF AIRWAY INFLAMMATION IN CF PATIENTS?;499;2220
00063;WHAT ARE THE BIOCHEMICAL OR MICROSCOPIC CHARACTERISTICS OF AIRWAY INFLAMMATION IN CF PATIENTS?;500;0100
00063;WHAT ARE THE BIOCHEMICAL OR MICROSCOPIC CHARACTERISTICS OF AIRWAY INFLAMMATION IN CF PATIENTS?;501;0100
00063;WHAT ARE THE BIOCHEMICAL OR MICROSCOPIC CHARACTERISTICS OF AIRWAY INFLAMMATION IN CF PATIENTS?;502;0100
00063;WHAT ARE THE BIOCHEMICAL OR MICROSCOPIC CHARACTERISTICS OF AIRWAY INFLAMMATION IN CF PATIENTS?;505;0100
00063;WHAT ARE THE BIOCHEMICAL OR MICROSCOPIC CHARACTERISTICS OF AIRWAY INFLAMMATION IN CF PATIENTS?;592;1100
00063;WHAT ARE THE BIOCHEMICAL OR MICROSCOPIC CHARACTERISTICS OF AIRWAY INFLAMMATION IN CF PATIENTS?;669;0100
00063;WHAT ARE THE BIOCHEMICAL OR MICROSCOPIC CHARACTERISTICS OF AIRWAY INFLAMMATION IN CF PATIENTS?;698;1000
00063;WHAT ARE THE BIOCHEMICAL OR MICROSCOPIC CHARACTERISTICS OF AIRWAY INFLAMMATION IN CF PATIENTS?;704;0001
00063;WHAT ARE THE BIOCHEMICAL OR MICROSCOPIC CHARACTERISTICS OF AIRWAY INFLAMMATION IN CF PATIENTS?;724;0001
00063;WHAT ARE THE BIOCHEMICAL OR MICROSCOPIC CHARACTERISTICS OF AIRWAY INFLAMMATION IN CF PATIENTS?;763;0001
00063;WHAT ARE THE BIOCHEMICAL OR MICROSCOPIC CHARACTERISTICS OF AIRWAY INFLAMMATION IN CF PATIENTS?;803;0100
00063;WHAT ARE THE BIOCHEMICAL OR MICROSCOPIC CHARACTERISTICS OF AIRWAY INFLAMMATION IN CF PATIENTS?;805;0101
00063;WHAT ARE THE BIOCHEMICAL OR MICROSCOPIC CHARACTERISTICS OF AIRWAY INFLAMMATION IN CF PATIENTS?;821;0010
00063;WHAT ARE THE BIOCHEMICAL OR MICROSCOPIC CHARACTERISTICS OF AIRWAY INFLAMMATION IN CF PATIENTS?;922;1000
00063;WHAT ARE THE BIOCHEMICAL OR MICROSCOPIC CHARACTERISTICS OF AIRWAY INFLAMMATION IN CF PATIENTS?;976;2210
00063;WHAT ARE THE BIOCHEMICAL OR MICROSCOPIC CHARACTERISTICS OF AIRWAY INFLAMMATION IN CF PATIENTS?;980;0100
00063;WHAT ARE THE BIOCHEMICAL OR MICROSCOPIC CHARACTERISTICS OF AIRWAY INFLAMMATION IN CF PATIENTS?;1040;0001
00063;WHAT ARE THE BIOCHEMICAL OR MICROSCOPIC CHARACTERISTICS OF AIRWAY INFLAMMATION IN CF PATIENTS?;1091;0010
00063;WHAT ARE THE BIOCHEMICAL OR MICROSCOPIC CHARACTERISTICS OF AIRWAY INFLAMMATION IN CF PATIENTS?;1155;2222
00063;WHAT ARE THE BIOCHEMICAL OR MICROSCOPIC CHARACTERISTICS OF AIRWAY INFLAMMATION IN CF PATIENTS?;1171;2110
00063;WHAT ARE THE BIOCHEMICAL OR MICROSCOPIC CHARACTERISTICS OF AIRWAY INFLAMMATION IN CF PATIENTS?;1192;1210
00063;WHAT ARE THE BIOCHEMICAL OR MICROSCOPIC CHARACTERISTICS OF AIRWAY INFLAMMATION IN CF PATIENTS?;1228;2120
00063;WHAT ARE THE BIOCHEMICAL OR MICROSCOPIC CHARACTERISTICS OF AIRWAY INFLAMMATION IN CF PATIENTS?;1229;2120
00064;HOW DOES LUNG FUNCTION CHANGE WITH TIME IN CF PATIENTS? (TIME PERIODS GREATER THAN A DAY);17;0012
00064;HOW DOES LUNG FUNCTION CHANGE WITH TIME IN CF PATIENTS? (TIME PERIODS GREATER THAN A DAY);20;0002
00064;HOW DOES LUNG FUNCTION CHANGE WITH TIME IN CF PATIENTS? (TIME PERIODS GREATER THAN A DAY);22;2222
00064;HOW DOES LUNG FUNCTION CHANGE WITH TIME IN CF PATIENTS? (TIME PERIODS GREATER THAN A DAY);24;0001
00064;HOW DOES LUNG FUNCTION CHANGE WITH TIME IN CF PATIENTS? (TIME PERIODS GREATER THAN A DAY);64;1211
00064;HOW DOES LUNG FUNCTION CHANGE WITH TIME IN CF PATIENTS? (TIME PERIODS GREATER THAN A DAY);144;0101
00064;HOW DOES LUNG FUNCTION CHANGE WITH TIME IN CF PATIENTS? (TIME PERIODS GREATER THAN A DAY);148;0101
00064;HOW DOES LUNG FUNCTION CHANGE WITH TIME IN CF PATIENTS? (TIME PERIODS GREATER THAN A DAY);155;0001
00064;HOW DOES LUNG FUNCTION CHANGE WITH TIME IN CF PATIENTS? (TIME PERIODS GREATER THAN A DAY);160;0001
00064;HOW DOES LUNG FUNCTION CHANGE WITH TIME IN CF PATIENTS? (TIME PERIODS GREATER THAN A DAY);197;0101
00064;HOW DOES LUNG FUNCTION CHANGE WITH TIME IN CF PATIENTS? (TIME PERIODS GREATER THAN A DAY);227;0100
00064;HOW DOES LUNG FUNCTION CHANGE WITH TIME IN CF PATIENTS? (TIME PERIODS GREATER THAN A DAY);267;0001
00064;HOW DOES LUNG FUNCTION CHANGE WITH TIME IN CF PATIENTS? (TIME PERIODS GREATER THAN A DAY);322;0001
00064;HOW DOES LUNG FUNCTION CHANGE WITH TIME IN CF PATIENTS? (TIME PERIODS GREATER THAN A DAY);331;0001
00064;HOW DOES LUNG FUNCTION CHANGE WITH TIME IN CF PATIENTS? (TIME PERIODS GREATER THAN A DAY);349;1000
00064;HOW DOES LUNG FUNCTION CHANGE WITH TIME IN CF PATIENTS? (TIME PERIODS GREATER THAN A DAY);358;1000
00064;HOW DOES LUNG FUNCTION CHANGE WITH TIME IN CF PATIENTS? (TIME PERIODS GREATER THAN A DAY);370;1110
00064;HOW DOES LUNG FUNCTION CHANGE WITH TIME IN CF PATIENTS? (TIME PERIODS GREATER THAN A DAY);372;2222
00064;HOW DOES LUNG FUNCTION CHANGE WITH TIME IN CF PATIENTS? (TIME PERIODS GREATER THAN A DAY);382;0001
00064;HOW DOES LUNG FUNCTION CHANGE WITH TIME IN CF PATIENTS? (TIME PERIODS GREATER THAN A DAY);434;0001
00064;HOW DOES LUNG FUNCTION CHANGE WITH TIME IN CF PATIENTS? (TIME PERIODS GREATER THAN A DAY);437;2222
00064;HOW DOES LUNG FUNCTION CHANGE WITH TIME IN CF PATIENTS? (TIME PERIODS GREATER THAN A DAY);472;0100
00064;HOW DOES LUNG FUNCTION CHANGE WITH TIME IN CF PATIENTS? (TIME PERIODS GREATER THAN A DAY);550;0002
00064;HOW DOES LUNG FUNCTION CHANGE WITH TIME IN CF PATIENTS? (TIME PERIODS GREATER THAN A DAY);590;0001
00064;HOW DOES LUNG FUNCTION CHANGE WITH TIME IN CF PATIENTS? (TIME PERIODS GREATER THAN A DAY);605;0001
00064;HOW DOES LUNG FUNCTION CHANGE WITH TIME IN CF PATIENTS? (TIME PERIODS GREATER THAN A DAY);606;0010
00064;HOW DOES LUNG FUNCTION CHANGE WITH TIME IN CF PATIENTS? (TIME PERIODS GREATER THAN A DAY);674;0010
00064;HOW DOES LUNG FUNCTION CHANGE WITH TIME IN CF PATIENTS? (TIME PERIODS GREATER THAN A DAY);698;0001
00064;HOW DOES LUNG FUNCTION CHANGE WITH TIME IN CF PATIENTS? (TIME PERIODS GREATER THAN A DAY);703;0001
00064;HOW DOES LUNG FUNCTION CHANGE WITH TIME IN CF PATIENTS? (TIME PERIODS GREATER THAN A DAY);722;0010
00064;HOW DOES LUNG FUNCTION CHANGE WITH TIME IN CF PATIENTS? (TIME PERIODS GREATER THAN A DAY);724;0001
00064;HOW DOES LUNG FUNCTION CHANGE WITH TIME IN CF PATIENTS? (TIME PERIODS GREATER THAN A DAY);768;0001
00064;HOW DOES LUNG FUNCTION CHANGE WITH TIME IN CF PATIENTS? (TIME PERIODS GREATER THAN A DAY);814;2222
00064;HOW DOES LUNG FUNCTION CHANGE WITH TIME IN CF PATIENTS? (TIME PERIODS GREATER THAN A DAY);842;2222
00064;HOW DOES LUNG FUNCTION CHANGE WITH TIME IN CF PATIENTS? (TIME PERIODS GREATER THAN A DAY);844;0002
00064;HOW DOES LUNG FUNCTION CHANGE WITH TIME IN CF PATIENTS? (TIME PERIODS GREATER THAN A DAY);882;0001
00064;HOW DOES LUNG FUNCTION CHANGE WITH TIME IN CF PATIENTS? (TIME PERIODS GREATER THAN A DAY);889;0002
00064;HOW DOES LUNG FUNCTION CHANGE WITH TIME IN CF PATIENTS? (TIME PERIODS GREATER THAN A DAY);907;0001
00064;HOW DOES LUNG FUNCTION CHANGE WITH TIME IN CF PATIENTS? (TIME PERIODS GREATER THAN A DAY);944;0001
00064;HOW DOES LUNG FUNCTION CHANGE WITH TIME IN CF PATIENTS? (TIME PERIODS GREATER THAN A DAY);963;1001
00064;HOW DOES LUNG FUNCTION CHANGE WITH TIME IN CF PATIENTS? (TIME PERIODS GREATER THAN A DAY);1000;0002
00064;HOW DOES LUNG FUNCTION CHANGE WITH TIME IN CF PATIENTS? (TIME PERIODS GREATER THAN A DAY);1033;0001
00064;HOW DOES LUNG FUNCTION CHANGE WITH TIME IN CF PATIENTS? (TIME PERIODS GREATER THAN A DAY);1038;2222
00064;HOW DOES LUNG FUNCTION CHANGE WITH TIME IN CF PATIENTS? (TIME PERIODS GREATER THAN A DAY);1067;0001
00064;HOW DOES LUNG FUNCTION CHANGE WITH TIME IN CF PATIENTS? (TIME PERIODS GREATER THAN A DAY);1071;0001
00064;HOW DOES LUNG FUNCTION CHANGE WITH TIME IN CF PATIENTS? (TIME PERIODS GREATER THAN A DAY);1076;0001
00064;HOW DOES LUNG FUNCTION CHANGE WITH TIME IN CF PATIENTS? (TIME PERIODS GREATER THAN A DAY);1091;0002
00064;HOW DOES LUNG FUNCTION CHANGE WITH TIME IN CF PATIENTS? (TIME PERIODS GREATER THAN A DAY);1093;0002
00064;HOW DOES LUNG FUNCTION CHANGE WITH TIME IN CF PATIENTS? (TIME PERIODS GREATER THAN A DAY);1188;0001
00064;HOW DOES LUNG FUNCTION CHANGE WITH TIME IN CF PATIENTS? (TIME PERIODS GREATER THAN A DAY);1195;2222
00065;WHAT ARE THE ABNORMALITIES OF PULMONARY FUNCTION IN CF PATIENTS?;17;0012
00065;WHAT ARE THE ABNORMALITIES OF PULMONARY FUNCTION IN CF PATIENTS?;20;2121
00065;WHAT ARE THE ABNORMALITIES OF PULMONARY FUNCTION IN CF PATIENTS?;22;0112
00065;WHAT ARE THE ABNORMALITIES OF PULMONARY FUNCTION IN CF PATIENTS?;24;2122
00065;WHAT ARE THE ABNORMALITIES OF PULMONARY FUNCTION IN CF PATIENTS?;64;2222
00065;WHAT ARE THE ABNORMALITIES OF PULMONARY FUNCTION IN CF PATIENTS?;87;1002
00065;WHAT ARE THE ABNORMALITIES OF PULMONARY FUNCTION IN CF PATIENTS?;93;0001
00065;WHAT ARE THE ABNORMALITIES OF PULMONARY FUNCTION IN CF PATIENTS?;132;0001
00065;WHAT ARE THE ABNORMALITIES OF PULMONARY FUNCTION IN CF PATIENTS?;135;0001
00065;WHAT ARE THE ABNORMALITIES OF PULMONARY FUNCTION IN CF PATIENTS?;144;2222
00065;WHAT ARE THE ABNORMALITIES OF PULMONARY FUNCTION IN CF PATIENTS?;148;0102
00065;WHAT ARE THE ABNORMALITIES OF PULMONARY FUNCTION IN CF PATIENTS?;155;2122
00065;WHAT ARE THE ABNORMALITIES OF PULMONARY FUNCTION IN CF PATIENTS?;192;2220
00065;WHAT ARE THE ABNORMALITIES OF PULMONARY FUNCTION IN CF PATIENTS?;194;2222
00065;WHAT ARE THE ABNORMALITIES OF PULMONARY FUNCTION IN CF PATIENTS?;197;0102
00065;WHAT ARE THE ABNORMALITIES OF PULMONARY FUNCTION IN CF PATIENTS?;206;1211
00065;WHAT ARE THE ABNORMALITIES OF PULMONARY FUNCTION IN CF PATIENTS?;211;2222
00065;WHAT ARE THE ABNORMALITIES OF PULMONARY FUNCTION IN CF PATIENTS?;224;0100
00065;WHAT ARE THE ABNORMALITIES OF PULMONARY FUNCTION IN CF PATIENTS?;227;0001
00065;WHAT ARE THE ABNORMALITIES OF PULMONARY FUNCTION IN CF PATIENTS?;238;0001
00065;WHAT ARE THE ABNORMALITIES OF PULMONARY FUNCTION IN CF PATIENTS?;267;0001
00065;WHAT ARE THE ABNORMALITIES OF PULMONARY FUNCTION IN CF PATIENTS?;297;0001
00065;WHAT ARE THE ABNORMALITIES OF PULMONARY FUNCTION IN CF PATIENTS?;322;0001
00065;WHAT ARE THE ABNORMALITIES OF PULMONARY FUNCTION IN CF PATIENTS?;323;0002
00065;WHAT ARE THE ABNORMALITIES OF PULMONARY FUNCTION IN CF PATIENTS?;331;0011
00065;WHAT ARE THE ABNORMALITIES OF PULMONARY FUNCTION IN CF PATIENTS?;341;0012
00065;WHAT ARE THE ABNORMALITIES OF PULMONARY FUNCTION IN CF PATIENTS?;349;2112
00065;WHAT ARE THE ABNORMALITIES OF PULMONARY FUNCTION IN CF PATIENTS?;358;1000
00065;WHAT ARE THE ABNORMALITIES OF PULMONARY FUNCTION IN CF PATIENTS?;368;2112
00065;WHAT ARE THE ABNORMALITIES OF PULMONARY FUNCTION IN CF PATIENTS?;370;1212
00065;WHAT ARE THE ABNORMALITIES OF PULMONARY FUNCTION IN CF PATIENTS?;372;2212
00065;WHAT ARE THE ABNORMALITIES OF PULMONARY FUNCTION IN CF PATIENTS?;383;0001
00065;WHAT ARE THE ABNORMALITIES OF PULMONARY FUNCTION IN CF PATIENTS?;386;0001
00065;WHAT ARE THE ABNORMALITIES OF PULMONARY FUNCTION IN CF PATIENTS?;387;2122
00065;WHAT ARE THE ABNORMALITIES OF PULMONARY FUNCTION IN CF PATIENTS?;388;2122
00065;WHAT ARE THE ABNORMALITIES OF PULMONARY FUNCTION IN CF PATIENTS?;437;2222
00065;WHAT ARE THE ABNORMALITIES OF PULMONARY FUNCTION IN CF PATIENTS?;519;0001
00065;WHAT ARE THE ABNORMALITIES OF PULMONARY FUNCTION IN CF PATIENTS?;539;0100
00065;WHAT ARE THE ABNORMALITIES OF PULMONARY FUNCTION IN CF PATIENTS?;543;0001
00065;WHAT ARE THE ABNORMALITIES OF PULMONARY FUNCTION IN CF PATIENTS?;546;0001
00065;WHAT ARE THE ABNORMALITIES OF PULMONARY FUNCTION IN CF PATIENTS?;550;0002
00065;WHAT ARE THE ABNORMALITIES OF PULMONARY FUNCTION IN CF PATIENTS?;578;2222
00065;WHAT ARE THE ABNORMALITIES OF PULMONARY FUNCTION IN CF PATIENTS?;587;0001
00065;WHAT ARE THE ABNORMALITIES OF PULMONARY FUNCTION IN CF PATIENTS?;597;0002
00065;WHAT ARE THE ABNORMALITIES OF PULMONARY FUNCTION IN CF PATIENTS?;599;0001
00065;WHAT ARE THE ABNORMALITIES OF PULMONARY FUNCTION IN CF PATIENTS?;606;1111
00065;WHAT ARE THE ABNORMALITIES OF PULMONARY FUNCTION IN CF PATIENTS?;611;0001
00065;WHAT ARE THE ABNORMALITIES OF PULMONARY FUNCTION IN CF PATIENTS?;629;0001
00065;WHAT ARE THE ABNORMALITIES OF PULMONARY FUNCTION IN CF PATIENTS?;653;0011
00065;WHAT ARE THE ABNORMALITIES OF PULMONARY FUNCTION IN CF PATIENTS?;674;2122
00065;WHAT ARE THE ABNORMALITIES OF PULMONARY FUNCTION IN CF PATIENTS?;699;2111
00065;WHAT ARE THE ABNORMALITIES OF PULMONARY FUNCTION IN CF PATIENTS?;722;1012
00065;WHAT ARE THE ABNORMALITIES OF PULMONARY FUNCTION IN CF PATIENTS?;736;1121
00065;WHAT ARE THE ABNORMALITIES OF PULMONARY FUNCTION IN CF PATIENTS?;763;0001
00065;WHAT ARE THE ABNORMALITIES OF PULMONARY FUNCTION IN CF PATIENTS?;788;0001
00065;WHAT ARE THE ABNORMALITIES OF PULMONARY FUNCTION IN CF PATIENTS?;803;0001
00065;WHAT ARE THE ABNORMALITIES OF PULMONARY FUNCTION IN CF PATIENTS?;814;1002
00065;WHAT ARE THE ABNORMALITIES OF PULMONARY FUNCTION IN CF PATIENTS?;819;0100
00065;WHAT ARE THE ABNORMALITIES OF PULMONARY FUNCTION IN CF PATIENTS?;821;1010
00065;WHAT ARE THE ABNORMALITIES OF PULMONARY FUNCTION IN CF PATIENTS?;833;0001
00065;WHAT ARE THE ABNORMALITIES OF PULMONARY FUNCTION IN CF PATIENTS?;842;2222
00065;WHAT ARE THE ABNORMALITIES OF PULMONARY FUNCTION IN CF PATIENTS?;882;0001
00065;WHAT ARE THE ABNORMALITIES OF PULMONARY FUNCTION IN CF PATIENTS?;885;2112
00065;WHAT ARE THE ABNORMALITIES OF PULMONARY FUNCTION IN CF PATIENTS?;886;2112
00065;WHAT ARE THE ABNORMALITIES OF PULMONARY FUNCTION IN CF PATIENTS?;889;0001
00065;WHAT ARE THE ABNORMALITIES OF PULMONARY FUNCTION IN CF PATIENTS?;904;2220
00065;WHAT ARE THE ABNORMALITIES OF PULMONARY FUNCTION IN CF PATIENTS?;913;0001
00065;WHAT ARE THE ABNORMALITIES OF PULMONARY FUNCTION IN CF PATIENTS?;963;0001
00065;WHAT ARE THE ABNORMALITIES OF PULMONARY FUNCTION IN CF PATIENTS?;964;1210
00065;WHAT ARE THE ABNORMALITIES OF PULMONARY FUNCTION IN CF PATIENTS?;990;0002
00065;WHAT ARE THE ABNORMALITIES OF PULMONARY FUNCTION IN CF PATIENTS?;1000;0002
00065;WHAT ARE THE ABNORMALITIES OF PULMONARY FUNCTION IN CF PATIENTS?;1006;1000
00065;WHAT ARE THE ABNORMALITIES OF PULMONARY FUNCTION IN CF PATIENTS?;1007;1220
00065;WHAT ARE THE ABNORMALITIES OF PULMONARY FUNCTION IN CF PATIENTS?;1038;2222
00065;WHAT ARE THE ABNORMALITIES OF PULMONARY FUNCTION IN CF PATIENTS?;1042;0001
00065;WHAT ARE THE ABNORMALITIES OF PULMONARY FUNCTION IN CF PATIENTS?;1045;1012
00065;WHAT ARE THE ABNORMALITIES OF PULMONARY FUNCTION IN CF PATIENTS?;1046;2221
00065;WHAT ARE THE ABNORMALITIES OF PULMONARY FUNCTION IN CF PATIENTS?;1048;0101
00065;WHAT ARE THE ABNORMALITIES OF PULMONARY FUNCTION IN CF PATIENTS?;1067;1012
00065;WHAT ARE THE ABNORMALITIES OF PULMONARY FUNCTION IN CF PATIENTS?;1073;2222
00065;WHAT ARE THE ABNORMALITIES OF PULMONARY FUNCTION IN CF PATIENTS?;1092;0002
00065;WHAT ARE THE ABNORMALITIES OF PULMONARY FUNCTION IN CF PATIENTS?;1093;0001
00065;WHAT ARE THE ABNORMALITIES OF PULMONARY FUNCTION IN CF PATIENTS?;1099;1121
00065;WHAT ARE THE ABNORMALITIES OF PULMONARY FUNCTION IN CF PATIENTS?;1149;0001
00065;WHAT ARE THE ABNORMALITIES OF PULMONARY FUNCTION IN CF PATIENTS?;1150;0001
00065;WHAT ARE THE ABNORMALITIES OF PULMONARY FUNCTION IN CF PATIENTS?;1151;1122
00065;WHAT ARE THE ABNORMALITIES OF PULMONARY FUNCTION IN CF PATIENTS?;1153;0001
00065;WHAT ARE THE ABNORMALITIES OF PULMONARY FUNCTION IN CF PATIENTS?;1164;0001
00065;WHAT ARE THE ABNORMALITIES OF PULMONARY FUNCTION IN CF PATIENTS?;1188;0001
00065;WHAT ARE THE ABNORMALITIES OF PULMONARY FUNCTION IN CF PATIENTS?;1195;1122
00065;WHAT ARE THE ABNORMALITIES OF PULMONARY FUNCTION IN CF PATIENTS?;1214;0001
00065;WHAT ARE THE ABNORMALITIES OF PULMONARY FUNCTION IN CF PATIENTS?;1232;0001
00065;WHAT ARE THE ABNORMALITIES OF PULMONARY FUNCTION IN CF PATIENTS?;1234;0002
00065;WHAT ARE THE ABNORMALITIES OF PULMONARY FUNCTION IN CF PATIENTS?;1237;2122
00066;WHAT ARE THE PATHOLOGIC FEATURES OF LUNG DISEASE IN CF PATIENTS?;1;0001
00066;WHAT ARE THE PATHOLOGIC FEATURES OF LUNG DISEASE IN CF PATIENTS?;10;0001
00066;WHAT ARE THE PATHOLOGIC FEATURES OF LUNG DISEASE IN CF PATIENTS?;11;0001
00066;WHAT ARE THE PATHOLOGIC FEATURES OF LUNG DISEASE IN CF PATIENTS?;13;0001
00066;WHAT ARE THE PATHOLOGIC FEATURES OF LUNG DISEASE IN CF PATIENTS?;17;0012
00066;WHAT ARE THE PATHOLOGIC FEATURES OF LUNG DISEASE IN CF PATIENTS?;22;0002
00066;WHAT ARE THE PATHOLOGIC FEATURES OF LUNG DISEASE IN CF PATIENTS?;63;0100
00066;WHAT ARE THE PATHOLOGIC FEATURES OF LUNG DISEASE IN CF PATIENTS?;100;2210
00066;WHAT ARE THE PATHOLOGIC FEATURES OF LUNG DISEASE IN CF PATIENTS?;148;0012
00066;WHAT ARE THE PATHOLOGIC FEATURES OF LUNG DISEASE IN CF PATIENTS?;155;0001
00066;WHAT ARE THE PATHOLOGIC FEATURES OF LUNG DISEASE IN CF PATIENTS?;160;0001
00066;WHAT ARE THE PATHOLOGIC FEATURES OF LUNG DISEASE IN CF PATIENTS?;166;0001
00066;WHAT ARE THE PATHOLOGIC FEATURES OF LUNG DISEASE IN CF PATIENTS?;187;0100
00066;WHAT ARE THE PATHOLOGIC FEATURES OF LUNG DISEASE IN CF PATIENTS?;200;1101
00066;WHAT ARE THE PATHOLOGIC FEATURES OF LUNG DISEASE IN CF PATIENTS?;267;0001
00066;WHAT ARE THE PATHOLOGIC FEATURES OF LUNG DISEASE IN CF PATIENTS?;322;2222
00066;WHAT ARE THE PATHOLOGIC FEATURES OF LUNG DISEASE IN CF PATIENTS?;340;2110
00066;WHAT ARE THE PATHOLOGIC FEATURES OF LUNG DISEASE IN CF PATIENTS?;348;2212
00066;WHAT ARE THE PATHOLOGIC FEATURES OF LUNG DISEASE IN CF PATIENTS?;350;1012
00066;WHAT ARE THE PATHOLOGIC FEATURES OF LUNG DISEASE IN CF PATIENTS?;370;2212
00066;WHAT ARE THE PATHOLOGIC FEATURES OF LUNG DISEASE IN CF PATIENTS?;385;0001
00066;WHAT ARE THE PATHOLOGIC FEATURES OF LUNG DISEASE IN CF PATIENTS?;427;0001
00066;WHAT ARE THE PATHOLOGIC FEATURES OF LUNG DISEASE IN CF PATIENTS?;429;2222
00066;WHAT ARE THE PATHOLOGIC FEATURES OF LUNG DISEASE IN CF PATIENTS?;434;2212
00066;WHAT ARE THE PATHOLOGIC FEATURES OF LUNG DISEASE IN CF PATIENTS?;446;1000
00066;WHAT ARE THE PATHOLOGIC FEATURES OF LUNG DISEASE IN CF PATIENTS?;463;1220
00066;WHAT ARE THE PATHOLOGIC FEATURES OF LUNG DISEASE IN CF PATIENTS?;498;1000
00066;WHAT ARE THE PATHOLOGIC FEATURES OF LUNG DISEASE IN CF PATIENTS?;558;0011
00066;WHAT ARE THE PATHOLOGIC FEATURES OF LUNG DISEASE IN CF PATIENTS?;590;0001
00066;WHAT ARE THE PATHOLOGIC FEATURES OF LUNG DISEASE IN CF PATIENTS?;605;0001
00066;WHAT ARE THE PATHOLOGIC FEATURES OF LUNG DISEASE IN CF PATIENTS?;607;0010
00066;WHAT ARE THE PATHOLOGIC FEATURES OF LUNG DISEASE IN CF PATIENTS?;630;0001
00066;WHAT ARE THE PATHOLOGIC FEATURES OF LUNG DISEASE IN CF PATIENTS?;698;1102
00066;WHAT ARE THE PATHOLOGIC FEATURES OF LUNG DISEASE IN CF PATIENTS?;722;0002
00066;WHAT ARE THE PATHOLOGIC FEATURES OF LUNG DISEASE IN CF PATIENTS?;724;0002
00066;WHAT ARE THE PATHOLOGIC FEATURES OF LUNG DISEASE IN CF PATIENTS?;731;0001
00066;WHAT ARE THE PATHOLOGIC FEATURES OF LUNG DISEASE IN CF PATIENTS?;736;0002
00066;WHAT ARE THE PATHOLOGIC FEATURES OF LUNG DISEASE IN CF PATIENTS?;763;1002
00066;WHAT ARE THE PATHOLOGIC FEATURES OF LUNG DISEASE IN CF PATIENTS?;767;0001
00066;WHAT ARE THE PATHOLOGIC FEATURES OF LUNG DISEASE IN CF PATIENTS?;771;0010
00066;WHAT ARE THE PATHOLOGIC FEATURES OF LUNG DISEASE IN CF PATIENTS?;788;1000
00066;WHAT ARE THE PATHOLOGIC FEATURES OF LUNG DISEASE IN CF PATIENTS?;821;1011
00066;WHAT ARE THE PATHOLOGIC FEATURES OF LUNG DISEASE IN CF PATIENTS?;837;0100
00066;WHAT ARE THE PATHOLOGIC FEATURES OF LUNG DISEASE IN CF PATIENTS?;882;0002
00066;WHAT ARE THE PATHOLOGIC FEATURES OF LUNG DISEASE IN CF PATIENTS?;907;1000
00066;WHAT ARE THE PATHOLOGIC FEATURES OF LUNG DISEASE IN CF PATIENTS?;912;1000
00066;WHAT ARE THE PATHOLOGIC FEATURES OF LUNG DISEASE IN CF PATIENTS?;913;0001
00066;WHAT ARE THE PATHOLOGIC FEATURES OF LUNG DISEASE IN CF PATIENTS?;944;1002
00066;WHAT ARE THE PATHOLOGIC FEATURES OF LUNG DISEASE IN CF PATIENTS?;969;0100
00066;WHAT ARE THE PATHOLOGIC FEATURES OF LUNG DISEASE IN CF PATIENTS?;976;0100
00066;WHAT ARE THE PATHOLOGIC FEATURES OF LUNG DISEASE IN CF PATIENTS?;980;0100
00066;WHAT ARE THE PATHOLOGIC FEATURES OF LUNG DISEASE IN CF PATIENTS?;990;0002
00066;WHAT ARE THE PATHOLOGIC FEATURES OF LUNG DISEASE IN CF PATIENTS?;1004;0100
00066;WHAT ARE THE PATHOLOGIC FEATURES OF LUNG DISEASE IN CF PATIENTS?;1098;0001
00066;WHAT ARE THE PATHOLOGIC FEATURES OF LUNG DISEASE IN CF PATIENTS?;1104;0001
00066;WHAT ARE THE PATHOLOGIC FEATURES OF LUNG DISEASE IN CF PATIENTS?;1109;0001
00066;WHAT ARE THE PATHOLOGIC FEATURES OF LUNG DISEASE IN CF PATIENTS?;1134;0001
00066;WHAT ARE THE PATHOLOGIC FEATURES OF LUNG DISEASE IN CF PATIENTS?;1155;2120
00066;WHAT ARE THE PATHOLOGIC FEATURES OF LUNG DISEASE IN CF PATIENTS?;1192;2222
00066;WHAT ARE THE PATHOLOGIC FEATURES OF LUNG DISEASE IN CF PATIENTS?;1194;0011
00066;WHAT ARE THE PATHOLOGIC FEATURES OF LUNG DISEASE IN CF PATIENTS?;1195;0001
00066;WHAT ARE THE PATHOLOGIC FEATURES OF LUNG DISEASE IN CF PATIENTS?;1214;0010
00066;WHAT ARE THE PATHOLOGIC FEATURES OF LUNG DISEASE IN CF PATIENTS?;1226;0001
00067;WHAT IS THE PROGNOSIS FOR PATIENTS WHO HAVE HAD AN EPISODE OF RESPIRATORY FAILURE?;43;0100
00067;WHAT IS THE PROGNOSIS FOR PATIENTS WHO HAVE HAD AN EPISODE OF RESPIRATORY FAILURE?;61;0001
00067;WHAT IS THE PROGNOSIS FOR PATIENTS WHO HAVE HAD AN EPISODE OF RESPIRATORY FAILURE?;148;2212
00067;WHAT IS THE PROGNOSIS FOR PATIENTS WHO HAVE HAD AN EPISODE OF RESPIRATORY FAILURE?;354;1000
00067;WHAT IS THE PROGNOSIS FOR PATIENTS WHO HAVE HAD AN EPISODE OF RESPIRATORY FAILURE?;370;1012
00067;WHAT IS THE PROGNOSIS FOR PATIENTS WHO HAVE HAD AN EPISODE OF RESPIRATORY FAILURE?;472;1220
00067;WHAT IS THE PROGNOSIS FOR PATIENTS WHO HAVE HAD AN EPISODE OF RESPIRATORY FAILURE?;473;0100
00067;WHAT IS THE PROGNOSIS FOR PATIENTS WHO HAVE HAD AN EPISODE OF RESPIRATORY FAILURE?;519;0100
00067;WHAT IS THE PROGNOSIS FOR PATIENTS WHO HAVE HAD AN EPISODE OF RESPIRATORY FAILURE?;724;1001
00067;WHAT IS THE PROGNOSIS FOR PATIENTS WHO HAVE HAD AN EPISODE OF RESPIRATORY FAILURE?;764;0001
00067;WHAT IS THE PROGNOSIS FOR PATIENTS WHO HAVE HAD AN EPISODE OF RESPIRATORY FAILURE?;842;0011
00067;WHAT IS THE PROGNOSIS FOR PATIENTS WHO HAVE HAD AN EPISODE OF RESPIRATORY FAILURE?;910;2120
00067;WHAT IS THE PROGNOSIS FOR PATIENTS WHO HAVE HAD AN EPISODE OF RESPIRATORY FAILURE?;914;2220
00067;WHAT IS THE PROGNOSIS FOR PATIENTS WHO HAVE HAD AN EPISODE OF RESPIRATORY FAILURE?;1234;0002
00068;WHAT ARE THE EFFECTS OF BRONCHODILATORS IN CF PATIENTS?;11;0100
00068;WHAT ARE THE EFFECTS OF BRONCHODILATORS IN CF PATIENTS?;64;1000
00068;WHAT ARE THE EFFECTS OF BRONCHODILATORS IN CF PATIENTS?;90;1112
00068;WHAT ARE THE EFFECTS OF BRONCHODILATORS IN CF PATIENTS?;135;0001
00068;WHAT ARE THE EFFECTS OF BRONCHODILATORS IN CF PATIENTS?;195;2220
00068;WHAT ARE THE EFFECTS OF BRONCHODILATORS IN CF PATIENTS?;206;2121
00068;WHAT ARE THE EFFECTS OF BRONCHODILATORS IN CF PATIENTS?;297;0001
00068;WHAT ARE THE EFFECTS OF BRONCHODILATORS IN CF PATIENTS?;327;0001
00068;WHAT ARE THE EFFECTS OF BRONCHODILATORS IN CF PATIENTS?;331;0001
00068;WHAT ARE THE EFFECTS OF BRONCHODILATORS IN CF PATIENTS?;341;1100
00068;WHAT ARE THE EFFECTS OF BRONCHODILATORS IN CF PATIENTS?;349;2212
00068;WHAT ARE THE EFFECTS OF BRONCHODILATORS IN CF PATIENTS?;358;1000
00068;WHAT ARE THE EFFECTS OF BRONCHODILATORS IN CF PATIENTS?;359;0001
00068;WHAT ARE THE EFFECTS OF BRONCHODILATORS IN CF PATIENTS?;370;1000
00068;WHAT ARE THE EFFECTS OF BRONCHODILATORS IN CF PATIENTS?;437;0010
00068;WHAT ARE THE EFFECTS OF BRONCHODILATORS IN CF PATIENTS?;438;1220
00068;WHAT ARE THE EFFECTS OF BRONCHODILATORS IN CF PATIENTS?;543;2222
00068;WHAT ARE THE EFFECTS OF BRONCHODILATORS IN CF PATIENTS?;546;1002
00068;WHAT ARE THE EFFECTS OF BRONCHODILATORS IN CF PATIENTS?;550;0001
00068;WHAT ARE THE EFFECTS OF BRONCHODILATORS IN CF PATIENTS?;607;0001
00068;WHAT ARE THE EFFECTS OF BRONCHODILATORS IN CF PATIENTS?;632;0001
00068;WHAT ARE THE EFFECTS OF BRONCHODILATORS IN CF PATIENTS?;734;1002
00068;WHAT ARE THE EFFECTS OF BRONCHODILATORS IN CF PATIENTS?;819;1000
00068;WHAT ARE THE EFFECTS OF BRONCHODILATORS IN CF PATIENTS?;826;0001
00068;WHAT ARE THE EFFECTS OF BRONCHODILATORS IN CF PATIENTS?;838;0001
00068;WHAT ARE THE EFFECTS OF BRONCHODILATORS IN CF PATIENTS?;882;0001
00068;WHAT ARE THE EFFECTS OF BRONCHODILATORS IN CF PATIENTS?;889;0002
00068;WHAT ARE THE EFFECTS OF BRONCHODILATORS IN CF PATIENTS?;904;1111
00068;WHAT ARE THE EFFECTS OF BRONCHODILATORS IN CF PATIENTS?;913;1000
00068;WHAT ARE THE EFFECTS OF BRONCHODILATORS IN CF PATIENTS?;944;0001
00068;WHAT ARE THE EFFECTS OF BRONCHODILATORS IN CF PATIENTS?;964;2120
00068;WHAT ARE THE EFFECTS OF BRONCHODILATORS IN CF PATIENTS?;969;0001
00068;WHAT ARE THE EFFECTS OF BRONCHODILATORS IN CF PATIENTS?;1000;0001
00068;WHAT ARE THE EFFECTS OF BRONCHODILATORS IN CF PATIENTS?;1003;2222
00068;WHAT ARE THE EFFECTS OF BRONCHODILATORS IN CF PATIENTS?;1040;0001
00068;WHAT ARE THE EFFECTS OF BRONCHODILATORS IN CF PATIENTS?;1046;0002
00068;WHAT ARE THE EFFECTS OF BRONCHODILATORS IN CF PATIENTS?;1048;1100
00068;WHAT ARE THE EFFECTS OF BRONCHODILATORS IN CF PATIENTS?;1093;0002
00068;WHAT ARE THE EFFECTS OF BRONCHODILATORS IN CF PATIENTS?;1099;2120
00068;WHAT ARE THE EFFECTS OF BRONCHODILATORS IN CF PATIENTS?;1134;0100
00068;WHAT ARE THE EFFECTS OF BRONCHODILATORS IN CF PATIENTS?;1149;0010
00068;WHAT ARE THE EFFECTS OF BRONCHODILATORS IN CF PATIENTS?;1150;0010
00068;WHAT ARE THE EFFECTS OF BRONCHODILATORS IN CF PATIENTS?;1164;1110
00068;WHAT ARE THE EFFECTS OF BRONCHODILATORS IN CF PATIENTS?;1172;1000
00068;WHAT ARE THE EFFECTS OF BRONCHODILATORS IN CF PATIENTS?;1234;0001
00069;WHAT IS THE BEST WAY TO TREAT PNEUMOTHORAX IN CF PATIENTS?;193;2222
00069;WHAT IS THE BEST WAY TO TREAT PNEUMOTHORAX IN CF PATIENTS?;326;0001
00069;WHAT IS THE BEST WAY TO TREAT PNEUMOTHORAX IN CF PATIENTS?;327;1001
00069;WHAT IS THE BEST WAY TO TREAT PNEUMOTHORAX IN CF PATIENTS?;359;2112
00069;WHAT IS THE BEST WAY TO TREAT PNEUMOTHORAX IN CF PATIENTS?;363;2122
00069;WHAT IS THE BEST WAY TO TREAT PNEUMOTHORAX IN CF PATIENTS?;370;1112
00069;WHAT IS THE BEST WAY TO TREAT PNEUMOTHORAX IN CF PATIENTS?;438;2122
00069;WHAT IS THE BEST WAY TO TREAT PNEUMOTHORAX IN CF PATIENTS?;550;0001
00069;WHAT IS THE BEST WAY TO TREAT PNEUMOTHORAX IN CF PATIENTS?;703;2222
00069;WHAT IS THE BEST WAY TO TREAT PNEUMOTHORAX IN CF PATIENTS?;724;0001
00069;WHAT IS THE BEST WAY TO TREAT PNEUMOTHORAX IN CF PATIENTS?;837;0001
00069;WHAT IS THE BEST WAY TO TREAT PNEUMOTHORAX IN CF PATIENTS?;907;2222
00069;WHAT IS THE BEST WAY TO TREAT PNEUMOTHORAX IN CF PATIENTS?;944;1101
00069;WHAT IS THE BEST WAY TO TREAT PNEUMOTHORAX IN CF PATIENTS?;1000;1102
00069;WHAT IS THE BEST WAY TO TREAT PNEUMOTHORAX IN CF PATIENTS?;1234;1101
00070;WHAT IS THE TREATMENT FOR AND PROGNOSIS OF HEMOPTYSIS IN CF PATIENTS?;17;0100
00070;WHAT IS THE TREATMENT FOR AND PROGNOSIS OF HEMOPTYSIS IN CF PATIENTS?;327;1001
00070;WHAT IS THE TREATMENT FOR AND PROGNOSIS OF HEMOPTYSIS IN CF PATIENTS?;340;2222
00070;WHAT IS THE TREATMENT FOR AND PROGNOSIS OF HEMOPTYSIS IN CF PATIENTS?;370;1112
00070;WHAT IS THE TREATMENT FOR AND PROGNOSIS OF HEMOPTYSIS IN CF PATIENTS?;438;1122
00070;WHAT IS THE TREATMENT FOR AND PROGNOSIS OF HEMOPTYSIS IN CF PATIENTS?;698;2222
00070;WHAT IS THE TREATMENT FOR AND PROGNOSIS OF HEMOPTYSIS IN CF PATIENTS?;722;0100
00070;WHAT IS THE TREATMENT FOR AND PROGNOSIS OF HEMOPTYSIS IN CF PATIENTS?;804;2222
00070;WHAT IS THE TREATMENT FOR AND PROGNOSIS OF HEMOPTYSIS IN CF PATIENTS?;837;0001
00070;WHAT IS THE TREATMENT FOR AND PROGNOSIS OF HEMOPTYSIS IN CF PATIENTS?;944;1101
00070;WHAT IS THE TREATMENT FOR AND PROGNOSIS OF HEMOPTYSIS IN CF PATIENTS?;952;0100
00070;WHAT IS THE TREATMENT FOR AND PROGNOSIS OF HEMOPTYSIS IN CF PATIENTS?;1000;1102
00070;WHAT IS THE TREATMENT FOR AND PROGNOSIS OF HEMOPTYSIS IN CF PATIENTS?;1009;2222
00070;WHAT IS THE TREATMENT FOR AND PROGNOSIS OF HEMOPTYSIS IN CF PATIENTS?;1032;2222
00070;WHAT IS THE TREATMENT FOR AND PROGNOSIS OF HEMOPTYSIS IN CF PATIENTS?;1104;2222
00070;WHAT IS THE TREATMENT FOR AND PROGNOSIS OF HEMOPTYSIS IN CF PATIENTS?;1232;0001
00070;WHAT IS THE TREATMENT FOR AND PROGNOSIS OF HEMOPTYSIS IN CF PATIENTS?;1234;1102
00071;WHAT IS THE PROGNOSIS FOR INFANTS WITH WHEEZING AND CYSTIC FIBROSIS?;11;0010
00071;WHAT IS THE PROGNOSIS FOR INFANTS WITH WHEEZING AND CYSTIC FIBROSIS?;56;1000
00071;WHAT IS THE PROGNOSIS FOR INFANTS WITH WHEEZING AND CYSTIC FIBROSIS?;148;2222
00071;WHAT IS THE PROGNOSIS FOR INFANTS WITH WHEEZING AND CYSTIC FIBROSIS?;327;1000
00071;WHAT IS THE PROGNOSIS FOR INFANTS WITH WHEEZING AND CYSTIC FIBROSIS?;370;0001
00071;WHAT IS THE PROGNOSIS FOR INFANTS WITH WHEEZING AND CYSTIC FIBROSIS?;547;0001
00072;WHAT IS THE BEST TREATMENT FOR NASAL POLYPS IN CF PATIENTS?;58;1011
00072;WHAT IS THE BEST TREATMENT FOR NASAL POLYPS IN CF PATIENTS?;250;1000
00072;WHAT IS THE BEST TREATMENT FOR NASAL POLYPS IN CF PATIENTS?;323;2220
00072;WHAT IS THE BEST TREATMENT FOR NASAL POLYPS IN CF PATIENTS?;333;0001
00072;WHAT IS THE BEST TREATMENT FOR NASAL POLYPS IN CF PATIENTS?;682;2122
00072;WHAT IS THE BEST TREATMENT FOR NASAL POLYPS IN CF PATIENTS?;683;2120
00072;WHAT IS THE BEST TREATMENT FOR NASAL POLYPS IN CF PATIENTS?;732;2222
00072;WHAT IS THE BEST TREATMENT FOR NASAL POLYPS IN CF PATIENTS?;733;0002
00072;WHAT IS THE BEST TREATMENT FOR NASAL POLYPS IN CF PATIENTS?;837;0001
00072;WHAT IS THE BEST TREATMENT FOR NASAL POLYPS IN CF PATIENTS?;941;0001
00072;WHAT IS THE BEST TREATMENT FOR NASAL POLYPS IN CF PATIENTS?;1000;0001
00072;WHAT IS THE BEST TREATMENT FOR NASAL POLYPS IN CF PATIENTS?;1019;0001
00072;WHAT IS THE BEST TREATMENT FOR NASAL POLYPS IN CF PATIENTS?;1125;0001
00073;HOW EFFECTIVE IS BRONCHIAL LAVAGE IN CF PATIENTS?;50;2222
00073;HOW EFFECTIVE IS BRONCHIAL LAVAGE IN CF PATIENTS?;224;1122
00073;HOW EFFECTIVE IS BRONCHIAL LAVAGE IN CF PATIENTS?;227;2222
00073;HOW EFFECTIVE IS BRONCHIAL LAVAGE IN CF PATIENTS?;359;2112
00073;HOW EFFECTIVE IS BRONCHIAL LAVAGE IN CF PATIENTS?;370;1111
00073;HOW EFFECTIVE IS BRONCHIAL LAVAGE IN CF PATIENTS?;438;1122
00073;HOW EFFECTIVE IS BRONCHIAL LAVAGE IN CF PATIENTS?;629;2220
00073;HOW EFFECTIVE IS BRONCHIAL LAVAGE IN CF PATIENTS?;630;2222
00073;HOW EFFECTIVE IS BRONCHIAL LAVAGE IN CF PATIENTS?;724;0001
00073;HOW EFFECTIVE IS BRONCHIAL LAVAGE IN CF PATIENTS?;806;2110
00073;HOW EFFECTIVE IS BRONCHIAL LAVAGE IN CF PATIENTS?;843;2222
00073;HOW EFFECTIVE IS BRONCHIAL LAVAGE IN CF PATIENTS?;844;2222
00073;HOW EFFECTIVE IS BRONCHIAL LAVAGE IN CF PATIENTS?;990;0001
00073;HOW EFFECTIVE IS BRONCHIAL LAVAGE IN CF PATIENTS?;1000;0001
00073;HOW EFFECTIVE IS BRONCHIAL LAVAGE IN CF PATIENTS?;1093;0002
00073;HOW EFFECTIVE IS BRONCHIAL LAVAGE IN CF PATIENTS?;1228;0010
00073;HOW EFFECTIVE IS BRONCHIAL LAVAGE IN CF PATIENTS?;1229;0010
00073;HOW EFFECTIVE IS BRONCHIAL LAVAGE IN CF PATIENTS?;1234;0001
00074;WHAT ARE THE RESULTS OF MECHANICAL VENTILATION IN CF PATIENTS WITH RESPIRATORY FAILURE?;148;2220
00074;WHAT ARE THE RESULTS OF MECHANICAL VENTILATION IN CF PATIENTS WITH RESPIRATORY FAILURE?;370;1000
00074;WHAT ARE THE RESULTS OF MECHANICAL VENTILATION IN CF PATIENTS WITH RESPIRATORY FAILURE?;724;1001
00074;WHAT ARE THE RESULTS OF MECHANICAL VENTILATION IN CF PATIENTS WITH RESPIRATORY FAILURE?;910;2122
00074;WHAT ARE THE RESULTS OF MECHANICAL VENTILATION IN CF PATIENTS WITH RESPIRATORY FAILURE?;914;2222
00074;WHAT ARE THE RESULTS OF MECHANICAL VENTILATION IN CF PATIENTS WITH RESPIRATORY FAILURE?;1000;0001
00074;WHAT ARE THE RESULTS OF MECHANICAL VENTILATION IN CF PATIENTS WITH RESPIRATORY FAILURE?;1093;0002
00075;WHAT IS THE BEST TREATMENT FOR PULMONARY HYPERTENSION AND/OR COR PULMONALE IN CF PATIENTS?;100;1000
00075;WHAT IS THE BEST TREATMENT FOR PULMONARY HYPERTENSION AND/OR COR PULMONALE IN CF PATIENTS?;241;0102
00075;WHAT IS THE BEST TREATMENT FOR PULMONARY HYPERTENSION AND/OR COR PULMONALE IN CF PATIENTS?;273;0011
00075;WHAT IS THE BEST TREATMENT FOR PULMONARY HYPERTENSION AND/OR COR PULMONALE IN CF PATIENTS?;316;2222
00075;WHAT IS THE BEST TREATMENT FOR PULMONARY HYPERTENSION AND/OR COR PULMONALE IN CF PATIENTS?;348;1010
00075;WHAT IS THE BEST TREATMENT FOR PULMONARY HYPERTENSION AND/OR COR PULMONALE IN CF PATIENTS?;354;1010
00075;WHAT IS THE BEST TREATMENT FOR PULMONARY HYPERTENSION AND/OR COR PULMONALE IN CF PATIENTS?;359;2110
00075;WHAT IS THE BEST TREATMENT FOR PULMONARY HYPERTENSION AND/OR COR PULMONALE IN CF PATIENTS?;370;1112
00075;WHAT IS THE BEST TREATMENT FOR PULMONARY HYPERTENSION AND/OR COR PULMONALE IN CF PATIENTS?;446;2222
00075;WHAT IS THE BEST TREATMENT FOR PULMONARY HYPERTENSION AND/OR COR PULMONALE IN CF PATIENTS?;519;1001
00075;WHAT IS THE BEST TREATMENT FOR PULMONARY HYPERTENSION AND/OR COR PULMONALE IN CF PATIENTS?;587;1010
00075;WHAT IS THE BEST TREATMENT FOR PULMONARY HYPERTENSION AND/OR COR PULMONALE IN CF PATIENTS?;597;1000
00075;WHAT IS THE BEST TREATMENT FOR PULMONARY HYPERTENSION AND/OR COR PULMONALE IN CF PATIENTS?;751;0110
00075;WHAT IS THE BEST TREATMENT FOR PULMONARY HYPERTENSION AND/OR COR PULMONALE IN CF PATIENTS?;757;0010
00075;WHAT IS THE BEST TREATMENT FOR PULMONARY HYPERTENSION AND/OR COR PULMONALE IN CF PATIENTS?;837;0001
00075;WHAT IS THE BEST TREATMENT FOR PULMONARY HYPERTENSION AND/OR COR PULMONALE IN CF PATIENTS?;944;1101
00075;WHAT IS THE BEST TREATMENT FOR PULMONARY HYPERTENSION AND/OR COR PULMONALE IN CF PATIENTS?;1043;1000
00075;WHAT IS THE BEST TREATMENT FOR PULMONARY HYPERTENSION AND/OR COR PULMONALE IN CF PATIENTS?;1047;1000
00075;WHAT IS THE BEST TREATMENT FOR PULMONARY HYPERTENSION AND/OR COR PULMONALE IN CF PATIENTS?;1110;1012
00075;WHAT IS THE BEST TREATMENT FOR PULMONARY HYPERTENSION AND/OR COR PULMONALE IN CF PATIENTS?;1234;0002
00075;WHAT IS THE BEST TREATMENT FOR PULMONARY HYPERTENSION AND/OR COR PULMONALE IN CF PATIENTS?;1235;0100
00076;WHAT ARE THE EFFECTS OF EXERCISE TRAINING PROGRAMS ON LUNG FUNCTION IN CF PATIENTS?;329;0001
00076;WHAT ARE THE EFFECTS OF EXERCISE TRAINING PROGRAMS ON LUNG FUNCTION IN CF PATIENTS?;330;0100
00076;WHAT ARE THE EFFECTS OF EXERCISE TRAINING PROGRAMS ON LUNG FUNCTION IN CF PATIENTS?;359;0101
00076;WHAT ARE THE EFFECTS OF EXERCISE TRAINING PROGRAMS ON LUNG FUNCTION IN CF PATIENTS?;370;0110
00076;WHAT ARE THE EFFECTS OF EXERCISE TRAINING PROGRAMS ON LUNG FUNCTION IN CF PATIENTS?;437;2212
00076;WHAT ARE THE EFFECTS OF EXERCISE TRAINING PROGRAMS ON LUNG FUNCTION IN CF PATIENTS?;438;1011
00076;WHAT ARE THE EFFECTS OF EXERCISE TRAINING PROGRAMS ON LUNG FUNCTION IN CF PATIENTS?;606;2222
00076;WHAT ARE THE EFFECTS OF EXERCISE TRAINING PROGRAMS ON LUNG FUNCTION IN CF PATIENTS?;731;0001
00076;WHAT ARE THE EFFECTS OF EXERCISE TRAINING PROGRAMS ON LUNG FUNCTION IN CF PATIENTS?;882;0001
00076;WHAT ARE THE EFFECTS OF EXERCISE TRAINING PROGRAMS ON LUNG FUNCTION IN CF PATIENTS?;889;0001
00076;WHAT ARE THE EFFECTS OF EXERCISE TRAINING PROGRAMS ON LUNG FUNCTION IN CF PATIENTS?;1007;1012
00076;WHAT ARE THE EFFECTS OF EXERCISE TRAINING PROGRAMS ON LUNG FUNCTION IN CF PATIENTS?;1023;0001
00076;WHAT ARE THE EFFECTS OF EXERCISE TRAINING PROGRAMS ON LUNG FUNCTION IN CF PATIENTS?;1039;0001
00076;WHAT ARE THE EFFECTS OF EXERCISE TRAINING PROGRAMS ON LUNG FUNCTION IN CF PATIENTS?;1048;1010
00076;WHAT ARE THE EFFECTS OF EXERCISE TRAINING PROGRAMS ON LUNG FUNCTION IN CF PATIENTS?;1080;0001
00076;WHAT ARE THE EFFECTS OF EXERCISE TRAINING PROGRAMS ON LUNG FUNCTION IN CF PATIENTS?;1134;0001
00076;WHAT ARE THE EFFECTS OF EXERCISE TRAINING PROGRAMS ON LUNG FUNCTION IN CF PATIENTS?;1188;1222
00077;WHAT TECHNIQUES ARE EFFECTIVE IN PROMOTING CLEARANCE OF MUCUS FROM THE LUNGS OF CF PATIENTS?;25;0101
00077;WHAT TECHNIQUES ARE EFFECTIVE IN PROMOTING CLEARANCE OF MUCUS FROM THE LUNGS OF CF PATIENTS?;27;2222
00077;WHAT TECHNIQUES ARE EFFECTIVE IN PROMOTING CLEARANCE OF MUCUS FROM THE LUNGS OF CF PATIENTS?;31;0010
00077;WHAT TECHNIQUES ARE EFFECTIVE IN PROMOTING CLEARANCE OF MUCUS FROM THE LUNGS OF CF PATIENTS?;50;0001
00077;WHAT TECHNIQUES ARE EFFECTIVE IN PROMOTING CLEARANCE OF MUCUS FROM THE LUNGS OF CF PATIENTS?;90;1212
00077;WHAT TECHNIQUES ARE EFFECTIVE IN PROMOTING CLEARANCE OF MUCUS FROM THE LUNGS OF CF PATIENTS?;128;0012
00077;WHAT TECHNIQUES ARE EFFECTIVE IN PROMOTING CLEARANCE OF MUCUS FROM THE LUNGS OF CF PATIENTS?;135;0101
00077;WHAT TECHNIQUES ARE EFFECTIVE IN PROMOTING CLEARANCE OF MUCUS FROM THE LUNGS OF CF PATIENTS?;148;0001
00077;WHAT TECHNIQUES ARE EFFECTIVE IN PROMOTING CLEARANCE OF MUCUS FROM THE LUNGS OF CF PATIENTS?;168;0001
00077;WHAT TECHNIQUES ARE EFFECTIVE IN PROMOTING CLEARANCE OF MUCUS FROM THE LUNGS OF CF PATIENTS?;195;2221
00077;WHAT TECHNIQUES ARE EFFECTIVE IN PROMOTING CLEARANCE OF MUCUS FROM THE LUNGS OF CF PATIENTS?;197;0001
00077;WHAT TECHNIQUES ARE EFFECTIVE IN PROMOTING CLEARANCE OF MUCUS FROM THE LUNGS OF CF PATIENTS?;224;1122
00077;WHAT TECHNIQUES ARE EFFECTIVE IN PROMOTING CLEARANCE OF MUCUS FROM THE LUNGS OF CF PATIENTS?;226;0001
00077;WHAT TECHNIQUES ARE EFFECTIVE IN PROMOTING CLEARANCE OF MUCUS FROM THE LUNGS OF CF PATIENTS?;227;1220
00077;WHAT TECHNIQUES ARE EFFECTIVE IN PROMOTING CLEARANCE OF MUCUS FROM THE LUNGS OF CF PATIENTS?;267;0001
00077;WHAT TECHNIQUES ARE EFFECTIVE IN PROMOTING CLEARANCE OF MUCUS FROM THE LUNGS OF CF PATIENTS?;297;0001
00077;WHAT TECHNIQUES ARE EFFECTIVE IN PROMOTING CLEARANCE OF MUCUS FROM THE LUNGS OF CF PATIENTS?;298;0001
00077;WHAT TECHNIQUES ARE EFFECTIVE IN PROMOTING CLEARANCE OF MUCUS FROM THE LUNGS OF CF PATIENTS?;321;0010
00077;WHAT TECHNIQUES ARE EFFECTIVE IN PROMOTING CLEARANCE OF MUCUS FROM THE LUNGS OF CF PATIENTS?;323;2222
00077;WHAT TECHNIQUES ARE EFFECTIVE IN PROMOTING CLEARANCE OF MUCUS FROM THE LUNGS OF CF PATIENTS?;326;0010
00077;WHAT TECHNIQUES ARE EFFECTIVE IN PROMOTING CLEARANCE OF MUCUS FROM THE LUNGS OF CF PATIENTS?;327;1212
00077;WHAT TECHNIQUES ARE EFFECTIVE IN PROMOTING CLEARANCE OF MUCUS FROM THE LUNGS OF CF PATIENTS?;329;1012
00077;WHAT TECHNIQUES ARE EFFECTIVE IN PROMOTING CLEARANCE OF MUCUS FROM THE LUNGS OF CF PATIENTS?;330;0102
00077;WHAT TECHNIQUES ARE EFFECTIVE IN PROMOTING CLEARANCE OF MUCUS FROM THE LUNGS OF CF PATIENTS?;333;0001
00077;WHAT TECHNIQUES ARE EFFECTIVE IN PROMOTING CLEARANCE OF MUCUS FROM THE LUNGS OF CF PATIENTS?;359;2112
00077;WHAT TECHNIQUES ARE EFFECTIVE IN PROMOTING CLEARANCE OF MUCUS FROM THE LUNGS OF CF PATIENTS?;370;1112
00077;WHAT TECHNIQUES ARE EFFECTIVE IN PROMOTING CLEARANCE OF MUCUS FROM THE LUNGS OF CF PATIENTS?;428;0001
00077;WHAT TECHNIQUES ARE EFFECTIVE IN PROMOTING CLEARANCE OF MUCUS FROM THE LUNGS OF CF PATIENTS?;437;1222
00077;WHAT TECHNIQUES ARE EFFECTIVE IN PROMOTING CLEARANCE OF MUCUS FROM THE LUNGS OF CF PATIENTS?;438;1222
00077;WHAT TECHNIQUES ARE EFFECTIVE IN PROMOTING CLEARANCE OF MUCUS FROM THE LUNGS OF CF PATIENTS?;542;1010
00077;WHAT TECHNIQUES ARE EFFECTIVE IN PROMOTING CLEARANCE OF MUCUS FROM THE LUNGS OF CF PATIENTS?;546;2222
00077;WHAT TECHNIQUES ARE EFFECTIVE IN PROMOTING CLEARANCE OF MUCUS FROM THE LUNGS OF CF PATIENTS?;550;0001
00077;WHAT TECHNIQUES ARE EFFECTIVE IN PROMOTING CLEARANCE OF MUCUS FROM THE LUNGS OF CF PATIENTS?;551;0001
00077;WHAT TECHNIQUES ARE EFFECTIVE IN PROMOTING CLEARANCE OF MUCUS FROM THE LUNGS OF CF PATIENTS?;558;0001
00077;WHAT TECHNIQUES ARE EFFECTIVE IN PROMOTING CLEARANCE OF MUCUS FROM THE LUNGS OF CF PATIENTS?;586;0001
00077;WHAT TECHNIQUES ARE EFFECTIVE IN PROMOTING CLEARANCE OF MUCUS FROM THE LUNGS OF CF PATIENTS?;592;0110
00077;WHAT TECHNIQUES ARE EFFECTIVE IN PROMOTING CLEARANCE OF MUCUS FROM THE LUNGS OF CF PATIENTS?;629;2222
00077;WHAT TECHNIQUES ARE EFFECTIVE IN PROMOTING CLEARANCE OF MUCUS FROM THE LUNGS OF CF PATIENTS?;630;2221
00077;WHAT TECHNIQUES ARE EFFECTIVE IN PROMOTING CLEARANCE OF MUCUS FROM THE LUNGS OF CF PATIENTS?;663;0001
00077;WHAT TECHNIQUES ARE EFFECTIVE IN PROMOTING CLEARANCE OF MUCUS FROM THE LUNGS OF CF PATIENTS?;722;0002
00077;WHAT TECHNIQUES ARE EFFECTIVE IN PROMOTING CLEARANCE OF MUCUS FROM THE LUNGS OF CF PATIENTS?;724;0001
00077;WHAT TECHNIQUES ARE EFFECTIVE IN PROMOTING CLEARANCE OF MUCUS FROM THE LUNGS OF CF PATIENTS?;729;0001
00077;WHAT TECHNIQUES ARE EFFECTIVE IN PROMOTING CLEARANCE OF MUCUS FROM THE LUNGS OF CF PATIENTS?;731;0002
00077;WHAT TECHNIQUES ARE EFFECTIVE IN PROMOTING CLEARANCE OF MUCUS FROM THE LUNGS OF CF PATIENTS?;734;2222
00077;WHAT TECHNIQUES ARE EFFECTIVE IN PROMOTING CLEARANCE OF MUCUS FROM THE LUNGS OF CF PATIENTS?;735;0002
00077;WHAT TECHNIQUES ARE EFFECTIVE IN PROMOTING CLEARANCE OF MUCUS FROM THE LUNGS OF CF PATIENTS?;754;2222
00077;WHAT TECHNIQUES ARE EFFECTIVE IN PROMOTING CLEARANCE OF MUCUS FROM THE LUNGS OF CF PATIENTS?;806;1000
00077;WHAT TECHNIQUES ARE EFFECTIVE IN PROMOTING CLEARANCE OF MUCUS FROM THE LUNGS OF CF PATIENTS?;826;0001
00077;WHAT TECHNIQUES ARE EFFECTIVE IN PROMOTING CLEARANCE OF MUCUS FROM THE LUNGS OF CF PATIENTS?;837;0001
00077;WHAT TECHNIQUES ARE EFFECTIVE IN PROMOTING CLEARANCE OF MUCUS FROM THE LUNGS OF CF PATIENTS?;839;0001
00077;WHAT TECHNIQUES ARE EFFECTIVE IN PROMOTING CLEARANCE OF MUCUS FROM THE LUNGS OF CF PATIENTS?;843;2122
00077;WHAT TECHNIQUES ARE EFFECTIVE IN PROMOTING CLEARANCE OF MUCUS FROM THE LUNGS OF CF PATIENTS?;844;2122
00077;WHAT TECHNIQUES ARE EFFECTIVE IN PROMOTING CLEARANCE OF MUCUS FROM THE LUNGS OF CF PATIENTS?;845;0002
00077;WHAT TECHNIQUES ARE EFFECTIVE IN PROMOTING CLEARANCE OF MUCUS FROM THE LUNGS OF CF PATIENTS?;879;0001
00077;WHAT TECHNIQUES ARE EFFECTIVE IN PROMOTING CLEARANCE OF MUCUS FROM THE LUNGS OF CF PATIENTS?;882;0002
00077;WHAT TECHNIQUES ARE EFFECTIVE IN PROMOTING CLEARANCE OF MUCUS FROM THE LUNGS OF CF PATIENTS?;889;0002
00077;WHAT TECHNIQUES ARE EFFECTIVE IN PROMOTING CLEARANCE OF MUCUS FROM THE LUNGS OF CF PATIENTS?;912;0001
00077;WHAT TECHNIQUES ARE EFFECTIVE IN PROMOTING CLEARANCE OF MUCUS FROM THE LUNGS OF CF PATIENTS?;937;0001
00077;WHAT TECHNIQUES ARE EFFECTIVE IN PROMOTING CLEARANCE OF MUCUS FROM THE LUNGS OF CF PATIENTS?;939;1112
00077;WHAT TECHNIQUES ARE EFFECTIVE IN PROMOTING CLEARANCE OF MUCUS FROM THE LUNGS OF CF PATIENTS?;941;0001
00077;WHAT TECHNIQUES ARE EFFECTIVE IN PROMOTING CLEARANCE OF MUCUS FROM THE LUNGS OF CF PATIENTS?;944;0002
00077;WHAT TECHNIQUES ARE EFFECTIVE IN PROMOTING CLEARANCE OF MUCUS FROM THE LUNGS OF CF PATIENTS?;963;1211
00077;WHAT TECHNIQUES ARE EFFECTIVE IN PROMOTING CLEARANCE OF MUCUS FROM THE LUNGS OF CF PATIENTS?;990;0002
00077;WHAT TECHNIQUES ARE EFFECTIVE IN PROMOTING CLEARANCE OF MUCUS FROM THE LUNGS OF CF PATIENTS?;1006;2222
00077;WHAT TECHNIQUES ARE EFFECTIVE IN PROMOTING CLEARANCE OF MUCUS FROM THE LUNGS OF CF PATIENTS?;1012;2222
00077;WHAT TECHNIQUES ARE EFFECTIVE IN PROMOTING CLEARANCE OF MUCUS FROM THE LUNGS OF CF PATIENTS?;1023;0001
00077;WHAT TECHNIQUES ARE EFFECTIVE IN PROMOTING CLEARANCE OF MUCUS FROM THE LUNGS OF CF PATIENTS?;1034;2222
00077;WHAT TECHNIQUES ARE EFFECTIVE IN PROMOTING CLEARANCE OF MUCUS FROM THE LUNGS OF CF PATIENTS?;1035;2222
00077;WHAT TECHNIQUES ARE EFFECTIVE IN PROMOTING CLEARANCE OF MUCUS FROM THE LUNGS OF CF PATIENTS?;1040;0001
00077;WHAT TECHNIQUES ARE EFFECTIVE IN PROMOTING CLEARANCE OF MUCUS FROM THE LUNGS OF CF PATIENTS?;1080;0001
00077;WHAT TECHNIQUES ARE EFFECTIVE IN PROMOTING CLEARANCE OF MUCUS FROM THE LUNGS OF CF PATIENTS?;1092;0002
00077;WHAT TECHNIQUES ARE EFFECTIVE IN PROMOTING CLEARANCE OF MUCUS FROM THE LUNGS OF CF PATIENTS?;1093;0002
00077;WHAT TECHNIQUES ARE EFFECTIVE IN PROMOTING CLEARANCE OF MUCUS FROM THE LUNGS OF CF PATIENTS?;1134;0001
00077;WHAT TECHNIQUES ARE EFFECTIVE IN PROMOTING CLEARANCE OF MUCUS FROM THE LUNGS OF CF PATIENTS?;1138;1122
00077;WHAT TECHNIQUES ARE EFFECTIVE IN PROMOTING CLEARANCE OF MUCUS FROM THE LUNGS OF CF PATIENTS?;1149;1112
00077;WHAT TECHNIQUES ARE EFFECTIVE IN PROMOTING CLEARANCE OF MUCUS FROM THE LUNGS OF CF PATIENTS?;1150;0112
00077;WHAT TECHNIQUES ARE EFFECTIVE IN PROMOTING CLEARANCE OF MUCUS FROM THE LUNGS OF CF PATIENTS?;1152;2122
00077;WHAT TECHNIQUES ARE EFFECTIVE IN PROMOTING CLEARANCE OF MUCUS FROM THE LUNGS OF CF PATIENTS?;1153;2122
00077;WHAT TECHNIQUES ARE EFFECTIVE IN PROMOTING CLEARANCE OF MUCUS FROM THE LUNGS OF CF PATIENTS?;1188;0001
00077;WHAT TECHNIQUES ARE EFFECTIVE IN PROMOTING CLEARANCE OF MUCUS FROM THE LUNGS OF CF PATIENTS?;1220;2222
00077;WHAT TECHNIQUES ARE EFFECTIVE IN PROMOTING CLEARANCE OF MUCUS FROM THE LUNGS OF CF PATIENTS?;1232;0001
00077;WHAT TECHNIQUES ARE EFFECTIVE IN PROMOTING CLEARANCE OF MUCUS FROM THE LUNGS OF CF PATIENTS?;1234;1102
00078;WHAT SPECIAL CONSIDERATIONS ARE THERE FOR TREATMENT OF CF PATIENTS WITH ANTIBIOTICS (IE, ARE THE PHARMACODYNAMICS OF ANTIBIOTICS DIFFERENT IN CF PATIENTS, OR ARE THERE OTHER SPECIAL PROBLEMS PECULIAR TO CF)?;61;0112
00078;WHAT SPECIAL CONSIDERATIONS ARE THERE FOR TREATMENT OF CF PATIENTS WITH ANTIBIOTICS (IE, ARE THE PHARMACODYNAMICS OF ANTIBIOTICS DIFFERENT IN CF PATIENTS, OR ARE THERE OTHER SPECIAL PROBLEMS PECULIAR TO CF)?;65;0100
00078;WHAT SPECIAL CONSIDERATIONS ARE THERE FOR TREATMENT OF CF PATIENTS WITH ANTIBIOTICS (IE, ARE THE PHARMACODYNAMICS OF ANTIBIOTICS DIFFERENT IN CF PATIENTS, OR ARE THERE OTHER SPECIAL PROBLEMS PECULIAR TO CF)?;82;0001
00078;WHAT SPECIAL CONSIDERATIONS ARE THERE FOR TREATMENT OF CF PATIENTS WITH ANTIBIOTICS (IE, ARE THE PHARMACODYNAMICS OF ANTIBIOTICS DIFFERENT IN CF PATIENTS, OR ARE THERE OTHER SPECIAL PROBLEMS PECULIAR TO CF)?;90;0100
00078;WHAT SPECIAL CONSIDERATIONS ARE THERE FOR TREATMENT OF CF PATIENTS WITH ANTIBIOTICS (IE, ARE THE PHARMACODYNAMICS OF ANTIBIOTICS DIFFERENT IN CF PATIENTS, OR ARE THERE OTHER SPECIAL PROBLEMS PECULIAR TO CF)?;93;0100
00078;WHAT SPECIAL CONSIDERATIONS ARE THERE FOR TREATMENT OF CF PATIENTS WITH ANTIBIOTICS (IE, ARE THE PHARMACODYNAMICS OF ANTIBIOTICS DIFFERENT IN CF PATIENTS, OR ARE THERE OTHER SPECIAL PROBLEMS PECULIAR TO CF)?;135;0010
00078;WHAT SPECIAL CONSIDERATIONS ARE THERE FOR TREATMENT OF CF PATIENTS WITH ANTIBIOTICS (IE, ARE THE PHARMACODYNAMICS OF ANTIBIOTICS DIFFERENT IN CF PATIENTS, OR ARE THERE OTHER SPECIAL PROBLEMS PECULIAR TO CF)?;146;1002
00078;WHAT SPECIAL CONSIDERATIONS ARE THERE FOR TREATMENT OF CF PATIENTS WITH ANTIBIOTICS (IE, ARE THE PHARMACODYNAMICS OF ANTIBIOTICS DIFFERENT IN CF PATIENTS, OR ARE THERE OTHER SPECIAL PROBLEMS PECULIAR TO CF)?;152;0011
00078;WHAT SPECIAL CONSIDERATIONS ARE THERE FOR TREATMENT OF CF PATIENTS WITH ANTIBIOTICS (IE, ARE THE PHARMACODYNAMICS OF ANTIBIOTICS DIFFERENT IN CF PATIENTS, OR ARE THERE OTHER SPECIAL PROBLEMS PECULIAR TO CF)?;159;1122
00078;WHAT SPECIAL CONSIDERATIONS ARE THERE FOR TREATMENT OF CF PATIENTS WITH ANTIBIOTICS (IE, ARE THE PHARMACODYNAMICS OF ANTIBIOTICS DIFFERENT IN CF PATIENTS, OR ARE THERE OTHER SPECIAL PROBLEMS PECULIAR TO CF)?;161;0010
00078;WHAT SPECIAL CONSIDERATIONS ARE THERE FOR TREATMENT OF CF PATIENTS WITH ANTIBIOTICS (IE, ARE THE PHARMACODYNAMICS OF ANTIBIOTICS DIFFERENT IN CF PATIENTS, OR ARE THERE OTHER SPECIAL PROBLEMS PECULIAR TO CF)?;179;0011
00078;WHAT SPECIAL CONSIDERATIONS ARE THERE FOR TREATMENT OF CF PATIENTS WITH ANTIBIOTICS (IE, ARE THE PHARMACODYNAMICS OF ANTIBIOTICS DIFFERENT IN CF PATIENTS, OR ARE THERE OTHER SPECIAL PROBLEMS PECULIAR TO CF)?;184;1000
00078;WHAT SPECIAL CONSIDERATIONS ARE THERE FOR TREATMENT OF CF PATIENTS WITH ANTIBIOTICS (IE, ARE THE PHARMACODYNAMICS OF ANTIBIOTICS DIFFERENT IN CF PATIENTS, OR ARE THERE OTHER SPECIAL PROBLEMS PECULIAR TO CF)?;188;0001
00078;WHAT SPECIAL CONSIDERATIONS ARE THERE FOR TREATMENT OF CF PATIENTS WITH ANTIBIOTICS (IE, ARE THE PHARMACODYNAMICS OF ANTIBIOTICS DIFFERENT IN CF PATIENTS, OR ARE THERE OTHER SPECIAL PROBLEMS PECULIAR TO CF)?;238;0100
00078;WHAT SPECIAL CONSIDERATIONS ARE THERE FOR TREATMENT OF CF PATIENTS WITH ANTIBIOTICS (IE, ARE THE PHARMACODYNAMICS OF ANTIBIOTICS DIFFERENT IN CF PATIENTS, OR ARE THERE OTHER SPECIAL PROBLEMS PECULIAR TO CF)?;253;1211
00078;WHAT SPECIAL CONSIDERATIONS ARE THERE FOR TREATMENT OF CF PATIENTS WITH ANTIBIOTICS (IE, ARE THE PHARMACODYNAMICS OF ANTIBIOTICS DIFFERENT IN CF PATIENTS, OR ARE THERE OTHER SPECIAL PROBLEMS PECULIAR TO CF)?;255;2212
00078;WHAT SPECIAL CONSIDERATIONS ARE THERE FOR TREATMENT OF CF PATIENTS WITH ANTIBIOTICS (IE, ARE THE PHARMACODYNAMICS OF ANTIBIOTICS DIFFERENT IN CF PATIENTS, OR ARE THERE OTHER SPECIAL PROBLEMS PECULIAR TO CF)?;265;0001
00078;WHAT SPECIAL CONSIDERATIONS ARE THERE FOR TREATMENT OF CF PATIENTS WITH ANTIBIOTICS (IE, ARE THE PHARMACODYNAMICS OF ANTIBIOTICS DIFFERENT IN CF PATIENTS, OR ARE THERE OTHER SPECIAL PROBLEMS PECULIAR TO CF)?;282;0002
00078;WHAT SPECIAL CONSIDERATIONS ARE THERE FOR TREATMENT OF CF PATIENTS WITH ANTIBIOTICS (IE, ARE THE PHARMACODYNAMICS OF ANTIBIOTICS DIFFERENT IN CF PATIENTS, OR ARE THERE OTHER SPECIAL PROBLEMS PECULIAR TO CF)?;315;0100
00078;WHAT SPECIAL CONSIDERATIONS ARE THERE FOR TREATMENT OF CF PATIENTS WITH ANTIBIOTICS (IE, ARE THE PHARMACODYNAMICS OF ANTIBIOTICS DIFFERENT IN CF PATIENTS, OR ARE THERE OTHER SPECIAL PROBLEMS PECULIAR TO CF)?;320;2222
00078;WHAT SPECIAL CONSIDERATIONS ARE THERE FOR TREATMENT OF CF PATIENTS WITH ANTIBIOTICS (IE, ARE THE PHARMACODYNAMICS OF ANTIBIOTICS DIFFERENT IN CF PATIENTS, OR ARE THERE OTHER SPECIAL PROBLEMS PECULIAR TO CF)?;321;0100
00078;WHAT SPECIAL CONSIDERATIONS ARE THERE FOR TREATMENT OF CF PATIENTS WITH ANTIBIOTICS (IE, ARE THE PHARMACODYNAMICS OF ANTIBIOTICS DIFFERENT IN CF PATIENTS, OR ARE THERE OTHER SPECIAL PROBLEMS PECULIAR TO CF)?;326;0100
00078;WHAT SPECIAL CONSIDERATIONS ARE THERE FOR TREATMENT OF CF PATIENTS WITH ANTIBIOTICS (IE, ARE THE PHARMACODYNAMICS OF ANTIBIOTICS DIFFERENT IN CF PATIENTS, OR ARE THERE OTHER SPECIAL PROBLEMS PECULIAR TO CF)?;330;0100
00078;WHAT SPECIAL CONSIDERATIONS ARE THERE FOR TREATMENT OF CF PATIENTS WITH ANTIBIOTICS (IE, ARE THE PHARMACODYNAMICS OF ANTIBIOTICS DIFFERENT IN CF PATIENTS, OR ARE THERE OTHER SPECIAL PROBLEMS PECULIAR TO CF)?;333;0100
00078;WHAT SPECIAL CONSIDERATIONS ARE THERE FOR TREATMENT OF CF PATIENTS WITH ANTIBIOTICS (IE, ARE THE PHARMACODYNAMICS OF ANTIBIOTICS DIFFERENT IN CF PATIENTS, OR ARE THERE OTHER SPECIAL PROBLEMS PECULIAR TO CF)?;359;0001
00078;WHAT SPECIAL CONSIDERATIONS ARE THERE FOR TREATMENT OF CF PATIENTS WITH ANTIBIOTICS (IE, ARE THE PHARMACODYNAMICS OF ANTIBIOTICS DIFFERENT IN CF PATIENTS, OR ARE THERE OTHER SPECIAL PROBLEMS PECULIAR TO CF)?;370;1011
00078;WHAT SPECIAL CONSIDERATIONS ARE THERE FOR TREATMENT OF CF PATIENTS WITH ANTIBIOTICS (IE, ARE THE PHARMACODYNAMICS OF ANTIBIOTICS DIFFERENT IN CF PATIENTS, OR ARE THERE OTHER SPECIAL PROBLEMS PECULIAR TO CF)?;373;2212
00078;WHAT SPECIAL CONSIDERATIONS ARE THERE FOR TREATMENT OF CF PATIENTS WITH ANTIBIOTICS (IE, ARE THE PHARMACODYNAMICS OF ANTIBIOTICS DIFFERENT IN CF PATIENTS, OR ARE THERE OTHER SPECIAL PROBLEMS PECULIAR TO CF)?;427;0101
00078;WHAT SPECIAL CONSIDERATIONS ARE THERE FOR TREATMENT OF CF PATIENTS WITH ANTIBIOTICS (IE, ARE THE PHARMACODYNAMICS OF ANTIBIOTICS DIFFERENT IN CF PATIENTS, OR ARE THERE OTHER SPECIAL PROBLEMS PECULIAR TO CF)?;438;0102
00078;WHAT SPECIAL CONSIDERATIONS ARE THERE FOR TREATMENT OF CF PATIENTS WITH ANTIBIOTICS (IE, ARE THE PHARMACODYNAMICS OF ANTIBIOTICS DIFFERENT IN CF PATIENTS, OR ARE THERE OTHER SPECIAL PROBLEMS PECULIAR TO CF)?;451;0001
00078;WHAT SPECIAL CONSIDERATIONS ARE THERE FOR TREATMENT OF CF PATIENTS WITH ANTIBIOTICS (IE, ARE THE PHARMACODYNAMICS OF ANTIBIOTICS DIFFERENT IN CF PATIENTS, OR ARE THERE OTHER SPECIAL PROBLEMS PECULIAR TO CF)?;452;1122
00078;WHAT SPECIAL CONSIDERATIONS ARE THERE FOR TREATMENT OF CF PATIENTS WITH ANTIBIOTICS (IE, ARE THE PHARMACODYNAMICS OF ANTIBIOTICS DIFFERENT IN CF PATIENTS, OR ARE THERE OTHER SPECIAL PROBLEMS PECULIAR TO CF)?;459;1220
00078;WHAT SPECIAL CONSIDERATIONS ARE THERE FOR TREATMENT OF CF PATIENTS WITH ANTIBIOTICS (IE, ARE THE PHARMACODYNAMICS OF ANTIBIOTICS DIFFERENT IN CF PATIENTS, OR ARE THERE OTHER SPECIAL PROBLEMS PECULIAR TO CF)?;460;1000
00078;WHAT SPECIAL CONSIDERATIONS ARE THERE FOR TREATMENT OF CF PATIENTS WITH ANTIBIOTICS (IE, ARE THE PHARMACODYNAMICS OF ANTIBIOTICS DIFFERENT IN CF PATIENTS, OR ARE THERE OTHER SPECIAL PROBLEMS PECULIAR TO CF)?;479;0100
00078;WHAT SPECIAL CONSIDERATIONS ARE THERE FOR TREATMENT OF CF PATIENTS WITH ANTIBIOTICS (IE, ARE THE PHARMACODYNAMICS OF ANTIBIOTICS DIFFERENT IN CF PATIENTS, OR ARE THERE OTHER SPECIAL PROBLEMS PECULIAR TO CF)?;556;0101
00078;WHAT SPECIAL CONSIDERATIONS ARE THERE FOR TREATMENT OF CF PATIENTS WITH ANTIBIOTICS (IE, ARE THE PHARMACODYNAMICS OF ANTIBIOTICS DIFFERENT IN CF PATIENTS, OR ARE THERE OTHER SPECIAL PROBLEMS PECULIAR TO CF)?;648;0010
00078;WHAT SPECIAL CONSIDERATIONS ARE THERE FOR TREATMENT OF CF PATIENTS WITH ANTIBIOTICS (IE, ARE THE PHARMACODYNAMICS OF ANTIBIOTICS DIFFERENT IN CF PATIENTS, OR ARE THERE OTHER SPECIAL PROBLEMS PECULIAR TO CF)?;663;0100
00078;WHAT SPECIAL CONSIDERATIONS ARE THERE FOR TREATMENT OF CF PATIENTS WITH ANTIBIOTICS (IE, ARE THE PHARMACODYNAMICS OF ANTIBIOTICS DIFFERENT IN CF PATIENTS, OR ARE THERE OTHER SPECIAL PROBLEMS PECULIAR TO CF)?;680;2222
00078;WHAT SPECIAL CONSIDERATIONS ARE THERE FOR TREATMENT OF CF PATIENTS WITH ANTIBIOTICS (IE, ARE THE PHARMACODYNAMICS OF ANTIBIOTICS DIFFERENT IN CF PATIENTS, OR ARE THERE OTHER SPECIAL PROBLEMS PECULIAR TO CF)?;686;1111
00078;WHAT SPECIAL CONSIDERATIONS ARE THERE FOR TREATMENT OF CF PATIENTS WITH ANTIBIOTICS (IE, ARE THE PHARMACODYNAMICS OF ANTIBIOTICS DIFFERENT IN CF PATIENTS, OR ARE THERE OTHER SPECIAL PROBLEMS PECULIAR TO CF)?;696;0001
00078;WHAT SPECIAL CONSIDERATIONS ARE THERE FOR TREATMENT OF CF PATIENTS WITH ANTIBIOTICS (IE, ARE THE PHARMACODYNAMICS OF ANTIBIOTICS DIFFERENT IN CF PATIENTS, OR ARE THERE OTHER SPECIAL PROBLEMS PECULIAR TO CF)?;718;0001
00078;WHAT SPECIAL CONSIDERATIONS ARE THERE FOR TREATMENT OF CF PATIENTS WITH ANTIBIOTICS (IE, ARE THE PHARMACODYNAMICS OF ANTIBIOTICS DIFFERENT IN CF PATIENTS, OR ARE THERE OTHER SPECIAL PROBLEMS PECULIAR TO CF)?;722;0001
00078;WHAT SPECIAL CONSIDERATIONS ARE THERE FOR TREATMENT OF CF PATIENTS WITH ANTIBIOTICS (IE, ARE THE PHARMACODYNAMICS OF ANTIBIOTICS DIFFERENT IN CF PATIENTS, OR ARE THERE OTHER SPECIAL PROBLEMS PECULIAR TO CF)?;724;0001
00078;WHAT SPECIAL CONSIDERATIONS ARE THERE FOR TREATMENT OF CF PATIENTS WITH ANTIBIOTICS (IE, ARE THE PHARMACODYNAMICS OF ANTIBIOTICS DIFFERENT IN CF PATIENTS, OR ARE THERE OTHER SPECIAL PROBLEMS PECULIAR TO CF)?;731;0001
00078;WHAT SPECIAL CONSIDERATIONS ARE THERE FOR TREATMENT OF CF PATIENTS WITH ANTIBIOTICS (IE, ARE THE PHARMACODYNAMICS OF ANTIBIOTICS DIFFERENT IN CF PATIENTS, OR ARE THERE OTHER SPECIAL PROBLEMS PECULIAR TO CF)?;734;0001
00078;WHAT SPECIAL CONSIDERATIONS ARE THERE FOR TREATMENT OF CF PATIENTS WITH ANTIBIOTICS (IE, ARE THE PHARMACODYNAMICS OF ANTIBIOTICS DIFFERENT IN CF PATIENTS, OR ARE THERE OTHER SPECIAL PROBLEMS PECULIAR TO CF)?;753;0100
00078;WHAT SPECIAL CONSIDERATIONS ARE THERE FOR TREATMENT OF CF PATIENTS WITH ANTIBIOTICS (IE, ARE THE PHARMACODYNAMICS OF ANTIBIOTICS DIFFERENT IN CF PATIENTS, OR ARE THERE OTHER SPECIAL PROBLEMS PECULIAR TO CF)?;800;0010
00078;WHAT SPECIAL CONSIDERATIONS ARE THERE FOR TREATMENT OF CF PATIENTS WITH ANTIBIOTICS (IE, ARE THE PHARMACODYNAMICS OF ANTIBIOTICS DIFFERENT IN CF PATIENTS, OR ARE THERE OTHER SPECIAL PROBLEMS PECULIAR TO CF)?;802;2221
00078;WHAT SPECIAL CONSIDERATIONS ARE THERE FOR TREATMENT OF CF PATIENTS WITH ANTIBIOTICS (IE, ARE THE PHARMACODYNAMICS OF ANTIBIOTICS DIFFERENT IN CF PATIENTS, OR ARE THERE OTHER SPECIAL PROBLEMS PECULIAR TO CF)?;838;0100
00078;WHAT SPECIAL CONSIDERATIONS ARE THERE FOR TREATMENT OF CF PATIENTS WITH ANTIBIOTICS (IE, ARE THE PHARMACODYNAMICS OF ANTIBIOTICS DIFFERENT IN CF PATIENTS, OR ARE THERE OTHER SPECIAL PROBLEMS PECULIAR TO CF)?;884;0001
00078;WHAT SPECIAL CONSIDERATIONS ARE THERE FOR TREATMENT OF CF PATIENTS WITH ANTIBIOTICS (IE, ARE THE PHARMACODYNAMICS OF ANTIBIOTICS DIFFERENT IN CF PATIENTS, OR ARE THERE OTHER SPECIAL PROBLEMS PECULIAR TO CF)?;889;0001
00078;WHAT SPECIAL CONSIDERATIONS ARE THERE FOR TREATMENT OF CF PATIENTS WITH ANTIBIOTICS (IE, ARE THE PHARMACODYNAMICS OF ANTIBIOTICS DIFFERENT IN CF PATIENTS, OR ARE THERE OTHER SPECIAL PROBLEMS PECULIAR TO CF)?;912;0100
00078;WHAT SPECIAL CONSIDERATIONS ARE THERE FOR TREATMENT OF CF PATIENTS WITH ANTIBIOTICS (IE, ARE THE PHARMACODYNAMICS OF ANTIBIOTICS DIFFERENT IN CF PATIENTS, OR ARE THERE OTHER SPECIAL PROBLEMS PECULIAR TO CF)?;944;0001
00078;WHAT SPECIAL CONSIDERATIONS ARE THERE FOR TREATMENT OF CF PATIENTS WITH ANTIBIOTICS (IE, ARE THE PHARMACODYNAMICS OF ANTIBIOTICS DIFFERENT IN CF PATIENTS, OR ARE THERE OTHER SPECIAL PROBLEMS PECULIAR TO CF)?;945;0100
00078;WHAT SPECIAL CONSIDERATIONS ARE THERE FOR TREATMENT OF CF PATIENTS WITH ANTIBIOTICS (IE, ARE THE PHARMACODYNAMICS OF ANTIBIOTICS DIFFERENT IN CF PATIENTS, OR ARE THERE OTHER SPECIAL PROBLEMS PECULIAR TO CF)?;1010;0011
00078;WHAT SPECIAL CONSIDERATIONS ARE THERE FOR TREATMENT OF CF PATIENTS WITH ANTIBIOTICS (IE, ARE THE PHARMACODYNAMICS OF ANTIBIOTICS DIFFERENT IN CF PATIENTS, OR ARE THERE OTHER SPECIAL PROBLEMS PECULIAR TO CF)?;1015;0001
00078;WHAT SPECIAL CONSIDERATIONS ARE THERE FOR TREATMENT OF CF PATIENTS WITH ANTIBIOTICS (IE, ARE THE PHARMACODYNAMICS OF ANTIBIOTICS DIFFERENT IN CF PATIENTS, OR ARE THERE OTHER SPECIAL PROBLEMS PECULIAR TO CF)?;1019;0100
00078;WHAT SPECIAL CONSIDERATIONS ARE THERE FOR TREATMENT OF CF PATIENTS WITH ANTIBIOTICS (IE, ARE THE PHARMACODYNAMICS OF ANTIBIOTICS DIFFERENT IN CF PATIENTS, OR ARE THERE OTHER SPECIAL PROBLEMS PECULIAR TO CF)?;1021;2222
00078;WHAT SPECIAL CONSIDERATIONS ARE THERE FOR TREATMENT OF CF PATIENTS WITH ANTIBIOTICS (IE, ARE THE PHARMACODYNAMICS OF ANTIBIOTICS DIFFERENT IN CF PATIENTS, OR ARE THERE OTHER SPECIAL PROBLEMS PECULIAR TO CF)?;1042;0002
00078;WHAT SPECIAL CONSIDERATIONS ARE THERE FOR TREATMENT OF CF PATIENTS WITH ANTIBIOTICS (IE, ARE THE PHARMACODYNAMICS OF ANTIBIOTICS DIFFERENT IN CF PATIENTS, OR ARE THERE OTHER SPECIAL PROBLEMS PECULIAR TO CF)?;1065;0100
00078;WHAT SPECIAL CONSIDERATIONS ARE THERE FOR TREATMENT OF CF PATIENTS WITH ANTIBIOTICS (IE, ARE THE PHARMACODYNAMICS OF ANTIBIOTICS DIFFERENT IN CF PATIENTS, OR ARE THERE OTHER SPECIAL PROBLEMS PECULIAR TO CF)?;1069;0001
00078;WHAT SPECIAL CONSIDERATIONS ARE THERE FOR TREATMENT OF CF PATIENTS WITH ANTIBIOTICS (IE, ARE THE PHARMACODYNAMICS OF ANTIBIOTICS DIFFERENT IN CF PATIENTS, OR ARE THERE OTHER SPECIAL PROBLEMS PECULIAR TO CF)?;1071;0012
00078;WHAT SPECIAL CONSIDERATIONS ARE THERE FOR TREATMENT OF CF PATIENTS WITH ANTIBIOTICS (IE, ARE THE PHARMACODYNAMICS OF ANTIBIOTICS DIFFERENT IN CF PATIENTS, OR ARE THERE OTHER SPECIAL PROBLEMS PECULIAR TO CF)?;1078;0002
00078;WHAT SPECIAL CONSIDERATIONS ARE THERE FOR TREATMENT OF CF PATIENTS WITH ANTIBIOTICS (IE, ARE THE PHARMACODYNAMICS OF ANTIBIOTICS DIFFERENT IN CF PATIENTS, OR ARE THERE OTHER SPECIAL PROBLEMS PECULIAR TO CF)?;1081;0011
00078;WHAT SPECIAL CONSIDERATIONS ARE THERE FOR TREATMENT OF CF PATIENTS WITH ANTIBIOTICS (IE, ARE THE PHARMACODYNAMICS OF ANTIBIOTICS DIFFERENT IN CF PATIENTS, OR ARE THERE OTHER SPECIAL PROBLEMS PECULIAR TO CF)?;1086;0002
00078;WHAT SPECIAL CONSIDERATIONS ARE THERE FOR TREATMENT OF CF PATIENTS WITH ANTIBIOTICS (IE, ARE THE PHARMACODYNAMICS OF ANTIBIOTICS DIFFERENT IN CF PATIENTS, OR ARE THERE OTHER SPECIAL PROBLEMS PECULIAR TO CF)?;1089;0002
00078;WHAT SPECIAL CONSIDERATIONS ARE THERE FOR TREATMENT OF CF PATIENTS WITH ANTIBIOTICS (IE, ARE THE PHARMACODYNAMICS OF ANTIBIOTICS DIFFERENT IN CF PATIENTS, OR ARE THERE OTHER SPECIAL PROBLEMS PECULIAR TO CF)?;1090;0002
00078;WHAT SPECIAL CONSIDERATIONS ARE THERE FOR TREATMENT OF CF PATIENTS WITH ANTIBIOTICS (IE, ARE THE PHARMACODYNAMICS OF ANTIBIOTICS DIFFERENT IN CF PATIENTS, OR ARE THERE OTHER SPECIAL PROBLEMS PECULIAR TO CF)?;1091;0112
00078;WHAT SPECIAL CONSIDERATIONS ARE THERE FOR TREATMENT OF CF PATIENTS WITH ANTIBIOTICS (IE, ARE THE PHARMACODYNAMICS OF ANTIBIOTICS DIFFERENT IN CF PATIENTS, OR ARE THERE OTHER SPECIAL PROBLEMS PECULIAR TO CF)?;1093;0002
00078;WHAT SPECIAL CONSIDERATIONS ARE THERE FOR TREATMENT OF CF PATIENTS WITH ANTIBIOTICS (IE, ARE THE PHARMACODYNAMICS OF ANTIBIOTICS DIFFERENT IN CF PATIENTS, OR ARE THERE OTHER SPECIAL PROBLEMS PECULIAR TO CF)?;1111;2222
00078;WHAT SPECIAL CONSIDERATIONS ARE THERE FOR TREATMENT OF CF PATIENTS WITH ANTIBIOTICS (IE, ARE THE PHARMACODYNAMICS OF ANTIBIOTICS DIFFERENT IN CF PATIENTS, OR ARE THERE OTHER SPECIAL PROBLEMS PECULIAR TO CF)?;1112;0100
00078;WHAT SPECIAL CONSIDERATIONS ARE THERE FOR TREATMENT OF CF PATIENTS WITH ANTIBIOTICS (IE, ARE THE PHARMACODYNAMICS OF ANTIBIOTICS DIFFERENT IN CF PATIENTS, OR ARE THERE OTHER SPECIAL PROBLEMS PECULIAR TO CF)?;1118;0001
00078;WHAT SPECIAL CONSIDERATIONS ARE THERE FOR TREATMENT OF CF PATIENTS WITH ANTIBIOTICS (IE, ARE THE PHARMACODYNAMICS OF ANTIBIOTICS DIFFERENT IN CF PATIENTS, OR ARE THERE OTHER SPECIAL PROBLEMS PECULIAR TO CF)?;1179;0111
00078;WHAT SPECIAL CONSIDERATIONS ARE THERE FOR TREATMENT OF CF PATIENTS WITH ANTIBIOTICS (IE, ARE THE PHARMACODYNAMICS OF ANTIBIOTICS DIFFERENT IN CF PATIENTS, OR ARE THERE OTHER SPECIAL PROBLEMS PECULIAR TO CF)?;1180;0111
00078;WHAT SPECIAL CONSIDERATIONS ARE THERE FOR TREATMENT OF CF PATIENTS WITH ANTIBIOTICS (IE, ARE THE PHARMACODYNAMICS OF ANTIBIOTICS DIFFERENT IN CF PATIENTS, OR ARE THERE OTHER SPECIAL PROBLEMS PECULIAR TO CF)?;1181;2222
00078;WHAT SPECIAL CONSIDERATIONS ARE THERE FOR TREATMENT OF CF PATIENTS WITH ANTIBIOTICS (IE, ARE THE PHARMACODYNAMICS OF ANTIBIOTICS DIFFERENT IN CF PATIENTS, OR ARE THERE OTHER SPECIAL PROBLEMS PECULIAR TO CF)?;1227;1010
00078;WHAT SPECIAL CONSIDERATIONS ARE THERE FOR TREATMENT OF CF PATIENTS WITH ANTIBIOTICS (IE, ARE THE PHARMACODYNAMICS OF ANTIBIOTICS DIFFERENT IN CF PATIENTS, OR ARE THERE OTHER SPECIAL PROBLEMS PECULIAR TO CF)?;1234;0101
00079;WHAT IS THE ROLE OF ORALLY ADMINISTERED ANTIBIOTICS IN THE TREATMENT OF CF PATIENTS?;65;0100
00079;WHAT IS THE ROLE OF ORALLY ADMINISTERED ANTIBIOTICS IN THE TREATMENT OF CF PATIENTS?;75;1000
00079;WHAT IS THE ROLE OF ORALLY ADMINISTERED ANTIBIOTICS IN THE TREATMENT OF CF PATIENTS?;123;1121
00079;WHAT IS THE ROLE OF ORALLY ADMINISTERED ANTIBIOTICS IN THE TREATMENT OF CF PATIENTS?;132;0001
00079;WHAT IS THE ROLE OF ORALLY ADMINISTERED ANTIBIOTICS IN THE TREATMENT OF CF PATIENTS?;135;0101
00079;WHAT IS THE ROLE OF ORALLY ADMINISTERED ANTIBIOTICS IN THE TREATMENT OF CF PATIENTS?;146;0002
00079;WHAT IS THE ROLE OF ORALLY ADMINISTERED ANTIBIOTICS IN THE TREATMENT OF CF PATIENTS?;148;0001
00079;WHAT IS THE ROLE OF ORALLY ADMINISTERED ANTIBIOTICS IN THE TREATMENT OF CF PATIENTS?;179;1000
00079;WHAT IS THE ROLE OF ORALLY ADMINISTERED ANTIBIOTICS IN THE TREATMENT OF CF PATIENTS?;184;1000
00079;WHAT IS THE ROLE OF ORALLY ADMINISTERED ANTIBIOTICS IN THE TREATMENT OF CF PATIENTS?;255;0100
00079;WHAT IS THE ROLE OF ORALLY ADMINISTERED ANTIBIOTICS IN THE TREATMENT OF CF PATIENTS?;315;0010
00079;WHAT IS THE ROLE OF ORALLY ADMINISTERED ANTIBIOTICS IN THE TREATMENT OF CF PATIENTS?;320;2220
00079;WHAT IS THE ROLE OF ORALLY ADMINISTERED ANTIBIOTICS IN THE TREATMENT OF CF PATIENTS?;330;0101
00079;WHAT IS THE ROLE OF ORALLY ADMINISTERED ANTIBIOTICS IN THE TREATMENT OF CF PATIENTS?;333;0001
00079;WHAT IS THE ROLE OF ORALLY ADMINISTERED ANTIBIOTICS IN THE TREATMENT OF CF PATIENTS?;359;1011
00079;WHAT IS THE ROLE OF ORALLY ADMINISTERED ANTIBIOTICS IN THE TREATMENT OF CF PATIENTS?;370;1000
00079;WHAT IS THE ROLE OF ORALLY ADMINISTERED ANTIBIOTICS IN THE TREATMENT OF CF PATIENTS?;373;1210
00079;WHAT IS THE ROLE OF ORALLY ADMINISTERED ANTIBIOTICS IN THE TREATMENT OF CF PATIENTS?;384;2210
00079;WHAT IS THE ROLE OF ORALLY ADMINISTERED ANTIBIOTICS IN THE TREATMENT OF CF PATIENTS?;427;0100
00079;WHAT IS THE ROLE OF ORALLY ADMINISTERED ANTIBIOTICS IN THE TREATMENT OF CF PATIENTS?;438;1121
00079;WHAT IS THE ROLE OF ORALLY ADMINISTERED ANTIBIOTICS IN THE TREATMENT OF CF PATIENTS?;452;0100
00079;WHAT IS THE ROLE OF ORALLY ADMINISTERED ANTIBIOTICS IN THE TREATMENT OF CF PATIENTS?;648;1211
00079;WHAT IS THE ROLE OF ORALLY ADMINISTERED ANTIBIOTICS IN THE TREATMENT OF CF PATIENTS?;650;2221
00079;WHAT IS THE ROLE OF ORALLY ADMINISTERED ANTIBIOTICS IN THE TREATMENT OF CF PATIENTS?;663;0100
00079;WHAT IS THE ROLE OF ORALLY ADMINISTERED ANTIBIOTICS IN THE TREATMENT OF CF PATIENTS?;826;1001
00079;WHAT IS THE ROLE OF ORALLY ADMINISTERED ANTIBIOTICS IN THE TREATMENT OF CF PATIENTS?;829;0001
00079;WHAT IS THE ROLE OF ORALLY ADMINISTERED ANTIBIOTICS IN THE TREATMENT OF CF PATIENTS?;838;0100
00079;WHAT IS THE ROLE OF ORALLY ADMINISTERED ANTIBIOTICS IN THE TREATMENT OF CF PATIENTS?;882;0001
00079;WHAT IS THE ROLE OF ORALLY ADMINISTERED ANTIBIOTICS IN THE TREATMENT OF CF PATIENTS?;912;0100
00079;WHAT IS THE ROLE OF ORALLY ADMINISTERED ANTIBIOTICS IN THE TREATMENT OF CF PATIENTS?;923;1210
00079;WHAT IS THE ROLE OF ORALLY ADMINISTERED ANTIBIOTICS IN THE TREATMENT OF CF PATIENTS?;944;1001
00079;WHAT IS THE ROLE OF ORALLY ADMINISTERED ANTIBIOTICS IN THE TREATMENT OF CF PATIENTS?;945;2210
00079;WHAT IS THE ROLE OF ORALLY ADMINISTERED ANTIBIOTICS IN THE TREATMENT OF CF PATIENTS?;1000;0001
00079;WHAT IS THE ROLE OF ORALLY ADMINISTERED ANTIBIOTICS IN THE TREATMENT OF CF PATIENTS?;1010;1000
00079;WHAT IS THE ROLE OF ORALLY ADMINISTERED ANTIBIOTICS IN THE TREATMENT OF CF PATIENTS?;1023;0001
00079;WHAT IS THE ROLE OF ORALLY ADMINISTERED ANTIBIOTICS IN THE TREATMENT OF CF PATIENTS?;1065;0100
00079;WHAT IS THE ROLE OF ORALLY ADMINISTERED ANTIBIOTICS IN THE TREATMENT OF CF PATIENTS?;1082;2120
00079;WHAT IS THE ROLE OF ORALLY ADMINISTERED ANTIBIOTICS IN THE TREATMENT OF CF PATIENTS?;1089;0001
00079;WHAT IS THE ROLE OF ORALLY ADMINISTERED ANTIBIOTICS IN THE TREATMENT OF CF PATIENTS?;1091;0101
00079;WHAT IS THE ROLE OF ORALLY ADMINISTERED ANTIBIOTICS IN THE TREATMENT OF CF PATIENTS?;1112;2222
00079;WHAT IS THE ROLE OF ORALLY ADMINISTERED ANTIBIOTICS IN THE TREATMENT OF CF PATIENTS?;1179;1100
00079;WHAT IS THE ROLE OF ORALLY ADMINISTERED ANTIBIOTICS IN THE TREATMENT OF CF PATIENTS?;1181;2222
00079;WHAT IS THE ROLE OF ORALLY ADMINISTERED ANTIBIOTICS IN THE TREATMENT OF CF PATIENTS?;1234;1100
00080;WHAT IS THE EVIDENCE THAT COMBINATION THERAPY WITH AMINOGLYCOSIDES AND SEMISYNTHETIC PENICILLINS IS MORE EFFECTIVE THAN THERAPY WITH EITHER ALONE?;61;1000
00080;WHAT IS THE EVIDENCE THAT COMBINATION THERAPY WITH AMINOGLYCOSIDES AND SEMISYNTHETIC PENICILLINS IS MORE EFFECTIVE THAN THERAPY WITH EITHER ALONE?;135;0100
00080;WHAT IS THE EVIDENCE THAT COMBINATION THERAPY WITH AMINOGLYCOSIDES AND SEMISYNTHETIC PENICILLINS IS MORE EFFECTIVE THAN THERAPY WITH EITHER ALONE?;152;0100
00080;WHAT IS THE EVIDENCE THAT COMBINATION THERAPY WITH AMINOGLYCOSIDES AND SEMISYNTHETIC PENICILLINS IS MORE EFFECTIVE THAN THERAPY WITH EITHER ALONE?;159;1100
00080;WHAT IS THE EVIDENCE THAT COMBINATION THERAPY WITH AMINOGLYCOSIDES AND SEMISYNTHETIC PENICILLINS IS MORE EFFECTIVE THAN THERAPY WITH EITHER ALONE?;238;1010
00080;WHAT IS THE EVIDENCE THAT COMBINATION THERAPY WITH AMINOGLYCOSIDES AND SEMISYNTHETIC PENICILLINS IS MORE EFFECTIVE THAN THERAPY WITH EITHER ALONE?;330;0001
00080;WHAT IS THE EVIDENCE THAT COMBINATION THERAPY WITH AMINOGLYCOSIDES AND SEMISYNTHETIC PENICILLINS IS MORE EFFECTIVE THAN THERAPY WITH EITHER ALONE?;333;0101
00080;WHAT IS THE EVIDENCE THAT COMBINATION THERAPY WITH AMINOGLYCOSIDES AND SEMISYNTHETIC PENICILLINS IS MORE EFFECTIVE THAN THERAPY WITH EITHER ALONE?;427;0100
00080;WHAT IS THE EVIDENCE THAT COMBINATION THERAPY WITH AMINOGLYCOSIDES AND SEMISYNTHETIC PENICILLINS IS MORE EFFECTIVE THAN THERAPY WITH EITHER ALONE?;438;0100
00080;WHAT IS THE EVIDENCE THAT COMBINATION THERAPY WITH AMINOGLYCOSIDES AND SEMISYNTHETIC PENICILLINS IS MORE EFFECTIVE THAN THERAPY WITH EITHER ALONE?;451;1000
00080;WHAT IS THE EVIDENCE THAT COMBINATION THERAPY WITH AMINOGLYCOSIDES AND SEMISYNTHETIC PENICILLINS IS MORE EFFECTIVE THAN THERAPY WITH EITHER ALONE?;452;0100
00080;WHAT IS THE EVIDENCE THAT COMBINATION THERAPY WITH AMINOGLYCOSIDES AND SEMISYNTHETIC PENICILLINS IS MORE EFFECTIVE THAN THERAPY WITH EITHER ALONE?;453;0100
00080;WHAT IS THE EVIDENCE THAT COMBINATION THERAPY WITH AMINOGLYCOSIDES AND SEMISYNTHETIC PENICILLINS IS MORE EFFECTIVE THAN THERAPY WITH EITHER ALONE?;458;2122
00080;WHAT IS THE EVIDENCE THAT COMBINATION THERAPY WITH AMINOGLYCOSIDES AND SEMISYNTHETIC PENICILLINS IS MORE EFFECTIVE THAN THERAPY WITH EITHER ALONE?;459;0100
00080;WHAT IS THE EVIDENCE THAT COMBINATION THERAPY WITH AMINOGLYCOSIDES AND SEMISYNTHETIC PENICILLINS IS MORE EFFECTIVE THAN THERAPY WITH EITHER ALONE?;460;2222
00080;WHAT IS THE EVIDENCE THAT COMBINATION THERAPY WITH AMINOGLYCOSIDES AND SEMISYNTHETIC PENICILLINS IS MORE EFFECTIVE THAN THERAPY WITH EITHER ALONE?;612;1000
00080;WHAT IS THE EVIDENCE THAT COMBINATION THERAPY WITH AMINOGLYCOSIDES AND SEMISYNTHETIC PENICILLINS IS MORE EFFECTIVE THAN THERAPY WITH EITHER ALONE?;663;0100
00080;WHAT IS THE EVIDENCE THAT COMBINATION THERAPY WITH AMINOGLYCOSIDES AND SEMISYNTHETIC PENICILLINS IS MORE EFFECTIVE THAN THERAPY WITH EITHER ALONE?;696;2220
00080;WHAT IS THE EVIDENCE THAT COMBINATION THERAPY WITH AMINOGLYCOSIDES AND SEMISYNTHETIC PENICILLINS IS MORE EFFECTIVE THAN THERAPY WITH EITHER ALONE?;722;0001
00080;WHAT IS THE EVIDENCE THAT COMBINATION THERAPY WITH AMINOGLYCOSIDES AND SEMISYNTHETIC PENICILLINS IS MORE EFFECTIVE THAN THERAPY WITH EITHER ALONE?;753;1212
00080;WHAT IS THE EVIDENCE THAT COMBINATION THERAPY WITH AMINOGLYCOSIDES AND SEMISYNTHETIC PENICILLINS IS MORE EFFECTIVE THAN THERAPY WITH EITHER ALONE?;800;1111
00080;WHAT IS THE EVIDENCE THAT COMBINATION THERAPY WITH AMINOGLYCOSIDES AND SEMISYNTHETIC PENICILLINS IS MORE EFFECTIVE THAN THERAPY WITH EITHER ALONE?;884;1000
00080;WHAT IS THE EVIDENCE THAT COMBINATION THERAPY WITH AMINOGLYCOSIDES AND SEMISYNTHETIC PENICILLINS IS MORE EFFECTIVE THAN THERAPY WITH EITHER ALONE?;912;0001
00080;WHAT IS THE EVIDENCE THAT COMBINATION THERAPY WITH AMINOGLYCOSIDES AND SEMISYNTHETIC PENICILLINS IS MORE EFFECTIVE THAN THERAPY WITH EITHER ALONE?;945;1101
00080;WHAT IS THE EVIDENCE THAT COMBINATION THERAPY WITH AMINOGLYCOSIDES AND SEMISYNTHETIC PENICILLINS IS MORE EFFECTIVE THAN THERAPY WITH EITHER ALONE?;1010;1000
00080;WHAT IS THE EVIDENCE THAT COMBINATION THERAPY WITH AMINOGLYCOSIDES AND SEMISYNTHETIC PENICILLINS IS MORE EFFECTIVE THAN THERAPY WITH EITHER ALONE?;1042;1101
00080;WHAT IS THE EVIDENCE THAT COMBINATION THERAPY WITH AMINOGLYCOSIDES AND SEMISYNTHETIC PENICILLINS IS MORE EFFECTIVE THAN THERAPY WITH EITHER ALONE?;1065;0100
00080;WHAT IS THE EVIDENCE THAT COMBINATION THERAPY WITH AMINOGLYCOSIDES AND SEMISYNTHETIC PENICILLINS IS MORE EFFECTIVE THAN THERAPY WITH EITHER ALONE?;1071;0101
00080;WHAT IS THE EVIDENCE THAT COMBINATION THERAPY WITH AMINOGLYCOSIDES AND SEMISYNTHETIC PENICILLINS IS MORE EFFECTIVE THAN THERAPY WITH EITHER ALONE?;1078;2122
00080;WHAT IS THE EVIDENCE THAT COMBINATION THERAPY WITH AMINOGLYCOSIDES AND SEMISYNTHETIC PENICILLINS IS MORE EFFECTIVE THAN THERAPY WITH EITHER ALONE?;1091;0100
00080;WHAT IS THE EVIDENCE THAT COMBINATION THERAPY WITH AMINOGLYCOSIDES AND SEMISYNTHETIC PENICILLINS IS MORE EFFECTIVE THAN THERAPY WITH EITHER ALONE?;1179;0100
00080;WHAT IS THE EVIDENCE THAT COMBINATION THERAPY WITH AMINOGLYCOSIDES AND SEMISYNTHETIC PENICILLINS IS MORE EFFECTIVE THAN THERAPY WITH EITHER ALONE?;1180;0100
00080;WHAT IS THE EVIDENCE THAT COMBINATION THERAPY WITH AMINOGLYCOSIDES AND SEMISYNTHETIC PENICILLINS IS MORE EFFECTIVE THAN THERAPY WITH EITHER ALONE?;1227;2222
00080;WHAT IS THE EVIDENCE THAT COMBINATION THERAPY WITH AMINOGLYCOSIDES AND SEMISYNTHETIC PENICILLINS IS MORE EFFECTIVE THAN THERAPY WITH EITHER ALONE?;1234;1101
00081;HOW EFFECTIVE ARE INHALATIONS OF MUCOLYTIC AGENTS IN THE TREATMENT OF CF PATIENTS?;31;0010
00081;HOW EFFECTIVE ARE INHALATIONS OF MUCOLYTIC AGENTS IN THE TREATMENT OF CF PATIENTS?;90;1011
00081;HOW EFFECTIVE ARE INHALATIONS OF MUCOLYTIC AGENTS IN THE TREATMENT OF CF PATIENTS?;93;0010
00081;HOW EFFECTIVE ARE INHALATIONS OF MUCOLYTIC AGENTS IN THE TREATMENT OF CF PATIENTS?;132;0001
00081;HOW EFFECTIVE ARE INHALATIONS OF MUCOLYTIC AGENTS IN THE TREATMENT OF CF PATIENTS?;135;0001
00081;HOW EFFECTIVE ARE INHALATIONS OF MUCOLYTIC AGENTS IN THE TREATMENT OF CF PATIENTS?;195;0001
00081;HOW EFFECTIVE ARE INHALATIONS OF MUCOLYTIC AGENTS IN THE TREATMENT OF CF PATIENTS?;253;0010
00081;HOW EFFECTIVE ARE INHALATIONS OF MUCOLYTIC AGENTS IN THE TREATMENT OF CF PATIENTS?;321;2222
00081;HOW EFFECTIVE ARE INHALATIONS OF MUCOLYTIC AGENTS IN THE TREATMENT OF CF PATIENTS?;326;1011
00081;HOW EFFECTIVE ARE INHALATIONS OF MUCOLYTIC AGENTS IN THE TREATMENT OF CF PATIENTS?;359;0001
00081;HOW EFFECTIVE ARE INHALATIONS OF MUCOLYTIC AGENTS IN THE TREATMENT OF CF PATIENTS?;370;1111
00081;HOW EFFECTIVE ARE INHALATIONS OF MUCOLYTIC AGENTS IN THE TREATMENT OF CF PATIENTS?;438;1121
00081;HOW EFFECTIVE ARE INHALATIONS OF MUCOLYTIC AGENTS IN THE TREATMENT OF CF PATIENTS?;542;2120
00081;HOW EFFECTIVE ARE INHALATIONS OF MUCOLYTIC AGENTS IN THE TREATMENT OF CF PATIENTS?;546;2212
00081;HOW EFFECTIVE ARE INHALATIONS OF MUCOLYTIC AGENTS IN THE TREATMENT OF CF PATIENTS?;550;0001
00081;HOW EFFECTIVE ARE INHALATIONS OF MUCOLYTIC AGENTS IN THE TREATMENT OF CF PATIENTS?;551;0001
00081;HOW EFFECTIVE ARE INHALATIONS OF MUCOLYTIC AGENTS IN THE TREATMENT OF CF PATIENTS?;586;0001
00081;HOW EFFECTIVE ARE INHALATIONS OF MUCOLYTIC AGENTS IN THE TREATMENT OF CF PATIENTS?;592;0010
00081;HOW EFFECTIVE ARE INHALATIONS OF MUCOLYTIC AGENTS IN THE TREATMENT OF CF PATIENTS?;729;0001
00081;HOW EFFECTIVE ARE INHALATIONS OF MUCOLYTIC AGENTS IN THE TREATMENT OF CF PATIENTS?;731;0001
00081;HOW EFFECTIVE ARE INHALATIONS OF MUCOLYTIC AGENTS IN THE TREATMENT OF CF PATIENTS?;734;2222
00081;HOW EFFECTIVE ARE INHALATIONS OF MUCOLYTIC AGENTS IN THE TREATMENT OF CF PATIENTS?;941;1001
00081;HOW EFFECTIVE ARE INHALATIONS OF MUCOLYTIC AGENTS IN THE TREATMENT OF CF PATIENTS?;944;0001
00081;HOW EFFECTIVE ARE INHALATIONS OF MUCOLYTIC AGENTS IN THE TREATMENT OF CF PATIENTS?;990;0002
00081;HOW EFFECTIVE ARE INHALATIONS OF MUCOLYTIC AGENTS IN THE TREATMENT OF CF PATIENTS?;1092;2220
00081;HOW EFFECTIVE ARE INHALATIONS OF MUCOLYTIC AGENTS IN THE TREATMENT OF CF PATIENTS?;1134;0001
00081;HOW EFFECTIVE ARE INHALATIONS OF MUCOLYTIC AGENTS IN THE TREATMENT OF CF PATIENTS?;1232;0001
00081;HOW EFFECTIVE ARE INHALATIONS OF MUCOLYTIC AGENTS IN THE TREATMENT OF CF PATIENTS?;1234;0001
00082;WHAT IS THE ROLE OF AEROSOLS IN THE TREATMENT OF LUNG DISEASE IN CF PATIENTS?;25;2222
00082;WHAT IS THE ROLE OF AEROSOLS IN THE TREATMENT OF LUNG DISEASE IN CF PATIENTS?;31;0002
00082;WHAT IS THE ROLE OF AEROSOLS IN THE TREATMENT OF LUNG DISEASE IN CF PATIENTS?;90;2222
00082;WHAT IS THE ROLE OF AEROSOLS IN THE TREATMENT OF LUNG DISEASE IN CF PATIENTS?;93;2222
00082;WHAT IS THE ROLE OF AEROSOLS IN THE TREATMENT OF LUNG DISEASE IN CF PATIENTS?;132;0001
00082;WHAT IS THE ROLE OF AEROSOLS IN THE TREATMENT OF LUNG DISEASE IN CF PATIENTS?;135;2122
00082;WHAT IS THE ROLE OF AEROSOLS IN THE TREATMENT OF LUNG DISEASE IN CF PATIENTS?;148;0001
00082;WHAT IS THE ROLE OF AEROSOLS IN THE TREATMENT OF LUNG DISEASE IN CF PATIENTS?;152;0002
00082;WHAT IS THE ROLE OF AEROSOLS IN THE TREATMENT OF LUNG DISEASE IN CF PATIENTS?;159;1002
00082;WHAT IS THE ROLE OF AEROSOLS IN THE TREATMENT OF LUNG DISEASE IN CF PATIENTS?;189;0001
00082;WHAT IS THE ROLE OF AEROSOLS IN THE TREATMENT OF LUNG DISEASE IN CF PATIENTS?;195;0001
00082;WHAT IS THE ROLE OF AEROSOLS IN THE TREATMENT OF LUNG DISEASE IN CF PATIENTS?;197;0001
00082;WHAT IS THE ROLE OF AEROSOLS IN THE TREATMENT OF LUNG DISEASE IN CF PATIENTS?;238;0001
00082;WHAT IS THE ROLE OF AEROSOLS IN THE TREATMENT OF LUNG DISEASE IN CF PATIENTS?;253;2112
00082;WHAT IS THE ROLE OF AEROSOLS IN THE TREATMENT OF LUNG DISEASE IN CF PATIENTS?;297;0001
00082;WHAT IS THE ROLE OF AEROSOLS IN THE TREATMENT OF LUNG DISEASE IN CF PATIENTS?;321;2222
00082;WHAT IS THE ROLE OF AEROSOLS IN THE TREATMENT OF LUNG DISEASE IN CF PATIENTS?;326;2222
00082;WHAT IS THE ROLE OF AEROSOLS IN THE TREATMENT OF LUNG DISEASE IN CF PATIENTS?;327;1012
00082;WHAT IS THE ROLE OF AEROSOLS IN THE TREATMENT OF LUNG DISEASE IN CF PATIENTS?;330;0001
00082;WHAT IS THE ROLE OF AEROSOLS IN THE TREATMENT OF LUNG DISEASE IN CF PATIENTS?;331;0001
00082;WHAT IS THE ROLE OF AEROSOLS IN THE TREATMENT OF LUNG DISEASE IN CF PATIENTS?;333;0001
00082;WHAT IS THE ROLE OF AEROSOLS IN THE TREATMENT OF LUNG DISEASE IN CF PATIENTS?;359;2112
00082;WHAT IS THE ROLE OF AEROSOLS IN THE TREATMENT OF LUNG DISEASE IN CF PATIENTS?;370;1112
00082;WHAT IS THE ROLE OF AEROSOLS IN THE TREATMENT OF LUNG DISEASE IN CF PATIENTS?;427;0001
00082;WHAT IS THE ROLE OF AEROSOLS IN THE TREATMENT OF LUNG DISEASE IN CF PATIENTS?;438;2222
00082;WHAT IS THE ROLE OF AEROSOLS IN THE TREATMENT OF LUNG DISEASE IN CF PATIENTS?;458;1010
00082;WHAT IS THE ROLE OF AEROSOLS IN THE TREATMENT OF LUNG DISEASE IN CF PATIENTS?;542;2120
00082;WHAT IS THE ROLE OF AEROSOLS IN THE TREATMENT OF LUNG DISEASE IN CF PATIENTS?;543;0012
00082;WHAT IS THE ROLE OF AEROSOLS IN THE TREATMENT OF LUNG DISEASE IN CF PATIENTS?;546;2122
00082;WHAT IS THE ROLE OF AEROSOLS IN THE TREATMENT OF LUNG DISEASE IN CF PATIENTS?;550;0001
00082;WHAT IS THE ROLE OF AEROSOLS IN THE TREATMENT OF LUNG DISEASE IN CF PATIENTS?;551;0001
00082;WHAT IS THE ROLE OF AEROSOLS IN THE TREATMENT OF LUNG DISEASE IN CF PATIENTS?;586;0001
00082;WHAT IS THE ROLE OF AEROSOLS IN THE TREATMENT OF LUNG DISEASE IN CF PATIENTS?;592;0010
00082;WHAT IS THE ROLE OF AEROSOLS IN THE TREATMENT OF LUNG DISEASE IN CF PATIENTS?;722;0001
00082;WHAT IS THE ROLE OF AEROSOLS IN THE TREATMENT OF LUNG DISEASE IN CF PATIENTS?;724;0001
00082;WHAT IS THE ROLE OF AEROSOLS IN THE TREATMENT OF LUNG DISEASE IN CF PATIENTS?;729;0001
00082;WHAT IS THE ROLE OF AEROSOLS IN THE TREATMENT OF LUNG DISEASE IN CF PATIENTS?;731;0001
00082;WHAT IS THE ROLE OF AEROSOLS IN THE TREATMENT OF LUNG DISEASE IN CF PATIENTS?;734;2122
00082;WHAT IS THE ROLE OF AEROSOLS IN THE TREATMENT OF LUNG DISEASE IN CF PATIENTS?;826;1000
00082;WHAT IS THE ROLE OF AEROSOLS IN THE TREATMENT OF LUNG DISEASE IN CF PATIENTS?;837;0001
00082;WHAT IS THE ROLE OF AEROSOLS IN THE TREATMENT OF LUNG DISEASE IN CF PATIENTS?;845;0001
00082;WHAT IS THE ROLE OF AEROSOLS IN THE TREATMENT OF LUNG DISEASE IN CF PATIENTS?;879;0001
00082;WHAT IS THE ROLE OF AEROSOLS IN THE TREATMENT OF LUNG DISEASE IN CF PATIENTS?;882;0001
00082;WHAT IS THE ROLE OF AEROSOLS IN THE TREATMENT OF LUNG DISEASE IN CF PATIENTS?;889;0001
00082;WHAT IS THE ROLE OF AEROSOLS IN THE TREATMENT OF LUNG DISEASE IN CF PATIENTS?;904;0001
00082;WHAT IS THE ROLE OF AEROSOLS IN THE TREATMENT OF LUNG DISEASE IN CF PATIENTS?;912;0001
00082;WHAT IS THE ROLE OF AEROSOLS IN THE TREATMENT OF LUNG DISEASE IN CF PATIENTS?;937;0001
00082;WHAT IS THE ROLE OF AEROSOLS IN THE TREATMENT OF LUNG DISEASE IN CF PATIENTS?;941;0011
00082;WHAT IS THE ROLE OF AEROSOLS IN THE TREATMENT OF LUNG DISEASE IN CF PATIENTS?;944;0101
00082;WHAT IS THE ROLE OF AEROSOLS IN THE TREATMENT OF LUNG DISEASE IN CF PATIENTS?;952;0001
00082;WHAT IS THE ROLE OF AEROSOLS IN THE TREATMENT OF LUNG DISEASE IN CF PATIENTS?;963;2221
00082;WHAT IS THE ROLE OF AEROSOLS IN THE TREATMENT OF LUNG DISEASE IN CF PATIENTS?;990;0001
00082;WHAT IS THE ROLE OF AEROSOLS IN THE TREATMENT OF LUNG DISEASE IN CF PATIENTS?;1000;0001
00082;WHAT IS THE ROLE OF AEROSOLS IN THE TREATMENT OF LUNG DISEASE IN CF PATIENTS?;1003;2220
00082;WHAT IS THE ROLE OF AEROSOLS IN THE TREATMENT OF LUNG DISEASE IN CF PATIENTS?;1040;0001
00082;WHAT IS THE ROLE OF AEROSOLS IN THE TREATMENT OF LUNG DISEASE IN CF PATIENTS?;1078;1000
00082;WHAT IS THE ROLE OF AEROSOLS IN THE TREATMENT OF LUNG DISEASE IN CF PATIENTS?;1092;0001
00082;WHAT IS THE ROLE OF AEROSOLS IN THE TREATMENT OF LUNG DISEASE IN CF PATIENTS?;1150;0001
00082;WHAT IS THE ROLE OF AEROSOLS IN THE TREATMENT OF LUNG DISEASE IN CF PATIENTS?;1188;0001
00082;WHAT IS THE ROLE OF AEROSOLS IN THE TREATMENT OF LUNG DISEASE IN CF PATIENTS?;1227;0001
00082;WHAT IS THE ROLE OF AEROSOLS IN THE TREATMENT OF LUNG DISEASE IN CF PATIENTS?;1232;0001
00082;WHAT IS THE ROLE OF AEROSOLS IN THE TREATMENT OF LUNG DISEASE IN CF PATIENTS?;1234;1102
00083;WHAT IS THE ROLE OF BACTERIAL PHAGOCYTOSIS (BY ALVEOLAR MACROPHAGES OR POLYMORPHONUCLEAR LEUKOCYTES) IN LUNG DISEASE IN CF PATIENTS?;18;2121
00083;WHAT IS THE ROLE OF BACTERIAL PHAGOCYTOSIS (BY ALVEOLAR MACROPHAGES OR POLYMORPHONUCLEAR LEUKOCYTES) IN LUNG DISEASE IN CF PATIENTS?;166;2221
00083;WHAT IS THE ROLE OF BACTERIAL PHAGOCYTOSIS (BY ALVEOLAR MACROPHAGES OR POLYMORPHONUCLEAR LEUKOCYTES) IN LUNG DISEASE IN CF PATIENTS?;187;0001
00083;WHAT IS THE ROLE OF BACTERIAL PHAGOCYTOSIS (BY ALVEOLAR MACROPHAGES OR POLYMORPHONUCLEAR LEUKOCYTES) IN LUNG DISEASE IN CF PATIENTS?;238;0100
00083;WHAT IS THE ROLE OF BACTERIAL PHAGOCYTOSIS (BY ALVEOLAR MACROPHAGES OR POLYMORPHONUCLEAR LEUKOCYTES) IN LUNG DISEASE IN CF PATIENTS?;366;0100
00083;WHAT IS THE ROLE OF BACTERIAL PHAGOCYTOSIS (BY ALVEOLAR MACROPHAGES OR POLYMORPHONUCLEAR LEUKOCYTES) IN LUNG DISEASE IN CF PATIENTS?;370;1011
00083;WHAT IS THE ROLE OF BACTERIAL PHAGOCYTOSIS (BY ALVEOLAR MACROPHAGES OR POLYMORPHONUCLEAR LEUKOCYTES) IN LUNG DISEASE IN CF PATIENTS?;394;0100
00083;WHAT IS THE ROLE OF BACTERIAL PHAGOCYTOSIS (BY ALVEOLAR MACROPHAGES OR POLYMORPHONUCLEAR LEUKOCYTES) IN LUNG DISEASE IN CF PATIENTS?;427;0100
00083;WHAT IS THE ROLE OF BACTERIAL PHAGOCYTOSIS (BY ALVEOLAR MACROPHAGES OR POLYMORPHONUCLEAR LEUKOCYTES) IN LUNG DISEASE IN CF PATIENTS?;430;0001
00083;WHAT IS THE ROLE OF BACTERIAL PHAGOCYTOSIS (BY ALVEOLAR MACROPHAGES OR POLYMORPHONUCLEAR LEUKOCYTES) IN LUNG DISEASE IN CF PATIENTS?;432;1212
00083;WHAT IS THE ROLE OF BACTERIAL PHAGOCYTOSIS (BY ALVEOLAR MACROPHAGES OR POLYMORPHONUCLEAR LEUKOCYTES) IN LUNG DISEASE IN CF PATIENTS?;447;1100
00083;WHAT IS THE ROLE OF BACTERIAL PHAGOCYTOSIS (BY ALVEOLAR MACROPHAGES OR POLYMORPHONUCLEAR LEUKOCYTES) IN LUNG DISEASE IN CF PATIENTS?;463;0001
00083;WHAT IS THE ROLE OF BACTERIAL PHAGOCYTOSIS (BY ALVEOLAR MACROPHAGES OR POLYMORPHONUCLEAR LEUKOCYTES) IN LUNG DISEASE IN CF PATIENTS?;501;0001
00083;WHAT IS THE ROLE OF BACTERIAL PHAGOCYTOSIS (BY ALVEOLAR MACROPHAGES OR POLYMORPHONUCLEAR LEUKOCYTES) IN LUNG DISEASE IN CF PATIENTS?;505;0101
00083;WHAT IS THE ROLE OF BACTERIAL PHAGOCYTOSIS (BY ALVEOLAR MACROPHAGES OR POLYMORPHONUCLEAR LEUKOCYTES) IN LUNG DISEASE IN CF PATIENTS?;517;0001
00083;WHAT IS THE ROLE OF BACTERIAL PHAGOCYTOSIS (BY ALVEOLAR MACROPHAGES OR POLYMORPHONUCLEAR LEUKOCYTES) IN LUNG DISEASE IN CF PATIENTS?;550;0001
00083;WHAT IS THE ROLE OF BACTERIAL PHAGOCYTOSIS (BY ALVEOLAR MACROPHAGES OR POLYMORPHONUCLEAR LEUKOCYTES) IN LUNG DISEASE IN CF PATIENTS?;590;0011
00083;WHAT IS THE ROLE OF BACTERIAL PHAGOCYTOSIS (BY ALVEOLAR MACROPHAGES OR POLYMORPHONUCLEAR LEUKOCYTES) IN LUNG DISEASE IN CF PATIENTS?;609;1000
00083;WHAT IS THE ROLE OF BACTERIAL PHAGOCYTOSIS (BY ALVEOLAR MACROPHAGES OR POLYMORPHONUCLEAR LEUKOCYTES) IN LUNG DISEASE IN CF PATIENTS?;668;0001
00083;WHAT IS THE ROLE OF BACTERIAL PHAGOCYTOSIS (BY ALVEOLAR MACROPHAGES OR POLYMORPHONUCLEAR LEUKOCYTES) IN LUNG DISEASE IN CF PATIENTS?;767;0002
00083;WHAT IS THE ROLE OF BACTERIAL PHAGOCYTOSIS (BY ALVEOLAR MACROPHAGES OR POLYMORPHONUCLEAR LEUKOCYTES) IN LUNG DISEASE IN CF PATIENTS?;905;0001
00083;WHAT IS THE ROLE OF BACTERIAL PHAGOCYTOSIS (BY ALVEOLAR MACROPHAGES OR POLYMORPHONUCLEAR LEUKOCYTES) IN LUNG DISEASE IN CF PATIENTS?;912;0001
00083;WHAT IS THE ROLE OF BACTERIAL PHAGOCYTOSIS (BY ALVEOLAR MACROPHAGES OR POLYMORPHONUCLEAR LEUKOCYTES) IN LUNG DISEASE IN CF PATIENTS?;988;0100
00083;WHAT IS THE ROLE OF BACTERIAL PHAGOCYTOSIS (BY ALVEOLAR MACROPHAGES OR POLYMORPHONUCLEAR LEUKOCYTES) IN LUNG DISEASE IN CF PATIENTS?;989;0100
00083;WHAT IS THE ROLE OF BACTERIAL PHAGOCYTOSIS (BY ALVEOLAR MACROPHAGES OR POLYMORPHONUCLEAR LEUKOCYTES) IN LUNG DISEASE IN CF PATIENTS?;1074;0100
00083;WHAT IS THE ROLE OF BACTERIAL PHAGOCYTOSIS (BY ALVEOLAR MACROPHAGES OR POLYMORPHONUCLEAR LEUKOCYTES) IN LUNG DISEASE IN CF PATIENTS?;1077;0101
00083;WHAT IS THE ROLE OF BACTERIAL PHAGOCYTOSIS (BY ALVEOLAR MACROPHAGES OR POLYMORPHONUCLEAR LEUKOCYTES) IN LUNG DISEASE IN CF PATIENTS?;1091;0100
00083;WHAT IS THE ROLE OF BACTERIAL PHAGOCYTOSIS (BY ALVEOLAR MACROPHAGES OR POLYMORPHONUCLEAR LEUKOCYTES) IN LUNG DISEASE IN CF PATIENTS?;1102;1120
00083;WHAT IS THE ROLE OF BACTERIAL PHAGOCYTOSIS (BY ALVEOLAR MACROPHAGES OR POLYMORPHONUCLEAR LEUKOCYTES) IN LUNG DISEASE IN CF PATIENTS?;1143;1220
00083;WHAT IS THE ROLE OF BACTERIAL PHAGOCYTOSIS (BY ALVEOLAR MACROPHAGES OR POLYMORPHONUCLEAR LEUKOCYTES) IN LUNG DISEASE IN CF PATIENTS?;1170;0100
00083;WHAT IS THE ROLE OF BACTERIAL PHAGOCYTOSIS (BY ALVEOLAR MACROPHAGES OR POLYMORPHONUCLEAR LEUKOCYTES) IN LUNG DISEASE IN CF PATIENTS?;1171;0100
00083;WHAT IS THE ROLE OF BACTERIAL PHAGOCYTOSIS (BY ALVEOLAR MACROPHAGES OR POLYMORPHONUCLEAR LEUKOCYTES) IN LUNG DISEASE IN CF PATIENTS?;1203;1212
00084;WHAT IS THE RELATIONSHIP BETWEEN HAEMOPHILUS INFLUENZAE AND PSEUDOMONAS AERUGINOSA IN CF PATIENTS?;8;0102
00084;WHAT IS THE RELATIONSHIP BETWEEN HAEMOPHILUS INFLUENZAE AND PSEUDOMONAS AERUGINOSA IN CF PATIENTS?;160;2221
00084;WHAT IS THE RELATIONSHIP BETWEEN HAEMOPHILUS INFLUENZAE AND PSEUDOMONAS AERUGINOSA IN CF PATIENTS?;333;0100
00084;WHAT IS THE RELATIONSHIP BETWEEN HAEMOPHILUS INFLUENZAE AND PSEUDOMONAS AERUGINOSA IN CF PATIENTS?;346;1000
00084;WHAT IS THE RELATIONSHIP BETWEEN HAEMOPHILUS INFLUENZAE AND PSEUDOMONAS AERUGINOSA IN CF PATIENTS?;384;1000
00084;WHAT IS THE RELATIONSHIP BETWEEN HAEMOPHILUS INFLUENZAE AND PSEUDOMONAS AERUGINOSA IN CF PATIENTS?;555;1000
00084;WHAT IS THE RELATIONSHIP BETWEEN HAEMOPHILUS INFLUENZAE AND PSEUDOMONAS AERUGINOSA IN CF PATIENTS?;590;0010
00084;WHAT IS THE RELATIONSHIP BETWEEN HAEMOPHILUS INFLUENZAE AND PSEUDOMONAS AERUGINOSA IN CF PATIENTS?;778;0010
00084;WHAT IS THE RELATIONSHIP BETWEEN HAEMOPHILUS INFLUENZAE AND PSEUDOMONAS AERUGINOSA IN CF PATIENTS?;837;0001
00084;WHAT IS THE RELATIONSHIP BETWEEN HAEMOPHILUS INFLUENZAE AND PSEUDOMONAS AERUGINOSA IN CF PATIENTS?;912;0001
00084;WHAT IS THE RELATIONSHIP BETWEEN HAEMOPHILUS INFLUENZAE AND PSEUDOMONAS AERUGINOSA IN CF PATIENTS?;922;1001
00084;WHAT IS THE RELATIONSHIP BETWEEN HAEMOPHILUS INFLUENZAE AND PSEUDOMONAS AERUGINOSA IN CF PATIENTS?;952;0100
00084;WHAT IS THE RELATIONSHIP BETWEEN HAEMOPHILUS INFLUENZAE AND PSEUDOMONAS AERUGINOSA IN CF PATIENTS?;986;1100
00084;WHAT IS THE RELATIONSHIP BETWEEN HAEMOPHILUS INFLUENZAE AND PSEUDOMONAS AERUGINOSA IN CF PATIENTS?;1086;0001
00084;WHAT IS THE RELATIONSHIP BETWEEN HAEMOPHILUS INFLUENZAE AND PSEUDOMONAS AERUGINOSA IN CF PATIENTS?;1112;1001
00084;WHAT IS THE RELATIONSHIP BETWEEN HAEMOPHILUS INFLUENZAE AND PSEUDOMONAS AERUGINOSA IN CF PATIENTS?;1179;0001
00085;DO CF PATIENTS EVER DEVELOP INFECTION IN ORGANS OTHER THAN THE LUNG? IF SO, IN WHAT ORGANS?;29;1212
00085;DO CF PATIENTS EVER DEVELOP INFECTION IN ORGANS OTHER THAN THE LUNG? IF SO, IN WHAT ORGANS?;58;0112
00085;DO CF PATIENTS EVER DEVELOP INFECTION IN ORGANS OTHER THAN THE LUNG? IF SO, IN WHAT ORGANS?;88;1000
00085;DO CF PATIENTS EVER DEVELOP INFECTION IN ORGANS OTHER THAN THE LUNG? IF SO, IN WHAT ORGANS?;98;0001
00085;DO CF PATIENTS EVER DEVELOP INFECTION IN ORGANS OTHER THAN THE LUNG? IF SO, IN WHAT ORGANS?;179;0002
00085;DO CF PATIENTS EVER DEVELOP INFECTION IN ORGANS OTHER THAN THE LUNG? IF SO, IN WHAT ORGANS?;200;1002
00085;DO CF PATIENTS EVER DEVELOP INFECTION IN ORGANS OTHER THAN THE LUNG? IF SO, IN WHAT ORGANS?;202;1121
00085;DO CF PATIENTS EVER DEVELOP INFECTION IN ORGANS OTHER THAN THE LUNG? IF SO, IN WHAT ORGANS?;250;0100
00085;DO CF PATIENTS EVER DEVELOP INFECTION IN ORGANS OTHER THAN THE LUNG? IF SO, IN WHAT ORGANS?;370;1001
00085;DO CF PATIENTS EVER DEVELOP INFECTION IN ORGANS OTHER THAN THE LUNG? IF SO, IN WHAT ORGANS?;427;0002
00085;DO CF PATIENTS EVER DEVELOP INFECTION IN ORGANS OTHER THAN THE LUNG? IF SO, IN WHAT ORGANS?;432;1000
00085;DO CF PATIENTS EVER DEVELOP INFECTION IN ORGANS OTHER THAN THE LUNG? IF SO, IN WHAT ORGANS?;438;0001
00085;DO CF PATIENTS EVER DEVELOP INFECTION IN ORGANS OTHER THAN THE LUNG? IF SO, IN WHAT ORGANS?;469;0001
00085;DO CF PATIENTS EVER DEVELOP INFECTION IN ORGANS OTHER THAN THE LUNG? IF SO, IN WHAT ORGANS?;475;2120
00085;DO CF PATIENTS EVER DEVELOP INFECTION IN ORGANS OTHER THAN THE LUNG? IF SO, IN WHAT ORGANS?;589;1000
00085;DO CF PATIENTS EVER DEVELOP INFECTION IN ORGANS OTHER THAN THE LUNG? IF SO, IN WHAT ORGANS?;590;0001
00085;DO CF PATIENTS EVER DEVELOP INFECTION IN ORGANS OTHER THAN THE LUNG? IF SO, IN WHAT ORGANS?;724;0001
00085;DO CF PATIENTS EVER DEVELOP INFECTION IN ORGANS OTHER THAN THE LUNG? IF SO, IN WHAT ORGANS?;732;0001
00085;DO CF PATIENTS EVER DEVELOP INFECTION IN ORGANS OTHER THAN THE LUNG? IF SO, IN WHAT ORGANS?;733;0001
00085;DO CF PATIENTS EVER DEVELOP INFECTION IN ORGANS OTHER THAN THE LUNG? IF SO, IN WHAT ORGANS?;888;0001
00085;DO CF PATIENTS EVER DEVELOP INFECTION IN ORGANS OTHER THAN THE LUNG? IF SO, IN WHAT ORGANS?;912;0001
00085;DO CF PATIENTS EVER DEVELOP INFECTION IN ORGANS OTHER THAN THE LUNG? IF SO, IN WHAT ORGANS?;941;0001
00085;DO CF PATIENTS EVER DEVELOP INFECTION IN ORGANS OTHER THAN THE LUNG? IF SO, IN WHAT ORGANS?;969;0001
00085;DO CF PATIENTS EVER DEVELOP INFECTION IN ORGANS OTHER THAN THE LUNG? IF SO, IN WHAT ORGANS?;982;2120
00085;DO CF PATIENTS EVER DEVELOP INFECTION IN ORGANS OTHER THAN THE LUNG? IF SO, IN WHAT ORGANS?;983;0100
00085;DO CF PATIENTS EVER DEVELOP INFECTION IN ORGANS OTHER THAN THE LUNG? IF SO, IN WHAT ORGANS?;1018;2222
00085;DO CF PATIENTS EVER DEVELOP INFECTION IN ORGANS OTHER THAN THE LUNG? IF SO, IN WHAT ORGANS?;1019;0100
00085;DO CF PATIENTS EVER DEVELOP INFECTION IN ORGANS OTHER THAN THE LUNG? IF SO, IN WHAT ORGANS?;1022;0001
00085;DO CF PATIENTS EVER DEVELOP INFECTION IN ORGANS OTHER THAN THE LUNG? IF SO, IN WHAT ORGANS?;1036;0001
00085;DO CF PATIENTS EVER DEVELOP INFECTION IN ORGANS OTHER THAN THE LUNG? IF SO, IN WHAT ORGANS?;1065;0001
00085;DO CF PATIENTS EVER DEVELOP INFECTION IN ORGANS OTHER THAN THE LUNG? IF SO, IN WHAT ORGANS?;1118;2222
00086;WHAT IS THE ROLE OF BACTERIA OTHER THAN PSEUDOMONAS AERUGINOSA, STAPHYLOCOCCUS AUREUS, OR HAEMOPHILUS INFLUENZAE IN THE PATHOGENESIS OF LUNG DISEASE IN CF PATIENTS?;8;2221
00086;WHAT IS THE ROLE OF BACTERIA OTHER THAN PSEUDOMONAS AERUGINOSA, STAPHYLOCOCCUS AUREUS, OR HAEMOPHILUS INFLUENZAE IN THE PATHOGENESIS OF LUNG DISEASE IN CF PATIENTS?;61;0002
00086;WHAT IS THE ROLE OF BACTERIA OTHER THAN PSEUDOMONAS AERUGINOSA, STAPHYLOCOCCUS AUREUS, OR HAEMOPHILUS INFLUENZAE IN THE PATHOGENESIS OF LUNG DISEASE IN CF PATIENTS?;85;0100
00086;WHAT IS THE ROLE OF BACTERIA OTHER THAN PSEUDOMONAS AERUGINOSA, STAPHYLOCOCCUS AUREUS, OR HAEMOPHILUS INFLUENZAE IN THE PATHOGENESIS OF LUNG DISEASE IN CF PATIENTS?;110;1211
00086;WHAT IS THE ROLE OF BACTERIA OTHER THAN PSEUDOMONAS AERUGINOSA, STAPHYLOCOCCUS AUREUS, OR HAEMOPHILUS INFLUENZAE IN THE PATHOGENESIS OF LUNG DISEASE IN CF PATIENTS?;135;0101
00086;WHAT IS THE ROLE OF BACTERIA OTHER THAN PSEUDOMONAS AERUGINOSA, STAPHYLOCOCCUS AUREUS, OR HAEMOPHILUS INFLUENZAE IN THE PATHOGENESIS OF LUNG DISEASE IN CF PATIENTS?;148;1212
00086;WHAT IS THE ROLE OF BACTERIA OTHER THAN PSEUDOMONAS AERUGINOSA, STAPHYLOCOCCUS AUREUS, OR HAEMOPHILUS INFLUENZAE IN THE PATHOGENESIS OF LUNG DISEASE IN CF PATIENTS?;152;1002
00086;WHAT IS THE ROLE OF BACTERIA OTHER THAN PSEUDOMONAS AERUGINOSA, STAPHYLOCOCCUS AUREUS, OR HAEMOPHILUS INFLUENZAE IN THE PATHOGENESIS OF LUNG DISEASE IN CF PATIENTS?;160;0112
00086;WHAT IS THE ROLE OF BACTERIA OTHER THAN PSEUDOMONAS AERUGINOSA, STAPHYLOCOCCUS AUREUS, OR HAEMOPHILUS INFLUENZAE IN THE PATHOGENESIS OF LUNG DISEASE IN CF PATIENTS?;200;0001
00086;WHAT IS THE ROLE OF BACTERIA OTHER THAN PSEUDOMONAS AERUGINOSA, STAPHYLOCOCCUS AUREUS, OR HAEMOPHILUS INFLUENZAE IN THE PATHOGENESIS OF LUNG DISEASE IN CF PATIENTS?;238;0110
00086;WHAT IS THE ROLE OF BACTERIA OTHER THAN PSEUDOMONAS AERUGINOSA, STAPHYLOCOCCUS AUREUS, OR HAEMOPHILUS INFLUENZAE IN THE PATHOGENESIS OF LUNG DISEASE IN CF PATIENTS?;271;2212
00086;WHAT IS THE ROLE OF BACTERIA OTHER THAN PSEUDOMONAS AERUGINOSA, STAPHYLOCOCCUS AUREUS, OR HAEMOPHILUS INFLUENZAE IN THE PATHOGENESIS OF LUNG DISEASE IN CF PATIENTS?;330;0011
00086;WHAT IS THE ROLE OF BACTERIA OTHER THAN PSEUDOMONAS AERUGINOSA, STAPHYLOCOCCUS AUREUS, OR HAEMOPHILUS INFLUENZAE IN THE PATHOGENESIS OF LUNG DISEASE IN CF PATIENTS?;346;2111
00086;WHAT IS THE ROLE OF BACTERIA OTHER THAN PSEUDOMONAS AERUGINOSA, STAPHYLOCOCCUS AUREUS, OR HAEMOPHILUS INFLUENZAE IN THE PATHOGENESIS OF LUNG DISEASE IN CF PATIENTS?;370;1011
00086;WHAT IS THE ROLE OF BACTERIA OTHER THAN PSEUDOMONAS AERUGINOSA, STAPHYLOCOCCUS AUREUS, OR HAEMOPHILUS INFLUENZAE IN THE PATHOGENESIS OF LUNG DISEASE IN CF PATIENTS?;384;1000
00086;WHAT IS THE ROLE OF BACTERIA OTHER THAN PSEUDOMONAS AERUGINOSA, STAPHYLOCOCCUS AUREUS, OR HAEMOPHILUS INFLUENZAE IN THE PATHOGENESIS OF LUNG DISEASE IN CF PATIENTS?;427;0001
00086;WHAT IS THE ROLE OF BACTERIA OTHER THAN PSEUDOMONAS AERUGINOSA, STAPHYLOCOCCUS AUREUS, OR HAEMOPHILUS INFLUENZAE IN THE PATHOGENESIS OF LUNG DISEASE IN CF PATIENTS?;505;0101
00086;WHAT IS THE ROLE OF BACTERIA OTHER THAN PSEUDOMONAS AERUGINOSA, STAPHYLOCOCCUS AUREUS, OR HAEMOPHILUS INFLUENZAE IN THE PATHOGENESIS OF LUNG DISEASE IN CF PATIENTS?;554;2222
00086;WHAT IS THE ROLE OF BACTERIA OTHER THAN PSEUDOMONAS AERUGINOSA, STAPHYLOCOCCUS AUREUS, OR HAEMOPHILUS INFLUENZAE IN THE PATHOGENESIS OF LUNG DISEASE IN CF PATIENTS?;555;0001
00086;WHAT IS THE ROLE OF BACTERIA OTHER THAN PSEUDOMONAS AERUGINOSA, STAPHYLOCOCCUS AUREUS, OR HAEMOPHILUS INFLUENZAE IN THE PATHOGENESIS OF LUNG DISEASE IN CF PATIENTS?;577;1000
00086;WHAT IS THE ROLE OF BACTERIA OTHER THAN PSEUDOMONAS AERUGINOSA, STAPHYLOCOCCUS AUREUS, OR HAEMOPHILUS INFLUENZAE IN THE PATHOGENESIS OF LUNG DISEASE IN CF PATIENTS?;586;0001
00086;WHAT IS THE ROLE OF BACTERIA OTHER THAN PSEUDOMONAS AERUGINOSA, STAPHYLOCOCCUS AUREUS, OR HAEMOPHILUS INFLUENZAE IN THE PATHOGENESIS OF LUNG DISEASE IN CF PATIENTS?;590;2211
00086;WHAT IS THE ROLE OF BACTERIA OTHER THAN PSEUDOMONAS AERUGINOSA, STAPHYLOCOCCUS AUREUS, OR HAEMOPHILUS INFLUENZAE IN THE PATHOGENESIS OF LUNG DISEASE IN CF PATIENTS?;722;1011
00086;WHAT IS THE ROLE OF BACTERIA OTHER THAN PSEUDOMONAS AERUGINOSA, STAPHYLOCOCCUS AUREUS, OR HAEMOPHILUS INFLUENZAE IN THE PATHOGENESIS OF LUNG DISEASE IN CF PATIENTS?;731;0001
00086;WHAT IS THE ROLE OF BACTERIA OTHER THAN PSEUDOMONAS AERUGINOSA, STAPHYLOCOCCUS AUREUS, OR HAEMOPHILUS INFLUENZAE IN THE PATHOGENESIS OF LUNG DISEASE IN CF PATIENTS?;763;0101
00086;WHAT IS THE ROLE OF BACTERIA OTHER THAN PSEUDOMONAS AERUGINOSA, STAPHYLOCOCCUS AUREUS, OR HAEMOPHILUS INFLUENZAE IN THE PATHOGENESIS OF LUNG DISEASE IN CF PATIENTS?;769;1110
00086;WHAT IS THE ROLE OF BACTERIA OTHER THAN PSEUDOMONAS AERUGINOSA, STAPHYLOCOCCUS AUREUS, OR HAEMOPHILUS INFLUENZAE IN THE PATHOGENESIS OF LUNG DISEASE IN CF PATIENTS?;922;0001
00086;WHAT IS THE ROLE OF BACTERIA OTHER THAN PSEUDOMONAS AERUGINOSA, STAPHYLOCOCCUS AUREUS, OR HAEMOPHILUS INFLUENZAE IN THE PATHOGENESIS OF LUNG DISEASE IN CF PATIENTS?;944;0101
00086;WHAT IS THE ROLE OF BACTERIA OTHER THAN PSEUDOMONAS AERUGINOSA, STAPHYLOCOCCUS AUREUS, OR HAEMOPHILUS INFLUENZAE IN THE PATHOGENESIS OF LUNG DISEASE IN CF PATIENTS?;945;0101
00086;WHAT IS THE ROLE OF BACTERIA OTHER THAN PSEUDOMONAS AERUGINOSA, STAPHYLOCOCCUS AUREUS, OR HAEMOPHILUS INFLUENZAE IN THE PATHOGENESIS OF LUNG DISEASE IN CF PATIENTS?;952;0001
00086;WHAT IS THE ROLE OF BACTERIA OTHER THAN PSEUDOMONAS AERUGINOSA, STAPHYLOCOCCUS AUREUS, OR HAEMOPHILUS INFLUENZAE IN THE PATHOGENESIS OF LUNG DISEASE IN CF PATIENTS?;983;2110
00086;WHAT IS THE ROLE OF BACTERIA OTHER THAN PSEUDOMONAS AERUGINOSA, STAPHYLOCOCCUS AUREUS, OR HAEMOPHILUS INFLUENZAE IN THE PATHOGENESIS OF LUNG DISEASE IN CF PATIENTS?;990;0002
00086;WHAT IS THE ROLE OF BACTERIA OTHER THAN PSEUDOMONAS AERUGINOSA, STAPHYLOCOCCUS AUREUS, OR HAEMOPHILUS INFLUENZAE IN THE PATHOGENESIS OF LUNG DISEASE IN CF PATIENTS?;1000;0101
00086;WHAT IS THE ROLE OF BACTERIA OTHER THAN PSEUDOMONAS AERUGINOSA, STAPHYLOCOCCUS AUREUS, OR HAEMOPHILUS INFLUENZAE IN THE PATHOGENESIS OF LUNG DISEASE IN CF PATIENTS?;1015;0001
00086;WHAT IS THE ROLE OF BACTERIA OTHER THAN PSEUDOMONAS AERUGINOSA, STAPHYLOCOCCUS AUREUS, OR HAEMOPHILUS INFLUENZAE IN THE PATHOGENESIS OF LUNG DISEASE IN CF PATIENTS?;1033;0001
00086;WHAT IS THE ROLE OF BACTERIA OTHER THAN PSEUDOMONAS AERUGINOSA, STAPHYLOCOCCUS AUREUS, OR HAEMOPHILUS INFLUENZAE IN THE PATHOGENESIS OF LUNG DISEASE IN CF PATIENTS?;1071;0001
00086;WHAT IS THE ROLE OF BACTERIA OTHER THAN PSEUDOMONAS AERUGINOSA, STAPHYLOCOCCUS AUREUS, OR HAEMOPHILUS INFLUENZAE IN THE PATHOGENESIS OF LUNG DISEASE IN CF PATIENTS?;1077;0100
00086;WHAT IS THE ROLE OF BACTERIA OTHER THAN PSEUDOMONAS AERUGINOSA, STAPHYLOCOCCUS AUREUS, OR HAEMOPHILUS INFLUENZAE IN THE PATHOGENESIS OF LUNG DISEASE IN CF PATIENTS?;1086;0001
00086;WHAT IS THE ROLE OF BACTERIA OTHER THAN PSEUDOMONAS AERUGINOSA, STAPHYLOCOCCUS AUREUS, OR HAEMOPHILUS INFLUENZAE IN THE PATHOGENESIS OF LUNG DISEASE IN CF PATIENTS?;1090;0001
00086;WHAT IS THE ROLE OF BACTERIA OTHER THAN PSEUDOMONAS AERUGINOSA, STAPHYLOCOCCUS AUREUS, OR HAEMOPHILUS INFLUENZAE IN THE PATHOGENESIS OF LUNG DISEASE IN CF PATIENTS?;1091;0011
00086;WHAT IS THE ROLE OF BACTERIA OTHER THAN PSEUDOMONAS AERUGINOSA, STAPHYLOCOCCUS AUREUS, OR HAEMOPHILUS INFLUENZAE IN THE PATHOGENESIS OF LUNG DISEASE IN CF PATIENTS?;1112;0001
00086;WHAT IS THE ROLE OF BACTERIA OTHER THAN PSEUDOMONAS AERUGINOSA, STAPHYLOCOCCUS AUREUS, OR HAEMOPHILUS INFLUENZAE IN THE PATHOGENESIS OF LUNG DISEASE IN CF PATIENTS?;1118;0001
00086;WHAT IS THE ROLE OF BACTERIA OTHER THAN PSEUDOMONAS AERUGINOSA, STAPHYLOCOCCUS AUREUS, OR HAEMOPHILUS INFLUENZAE IN THE PATHOGENESIS OF LUNG DISEASE IN CF PATIENTS?;1173;1100
00086;WHAT IS THE ROLE OF BACTERIA OTHER THAN PSEUDOMONAS AERUGINOSA, STAPHYLOCOCCUS AUREUS, OR HAEMOPHILUS INFLUENZAE IN THE PATHOGENESIS OF LUNG DISEASE IN CF PATIENTS?;1181;0001
00086;WHAT IS THE ROLE OF BACTERIA OTHER THAN PSEUDOMONAS AERUGINOSA, STAPHYLOCOCCUS AUREUS, OR HAEMOPHILUS INFLUENZAE IN THE PATHOGENESIS OF LUNG DISEASE IN CF PATIENTS?;1227;0001
00086;WHAT IS THE ROLE OF BACTERIA OTHER THAN PSEUDOMONAS AERUGINOSA, STAPHYLOCOCCUS AUREUS, OR HAEMOPHILUS INFLUENZAE IN THE PATHOGENESIS OF LUNG DISEASE IN CF PATIENTS?;1232;0001
00086;WHAT IS THE ROLE OF BACTERIA OTHER THAN PSEUDOMONAS AERUGINOSA, STAPHYLOCOCCUS AUREUS, OR HAEMOPHILUS INFLUENZAE IN THE PATHOGENESIS OF LUNG DISEASE IN CF PATIENTS?;1234;0001
00087;WHAT IS THE ROLE OF FUNGI IN THE PATHOGENESIS OF LUNG DISEASE IN CF PATIENTS?;187;2222
00087;WHAT IS THE ROLE OF FUNGI IN THE PATHOGENESIS OF LUNG DISEASE IN CF PATIENTS?;223;1001
00087;WHAT IS THE ROLE OF FUNGI IN THE PATHOGENESIS OF LUNG DISEASE IN CF PATIENTS?;228;2222
00087;WHAT IS THE ROLE OF FUNGI IN THE PATHOGENESIS OF LUNG DISEASE IN CF PATIENTS?;229;2222
00087;WHAT IS THE ROLE OF FUNGI IN THE PATHOGENESIS OF LUNG DISEASE IN CF PATIENTS?;333;0101
00087;WHAT IS THE ROLE OF FUNGI IN THE PATHOGENESIS OF LUNG DISEASE IN CF PATIENTS?;369;2222
00087;WHAT IS THE ROLE OF FUNGI IN THE PATHOGENESIS OF LUNG DISEASE IN CF PATIENTS?;370;1111
00087;WHAT IS THE ROLE OF FUNGI IN THE PATHOGENESIS OF LUNG DISEASE IN CF PATIENTS?;382;0100
00087;WHAT IS THE ROLE OF FUNGI IN THE PATHOGENESIS OF LUNG DISEASE IN CF PATIENTS?;394;0001
00087;WHAT IS THE ROLE OF FUNGI IN THE PATHOGENESIS OF LUNG DISEASE IN CF PATIENTS?;401;1100
00087;WHAT IS THE ROLE OF FUNGI IN THE PATHOGENESIS OF LUNG DISEASE IN CF PATIENTS?;432;2122
00087;WHAT IS THE ROLE OF FUNGI IN THE PATHOGENESIS OF LUNG DISEASE IN CF PATIENTS?;438;1102
00087;WHAT IS THE ROLE OF FUNGI IN THE PATHOGENESIS OF LUNG DISEASE IN CF PATIENTS?;485;0001
00087;WHAT IS THE ROLE OF FUNGI IN THE PATHOGENESIS OF LUNG DISEASE IN CF PATIENTS?;513;0101
00087;WHAT IS THE ROLE OF FUNGI IN THE PATHOGENESIS OF LUNG DISEASE IN CF PATIENTS?;550;0101
00087;WHAT IS THE ROLE OF FUNGI IN THE PATHOGENESIS OF LUNG DISEASE IN CF PATIENTS?;590;1012
00087;WHAT IS THE ROLE OF FUNGI IN THE PATHOGENESIS OF LUNG DISEASE IN CF PATIENTS?;631;1001
00087;WHAT IS THE ROLE OF FUNGI IN THE PATHOGENESIS OF LUNG DISEASE IN CF PATIENTS?;632;0001
00087;WHAT IS THE ROLE OF FUNGI IN THE PATHOGENESIS OF LUNG DISEASE IN CF PATIENTS?;668;0001
00087;WHAT IS THE ROLE OF FUNGI IN THE PATHOGENESIS OF LUNG DISEASE IN CF PATIENTS?;722;0001
00087;WHAT IS THE ROLE OF FUNGI IN THE PATHOGENESIS OF LUNG DISEASE IN CF PATIENTS?;812;0101
00087;WHAT IS THE ROLE OF FUNGI IN THE PATHOGENESIS OF LUNG DISEASE IN CF PATIENTS?;819;1001
00087;WHAT IS THE ROLE OF FUNGI IN THE PATHOGENESIS OF LUNG DISEASE IN CF PATIENTS?;833;0001
00087;WHAT IS THE ROLE OF FUNGI IN THE PATHOGENESIS OF LUNG DISEASE IN CF PATIENTS?;860;1210
00087;WHAT IS THE ROLE OF FUNGI IN THE PATHOGENESIS OF LUNG DISEASE IN CF PATIENTS?;945;0100
00087;WHAT IS THE ROLE OF FUNGI IN THE PATHOGENESIS OF LUNG DISEASE IN CF PATIENTS?;990;0001
00087;WHAT IS THE ROLE OF FUNGI IN THE PATHOGENESIS OF LUNG DISEASE IN CF PATIENTS?;1005;2222
00087;WHAT IS THE ROLE OF FUNGI IN THE PATHOGENESIS OF LUNG DISEASE IN CF PATIENTS?;1007;0100
00087;WHAT IS THE ROLE OF FUNGI IN THE PATHOGENESIS OF LUNG DISEASE IN CF PATIENTS?;1015;2221
00087;WHAT IS THE ROLE OF FUNGI IN THE PATHOGENESIS OF LUNG DISEASE IN CF PATIENTS?;1025;0100
00087;WHAT IS THE ROLE OF FUNGI IN THE PATHOGENESIS OF LUNG DISEASE IN CF PATIENTS?;1032;0100
00087;WHAT IS THE ROLE OF FUNGI IN THE PATHOGENESIS OF LUNG DISEASE IN CF PATIENTS?;1060;2120
00087;WHAT IS THE ROLE OF FUNGI IN THE PATHOGENESIS OF LUNG DISEASE IN CF PATIENTS?;1071;0101
00087;WHAT IS THE ROLE OF FUNGI IN THE PATHOGENESIS OF LUNG DISEASE IN CF PATIENTS?;1134;0101
00087;WHAT IS THE ROLE OF FUNGI IN THE PATHOGENESIS OF LUNG DISEASE IN CF PATIENTS?;1163;0001
00087;WHAT IS THE ROLE OF FUNGI IN THE PATHOGENESIS OF LUNG DISEASE IN CF PATIENTS?;1169;0001
00087;WHAT IS THE ROLE OF FUNGI IN THE PATHOGENESIS OF LUNG DISEASE IN CF PATIENTS?;1180;0001
00087;WHAT IS THE ROLE OF FUNGI IN THE PATHOGENESIS OF LUNG DISEASE IN CF PATIENTS?;1234;0001
00088;WHAT IS THE ROLE OF VIRAL INFECTION IN THE LUNG DISEASE OF CF PATIENTS?;370;1011
00088;WHAT IS THE ROLE OF VIRAL INFECTION IN THE LUNG DISEASE OF CF PATIENTS?;443;0002
00088;WHAT IS THE ROLE OF VIRAL INFECTION IN THE LUNG DISEASE OF CF PATIENTS?;457;2222
00088;WHAT IS THE ROLE OF VIRAL INFECTION IN THE LUNG DISEASE OF CF PATIENTS?;590;1012
00088;WHAT IS THE ROLE OF VIRAL INFECTION IN THE LUNG DISEASE OF CF PATIENTS?;614;2220
00088;WHAT IS THE ROLE OF VIRAL INFECTION IN THE LUNG DISEASE OF CF PATIENTS?;668;0001
00088;WHAT IS THE ROLE OF VIRAL INFECTION IN THE LUNG DISEASE OF CF PATIENTS?;678;0110
00088;WHAT IS THE ROLE OF VIRAL INFECTION IN THE LUNG DISEASE OF CF PATIENTS?;679;0110
00088;WHAT IS THE ROLE OF VIRAL INFECTION IN THE LUNG DISEASE OF CF PATIENTS?;702;0100
00088;WHAT IS THE ROLE OF VIRAL INFECTION IN THE LUNG DISEASE OF CF PATIENTS?;945;0100
00088;WHAT IS THE ROLE OF VIRAL INFECTION IN THE LUNG DISEASE OF CF PATIENTS?;990;0001
00088;WHAT IS THE ROLE OF VIRAL INFECTION IN THE LUNG DISEASE OF CF PATIENTS?;1091;1211
00088;WHAT IS THE ROLE OF VIRAL INFECTION IN THE LUNG DISEASE OF CF PATIENTS?;1134;0001
00088;WHAT IS THE ROLE OF VIRAL INFECTION IN THE LUNG DISEASE OF CF PATIENTS?;1144;0100
00089;WHAT IS THE EPIDEMIOLOGY OF PSEUDOMONAS AERUGINOSA IN CF PATIENTS? SPECIFICALLY, DO CF PATIENTS SPREAD PSEUDOMONAS AERUGINOSA TO OTHER PATIENTS OR TO OTHER INDIVIDUALS (FAMILY)?;79;1210
00089;WHAT IS THE EPIDEMIOLOGY OF PSEUDOMONAS AERUGINOSA IN CF PATIENTS? SPECIFICALLY, DO CF PATIENTS SPREAD PSEUDOMONAS AERUGINOSA TO OTHER PATIENTS OR TO OTHER INDIVIDUALS (FAMILY)?;152;0002
00089;WHAT IS THE EPIDEMIOLOGY OF PSEUDOMONAS AERUGINOSA IN CF PATIENTS? SPECIFICALLY, DO CF PATIENTS SPREAD PSEUDOMONAS AERUGINOSA TO OTHER PATIENTS OR TO OTHER INDIVIDUALS (FAMILY)?;176;2221
00089;WHAT IS THE EPIDEMIOLOGY OF PSEUDOMONAS AERUGINOSA IN CF PATIENTS? SPECIFICALLY, DO CF PATIENTS SPREAD PSEUDOMONAS AERUGINOSA TO OTHER PATIENTS OR TO OTHER INDIVIDUALS (FAMILY)?;177;0110
00089;WHAT IS THE EPIDEMIOLOGY OF PSEUDOMONAS AERUGINOSA IN CF PATIENTS? SPECIFICALLY, DO CF PATIENTS SPREAD PSEUDOMONAS AERUGINOSA TO OTHER PATIENTS OR TO OTHER INDIVIDUALS (FAMILY)?;179;0001
00089;WHAT IS THE EPIDEMIOLOGY OF PSEUDOMONAS AERUGINOSA IN CF PATIENTS? SPECIFICALLY, DO CF PATIENTS SPREAD PSEUDOMONAS AERUGINOSA TO OTHER PATIENTS OR TO OTHER INDIVIDUALS (FAMILY)?;260;2212
00089;WHAT IS THE EPIDEMIOLOGY OF PSEUDOMONAS AERUGINOSA IN CF PATIENTS? SPECIFICALLY, DO CF PATIENTS SPREAD PSEUDOMONAS AERUGINOSA TO OTHER PATIENTS OR TO OTHER INDIVIDUALS (FAMILY)?;265;0002
00089;WHAT IS THE EPIDEMIOLOGY OF PSEUDOMONAS AERUGINOSA IN CF PATIENTS? SPECIFICALLY, DO CF PATIENTS SPREAD PSEUDOMONAS AERUGINOSA TO OTHER PATIENTS OR TO OTHER INDIVIDUALS (FAMILY)?;370;1000
00089;WHAT IS THE EPIDEMIOLOGY OF PSEUDOMONAS AERUGINOSA IN CF PATIENTS? SPECIFICALLY, DO CF PATIENTS SPREAD PSEUDOMONAS AERUGINOSA TO OTHER PATIENTS OR TO OTHER INDIVIDUALS (FAMILY)?;469;2222
00089;WHAT IS THE EPIDEMIOLOGY OF PSEUDOMONAS AERUGINOSA IN CF PATIENTS? SPECIFICALLY, DO CF PATIENTS SPREAD PSEUDOMONAS AERUGINOSA TO OTHER PATIENTS OR TO OTHER INDIVIDUALS (FAMILY)?;479;1000
00089;WHAT IS THE EPIDEMIOLOGY OF PSEUDOMONAS AERUGINOSA IN CF PATIENTS? SPECIFICALLY, DO CF PATIENTS SPREAD PSEUDOMONAS AERUGINOSA TO OTHER PATIENTS OR TO OTHER INDIVIDUALS (FAMILY)?;590;0010
00089;WHAT IS THE EPIDEMIOLOGY OF PSEUDOMONAS AERUGINOSA IN CF PATIENTS? SPECIFICALLY, DO CF PATIENTS SPREAD PSEUDOMONAS AERUGINOSA TO OTHER PATIENTS OR TO OTHER INDIVIDUALS (FAMILY)?;706;1100
00089;WHAT IS THE EPIDEMIOLOGY OF PSEUDOMONAS AERUGINOSA IN CF PATIENTS? SPECIFICALLY, DO CF PATIENTS SPREAD PSEUDOMONAS AERUGINOSA TO OTHER PATIENTS OR TO OTHER INDIVIDUALS (FAMILY)?;778;0100
00089;WHAT IS THE EPIDEMIOLOGY OF PSEUDOMONAS AERUGINOSA IN CF PATIENTS? SPECIFICALLY, DO CF PATIENTS SPREAD PSEUDOMONAS AERUGINOSA TO OTHER PATIENTS OR TO OTHER INDIVIDUALS (FAMILY)?;905;1210
00089;WHAT IS THE EPIDEMIOLOGY OF PSEUDOMONAS AERUGINOSA IN CF PATIENTS? SPECIFICALLY, DO CF PATIENTS SPREAD PSEUDOMONAS AERUGINOSA TO OTHER PATIENTS OR TO OTHER INDIVIDUALS (FAMILY)?;912;1101
00089;WHAT IS THE EPIDEMIOLOGY OF PSEUDOMONAS AERUGINOSA IN CF PATIENTS? SPECIFICALLY, DO CF PATIENTS SPREAD PSEUDOMONAS AERUGINOSA TO OTHER PATIENTS OR TO OTHER INDIVIDUALS (FAMILY)?;1065;0100
00089;WHAT IS THE EPIDEMIOLOGY OF PSEUDOMONAS AERUGINOSA IN CF PATIENTS? SPECIFICALLY, DO CF PATIENTS SPREAD PSEUDOMONAS AERUGINOSA TO OTHER PATIENTS OR TO OTHER INDIVIDUALS (FAMILY)?;1086;0001
00090;WHAT FACTORS ARE RESPONSIBLE FOR THE APPEARANCE OF MUCOID STRAINS OF PSEUDOMONAS AERUGINOSA IN CF PATIENTS?;7;1222
00090;WHAT FACTORS ARE RESPONSIBLE FOR THE APPEARANCE OF MUCOID STRAINS OF PSEUDOMONAS AERUGINOSA IN CF PATIENTS?;160;0001
00090;WHAT FACTORS ARE RESPONSIBLE FOR THE APPEARANCE OF MUCOID STRAINS OF PSEUDOMONAS AERUGINOSA IN CF PATIENTS?;161;0001
00090;WHAT FACTORS ARE RESPONSIBLE FOR THE APPEARANCE OF MUCOID STRAINS OF PSEUDOMONAS AERUGINOSA IN CF PATIENTS?;176;1222
00090;WHAT FACTORS ARE RESPONSIBLE FOR THE APPEARANCE OF MUCOID STRAINS OF PSEUDOMONAS AERUGINOSA IN CF PATIENTS?;177;2212
00090;WHAT FACTORS ARE RESPONSIBLE FOR THE APPEARANCE OF MUCOID STRAINS OF PSEUDOMONAS AERUGINOSA IN CF PATIENTS?;200;1122
00090;WHAT FACTORS ARE RESPONSIBLE FOR THE APPEARANCE OF MUCOID STRAINS OF PSEUDOMONAS AERUGINOSA IN CF PATIENTS?;260;1012
00090;WHAT FACTORS ARE RESPONSIBLE FOR THE APPEARANCE OF MUCOID STRAINS OF PSEUDOMONAS AERUGINOSA IN CF PATIENTS?;265;2212
00090;WHAT FACTORS ARE RESPONSIBLE FOR THE APPEARANCE OF MUCOID STRAINS OF PSEUDOMONAS AERUGINOSA IN CF PATIENTS?;370;1000
00090;WHAT FACTORS ARE RESPONSIBLE FOR THE APPEARANCE OF MUCOID STRAINS OF PSEUDOMONAS AERUGINOSA IN CF PATIENTS?;451;2122
00090;WHAT FACTORS ARE RESPONSIBLE FOR THE APPEARANCE OF MUCOID STRAINS OF PSEUDOMONAS AERUGINOSA IN CF PATIENTS?;479;1120
00090;WHAT FACTORS ARE RESPONSIBLE FOR THE APPEARANCE OF MUCOID STRAINS OF PSEUDOMONAS AERUGINOSA IN CF PATIENTS?;505;0001
00090;WHAT FACTORS ARE RESPONSIBLE FOR THE APPEARANCE OF MUCOID STRAINS OF PSEUDOMONAS AERUGINOSA IN CF PATIENTS?;589;0001
00090;WHAT FACTORS ARE RESPONSIBLE FOR THE APPEARANCE OF MUCOID STRAINS OF PSEUDOMONAS AERUGINOSA IN CF PATIENTS?;590;2222
00090;WHAT FACTORS ARE RESPONSIBLE FOR THE APPEARANCE OF MUCOID STRAINS OF PSEUDOMONAS AERUGINOSA IN CF PATIENTS?;763;0001
00090;WHAT FACTORS ARE RESPONSIBLE FOR THE APPEARANCE OF MUCOID STRAINS OF PSEUDOMONAS AERUGINOSA IN CF PATIENTS?;778;0110
00090;WHAT FACTORS ARE RESPONSIBLE FOR THE APPEARANCE OF MUCOID STRAINS OF PSEUDOMONAS AERUGINOSA IN CF PATIENTS?;874;0001
00090;WHAT FACTORS ARE RESPONSIBLE FOR THE APPEARANCE OF MUCOID STRAINS OF PSEUDOMONAS AERUGINOSA IN CF PATIENTS?;884;2222
00090;WHAT FACTORS ARE RESPONSIBLE FOR THE APPEARANCE OF MUCOID STRAINS OF PSEUDOMONAS AERUGINOSA IN CF PATIENTS?;912;1212
00090;WHAT FACTORS ARE RESPONSIBLE FOR THE APPEARANCE OF MUCOID STRAINS OF PSEUDOMONAS AERUGINOSA IN CF PATIENTS?;987;0100
00090;WHAT FACTORS ARE RESPONSIBLE FOR THE APPEARANCE OF MUCOID STRAINS OF PSEUDOMONAS AERUGINOSA IN CF PATIENTS?;1065;0100
00090;WHAT FACTORS ARE RESPONSIBLE FOR THE APPEARANCE OF MUCOID STRAINS OF PSEUDOMONAS AERUGINOSA IN CF PATIENTS?;1071;0001
00090;WHAT FACTORS ARE RESPONSIBLE FOR THE APPEARANCE OF MUCOID STRAINS OF PSEUDOMONAS AERUGINOSA IN CF PATIENTS?;1086;1211
00090;WHAT FACTORS ARE RESPONSIBLE FOR THE APPEARANCE OF MUCOID STRAINS OF PSEUDOMONAS AERUGINOSA IN CF PATIENTS?;1089;0001
00090;WHAT FACTORS ARE RESPONSIBLE FOR THE APPEARANCE OF MUCOID STRAINS OF PSEUDOMONAS AERUGINOSA IN CF PATIENTS?;1090;1210
00090;WHAT FACTORS ARE RESPONSIBLE FOR THE APPEARANCE OF MUCOID STRAINS OF PSEUDOMONAS AERUGINOSA IN CF PATIENTS?;1091;0112
00090;WHAT FACTORS ARE RESPONSIBLE FOR THE APPEARANCE OF MUCOID STRAINS OF PSEUDOMONAS AERUGINOSA IN CF PATIENTS?;1234;0001
00090;WHAT FACTORS ARE RESPONSIBLE FOR THE APPEARANCE OF MUCOID STRAINS OF PSEUDOMONAS AERUGINOSA IN CF PATIENTS?;1238;0010
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;1;0001
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;3;0002
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;4;0002
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;8;0001
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;9;0001
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;11;0101
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;13;0001
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;15;0102
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;17;0101
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;21;0100
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;29;1211
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;30;0100
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;32;0001
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;33;0001
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;40;0002
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;41;0001
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;45;0001
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;46;0101
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;50;0001
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;56;0001
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;57;2212
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;58;1212
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;59;1211
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;60;0001
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;69;2111
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;78;0001
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;88;2221
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;92;0001
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;94;0001
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;95;2222
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;97;2222
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;98;2211
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;100;0002
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;103;1012
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;105;1012
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;109;1012
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;115;1002
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;116;1012
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;118;0002
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;119;1012
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;121;0001
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;122;0001
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;124;0001
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;128;0001
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;134;0001
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;135;0001
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;139;1211
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;147;0001
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;163;0001
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;166;0001
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;170;0001
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;173;0001
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;174;1211
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;181;0001
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;182;2222
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;183;2220
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;186;2220
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;189;0010
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;199;0102
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;202;1120
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;204;1210
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;211;0100
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;226;0001
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;237;0001
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;240;2220
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;241;0012
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;242;0001
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;243;0001
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;244;0001
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;248;0001
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;250;2122
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;256;0001
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;259;0001
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;261;0001
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;263;0001
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;264;0001
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;265;0001
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;266;2212
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;267;2222
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;268;0100
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;272;0001
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;274;0100
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;275;0001
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;276;0001
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;278;0001
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;279;0001
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;281;0001
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;283;0001
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;286;0001
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;287;0001
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;294;2122
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;297;1001
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;300;0100
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;301;0010
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;314;2210
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;317;1220
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;322;2221
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;331;0001
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;333;0001
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;339;1111
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;348;0002
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;351;0110
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;352;0110
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;353;2122
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;354;0011
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;355;0010
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;359;1011
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;361;0110
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;362;2122
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;364;2220
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;370;2212
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;376;2221
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;381;2221
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;385;1221
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;392;0001
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;395;2121
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;396;2211
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;398;0011
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;405;0001
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;412;0002
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;413;2222
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;416;0100
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;422;2221
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;423;1100
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;426;0001
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;428;0100
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;431;0001
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;434;1002
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;443;1001
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;454;0100
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;455;0100
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;466;1210
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;468;2222
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;473;0001
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;474;2120
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;475;2221
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;478;1120
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;485;0100
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;486;0012
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;489;0100
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;508;0101
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;512;0011
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;538;0001
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;545;0110
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;549;0100
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;550;1212
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;551;0001
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;552;2112
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;553;0001
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;559;0101
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;562;0001
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;579;2110
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;582;0001
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;586;0001
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;594;1211
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;598;2121
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;601;0101
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;603;2012
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;611;1210
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;615;2121
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;626;0001
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;641;1111
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;642;0100
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;643;0001
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;648;0001
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;659;0100
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;667;0001
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;673;0100
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;682;2210
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;683;2210
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;684;1220
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;688;0100
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;690;0101
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;694;0100
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;695;1210
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;700;2222
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;704;0001
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;714;0110
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;719;0001
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;720;0102
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;722;2222
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;724;0101
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;725;0001
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;727;0001
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;728;2222
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;729;0001
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;731;0002
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;732;2222
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;733;2122
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;735;0001
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;751;0002
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;752;1111
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;756;2222
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;759;2122
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;762;0001
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;763;2112
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;764;1102
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;767;0001
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;768;0010
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;770;2222
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;771;0001
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;772;0102
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;773;0001
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;779;0001
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;781;2122
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;782;0001
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;784;1102
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;787;2122
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;788;0001
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;791;1001
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;794;1000
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;796;1220
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;797;2112
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;798;1100
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;799;1110
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;801;2122
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;803;2220
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;808;2122
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;809;0001
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;822;2122
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;833;2112
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;834;0100
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;835;0100
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;836;1010
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;838;0001
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;844;0002
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;854;0001
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;859;2122
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;866;0001
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;867;0001
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;868;0001
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;870;2221
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;872;0102
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;875;0001
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;880;0001
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;882;0001
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;883;0100
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;888;1002
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;893;2122
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;894;0001
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;896;0001
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;897;1000
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;900;1120
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;906;0001
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;913;0001
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;914;1000
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;935;0011
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;941;1001
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;944;0001
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;947;0001
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;965;2122
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;974;2221
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;982;1001
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;985;1122
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;990;1002
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;992;0001
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;993;0001
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;997;2222
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;998;2212
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;1000;2122
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;1018;2122
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;1019;0002
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;1023;0001
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;1033;0001
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;1040;0001
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;1041;0001
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;1043;0002
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;1047;0002
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;1051;0001
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;1054;0002
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;1056;0002
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;1057;0002
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;1058;0002
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;1063;0001
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;1080;0002
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;1085;0001
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;1091;0001
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;1093;0002
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;1095;2222
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;1097;2220
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;1098;1221
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;1103;1000
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;1106;0100
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;1107;0100
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;1108;0100
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;1115;0001
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;1116;0001
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;1118;2212
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;1119;0002
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;1125;1210
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;1134;0100
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;1177;2122
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;1184;2221
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;1186;0001
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;1189;2222
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;1191;0101
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;1192;0001
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;1216;2222
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;1217;2222
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;1219;2222
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;1226;2222
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;1232;0001
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;1234;1001
00091;WHAT ARE THE UNUSUAL MANIFESTATIONS OF CF (OTHER THAN LUNG DISEASE OR EXOCRINE PANCREATIC INSUFFICIENCY)?;1235;0102
00092;WHAT IS THE PROGNOSIS FOR SURVIVAL OF PATIENTS WITH CF?;17;0001
00092;WHAT IS THE PROGNOSIS FOR SURVIVAL OF PATIENTS WITH CF?;43;0001
00092;WHAT IS THE PROGNOSIS FOR SURVIVAL OF PATIENTS WITH CF?;111;0001
00092;WHAT IS THE PROGNOSIS FOR SURVIVAL OF PATIENTS WITH CF?;130;1000
00092;WHAT IS THE PROGNOSIS FOR SURVIVAL OF PATIENTS WITH CF?;135;1102
00092;WHAT IS THE PROGNOSIS FOR SURVIVAL OF PATIENTS WITH CF?;136;0001
00092;WHAT IS THE PROGNOSIS FOR SURVIVAL OF PATIENTS WITH CF?;148;0002
00092;WHAT IS THE PROGNOSIS FOR SURVIVAL OF PATIENTS WITH CF?;181;0001
00092;WHAT IS THE PROGNOSIS FOR SURVIVAL OF PATIENTS WITH CF?;185;1000
00092;WHAT IS THE PROGNOSIS FOR SURVIVAL OF PATIENTS WITH CF?;189;0001
00092;WHAT IS THE PROGNOSIS FOR SURVIVAL OF PATIENTS WITH CF?;193;1000
00092;WHAT IS THE PROGNOSIS FOR SURVIVAL OF PATIENTS WITH CF?;200;0001
00092;WHAT IS THE PROGNOSIS FOR SURVIVAL OF PATIENTS WITH CF?;213;2111
00092;WHAT IS THE PROGNOSIS FOR SURVIVAL OF PATIENTS WITH CF?;226;0012
00092;WHAT IS THE PROGNOSIS FOR SURVIVAL OF PATIENTS WITH CF?;238;1012
00092;WHAT IS THE PROGNOSIS FOR SURVIVAL OF PATIENTS WITH CF?;258;2222
00092;WHAT IS THE PROGNOSIS FOR SURVIVAL OF PATIENTS WITH CF?;333;1002
00092;WHAT IS THE PROGNOSIS FOR SURVIVAL OF PATIENTS WITH CF?;342;0100
00092;WHAT IS THE PROGNOSIS FOR SURVIVAL OF PATIENTS WITH CF?;354;2110
00092;WHAT IS THE PROGNOSIS FOR SURVIVAL OF PATIENTS WITH CF?;370;1102
00092;WHAT IS THE PROGNOSIS FOR SURVIVAL OF PATIENTS WITH CF?;377;1010
00092;WHAT IS THE PROGNOSIS FOR SURVIVAL OF PATIENTS WITH CF?;392;0001
00092;WHAT IS THE PROGNOSIS FOR SURVIVAL OF PATIENTS WITH CF?;429;0001
00092;WHAT IS THE PROGNOSIS FOR SURVIVAL OF PATIENTS WITH CF?;434;0100
00092;WHAT IS THE PROGNOSIS FOR SURVIVAL OF PATIENTS WITH CF?;446;0001
00092;WHAT IS THE PROGNOSIS FOR SURVIVAL OF PATIENTS WITH CF?;465;0011
00092;WHAT IS THE PROGNOSIS FOR SURVIVAL OF PATIENTS WITH CF?;472;2222
00092;WHAT IS THE PROGNOSIS FOR SURVIVAL OF PATIENTS WITH CF?;473;2221
00092;WHAT IS THE PROGNOSIS FOR SURVIVAL OF PATIENTS WITH CF?;479;0100
00092;WHAT IS THE PROGNOSIS FOR SURVIVAL OF PATIENTS WITH CF?;489;1121
00092;WHAT IS THE PROGNOSIS FOR SURVIVAL OF PATIENTS WITH CF?;492;0001
00092;WHAT IS THE PROGNOSIS FOR SURVIVAL OF PATIENTS WITH CF?;503;0001
00092;WHAT IS THE PROGNOSIS FOR SURVIVAL OF PATIENTS WITH CF?;510;0001
00092;WHAT IS THE PROGNOSIS FOR SURVIVAL OF PATIENTS WITH CF?;514;1010
00092;WHAT IS THE PROGNOSIS FOR SURVIVAL OF PATIENTS WITH CF?;550;1100
00092;WHAT IS THE PROGNOSIS FOR SURVIVAL OF PATIENTS WITH CF?;559;0011
00092;WHAT IS THE PROGNOSIS FOR SURVIVAL OF PATIENTS WITH CF?;586;0002
00092;WHAT IS THE PROGNOSIS FOR SURVIVAL OF PATIENTS WITH CF?;596;0001
00092;WHAT IS THE PROGNOSIS FOR SURVIVAL OF PATIENTS WITH CF?;599;2111
00092;WHAT IS THE PROGNOSIS FOR SURVIVAL OF PATIENTS WITH CF?;607;0001
00092;WHAT IS THE PROGNOSIS FOR SURVIVAL OF PATIENTS WITH CF?;611;2110
00092;WHAT IS THE PROGNOSIS FOR SURVIVAL OF PATIENTS WITH CF?;643;0001
00092;WHAT IS THE PROGNOSIS FOR SURVIVAL OF PATIENTS WITH CF?;653;0001
00092;WHAT IS THE PROGNOSIS FOR SURVIVAL OF PATIENTS WITH CF?;661;2222
00092;WHAT IS THE PROGNOSIS FOR SURVIVAL OF PATIENTS WITH CF?;671;1000
00092;WHAT IS THE PROGNOSIS FOR SURVIVAL OF PATIENTS WITH CF?;687;1000
00092;WHAT IS THE PROGNOSIS FOR SURVIVAL OF PATIENTS WITH CF?;692;0010
00092;WHAT IS THE PROGNOSIS FOR SURVIVAL OF PATIENTS WITH CF?;705;2210
00092;WHAT IS THE PROGNOSIS FOR SURVIVAL OF PATIENTS WITH CF?;722;2222
00092;WHAT IS THE PROGNOSIS FOR SURVIVAL OF PATIENTS WITH CF?;724;1111
00092;WHAT IS THE PROGNOSIS FOR SURVIVAL OF PATIENTS WITH CF?;729;0001
00092;WHAT IS THE PROGNOSIS FOR SURVIVAL OF PATIENTS WITH CF?;731;0002
00092;WHAT IS THE PROGNOSIS FOR SURVIVAL OF PATIENTS WITH CF?;735;0001
00092;WHAT IS THE PROGNOSIS FOR SURVIVAL OF PATIENTS WITH CF?;763;1001
00092;WHAT IS THE PROGNOSIS FOR SURVIVAL OF PATIENTS WITH CF?;764;1001
00092;WHAT IS THE PROGNOSIS FOR SURVIVAL OF PATIENTS WITH CF?;767;0001
00092;WHAT IS THE PROGNOSIS FOR SURVIVAL OF PATIENTS WITH CF?;778;1011
00092;WHAT IS THE PROGNOSIS FOR SURVIVAL OF PATIENTS WITH CF?;783;2122
00092;WHAT IS THE PROGNOSIS FOR SURVIVAL OF PATIENTS WITH CF?;788;0100
00092;WHAT IS THE PROGNOSIS FOR SURVIVAL OF PATIENTS WITH CF?;804;0001
00092;WHAT IS THE PROGNOSIS FOR SURVIVAL OF PATIENTS WITH CF?;806;0001
00092;WHAT IS THE PROGNOSIS FOR SURVIVAL OF PATIENTS WITH CF?;822;0100
00092;WHAT IS THE PROGNOSIS FOR SURVIVAL OF PATIENTS WITH CF?;824;0001
00092;WHAT IS THE PROGNOSIS FOR SURVIVAL OF PATIENTS WITH CF?;826;0010
00092;WHAT IS THE PROGNOSIS FOR SURVIVAL OF PATIENTS WITH CF?;837;0001
00092;WHAT IS THE PROGNOSIS FOR SURVIVAL OF PATIENTS WITH CF?;838;0001
00092;WHAT IS THE PROGNOSIS FOR SURVIVAL OF PATIENTS WITH CF?;839;0001
00092;WHAT IS THE PROGNOSIS FOR SURVIVAL OF PATIENTS WITH CF?;842;2111
00092;WHAT IS THE PROGNOSIS FOR SURVIVAL OF PATIENTS WITH CF?;845;0002
00092;WHAT IS THE PROGNOSIS FOR SURVIVAL OF PATIENTS WITH CF?;856;0001
00092;WHAT IS THE PROGNOSIS FOR SURVIVAL OF PATIENTS WITH CF?;858;0011
00092;WHAT IS THE PROGNOSIS FOR SURVIVAL OF PATIENTS WITH CF?;859;0001
00092;WHAT IS THE PROGNOSIS FOR SURVIVAL OF PATIENTS WITH CF?;879;1122
00092;WHAT IS THE PROGNOSIS FOR SURVIVAL OF PATIENTS WITH CF?;883;0001
00092;WHAT IS THE PROGNOSIS FOR SURVIVAL OF PATIENTS WITH CF?;888;0001
00092;WHAT IS THE PROGNOSIS FOR SURVIVAL OF PATIENTS WITH CF?;889;0001
00092;WHAT IS THE PROGNOSIS FOR SURVIVAL OF PATIENTS WITH CF?;908;0100
00092;WHAT IS THE PROGNOSIS FOR SURVIVAL OF PATIENTS WITH CF?;910;1100
00092;WHAT IS THE PROGNOSIS FOR SURVIVAL OF PATIENTS WITH CF?;914;1210
00092;WHAT IS THE PROGNOSIS FOR SURVIVAL OF PATIENTS WITH CF?;915;0100
00092;WHAT IS THE PROGNOSIS FOR SURVIVAL OF PATIENTS WITH CF?;926;0100
00092;WHAT IS THE PROGNOSIS FOR SURVIVAL OF PATIENTS WITH CF?;930;0101
00092;WHAT IS THE PROGNOSIS FOR SURVIVAL OF PATIENTS WITH CF?;934;1110
00092;WHAT IS THE PROGNOSIS FOR SURVIVAL OF PATIENTS WITH CF?;940;0001
00092;WHAT IS THE PROGNOSIS FOR SURVIVAL OF PATIENTS WITH CF?;941;1001
00092;WHAT IS THE PROGNOSIS FOR SURVIVAL OF PATIENTS WITH CF?;944;0001
00092;WHAT IS THE PROGNOSIS FOR SURVIVAL OF PATIENTS WITH CF?;946;0001
00092;WHAT IS THE PROGNOSIS FOR SURVIVAL OF PATIENTS WITH CF?;952;2222
00092;WHAT IS THE PROGNOSIS FOR SURVIVAL OF PATIENTS WITH CF?;990;1002
00092;WHAT IS THE PROGNOSIS FOR SURVIVAL OF PATIENTS WITH CF?;1000;2122
00092;WHAT IS THE PROGNOSIS FOR SURVIVAL OF PATIENTS WITH CF?;1014;0001
00092;WHAT IS THE PROGNOSIS FOR SURVIVAL OF PATIENTS WITH CF?;1023;0002
00092;WHAT IS THE PROGNOSIS FOR SURVIVAL OF PATIENTS WITH CF?;1031;0100
00092;WHAT IS THE PROGNOSIS FOR SURVIVAL OF PATIENTS WITH CF?;1033;1111
00092;WHAT IS THE PROGNOSIS FOR SURVIVAL OF PATIENTS WITH CF?;1040;0001
00092;WHAT IS THE PROGNOSIS FOR SURVIVAL OF PATIENTS WITH CF?;1066;0001
00092;WHAT IS THE PROGNOSIS FOR SURVIVAL OF PATIENTS WITH CF?;1071;0001
00092;WHAT IS THE PROGNOSIS FOR SURVIVAL OF PATIENTS WITH CF?;1093;0002
00092;WHAT IS THE PROGNOSIS FOR SURVIVAL OF PATIENTS WITH CF?;1147;2222
00092;WHAT IS THE PROGNOSIS FOR SURVIVAL OF PATIENTS WITH CF?;1151;0001
00092;WHAT IS THE PROGNOSIS FOR SURVIVAL OF PATIENTS WITH CF?;1186;0001
00092;WHAT IS THE PROGNOSIS FOR SURVIVAL OF PATIENTS WITH CF?;1188;0001
00092;WHAT IS THE PROGNOSIS FOR SURVIVAL OF PATIENTS WITH CF?;1192;1100
00092;WHAT IS THE PROGNOSIS FOR SURVIVAL OF PATIENTS WITH CF?;1195;2122
00092;WHAT IS THE PROGNOSIS FOR SURVIVAL OF PATIENTS WITH CF?;1226;0001
00092;WHAT IS THE PROGNOSIS FOR SURVIVAL OF PATIENTS WITH CF?;1227;0001
00092;WHAT IS THE PROGNOSIS FOR SURVIVAL OF PATIENTS WITH CF?;1232;1121
00092;WHAT IS THE PROGNOSIS FOR SURVIVAL OF PATIENTS WITH CF?;1234;2122
00092;WHAT IS THE PROGNOSIS FOR SURVIVAL OF PATIENTS WITH CF?;00093;00018
00092;WHAT IS THE PROGNOSIS FOR SURVIVAL OF PATIENTS WITH CF?;113;2212
00092;WHAT IS THE PROGNOSIS FOR SURVIVAL OF PATIENTS WITH CF?;145;2222
00092;WHAT IS THE PROGNOSIS FOR SURVIVAL OF PATIENTS WITH CF?;180;2122
00092;WHAT IS THE PROGNOSIS FOR SURVIVAL OF PATIENTS WITH CF?;272;2222
00092;WHAT IS THE PROGNOSIS FOR SURVIVAL OF PATIENTS WITH CF?;422;0001
00092;WHAT IS THE PROGNOSIS FOR SURVIVAL OF PATIENTS WITH CF?;467;1010
00092;WHAT IS THE PROGNOSIS FOR SURVIVAL OF PATIENTS WITH CF?;489;0011
00092;WHAT IS THE PROGNOSIS FOR SURVIVAL OF PATIENTS WITH CF?;550;0001
00092;WHAT IS THE PROGNOSIS FOR SURVIVAL OF PATIENTS WITH CF?;586;1002
00092;WHAT IS THE PROGNOSIS FOR SURVIVAL OF PATIENTS WITH CF?;722;0001
00092;WHAT IS THE PROGNOSIS FOR SURVIVAL OF PATIENTS WITH CF?;724;0001
00092;WHAT IS THE PROGNOSIS FOR SURVIVAL OF PATIENTS WITH CF?;873;0001
00092;WHAT IS THE PROGNOSIS FOR SURVIVAL OF PATIENTS WITH CF?;999;0002
00092;WHAT IS THE PROGNOSIS FOR SURVIVAL OF PATIENTS WITH CF?;1000;0002
00092;WHAT IS THE PROGNOSIS FOR SURVIVAL OF PATIENTS WITH CF?;1020;0002
00092;WHAT IS THE PROGNOSIS FOR SURVIVAL OF PATIENTS WITH CF?;1023;0001
00092;WHAT IS THE PROGNOSIS FOR SURVIVAL OF PATIENTS WITH CF?;1033;0002
00092;WHAT IS THE PROGNOSIS FOR SURVIVAL OF PATIENTS WITH CF?;1233;0001
00094;WHAT ANIMAL MODELS ARE AVAILABLE WHICH ARE RELEVANT TO CF?;78;0011
00094;WHAT ANIMAL MODELS ARE AVAILABLE WHICH ARE RELEVANT TO CF?;114;0002
00094;WHAT ANIMAL MODELS ARE AVAILABLE WHICH ARE RELEVANT TO CF?;122;0001
00094;WHAT ANIMAL MODELS ARE AVAILABLE WHICH ARE RELEVANT TO CF?;123;0001
00094;WHAT ANIMAL MODELS ARE AVAILABLE WHICH ARE RELEVANT TO CF?;137;0001
00094;WHAT ANIMAL MODELS ARE AVAILABLE WHICH ARE RELEVANT TO CF?;192;0001
00094;WHAT ANIMAL MODELS ARE AVAILABLE WHICH ARE RELEVANT TO CF?;209;0011
00094;WHAT ANIMAL MODELS ARE AVAILABLE WHICH ARE RELEVANT TO CF?;270;0002
00094;WHAT ANIMAL MODELS ARE AVAILABLE WHICH ARE RELEVANT TO CF?;277;0002
00094;WHAT ANIMAL MODELS ARE AVAILABLE WHICH ARE RELEVANT TO CF?;282;0001
00094;WHAT ANIMAL MODELS ARE AVAILABLE WHICH ARE RELEVANT TO CF?;309;2122
00094;WHAT ANIMAL MODELS ARE AVAILABLE WHICH ARE RELEVANT TO CF?;311;2122
00094;WHAT ANIMAL MODELS ARE AVAILABLE WHICH ARE RELEVANT TO CF?;322;0001
00094;WHAT ANIMAL MODELS ARE AVAILABLE WHICH ARE RELEVANT TO CF?;359;0001
00094;WHAT ANIMAL MODELS ARE AVAILABLE WHICH ARE RELEVANT TO CF?;370;1010
00094;WHAT ANIMAL MODELS ARE AVAILABLE WHICH ARE RELEVANT TO CF?;400;0001
00094;WHAT ANIMAL MODELS ARE AVAILABLE WHICH ARE RELEVANT TO CF?;435;0001
00094;WHAT ANIMAL MODELS ARE AVAILABLE WHICH ARE RELEVANT TO CF?;436;0001
00094;WHAT ANIMAL MODELS ARE AVAILABLE WHICH ARE RELEVANT TO CF?;440;2222
00094;WHAT ANIMAL MODELS ARE AVAILABLE WHICH ARE RELEVANT TO CF?;442;0001
00094;WHAT ANIMAL MODELS ARE AVAILABLE WHICH ARE RELEVANT TO CF?;494;2222
00094;WHAT ANIMAL MODELS ARE AVAILABLE WHICH ARE RELEVANT TO CF?;498;1212
00094;WHAT ANIMAL MODELS ARE AVAILABLE WHICH ARE RELEVANT TO CF?;504;0001
00094;WHAT ANIMAL MODELS ARE AVAILABLE WHICH ARE RELEVANT TO CF?;505;0001
00094;WHAT ANIMAL MODELS ARE AVAILABLE WHICH ARE RELEVANT TO CF?;533;0001
00094;WHAT ANIMAL MODELS ARE AVAILABLE WHICH ARE RELEVANT TO CF?;536;2222
00094;WHAT ANIMAL MODELS ARE AVAILABLE WHICH ARE RELEVANT TO CF?;571;0002
00094;WHAT ANIMAL MODELS ARE AVAILABLE WHICH ARE RELEVANT TO CF?;742;2222
00094;WHAT ANIMAL MODELS ARE AVAILABLE WHICH ARE RELEVANT TO CF?;745;2222
00094;WHAT ANIMAL MODELS ARE AVAILABLE WHICH ARE RELEVANT TO CF?;789;1010
00094;WHAT ANIMAL MODELS ARE AVAILABLE WHICH ARE RELEVANT TO CF?;955;2122
00094;WHAT ANIMAL MODELS ARE AVAILABLE WHICH ARE RELEVANT TO CF?;1016;0002
00094;WHAT ANIMAL MODELS ARE AVAILABLE WHICH ARE RELEVANT TO CF?;1091;0002
00094;WHAT ANIMAL MODELS ARE AVAILABLE WHICH ARE RELEVANT TO CF?;1092;0002
00094;WHAT ANIMAL MODELS ARE AVAILABLE WHICH ARE RELEVANT TO CF?;1121;1122
00094;WHAT ANIMAL MODELS ARE AVAILABLE WHICH ARE RELEVANT TO CF?;1143;2122
00094;WHAT ANIMAL MODELS ARE AVAILABLE WHICH ARE RELEVANT TO CF?;1156;1121
00094;WHAT ANIMAL MODELS ARE AVAILABLE WHICH ARE RELEVANT TO CF?;1158;0001
00094;WHAT ANIMAL MODELS ARE AVAILABLE WHICH ARE RELEVANT TO CF?;1197;2122
00094;WHAT ANIMAL MODELS ARE AVAILABLE WHICH ARE RELEVANT TO CF?;1199;2122
00094;WHAT ANIMAL MODELS ARE AVAILABLE WHICH ARE RELEVANT TO CF?;1200;0001
00094;WHAT ANIMAL MODELS ARE AVAILABLE WHICH ARE RELEVANT TO CF?;1204;2222
00094;WHAT ANIMAL MODELS ARE AVAILABLE WHICH ARE RELEVANT TO CF?;1223;1121
00095;WHAT ABNORMALITIES OF SKELETAL MUSCLE FUNCTION OR STRUCTURE HAVE BEEN FOUND IN CF PATIENTS?;12;0001
00095;WHAT ABNORMALITIES OF SKELETAL MUSCLE FUNCTION OR STRUCTURE HAVE BEEN FOUND IN CF PATIENTS?;30;2112
00095;WHAT ABNORMALITIES OF SKELETAL MUSCLE FUNCTION OR STRUCTURE HAVE BEEN FOUND IN CF PATIENTS?;43;0100
00095;WHAT ABNORMALITIES OF SKELETAL MUSCLE FUNCTION OR STRUCTURE HAVE BEEN FOUND IN CF PATIENTS?;192;0002
00095;WHAT ABNORMALITIES OF SKELETAL MUSCLE FUNCTION OR STRUCTURE HAVE BEEN FOUND IN CF PATIENTS?;257;1000
00095;WHAT ABNORMALITIES OF SKELETAL MUSCLE FUNCTION OR STRUCTURE HAVE BEEN FOUND IN CF PATIENTS?;322;0100
00095;WHAT ABNORMALITIES OF SKELETAL MUSCLE FUNCTION OR STRUCTURE HAVE BEEN FOUND IN CF PATIENTS?;603;2120
00095;WHAT ABNORMALITIES OF SKELETAL MUSCLE FUNCTION OR STRUCTURE HAVE BEEN FOUND IN CF PATIENTS?;606;2120
00095;WHAT ABNORMALITIES OF SKELETAL MUSCLE FUNCTION OR STRUCTURE HAVE BEEN FOUND IN CF PATIENTS?;1097;0001
00096;IS THERE AN INCREASED INCIDENCE OF DENTAL PROBLEMS (EG, CARIES OR PERIODONTAL DISEASE) IN CF PATIENTS?;9;0001
00096;IS THERE AN INCREASED INCIDENCE OF DENTAL PROBLEMS (EG, CARIES OR PERIODONTAL DISEASE) IN CF PATIENTS?;40;1001
00096;IS THERE AN INCREASED INCIDENCE OF DENTAL PROBLEMS (EG, CARIES OR PERIODONTAL DISEASE) IN CF PATIENTS?;43;0100
00096;IS THERE AN INCREASED INCIDENCE OF DENTAL PROBLEMS (EG, CARIES OR PERIODONTAL DISEASE) IN CF PATIENTS?;75;2212
00096;IS THERE AN INCREASED INCIDENCE OF DENTAL PROBLEMS (EG, CARIES OR PERIODONTAL DISEASE) IN CF PATIENTS?;454;2222
00096;IS THERE AN INCREASED INCIDENCE OF DENTAL PROBLEMS (EG, CARIES OR PERIODONTAL DISEASE) IN CF PATIENTS?;455;2222
00096;IS THERE AN INCREASED INCIDENCE OF DENTAL PROBLEMS (EG, CARIES OR PERIODONTAL DISEASE) IN CF PATIENTS?;520;1001
00096;IS THERE AN INCREASED INCIDENCE OF DENTAL PROBLEMS (EG, CARIES OR PERIODONTAL DISEASE) IN CF PATIENTS?;526;0011
00096;IS THERE AN INCREASED INCIDENCE OF DENTAL PROBLEMS (EG, CARIES OR PERIODONTAL DISEASE) IN CF PATIENTS?;527;0001
00096;IS THERE AN INCREASED INCIDENCE OF DENTAL PROBLEMS (EG, CARIES OR PERIODONTAL DISEASE) IN CF PATIENTS?;673;2222
00096;IS THERE AN INCREASED INCIDENCE OF DENTAL PROBLEMS (EG, CARIES OR PERIODONTAL DISEASE) IN CF PATIENTS?;883;0010
00096;IS THERE AN INCREASED INCIDENCE OF DENTAL PROBLEMS (EG, CARIES OR PERIODONTAL DISEASE) IN CF PATIENTS?;1087;0001
00097;IS OXYGEN TRANSPORT BY RED BLOOD CELLS ABNORMAL IN CF PATIENTS?;52;0100
00097;IS OXYGEN TRANSPORT BY RED BLOOD CELLS ABNORMAL IN CF PATIENTS?;68;1000
00097;IS OXYGEN TRANSPORT BY RED BLOOD CELLS ABNORMAL IN CF PATIENTS?;135;0001
00097;IS OXYGEN TRANSPORT BY RED BLOOD CELLS ABNORMAL IN CF PATIENTS?;140;0101
00097;IS OXYGEN TRANSPORT BY RED BLOOD CELLS ABNORMAL IN CF PATIENTS?;190;0001
00097;IS OXYGEN TRANSPORT BY RED BLOOD CELLS ABNORMAL IN CF PATIENTS?;392;0001
00097;IS OXYGEN TRANSPORT BY RED BLOOD CELLS ABNORMAL IN CF PATIENTS?;416;1001
00097;IS OXYGEN TRANSPORT BY RED BLOOD CELLS ABNORMAL IN CF PATIENTS?;538;0001
00097;IS OXYGEN TRANSPORT BY RED BLOOD CELLS ABNORMAL IN CF PATIENTS?;539;2222
00097;IS OXYGEN TRANSPORT BY RED BLOOD CELLS ABNORMAL IN CF PATIENTS?;751;2210
00097;IS OXYGEN TRANSPORT BY RED BLOOD CELLS ABNORMAL IN CF PATIENTS?;757;2222
00098;WHAT ARE THE EFFECTS OF CF ON THE DEVELOPMENT AND/OR FUNCTION OF THE BRAIN AND CENTRAL NERVOUS SYSTEM?;145;2221
00098;WHAT ARE THE EFFECTS OF CF ON THE DEVELOPMENT AND/OR FUNCTION OF THE BRAIN AND CENTRAL NERVOUS SYSTEM?;180;2120
00098;WHAT ARE THE EFFECTS OF CF ON THE DEVELOPMENT AND/OR FUNCTION OF THE BRAIN AND CENTRAL NERVOUS SYSTEM?;270;0001
00098;WHAT ARE THE EFFECTS OF CF ON THE DEVELOPMENT AND/OR FUNCTION OF THE BRAIN AND CENTRAL NERVOUS SYSTEM?;272;2210
00098;WHAT ARE THE EFFECTS OF CF ON THE DEVELOPMENT AND/OR FUNCTION OF THE BRAIN AND CENTRAL NERVOUS SYSTEM?;362;0002
00098;WHAT ARE THE EFFECTS OF CF ON THE DEVELOPMENT AND/OR FUNCTION OF THE BRAIN AND CENTRAL NERVOUS SYSTEM?;467;0010
00098;WHAT ARE THE EFFECTS OF CF ON THE DEVELOPMENT AND/OR FUNCTION OF THE BRAIN AND CENTRAL NERVOUS SYSTEM?;595;0010
00098;WHAT ARE THE EFFECTS OF CF ON THE DEVELOPMENT AND/OR FUNCTION OF THE BRAIN AND CENTRAL NERVOUS SYSTEM?;667;0002
00098;WHAT ARE THE EFFECTS OF CF ON THE DEVELOPMENT AND/OR FUNCTION OF THE BRAIN AND CENTRAL NERVOUS SYSTEM?;728;2222
00098;WHAT ARE THE EFFECTS OF CF ON THE DEVELOPMENT AND/OR FUNCTION OF THE BRAIN AND CENTRAL NERVOUS SYSTEM?;782;2122
00098;WHAT ARE THE EFFECTS OF CF ON THE DEVELOPMENT AND/OR FUNCTION OF THE BRAIN AND CENTRAL NERVOUS SYSTEM?;787;1011
00098;WHAT ARE THE EFFECTS OF CF ON THE DEVELOPMENT AND/OR FUNCTION OF THE BRAIN AND CENTRAL NERVOUS SYSTEM?;985;2110
00098;WHAT ARE THE EFFECTS OF CF ON THE DEVELOPMENT AND/OR FUNCTION OF THE BRAIN AND CENTRAL NERVOUS SYSTEM?;1018;0100
00098;WHAT ARE THE EFFECTS OF CF ON THE DEVELOPMENT AND/OR FUNCTION OF THE BRAIN AND CENTRAL NERVOUS SYSTEM?;1019;1000
00098;WHAT ARE THE EFFECTS OF CF ON THE DEVELOPMENT AND/OR FUNCTION OF THE BRAIN AND CENTRAL NERVOUS SYSTEM?;1118;0101
00099;ARE THERE ABNORMALITIES OF TASTE IN CF PATIENTS?;268;2222
00099;ARE THERE ABNORMALITIES OF TASTE IN CF PATIENTS?;324;2222
00099;ARE THERE ABNORMALITIES OF TASTE IN CF PATIENTS?;449;2122
00099;ARE THERE ABNORMALITIES OF TASTE IN CF PATIENTS?;992;1220
00099;ARE THERE ABNORMALITIES OF TASTE IN CF PATIENTS?;1191;1001
00100;WHAT IS THE INCIDENCE OF AND TREATMENT FOR HYPERTROPHIC OSTEOARTHROPATHY IN CF PATIENTS?;59;0101
00100;WHAT IS THE INCIDENCE OF AND TREATMENT FOR HYPERTROPHIC OSTEOARTHROPATHY IN CF PATIENTS?;183;2222
00100;WHAT IS THE INCIDENCE OF AND TREATMENT FOR HYPERTROPHIC OSTEOARTHROPATHY IN CF PATIENTS?;370;1211
00100;WHAT IS THE INCIDENCE OF AND TREATMENT FOR HYPERTROPHIC OSTEOARTHROPATHY IN CF PATIENTS?;579;2222
00100;WHAT IS THE INCIDENCE OF AND TREATMENT FOR HYPERTROPHIC OSTEOARTHROPATHY IN CF PATIENTS?;803;1100
00100;WHAT IS THE INCIDENCE OF AND TREATMENT FOR HYPERTROPHIC OSTEOARTHROPATHY IN CF PATIENTS?;833;0110
00100;WHAT IS THE INCIDENCE OF AND TREATMENT FOR HYPERTROPHIC OSTEOARTHROPATHY IN CF PATIENTS?;1000;1212
00100;WHAT IS THE INCIDENCE OF AND TREATMENT FOR HYPERTROPHIC OSTEOARTHROPATHY IN CF PATIENTS?;1017;2212
00100;WHAT IS THE INCIDENCE OF AND TREATMENT FOR HYPERTROPHIC OSTEOARTHROPATHY IN CF PATIENTS?;1033;0001
00100;WHAT IS THE INCIDENCE OF AND TREATMENT FOR HYPERTROPHIC OSTEOARTHROPATHY IN CF PATIENTS?;1097;1100
00100;WHAT IS THE INCIDENCE OF AND TREATMENT FOR HYPERTROPHIC OSTEOARTHROPATHY IN CF PATIENTS?;1232;0101
